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Abstract 
Mesoporous silicas have attracted growing attention in pharmaceutical drug delivery due to their 
synthetically tailored pore diameters, large pore volume and surface area. The narrow distribution 
of the pores makes mesoporous silicas exciting as nano-size crystallisation chambers for studies of 
molecular aggregation and drug polymorphism. Determination and understanding of structure and 
dynamics of confined solids presents significant analytical challenge due to lack of long range 
ordering. In this work we demonstrate how solid-state NMR can gain molecular insight into the 
structures of confined pharmaceuticals which are not accessible with other techniques. Using NMR 
as a probe for local mobility we demonstrated differences in the molecular dynamics of confined 
pre-nucleating species as compared to the confined crystals and amorphous molecules embedded 
in seemingly uniform composites. 
Indomethacin, tolbutamide and flufenamic acid were chosen as model systems. These compounds 
differ significantly in structural flexibility leading to a large number of polymorphs and challenges 
in controlling the phase transitions. Crystallisation processes from amorphous state into confined 
solvate and stable form V of indomethacin were monitored inside the pores of ca. 30 nm. Using 13C 
and 1H solid-state NMR we controlled the formation of metastable tolbutamide form V inside the 
pores of 3 nm, followed by its recrystallisation into the most stable form IH. Using 19F NMR and 19F 
T1 relaxation measurements we were able to gain molecular level insight into the crystallisation 
mechanisms of confined crystals, as we demonstrated the formation of a liquid-like layer on the 
silica surface prior to the build-up of confined crystal of flufenamic acid. All findings from NMR 
measurements were corroborated with PXRD, DSC and N2 adsorption proving the presence of nano 
confined crystals.   
Combined application of nano-size crystallisation methodology and solid-state NMR spectroscopy 
is essential in directing molecular aggregation and answering fundamental questions on self-
assembly of crystalline solids. 
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Introduction 
Porous materials with high surface areas and large volumes are of importance in material science 
due to possible applications in catalysis, gas storage, size exclusion chromatography or enzyme 
immobilisation.[1–6] International Union of Pure and Applied Chemistry classifies porous solids into 
three groups based on their pore size diameter into: 
1. Microporous solids with pore width smaller than ca. 2 nm, e.g., zeolites[7], metal organic 
frameworks (MOF)[8], microporous polymers[9]; 
2. Mesoporous solids with pore widths between 2 nm and 50 nm, e.g., silica and alumina 
based materials[10]; 
3. Macroporous solids, with pore widths exceeding about 50 nm, e.g., silica and alumina 
based materials, porous glasses[11] and macroporous metal oxide[12]. 
In the most recent IUPAC classification the micropores are further divided into narrow micropores 
(ultramicropores) with sizes < 0.7 nm and wide micropores (supermicropores) due to the 
differences in the physisorption mechanism of gases into narrow micropores.[13] 
 
 
Figure 1-1. IUPAC classification of porous solids. Adapted from [9,14,15] 
 
The application of porous solids in the chemical engineering and catalysis is well recognised with 
zeolites being the most widely used catalysts in the industrial processes, including oil refinement, 
synthetic organic chemistry or petrochemistry.[10] These microporous crystalline materials, 
composed of silicon, aluminium and oxygen organised in three dimensional structure forming 
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channels and cages in nanometer and subnanometer scale, are of particular importance for small 
molecules with kinetic diameters below 10 Å.[10,16] Zeolites have recently been reported as drug 
delivery carriers for encapsulation of small pharmaceuticals (sulphonamide antibiotics[17,18], 
ketoprofen[7], 5-fluorouracil[19] and α-cyano-4- hydroxycinnamic acid[16]) due to their structural 
properties, high affinity for guest molecules and low toxicity (for some natural compounds e.g., 
clinoptilolite)[7,18]. Although the successful incorporation and controlled release of ibuprofen, 5-
fluorouracil and indomethacin from microporous MOFs[8,20,14] and zeolitic imidazolate 
framework[21,22] has been demonstrated recently, application of these materials as drug delivery 
systems is debatable and more research is required in order to assure their safety.[23] The main 
drawback for a use of microporous solids for drug encapsulation is the small size of the pores/cages 
and even smaller diameter of the pores windows and interconnections, which makes encapsulation 
of large pharmaceutical molecules or biomolecules very difficult. 
The discovery of the M41S family of ordered mesoporous silica based materials by Mobil 
researchers in 1992 with pore sizes between 16-100 Å (and above) extended the possible 
applications of host-guest chemistry for larger molecules and small proteins.[24,25] The MCM-41 
material (Mobil Composition of Matter No. 41) in comparison to highly crystalline microporous 
zeolites or MOFs is composed of amorphous silica walls, with hexagonally ordered uniform pores, 
which are synthetically tailored by adjusting the reaction conditions. The unique features of silica 
based mesoporous scaffolds including high pore volume and high surface area, which can be 
chemically functionalised due to the presence of the silanol groups, made these materials promising 
multifunctional candidates for drug delivery systems. The properties of these materials and 
synthetic procedures, which enable control over the pore size and geometry, are discussed in the 
following sections. 
1.1 Mesoporous silicas 
In this work we used four different types of mesoporous silica hosts with different pore size 
diameter including MCM-41 (ca. 3 nm), SBA-15 (ca. 7 nm), MCF (ca. 29 nm) and CPG (ca. 55 nm) 
materials, therefore in this section we will focus on introducing the structural differences between 
these scaffolds. 
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Figure 1-2.  A. Two possible mechanisms for MCM-41 synthesis: 1) liquid crystal templating 
initiated; 2) silicate anion initiated; B. Series of reactions in sol-gel process: For TEOS: 1) hydrolysis 
of TEOS yields a silanol group OH-Si(OC2H5)3, silanol groups can react (condensation) with each 
other (3) or with alkoxide (2) forming siloxane bonds, which are the basis for gel network. C. TEM 
images of MCM-41 silicas with different pore sizes. Adapted from [25,26]. 
 
The synthesis of MCM-41 mesoporous silica was originally described as occurring via liquid crystal 
templating (LCT) mechanism, where the dissolved surfactant molecules act as the supramolecular 
template for condensation of the silica source.[24,25] The structure directing agents used as a 
templates for MCM-41 synthesis are usually quaternary alkylammonium salt cationic surfactants 
[CnH2n+1 (CH3)3N+, where n = 8-16][25], which form micelles in the acidic and basic solutions at room 
temperature. The length of the alkyl tail of the surfactant determines the size of the pores in the 
resulting solid, therefore one of the pathways for tuning of the pores diameter is simply to change 
the size of the micellar template.[25] The analogy of the architecture of the pores, e.g. hexagonal 
(MCM-41), cubic (MCM-48) or laminar (MCM-50),[10] is also determined through the 
supramolecular structure of the micellar mesophase, which is formed in solution prior to the 
addition of the silica source, e.g., TEOS, sodium silicate. The silica source in the acidic or basic 
environments undergoes hydrolysis and assembly around the micellar template followed by the 
condensation. The condensation of the silicate ion is facilitated by heating the mixture under static 
conditions and results in gel formation. The removal of the surfactant from the resulting solid is 
usually carried out through calcination or ion exchange.  
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The LCT mechanism for MCM-41 formation was developed based on the observation that the 
structure of resulting solid depends on the initial surfactant to silica molar ratios, e.g., a hexagonal 
array of the pores (MCM-41) was observed at 0.6, a cubic phase (MCM-48) at 1.0 and a lamellar 
phase (MCM-50) at 1.3 CTMAOH/TEOS molar ratios.[27,28] In this mechanism micelles form micellar 
rods, which in the next step will form hexagonal array of micellar rods followed by incorporation of 
the inorganic phase around the micellar template (mechanism (1) in Figure 1-2A.).[10,25] As the 
micellar liquid crystals formed in solution are highly sensitive to small changes in the composition, 
the authors did not exclude that the ordering of the micelles follows the addition of the silicate 
(mechanism (2) in Figure 1-2B.).[25] 
 
 
Figure 1-3. A. Modified LCT mechanism proposed by Steel et al.; B. cooperative formation of 
inorganic-organic interface proposed by Chmelka and co-workers. Adapted from [29,30]. 
 
The LCT mechanism proposed by Beck and co-workers[25] was challenged by Davies et al. who 
concluded, based on in situ 14N NMR, that the surfactant is not arranged into a liquid crystalline 
phase during the synthesis of MCM-41.[31] This was proven independently using 14N NMR by Steel 
et al. who proposed a modified LCT mechanism in which the template rods are intercalated 
between layers of silicate, which upon heating collapse forming a hexagonal mesophase.[32] A slight 
variation of this mechanism was proposed by Chmelka and co-workers based on PXRD results, 
which indicated the presence of a lamellar phase prior to the formation of a hexagonal silica 
arrangement.[30] The authors proposed cooperative formation of the silica:surfactant interface prior 
to silica condensation and subsequent charge density matching between the surfactant and 
silica.[10,30] This last step implements the curvature in order to balance the differences in the charge 
distribution between the silica anions and positively charged surfactant head groups. 
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Although the presented mechanisms show some differences in the detail of the formation of 
hexagonal array of mesophase all described hypothesis rely on the electrostatic interactions 
between the silica precursor and positively charged heads of surfactant. 
 
 
Figure 1-4. The synthetic pathway for mesoporous silica using block copolymer. The yellow frame 
shows the schematic structure of organic-inorganic interface, where PEO is molecularly mixed with 
inorganic phase. Adapted from [33,34]. 
 
Six years after the discovery of the MCM-41 scaffold, Zhao et al. reported the synthesis of a new 
family of mesoporous silica materials using triblock copolymer poly(ethylene oxide)-poly(propylene 
oxide)-poly(ethylene oxide) as a template for condensation of silica source.[35] The most frequently 
used copolymers for synthesis of SBA type materials are Poloxamers P123 (PEO20PPO70PEO20) and 
F127 (PEO101PPO56PEO101). The copolymer dispersed in the acidified aqueous solution forms 
micelles around which the silica source (typically TEOS), self-assembles and condensates in sol-gel 
processes (Figure 1-4). The resulting product forms two-dimensional, well-ordered hexagonal 
mesoporous silica material with uniform pore sizes between ca. 50 and 300 Å and thick pore walls, 
resulting in increased hydrothermal stability as compared to the MCM-41 silica.[35] The organic-
inorganic interface for PEO-PPO-PEO copolymers and silica is composed of the PEO blocks 
integrated with silica source as demonstrated by Spiess and co-workers using solid-state NMR.[33,34] 
The molecularly mixed interface composed of PEO and silica source results in the presence of 
micropores in the silica walls. The level of microporosity within the final product can be adjusted 
through the control of experimental conditions, i.e., the condensation and aging temperature and 
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time of both processes.[36,37] In general, extended aging time (48 h) and increased temperature of 
the process (363-373 K) results in a decrease in materials microporosity (Figure 1-5).[33,36,37] 
 
 
 
Figure 1-5. A. Changes in the organic-inorganic interphase segregation as a function of aging time 
SBA-15; B. Changes in the micropore fraction (yellow arrows) and BET surface area (black bars) as 
a function of aging time and temperature. Adapted from [33,36]. 
 
Further modifications of the synthetic conditions resulted in formation of new materials within the 
SBA family of mesoporous solids. For example, SBA-16 porous hosts with ink bottle pores and a 
three-dimensional cubic cage structure are formed using as a copolymer poloxamer F127.[15] 
Increase in the pore size diameter can be achieved using swelling agents (typically 
1,3,5-trimethylbenzene, TMB, mesitylene) during the synthesis of SBA-15 materials.[15] The addition 
of the swelling agent results in the enlargement of the micelles, and formation of a microemulsion 
as a colloidal template. Therefore this method developed by Stucky and co-workers is called 
microemulsion templating (Figure 1-6).[38]  
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Figure 1-6. A. MCF synthesis mechanism proposed by Stucky and co-workers. The process is 
described in details in the text. B. TEM image of MCF silica with cell sizes between 29 and 34 nm. 
Adapted from [38]. 
 
The synthesis of mesostructured cellular foam (MCF) starts with the formation of oil-in-water 
microemulsion composed of TMB droplets coated with P123 copolymer dispersed in an aqueous 
solution of HCl (Figure 1-6). Addition of hydrophobic TEOS results in its hydrolysis at the surface of 
the droplets and formation of the silica cation and ethanol, which acts as a co-surfactant. The silica 
cation may begin to condensate and aggregate at the microemulsion template resulting in the 
composite droplets. Aging in autoclave at higher temperatures results in further ordering and 
condensation of the silica. The organic phase is removed from the resulting solid through 
calcination.[38] The final product forms a three-dimensional sponge-like foam composed of large 
uniform spherical cells (15–50 nm), which are accessible via windows (5–20 nm).[15] The size of the 
windows can be increased synthetically through the addition of NH4F prior to aging. The 
morphology and particle size of the material is easily controlled during synthesis.[4,15] 
Due to large surface area, synthetically tailored pore sizes, and pore volumes, which enable 
encapsulation of larger pharmaceutical molecules, mesoporous silicas are promising materials for 
drug delivery.[39–41] The surface of the scaffolds, covered with silanol groups, is an attractive target 
for chemical decoration, alongside the modification of synthetic procedures towards incorporation 
of organic and inorganic functionalities within the framework expands the possible applications of 
this materials in advanced (bio)catalysis as well as controlled and targeted drug delivery.[2,42]  
1.2 Mesoporous silicas for drug delivery 
Mesoporous silica materials as promising candidates for drug delivery are frequently investigated 
for their performance in adsorption and release of drug molecules. Additionally, the possibility to 
synthesise mesoporous silicas as nanoparticles opened new area of research in nanomedicines, 
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targeted and intracellular delivery of drugs. These two important and exciting fields of 
pharmaceutical research are not the focus of this work and comprehensive reviews on both topics 
can be found elsewhere.[2,3,40,42–48] 
Here we discuss the fundamental effect of mesoporous confinement on the physical state of 
encapsulated molecules in order to understand the host-guest chemistry between the silica pores 
and pharmaceutical guest molecules. Therefore, the effect of confinement on intercalated 
pharmaceutical molecules will be discussed regarding the outcome of encapsulation, i.e., 
stabilisation of amorphous drug or formation of nanocrystalline solids inside the silica pores. The 
developed models will enable us to predict the phase of confined pharmaceuticals and gain 
molecular level understanding of aggregation processes on different length scales. 
1.3 Amorphous and crystalline Active Pharmaceuticals Ingredients 
(API) in drug delivery[49] 
Knowledge of the physical form of API during formulation and manufacturing process of new drug 
products is of paramount importance from a regulatory and industrial perspective. For solid-state 
pharmaceutical formulations one needs to consider whether the drug molecules form an 
amorphous or crystalline system. The amorphous solid lacks three-dimensional long range ordering 
of constituent molecules, and therefore can be defined as a disordered, non-crystalline solid. 
Molecules in amorphous materials have, however, some short range order with their neighbours, 
but in general are randomly distributed in the solid (Figure 1-7).[50,51] A crystalline solid can be 
defined as ‘a solid body having a characteristic internal structure and enclosed by symmetrically 
arranged plane surfaces, intersecting at deﬁnite and characteristic angles.’[52] A crystal can be 
thought as infinite 3D lattice of atoms (points) repeating periodically in all three dimensions.[53] 
Therefore, the molecules in a crystalline API form periodically repeated unit cells, which provide 
long range structural ordering and physical stability of the material (Figure 1-7).   
 
Figure 1-7. Structural differences between amorphous and crystalline solids.  
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One of the biggest challenges in the development of pharmaceutical solid oral formulations is 
related to the increasing number of drug candidates defined as having low solubility, estimated as 
70 % investigational new drugs.[54,55] These molecules require special manufacturing processes in 
order to increase their water solubility, including modification of the crystal form, micronisation, 
complexation, being delivered as lipid formulation or encapsulated in the polymer matrix.[54] It is 
also possible to formulate poorly water soluble API’s in the amorphous form, which greatly 
enhances dissolution rate and bioavailability.[51,54,56] It was demonstrated by Mullins and Macek 
early in 1960 that amorphous novobiocin has increased oral bioavailability in dogs as compared to 
the free acid and its sodium and calcium salts.[57] This observation was further confirmed for 
numerous API and 1.1 to 1000 fold increase in the apparent dissolution of amorphous API as 
compared to crystalline drug have been reported.[54] The preparation methods of amorphous API 
have been recently reviewed[51,55,56] and these includes quenching of melts, rapid precipitation, 
freeze-drying, spray-drying, introduction of impurities,  milling and vapour condensation.[49,51,56] The 
preparation method for successful amorphisation of pharmaceutical solids and decreased 
recrystalliation rate is of importance as it changes dynamic and energetic properties of the system. 
It was shown by Fukuoka et al. that amorphous indomethacin prepared by slow cooling of molten 
drug is stable for 2 years.[58] Yoshioka et al. showed later that grinding of amorphous IMC prepared 
by quench cooling of a melt decreased its physical stability.[59] Recently Karmwar et al. compared 
several methods for preparation of amorphous IMC and found quenched cooled amorphous 
materials most stable, followed by materials prepared using cryo-milling and spray-drying.[60]   
The main drawback of amorphous API formulations is their low stability as compared to crystalline 
solids due to their Gibbs free energy, which make disordered solids thermodynamically 
metastable.[50,51,56,61] Therefore, there is much interest towards the development of new ways for 
stabilisation of amorphous pharmaceuticals including formulation of polymer based amorphous 
solid dispersions, co-amorphous systems or nanoencapsulation within mesoporous silicas.[41,49,55,62–
65] Recent developments in solid-state NMR have enabled a molecular level understanding of 
structure and dynamics of amorphous drug-polymer solid dispersions, and these methods can be 
extended for application in other systems including amorphous composites based on mesoporous 
silica scaffolds.[66–69]  
1.4 Stabilisation of amorphous API within mesoporous silica scaffolds 
The first application of the MCM-41 silica scaffold as drug delivery carrier for ibuprofen (IBU) was 
demonstrated by Vallet-Regi et al. in 2001 and started a new era of nanoencapsulation in 
pharmaceutical formulations.[70] The early reports in this new field involved understanding the 
adsorption and release of drug molecules and there was very little attention paid towards physical 
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properties of confined molecules.[43,71–73] Babonneau and co-workers demonstrated increased 
mobility of IBU, benzoic acid[74], lauric acid[75] and benzamide confined within the MCM-41 and 
amino functionalised MCM-41 hosts compared to bulk drug.[76] The detailed understanding of the 
physical state of IBU confined within the 3.5 nm and 11.6 nm MCM-41 scaffolds was further 
developed by the group using advanced solid-state NMR methods. The drug molecules confined 
within the 3.5 nm MCM-41 were found in a highly mobile state at room temperature and vitrified 
into a glassy state at 223 K, as demonstrated using 1H-13C CP/MAS NMR.[77] On the other hand, 
cooling of IBU confined within the 11.6 nm MCM-41 resulted in crystallisation of confined 
molecules.[77] Increased mobility of confined molecules was also demonstrated by the authors using 
1H MAS PFG-NMR.[78] Further understanding of the physical state of IBU confined within the 
MCM-41 host at high drug loadings was developed by Skorupska et al.[79] and is further discussed 
in the General Discussion Chapter. The specific interactions between confined IBU and the MCM-
41 silica walls and the effect of microsolvation on the system was probed by Delle Piane et al. using 
DFT calculations. The authors suggested static disorder of adsorbed IBU due to surface 
heterogeneity and higher affinity of the silica surface for water molecules than for ibuprofen.[80,81]  
The promising application of SBA-15 as a carrier for ten poorly soluble drugs was demonstrated by 
Van Speybroeck et al.[41] The authors demonstrated increased dissolution rate of encapsulated 
species as compared to the bulk crystalline drug. The authors highlighted lack of the melting peaks 
and Tg in the DSC analysis of the composites indicating monomolecular adsorption of the drug at 
the silica surface. The confined molecules were stable in a non-crystalline state for a six month’s 
period of storage at 52 % RH and the performance of the composites was maintained.[41] In another 
study the authors demonstrated that glibenclamide encapsulated within SBA-15 in a non-crystalline 
state has four times higher absorption in rats as compared to the reference product.[82]   
The effect of the loading method and drug content within the SBA-15 scaffold on the physical state 
of two model compounds itraconazole (ITZ) and IBU was investigated by Mellaerts et al.[83] The 
authors demonstrated that encapsulated ITZ molecules at 30 wt. % loadings agglomerated to form 
glassy plugs inside the silica pores, whilst at low drug loadings monomolecular adsorption of the 
molecules was observed.[83] Kinnari et al. showed increased stability of amorphous ITZ confined 
within the mesoporous silicon and non-ordered mesoporous silica particles in an accelerated 
stability study.[84] The authors confirmed that at ca 30 wt. % loadings the ITZ molecules formed 
glassy plugs inside the pores due to the presence of a glass transition in DSC thermograms.[84]  
Limnell et al. investigated physical stability of amorphous IMC confined within the MCM-41 and 
SBA-15 porous hosts for three months under stressed conditions (303 K and 56 % RH). The confined 
molecules stayed amorphous over the storage time, with no detectable traces of crystalline species 
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in PXRD.[85] Ukmar et al. also observed formation of highly mobile amorphous IMC confined within 
the MCM-41 and SBA-15 scaffolds through the analysis of solid-state NMR analysis and 1H T1 
relaxation measurements.[86,87] It was shown by our group that thermally induced recrystallisation 
of amorphous IMC could be supressed after encapsulation within 30 nm pores of the MCF silica 
scaffold at loadings up to 50 wt. % (Chapter 5).[88] More recently, Kiwilsza et al. demonstrated 70 
times faster dissolution rate of amorphous nimodipine confined inside the MCM-41 and SBA-15 
pores as compared to the bulk drug. Using solid-state NMR the authors demonstrated that the API 
loaded outside is in crystalline phase whilst that encapsulated drug is in highly mobile regime.[89,90] 
Skorpupska et al. has shown recently that it is possible to encapsulate two compounds inside the 
silica pores using the melting method (present in the bulk in form of co-crystal).[91,92] The 
encapsulated molecules inside the pores did not recrystallise and remained in highly mobile 
amorphous state. Furthermore, it was shown that for a mixture of two compounds MCM-41 may 
work as a molecular sieve selectively encapsulating only compound with lower molecular mass.[92]  
In summary, the presented examples demonstrated possible application of MCM-41 and SBA-15 
(ca. 3-12 nm) mesoporous silicas as new promising carriers for amorphous drug delivery systems. 
The confined molecules demonstrated increased stability in the amorphous state likely due to 
molecular adsorption at the silica surface. We will discuss further the possibility of designing 
amorphous composites based on the mesoporous silicas in Chapter 8 (General discussion and 
conclusions) with respect to the size of the pores, drug loading level and size of the molecules.  
1.5 Polymorphism of crystalline API 
Investigation of the physical state of confined molecules requires knowledge of the crystalline 
forms of API as encapsulated molecules may form confined nanocrystals.[93] It is known that 
chemical compounds can exist in different molecular arrangements in the solid state leading to 
variety of crystalline structures, known as polymorphs.[94] According to McCrone’s definition ‘a 
polymorph is a solid crystalline phase of a given compound resulting from the possibility of at least 
two different arrangements of the molecules of that compound in the solid state’.[95] Although over 
the years many definitions of polymorph and polymorphism were developed, that of McCrone 
seems to be the most recognised and frequently used by chemists.[96]  Identification of a range of 
experimental crystallisation conditions suitable for production of a specific  polymorph is an 
important challenge in industrial and academic research. Nucleation and crystal growth processes 
are influenced by crystallisation conditions i.e., nature of solvent, temperature, seeding method, 
humidity or the presence of additives. Moreover, crystallisation method e.g., solvent evaporation, 
cooling of supersaturated solution, crystallisation from a melt, high pressure treatment or 
sublimation may determine the crystallisation outcome.[96–99]  
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The importance of polymorphism from a pharmaceutical perspective was firstly highlighted by 
Haleblian and McCrone in 1969. The authors identified several polymorphism related problems in 
drug delivery, including stability issues in suspensions or differences in bioavailability after 
administration of API in different crystalline forms.[100] Despite years of studies on pharmaceutical 
polymorphism, the problems highlighted nearly fifty years ago by Haleblian and McCrone are still 
relevant from industrial and regulatory perspective and represent large part of pharmaceutical 
research.[98,101] The crystalline structure of an API determines the physicochemical properties of a 
solid including dissolution, thermal conductivity or fusion temperature (Table 1-1). These properties 
may significantly affect manufacturing processes such as filtering, drying or tableting and in turn 
the final quality of a drug product.[101] 
 
Table 1-1. Properties which can differ between polymorphs.[49,102] 
Thermodynamic Kinetic Packing Surface Mechanical  
Melting temperature Dissolution rate Density 
Surface free 
energy 
Hardness 
Enthalpy, entropy, heat 
capacity 
Solid-state reaction 
rates 
Conductivity 
Interfacial 
tensions 
Tensile 
strength 
Free energy 
Physical/chemical 
stability 
Morphology Habit Compactability 
 Rate of nucleation  Colour 
Flow 
properties 
 
It is, therefore, fundamentally important to identify possible polymorphs of an API and their relative 
stability during early stages of development, prior to the manufacturing process. Diﬀerent 
thermodynamic properties of these forms can significantly affect the properties of the drug during 
storage and handling.[101] One well documented example of the effect of lack of understanding of 
API polymorphism on the drug formulation quality is that of ritonavir, marketed firstly as Norvir by 
Abbot Laboratories.[103] The occurrence of a new thermodynamically more stable and less soluble 
crystalline phase of ritonavir (form II) in the marketed formulation of Norvir resulted in decreased 
bioavailability of the drug. This in turn led to the temporary withdrawal of the product from the 
market affecting the supply chain of the lifesaving drug.[103,104] The company had to prepare new 
formulation of the drug using ritonavir form II as the previously used phase (form I) could not be 
stabilised within the formulation.[103,104] 
The transitions between different polymorphs occur to increase the stability of the system through 
the decrease of the Gibbs free energy. Thermodynamically, the relationship between two phases 
can be either monotropic or enantiotropic. For an enantiotropic system, reversible phase transition 
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between two phase is possible through the changes of temperature of the system. In monotropic 
system any transition from one polymorph to another is irreversible below the melting point.[101] 
The pharmaceutical processing (e.g., wet granulation or milling) may trigger the polymorphic 
transition between different crystalline phases of API.  It is therefore important to understand 
relative stability of different phases during development process and identify the candidate which 
demonstrates a compromise between desirable properties and physical stability in the 
formulation.[101] Although polymorphism is not a recently discovered phenomenon, the controllable 
and predictable formation of polymorphs is a broad and challenging field of the interest in chemical 
and pharmaceutical sciences.  
1.6 Thermal behaviour of confined solids 
The phase behaviour of small molecules (gases, organic liquids, water), polymers and metals 
constrained in the nanosize spaces have been widely studied since the first observation of the pore 
size dependent decrease of glass transition temperature of confined liquids by Jackson and 
McKenna in 1991.[105–109] Although much work has been done to understand the phase behaviour 
of nanoencapsulated materials, there is still a lack of molecular level understanding of the impact 
of mesoscopic confinement and surface chemistry on phase transition, formation of clusters and 
specific molecular alignment inside the mesopores.[106–109] Understanding of such complex 
heterogeneous systems requires combined application of analytical methods, which enable probing 
of both structure and dynamics of confined molecules at the molecular level.  
The phase behaviour of encapsulated materials is different to that of the bulk size species mostly 
due to the changes in the surface-to-volume ratio of the nanosize confined solids.[93,106,110] This 
phenomenon is the most noticeable in the melting point depression, which is correlated with the 
size of the crystal (Figure 1-8 A. C.).[93,110,111] The melting point depression of a nanocrystal in relation 
to the melting temperature of a bulk phase is described by the Gibbs-Thomson equation (Eq. 1-1): 
 
∆𝑇𝑚
𝑇𝑚,𝑏𝑢𝑙𝑘
= −
2𝑀
∆𝐻𝑓𝑢𝑠𝜌𝑟
𝛾𝑛𝑙 cos 𝜃  (Eq. 1-1) 
 
where M is the molecular mass of the chemical compound, ρ is the particle density, r is the particle 
radius (assuming spherical shape), γnl is the specific interfacial energy (surface tension) between 
the solid phase and the surrounding it fluid, θ is the interfacial angle between the nucleating 
condensed phase and the contacting surface, ΔHfus is the molar heat of fusion of the bulk solid 
phase, ΔTm is the change in the melting temperature between bulk and the solid with radius (r) and 
Tm,bulk is the melting temperature of the bulk solid (r→∞).[93,110] The equation predicts the change in 
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the melting point ΔTm as a linear function of inverse particle radius (1/r), assuming that other 
parameters are constant and size independent.[93,110] For the practical use of the (Eq. 1-1) the 
contact angle of 180° is assumed, indicating that the confined nuclei are homogenous and do not 
wet the surface of the pore.[93,110] Therefore, the equation (Eq. 1-1) simplifies to the form given in 
(Eq. 1-2): 
 
∆𝑇𝑚
𝑇𝑚,𝑏𝑢𝑙𝑘
= −
2𝑀
∆𝐻𝑓𝑢𝑠𝜌𝑟
𝛾𝑛𝑙   (Eq. 1-2) 
 
It was hypothesised that confined materials form a liquid-like non-freezing layer of the thickness of 
one or two molecules at the pore surface prior to the formation of solid in the centre of the pore.[107] 
This layer effectively changes the diameter of frozen or crystalline material inside the pores and 
may change the phase behaviour of confined molecules likely due to changes of energy of the 
system. Furthermore, the presence of a molecular liquid-like layer may be reason for enhanced 
mobility of confined molecules and a decreased average enthalpy of melting of confined 
crystals.[107] This may also explain observed increased mobility of amorphous pharmaceuticals 
confined within MCM-41 and SBA-15 silicas[77,79,90,112]  
To encompass the dependence of the melting point on the interfacial energies between the 
nucleus, and surrounding liquid and surface one may combine the Young equation (Eq. 1-3) with 
the simplified Gibbs-Thomson equation (Eq. 1-2) equation leading to (Eq. 1-4) (Figure 1-8 C.): 
 
𝛾𝑛𝑠 − 𝛾𝑠𝑙 = 𝛾𝑛𝑙 cos 𝜃  (Eq. 1-3) 
∆𝑇𝑚
𝑇𝑚,𝑏𝑢𝑙𝑘
= −
2𝑀(𝛾𝑛𝑠−𝛾𝑠𝑙)
∆𝐻𝑓𝑢𝑠𝜌𝑟
  (Eq. 1-4) 
 
where γns is the interfacial energy between the particle and surface, γsl is the interfacial energy 
between the surface and liquid and γnl is the interfacial energy between the particle and liquid.  
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Figure 1-8. A. Linear inverse relationship between melting point of confined fenofibrate and pore 
size diameter; B. Use of the melting point depression to distinguish between bulk and confined 
crystals of ROY (5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile). Washed composites 
shows only melting point of confined species; C. Illustration of the static equilibrium described by 
the Young equation: Top: favourable surface-nucleus interactions, (wetting of the surface), Middle: 
unfavourable surface-nucleus interactions 90° < θ < 180° (poor wetting), Bottom: absence of 
surface wetting – assumption for simplified Gibbs-Thomson equation. Adapted from [93,110,111] 
 
The decrease of the melting point of confined nanocrystals is an important indicator, which enables 
distinguishing between bulk and encapsulated crystalline phase (Figure 1-8 B.). It has been used in 
confined crystallisation studies to confirm the formation of encapsulated crystals.[113–115] This 
fundamental property of nanosize crystals was used in this study to assess the extent of the loading 
of the drug within the silica pores and to distinguish drug molecules loaded outside the pores of 
the scaffold from encapsulated crystalline pharmaceuticals.  
1.7 Formation of nanocrystalline solids inside mesoporous silicas 
The crystallisation outcome is determined very early during nucleation and strongly depends on the 
size of critical nuclei formed during crystal nucleation.[94] Therefore, it is possible to control the 
crystallisation outcome through the control of the size of critical nucleus by encapsulation of the 
molecules inside nanopores, which are of the size of critical nuclei.[93,110,114,116]  
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Investigation of crystallisation processes of organic molecules within mesoscopic confinement of 
CPG (controlled pore glasses) materials, polymeric monoliths and AAO membranes (anodic 
aluminium oxide) was started by Ward et al. and Beiner at al. [113–115,117–119] and recently reviewed 
by Ward et. al.[93,110] Ha et al. demonstrated selective crystallisation of a metastable polymorph of 
anthranilic acid within 7.5 nm pores of CPG host.[116] Using a well-known polymorphic model 
compound ROY [5-methyl-2-[(2-nitrophenyl)-amino]-3-thiophenecarbonitrile] confined inside 30 
nm pores of polymer monolith the authors were able to exclusively obtain red prisms of the 
compound.[116] Interestingly, crystallisation of ROY inside smaller pores of 20 nm was successively 
suppressed indicating critical size effects.[116] In another study, Ward and co-workers obtained new 
polymorphs of pimelic acid, suberic acid and coumarine encapsulated in the CPG and polymer 
monoliths with pores size diameter smaller than 23 nm and 40 nm respectively.[115] Additionally, 
the authors noted that enantiotropic phase behaviour of glutaric acid and suberic acid in the bulk 
is switched to monothropic upon the confinement in CPG and p-PCHE monoliths.[115] Beiner et al. 
demonstrated selective crystallisation of metastable polymorph of paracetamol inside the pores of 
CPG between 22 and 103 nm and stabilisation of amorphous drug inside the pores smaller than 10 
nm.[113,114]  
The controlled crystallisation of organic molecules inside the mesoporous materials is a growing 
and attractive area of crystal engineering as it enables discoveries of new crystalline phases and 
stabilisation of metastable polymorphs inside the nanopores. Despite the increasing amount of 
research in the field, the effect of the pore size and surface properties on the confined 
crystallisation outcome is poorly understood and largely unpredictable. Therefore, there is a need 
for systematic studies of drug-silica systems to gain full understanding of these complex 
heterogeneous materials. The application of solid-state NMR due to its sensitivity to local 
environment of atoms may help to gain an insight into molecular aggregation processes on the 
nanoscale and role of the interface in directing crystallisation towards new or metastable 
polymorphs.   
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1.8 Aims of the project 
Despite the increasing amount of published research on mesoporous silicas for drug delivery, there 
is still a lack of molecular level understanding of host-guest chemistry between the silica scaffold 
and encapsulated molecules. The understanding of the physical stability and possible phase 
transitions of confined molecules is of importance for knowledge based design of new functional 
porous materials, which can be used as drug carriers. Further developments in this field, for 
example tuning the surface properties through the incorporation of additional functionalities, or 
encapsulation of complex biomolecules require an in-depth understanding of the host-guest 
interactions in model materials.  
As molecules intercalated in the mesopores can be frequently found in the amorphous state, the 
detailed structural analysis of silica-drug composite solids using methods sensitive to long range 
ordering is limited. Confined nanocrystalline solids pose significant analytical challenge due to the 
broadening of the PXRD peaks and decrease and broadening of the melting point. These limitations 
of more traditional methods used in formulation science encourage us to exploit the huge potential 
of solid-state NMR towards molecular level understanding of structure and dynamics of 
pharmaceutical molecules encapsulated within the mesoporous silicas.  
Therefore, the project aims are divided into synthetic and analytical categories. Firstly, we will 
develop synthetic procedures for encapsulation of model pharmaceuticals (IMC, FFA, TB), with 
different structural and physicochemical properties within the pores of model mesoporous silicas, 
namely MCM-41, SBA-15, MCF and CPG, which differ in the pore size diameter and available surface 
area and pore volume for drug adsorption. Synthesis of homogenous composites, with different 
loading levels and all drug molecules encapsulated inside the pores of silica is not trivial and 
requires development of control methods and efficient screening techniques prior to advanced 
characterisation using solid-state NMR. Due to this we aim to develop a multi technique approach 
in order to assure unequivocally the deposition of the drug molecules exclusively in the silica pores. 
This will employ the combined use of nitrogen physisorption together with diffraction (PXRD), 
thermal (DSC, TGA), microscopic (SEM) methods. 
Secondly, through the combined application of the 1H-13C excitation methods, which are sensitive 
to different molecular motions and 1H T1(ρ) relaxation measurements we aim to investigate local 
structure and dynamics of molecules confined within mesoporous silicas and identify species in 
different environments. By using materials with different pore sizes and different levels of drug 
content within the pores we aim to investigate molecular aggregation in confined geometries to 
develop models for better understanding of crystallisation processes at different length scales. 
Through the application of variable temperature studies and relaxation measurement we are going 
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to obtain clearer information on the dynamics of confined molecules alongside development of in 
situ methods NMR for monitoring the phase transitions of encapsulated molecules. Finally, the 
physical stability of the confined species in contact with organic solvents or atmospheric moisture 
will be investigated through an accelerated stability study at 75 % RH. This will determine the 
performance of the materials during long term storage and further enable us to gain an insight into 
microsolvation of confined species during early stages of drug dissolution and release, which is of 
importance from industrial perspective. 
Finally, we aim to develop combined computational and solid-state NMR approach, to determine 
the conformation of indomethacin molecules in two low crystallinity polymorphs and use this 
information in crystal structure prediction.  In order to achieve this goal, we will perform calculation 
of 1H and 13C chemical shifts of IMC molecules isolated from different crystal structures available in 
the CSD using the CASTEP code, and identify 1H and 13C sites sensitive to major conformational 
changes. This information will be further applied for comparison of experimental and calculated 
chemical shifts of both investigated materials to determine the spatial position of structurally 
important motifs.  
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2 Characterisation Techniques 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2  
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2.1 Nuclear Magnetic Resonance (NMR) 
Nuclear Magnetic Resonance (NMR) spectroscopy relies on the interaction of nuclei placed in an 
external magnetic field under the application of oscillating radiofrequency electromagnetic field, 
and is used to study structure and dynamics of a variety of materials, from solutions, through semi-
solids and soft materials to solid materials. Full understanding of the NMR phenomenon and 
advanced methodology requires bringing together quantum mechanics and the product operator 
formulism, nevertheless semi-classical approach can be used to some extent to explain NMR 
concepts. 
2.1.1 Basic NMR principles[120–123] 
Nucleus, composed of protons and neutrons, with intrinsic properties including charge, mass and 
spin angular momentum (𝐼), give rise to a magnetic moment (𝜇) in an analogy to an electric charge, 
which creates magnetic field when rotating. The magnetic moment is proportional to the spin 
quantum number (I) and the gyromagnetic ratio, a constant characteristic for a particular nucleus. 
Only nuclei with spin quantum number I ≠ 0 are magnetically active (e.g., 
1
2
, 1,
3
2
, 2,
5
2
… ). The 
magnetic moment of the nucleus is given as: 
 
?⃗? = 𝛾ħ𝐼  (Eq. 2-1) 
 
where γ is the gyromagnetic ratio of a given nucleus, ħ is the reduced Planck’s constant and 𝐼 is the 
spin angular momentum. 
The spin quantum number is related to the spin angular momentum, being a vector quantity 
through an equation: 
 
𝐼2 = (𝐼(𝐼 + 1)ħ2)  (Eq. 2-2) 
 
Without the application of strong external magnetic field, all 2I+1 orientations of 𝐼 have the same 
energy. When a strong external magnetic field is applied (B0), arbitrarily chosen to be oriented along 
the z axis, the magnetic moments will align either with (spin-up) or against (spin-down) the applied 
field. The energy associated with a magnetic moment can be considered as: 
 
𝐸 = −?⃗?𝐵0  (Eq. 2-3) 
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When a strong magnetic field oriented along the z axis is considered, the quantisation coincides 
with applied field B0, and can be given as: 
 
𝐸 = −𝜇𝑧𝐵0 = −𝑚ħ𝛾𝐵0  (Eq. 2-4) 
 
where m is the magnetic quantum number, taking 2I+1 values in integer steps between +I and −I 
with a selection rule Δm = ± 1. The nuclear spin energy levels are now split into 2I+1 non-degenerate 
levels, which are separated by ΔE proportional to the applied field and the gyromagnetic ratio, and 
therefore different for each nucleus (Figure 2-1). This effect is known as Zeeman interaction or 
Zeeman splitting.  
 
∆𝐸 = ħ𝛾𝐵0  (Eq. 2-5) 
 
 
 
Figure 2-1. Relative energy levels and two magnetic a spin states (α and β) of spin ½ nucleus with 
increasing strength of external field B0. Adapted from [120–122] 
 
2.1.1.1 Larmor precession[120–123] 
The overall net magnetisation of a nuclear spin is the result of its magnetic moment and the angular 
momentum of the spin. A nucleus placed in the external magnetic field B0 experiences a torque, 
which acts on the magnetic moment and aligns it perpendicular to the field. The angular velocity 
(ω0) of this motion is given by equation:  
𝜔0 = −𝛾𝐵0 , (Eq. 2-6) 
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This motion is specific to each type of nucleus and is known as the Larmor frequency (v0): 
 
𝑣0 = |
𝛾
2𝜋
| 𝐵0  (Eq. 2-7) 
 
If we assume a 1H nucleus is placed in an external field of 9.4 T, its Larmor frequency is equal to 400 
MHz. This is in the radiofrequency range of the electromagnetic spectrum and corresponds to the 
wavelength of 75 cm. When compared (Eq. 2-7) with (Eq. 2-5) it is evident that the energy difference 
between α and β spin states is proportional to the gyromagnetic ratio of the nucleus and applied 
external magnetic field, i.e., Larmor frequency. Therefore, to induce NMR transitions 
radiofrequency radiation (radiofrequency (rf) pulses) close to that of Larmor frequency is required.  
2.1.1.2 Bulk magnetisation[120–124] 
In real samples we measure the interactions of large number of spins with the external magnetic 
field at the same time. In the case of multiple nuclear spins being placed in an external magnetic 
field (B0) at temperature (T) thermal equilibrium is achieved according to the Boltzman distribution: 
 
𝑁𝑈
𝑁𝐿
= 𝑒
−∆𝐸
𝑘𝑇   (Eq. 2-8) 
 
Where ΔE is the energy difference between spin states, k is the Boltzman constant, T is the absolute 
temperature and N is the population of spins in lower (L) and upper (U) states. Let us consider 1H 
nuclei placed in a 9.4 T magnet at temperature T = 300 K. Based on (Eq. 2-8), the energy difference 
ΔE between two spin states equals 2.65 x 10-25 J and kT = 4.14 x 10-21 J, hence ΔE/kT = 6.4 X 10-5. 
Therefore, for 1 million spins, an extremely small population difference of ca. 32 spins in the α state 
is observed as compared to the β state. This small difference of spins in α state forms a net 
magnetisation aligned along z axis which is called bulk magnetisation (M0). 
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Figure 2-2. Vector model of bulk magnetisation for spin ½ nuclei, where differences in population 
of spins in both states give rise to bulk magnetisation M0 aligned with B0. Adapted from [124]. 
 
As mentioned in the previous section, to satisfy the energy difference between α and β spin states 
radiofrequency pulses close to the Larmor frequency can be used to induce NMR transitions. This 
is simply done by passing current via a coil surrounding the sample, which in turn produces 
a magnetic field of the applied rf field denoted B1. The introduced magnetic field B1 is oscillating at 
the Larmor frequency of the spin in the transverse plane, perpendicular to B0 (z axis). To aid 
visualisation of the effects of rf pulses on the bulk magnetisation, the concept of a rotating frame 
of reference was introduced (Figure 2-3). 
 
 
Figure 2-3. Representation of laboratory and rotating frame of reference. Adapted from [124] 
 
In the laboratory frame x, y, z coordinates are viewed as static, while the rotating frame of reference 
uses coordinates x’, y’ which are rotating with the frequency of nuclear precession. The magnetic 
field introduced by the rf pulse oscillates in the transverse plane with a nuclear precession (for NMR 
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condition to be satisfied), represented by ± v0 in Figure 2-3. In the rotating frame of reference one 
of the rf field vectors is now static and the second rotates with 2v0 in opposite (-) direction far from 
resonance and can be ignored. Therefore, in the rotating frame, time dependency of the rf field is 
removed and both M0 and B1 are seen as static and perpendicular to each other. 
2.1.1.3 Chemical shift[120–123] 
As discussed in the previous sections the resonance frequency of a particular nucleus depends on 
its gyromagnetic ratio (γ) and applied external field B0. If only one resonance frequency was 
observed for a particular nucleus, NMR would be a rather limited analytical technique. In reality, 
one can observe a spared of the resonance frequencies for each nucleus in the NMR spectrum. This 
is due to the NMR frequency being sensitive to the local environment of the nucleus in the 
molecule, which in turn is affected not only by the external magnetic field but also by the 
surrounding electrons.  
Electrons circulating in their orbitals can be seen in a similar way as current passing through the 
wire producing small (local) magnetic field in the opposite direction to B0. This secondary field which 
adds to the field felt by nucleus, is called the shielding interaction, and depends on the chemical 
environment of the nuclei giving rise to the chemical shift (δ). 
The effective (local) magnetic field (B) felt by the nucleus is slightly smaller than the applied external 
magnetic field (B0) and is given by the equation: 
 
𝐵 = 𝐵0 − 𝐵
′ = 𝐵0(1 − 𝜎)  (Eq. 2-9) 
 
where σ is the shielding constant.  
The electron density around atoms in molecules is rather complex and depends on several factors 
including formation of bonds, presence of electronegative nuclei in close proximity, unpaired 
electrons or through space interactions within molecular clusters. Experimentally, chemical shift (γ) 
is measured as a frequency difference of the analysed nucleus (v) with respect to the reference 
nucleus (vref) of known frequency and presented on the ppm (parts per million) scale:  
 
𝛿 = 106 (
𝑣−𝑣𝑟𝑒𝑓
𝑣𝑟𝑒𝑓
)  (Eq. 2-10) 
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For different nuclei there are different reference compounds used as standards e.g., TMS 
(tetramethylsilane) being a reference for 1H, 29Si, 13C chemical shift or 1 M NaCl solution as a 
reference for 23Na chemical shift. 
2.1.2 Solid-state NMR[125,126] 
Nuclear spin interactions in solid state have very different effect on the spectrum compared to the 
same interactions in solution state. Nuclear spins of dissolved molecules interacting with external 
magnetic field average most of their interactions due to fast molecular tumbling, leading to narrow 
isotropic (orientation independent) chemical shifts. In solid state, due to significantly decreased 
molecular motions, orientation dependent nuclear spin interactions are no longer averaged as in 
solution state, leading to broadening of the NMR peaks.   
The energy of different types of interactions of nuclear spin with local magnetic field can be 
described in quantum mechanical terms using Hamiltonian operators (Ĥ): 
 
?̂? = 𝐼 ∙⃗⃗⃗⃗ 𝐴 ∙ ?⃗⃗? ,  (Eq. 2-11) 
 
where A is the orientation dependence of the NMR interaction with respect to the x, y, z axes and 
?⃗⃗? represents the external magnetic field. The quantum mechanical description of the energy of 
nuclear spin interactions, which may contribute to the observed line widths in the NMR spectrum, 
are implemented in the spin Hamiltonian equation: 
 
?̂?𝑇𝑂𝑇𝐴𝐿 = ?̂?𝑧 + ?̂?𝐶𝑆𝐴 + ?̂?𝐷 + ?̂?𝑄 + ?̂?𝐽  (Eq. 2-12) 
 
Where Ĥz is the Zeeman interaction Hamiltonian, ĤCSA is the chemical shift anisotropy Hamiltonian, 
ĤD is the dipolar coupling Hamiltonian, ĤQ is the quadrupolar coupling Hamiltonian (observed only 
if I > 1) and ĤJ is the J-coupling Hamiltonian.  
The above equation for molecules undergoing significant molecular motions, i.e., for isotropic 
liquid, is simplified and only the Zeeman interaction (ĤZ), the isotropic chemical shift interaction 
(ĤCS) and the spin-spin (J-coupling) interaction (ĤJ) are observed.  
2.1.3 Nuclear magnetic interactions[125,126] 
In solid-state NMR orientation dependant interactions contribute to significant broadening of the 
resonances, therefore several methodologies have been developed to overcome CSA interactions, 
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dipolar coupling interactions and quadrupolar coupling interactions (not observed in this research). 
Zeeman interactions are of the same order of magnitude in solid and solution state, and J-coupling 
interactions in solid-state NMR are considerably smaller compared than the anisotropic 
interactions. Therefore, only chemical shift anisotropy and dipolar interactions will be discussed in 
the following sections. 
2.1.3.1 Chemical shift anisotropy[125,126] 
The chemical shift originates from the effect of the external magnetic field B0 on the electrons of 
the nuclei circulating in its electronic cloud. An electron in motion produces a small magnetic field 
which in turn can add or subtract to the local field felt by a nucleus. The orientation dependence of 
this interaction is due to the fact that atoms in molecules rarely possess spherical and symmetrical 
electronic clouds. More often an electronic cloud can be seen as an ellipsoid which elongates in the 
direction of hydrogen bonds or bonding orbitals. As molecules in solution state are in the fast 
motional regime this interaction are isotropic; solid powdered materials, however, may adopt 
several different orientations with respect to the external magnetic field B0. As the chemical 
shielding interaction felt by the nucleus is slightly different in all three dimensions, the distribution 
of chemical shifts is observed. This in turn leads to line broadening in the solid-state NMR spectra.  
 
 
Figure 2-4. Principal values of the chemical shift tensor (δ11, δ22, δ33) and its orientation dependence 
with respect to the external magnetic field. Adapted from [125]. 
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For better understanding of the chemical shift Hamiltonian one can divide it into isotropic and 
anisotropic components. For a shielding tensor with axial symmetry, δXX = δYY, so that the ellipsoid 
will look like a symmetrical cigar in Figure 2-4, the chemical shift Hamiltonian equation is simplified 
to: 
 
?̂?𝐶𝑆 = 𝛾𝐵0𝐼𝑧 [𝛿𝑖𝑠𝑜 +
1
2
𝛿𝐶𝑆𝐴(3𝑐𝑜𝑠
2Ɵ − 1)]  (Eq. 2-13) 
 
where Ɵ describes the molecular orientation with respect to the external magnetic field, δiso is the 
isotropic chemical shielding factor, δCSA is the magnitude of CSA; using Haeberlen conventions for 
shielding parameters both the latter can be described through the equations : 
 
Isotropic shielding, 𝛿𝑖𝑠𝑜 =
1
3
(𝛿𝑋𝑋 + 𝛿𝑌𝑌 + 𝛿𝑍𝑍)  (Eq. 2-14) 
 
Anisotropy, 𝜁 = 𝛿𝑍𝑍 − 𝛿𝑖𝑠𝑜  (Eq. 2-15) 
 
The isotropic part of the Hamiltonian is simply an average of all three principal components of the 
chemical shift tensor, while the magnitude of the anisotropy is related to the isotropic chemical 
shift minus that of the widest part of the electronic cloud aligned with the external magnetic field B0. 
In real powder samples, molecules are aligned with all possible orientations, therefore 
a distribution of the chemical shifts is observed in the spectrum with the characteristic shape called 
powder pattern (Figure 2-5).  
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Figure 2-5. Static powder pattern of molecule having axial symmetry with respect to B0. Adapted 
from[126]. 
 
The anisotropic component of the chemical shift Hamiltonian has a geometric component 
(3cos2Ɵ-1), which means that at a particular well-chosen axis this component of the chemical shift 
Hamiltonian can be eliminated. Techniques to eliminate CSA by using its geometrical dependence 
on the orientation angle with respect to static magnetic field will be discussed in section 2.1.4.1. 
2.1.3.2 Dipolar coupling[125,126] 
The dipolar coupling is a through space interaction between nuclear magnetic moments of two 
spins. It can either occur between two like spins (homonuclear, I-I) or two spins of different nuclei 
(heteronuclear, I-S). In solid-state NMR dipolar interactions can lead to significant line broadening, 
therefore experimental techniques which are used to overcome dipolar interactions are described 
in section 2.1.4. 
A. Homonuclear dipolar couplings 
The homonuclear dipolar coupling is an interaction between the magnetic moment of like spins 
which are close in space and the energy of this interaction for a two spin system can be described 
using the Hamiltonian: 
?̂?𝐷
ℎ𝑜𝑚𝑜 = − (
𝜇0
4𝜋
) (
𝛾𝐼1𝛾𝐼2ħ
𝑟𝐼1𝐼2
3 )
1
2
(3𝑐𝑜𝑠2Ɵ𝐼1𝐼2 − 1) [2𝐼1𝑧𝐼2𝑧 −
1
2
(𝐼1
+𝐼2
− + 𝐼1
−𝐼2
+)]  (Eq. 2-16) 
 
where I1 and I2 are like spins, rI1I2 is the distance between both like spins, μ0 is the permeability of 
free space and γ is the gyromagnetic ratio of each spin.  
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Despite its complexity, the dipolar Hamiltonian can be divided in three general terms, i.e., the 
dipolar constant term labelled in green, the geometric term labelled in yellow and the spin term 
labelled in blue. The individual analysis of each of the three components of the dipolar Hamiltonian 
equation enables a better understanding of its effect on the NMR spectrum.  
From the dipolar constant component it is evident that the dipolar interactions are directly 
proportional to the gyromagnetic ratio of interacting spins, and inversely proportional to the third 
power of the distance between two like spins. Therefore, it is evident that for abundant nuclei, with 
high gyromagnetic ratio, dipolar interactions are extremely strong (1H-1H in the range of 100 kHz), 
while for pairs of nuclei with low gyromagnetic ratio and low natural abundance (13C-13C or 29Si-29Si) 
these are almost negligible.  
The geometric component of the equation describes the orientation dependence of the interaction 
and, as seen previously in CSA, it can be eliminated by alignment of the interacting spins along a 
particular axis with respect to the external magnetic field. This will be further discussed in section 
2.1.4.1. 
Finally, the spin term of the equation describes the energy conserving ‘flip-flop’ transition of two 
like spins with similar resonance frequencies. In this interaction one spin can ‘flip’ up to the higher 
energy state, while at the same time the second spin is ‘flipping’ down to the lower energy state. 
This interaction is commonly known as spin diffusion (Figure 2-6). The ‘flip-flop’ transition of two 
spins is given in the equation by two operators: I+ (rising operator) and I- (lowering operator), which 
increase (I+) or decrease (I-) the angular momentum leading to transitions between two energy 
levels. 
 
 
Figure 2-6. Schematic representation of ‘flip-flop’ transition of two like spins I1 and I2. Adapted 
from [125]. 
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B. Heteronuclear dipolar couplings 
The heteronuclear dipolar coupling is an interaction between the magnetic moments of two unlike 
spins being in close proximity to each other. In NMR terms two unlike spins can be labelled I (for 
abundant nuclei like 1H or 19F) and S (for rare nuclei like 13C or 29Si). In the presence of the external 
magnetic field both spins I and S undergo the Zeeman interaction and align themselves either with 
(spin up) or against (spin down) the external magnetic field (B0). As each of the spins possesses 
nuclear magnetic moment they can be seen as small magnets with a local magnetic field. Therefore, 
if spin I is in close proximity to spin S its local magnetic field will be affected by the local magnetic 
field of spin S and vice versa. The energy of the interaction is described using the dipolar 
Hamiltonian: 
 
?̂?𝐷
ℎ𝑒𝑡𝑒𝑟𝑜 = − (
𝜇0
4𝜋
) (
𝛾𝐼𝛾𝑆ħ
𝑟𝐼𝑆
3 ) (3𝑐𝑜𝑠
2Ɵ𝐼𝑆 − 1)𝐼𝑧𝑆𝑧  (Eq. 2-17) 
 
The heteronuclear dipolar coupling Hamiltonian has a similar form to the homonuclear dipolar 
Hamiltonian, however its spin component is significantly reduced. This is due to the energy 
conserving ‘flip-flop’ transition being only possible between two spins with similar resonance 
frequencies (Figure 2-7). The strength of the dipolar interaction between unlike spins, similarly to 
like spins, depends on the gyromagnetic ratio of interacting spins, the distance between them and 
their orientation with respect to the external magnetic field.  
 
 
Figure 2-7. For two spins I and S with different frequencies energy conserving ‘flip-flop’ transitions 
cannot occur. Adapted from [125]  
 
The effect of the heteronuclear dipolar coupling between two spins I and S on the NMR spectrum 
of a polycrystalline powder sample, where all crystallites have random orientation with respect to 
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the external magnetic field, is represented by Pake pattern (Figure 2-8). The observed Pake doublet 
is a result of the orientation dependence of the two spin states (α and β) with respect to the external 
magnetic field, where Ɵ is between 0° and 90°. The maximum intensity of the ‘horn’ is observed 
when molecules are aligned perpendicularly with respect to B0. The splitting of Pake doublet is 
equal to the dipolar coupling constant (D). When the sample is placed at an angle Ɵ=54.74° the 
resonance frequency is not dependant of the heteronuclear dipolar constant, as the geometric term 
of the Hamiltonian is averaged out, (3cos2Ɵ – 1) = 0. This angle is known in solid-state NMR as the 
‘magic angle’ and, as it will be shown in next sections, alignment along this axis can effectively 
reduce or totally remove geometry dependence of the nuclear spin interactions.  
 
 
Figure 2-8. Powder pattern (Pake doublet) resulting from heteronuclear dipolar interactions 
between two unlike (I and S) spin ½ nuclei. Adapted from [26,125,126]. 
 
2.1.4 Experimental techniques in solid-state NMR 
The complexity of nuclear spins interactions with the external magnetic field and with each other 
makes NMR spectroscopy challenging to apply in solid samples. As the field of solid-state NMR has 
been further developed, several experimental techniques have been proposed and successfully 
implemented in commercially available spectrometers to either compensate or selectively extract 
the most important interactions of interacting spins, gaining molecular level information of solid 
materials. The most frequently used experimental methodologies are described in the following 
sections. 
2.1.4.1 Magic angle spinning (MAS)[125,126] 
The orientation dependence of the spin-spin interactions described by the term (3cos2Ɵ-1) in CSA 
and dipolar coupling Hamiltonians can be eliminated assuming the analysed material is spun at an 
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angle of 54.74° with respect to the external magnetic field (Figure 2-9). By spinning a sample at the 
‘magic angle’ conditions, the geometric term (3cos2Ɵ-1) is averaged to 0 and the anisotropy of the 
interactions is eliminated, resulting in an isotropic chemical shift. This was firstly proposed by 
Andrew et al. in 1958 for a single crystal of sodium chloride and revolutionised the field of solid-
state NMR.[127] 
 
 
Figure 2-9. A. Schematic representation of the NMR rotor aligned at a ‘magic angle’ with respect to 
the external magnetic field. B. Variety of NMR rotor sizes available to reach different MAS rates. 
Adapted from[128] 
 
To effectively eliminate the geometric term of the spin-spin interaction described by the 
Hamiltonians, MAS rates need to be at least three times higher than the strength of the 
interactions. For example, the 1H-13C heteronuclear dipolar coupling can be successfully eliminated 
by the application of an MAS rate of 10-15 kHz. Much stronger interactions (in the range of ca. 80 
kHz) are frequently observed in solid-state NMR for the homonuclear dipolar couplings of high 
abundance, high gyromagnetic ratio nuclei (1H, 19F). Although in such cases the application of 
ultrafast MAS rates of 120 kHz is now possible with currently developed solid-state NMR probes, 
the dipolar interactions cannot be fully averaged and are still present in the spectrum.  
2.1.4.2 Decoupling and rf pulses[125,126] 
As seen in the previous section, MAS is an effective technique to eliminate CSA, however it shows 
limitations when applied to systems with strong homo- and heteronuclear dipolar couplings. 
Therefore, to further improve the resolution of solid-state NMR spectra of such materials, 
decoupling techniques using complex rf pulses were developed. Through the analysis of the dipolar 
Hamiltonian (section 2.1.3.2) one can see differences in the spin term of the equation when like or 
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unlike spin couples are considered. Due to differences in homo- and heteronuclear decoupling, such 
schemes will be discussed separately in next two sections.   
A. Heteronuclear decoupling 
Let us consider a pair of spins, abundant (I) and dilute (S), being in close proximity such that dipolar 
interactions are possible, leading to significant broadening of the spectral lines (e.g., directly 
bounded 1H to 13C with a dipolar interaction equal 30 kHz). Based on the heteronuclear dipolar 
Hamiltonian one can think of eliminating the dipolar interaction in two ways: either by the 
application of MAS to average the geometrical term of the Hamiltonian, or by the manipulation of 
the spin part of the Hamiltonian equation in such a way that the effect of the abundant spin I on 
the dilute spin S averages to 0 over time. This can be achieved through the application of continuous 
high power irradiation at a frequency close to the frequency of the abundant spin (I) during FID 
acquisition of the dilute spin (S). This method, called continuous wave (CW) spin decoupling,[129] 
results in continuous exchange of spins between high and low energy states at a rate determined 
by the decoupling power. As the continuous application of decoupling rf pulses during long 
acquisition periods may lead to sample (and probe) overheating, CW decoupling method is not 
frequently used as more robust, and material (probe) friendly, decoupling techniques were 
developed.  
The most frequently used pulse sequence for heteronuclear dipolar decoupling is the two pulse 
phase modulation (TPPM)[130] which consist of two high power pulses 𝑃 = 165° +  𝜑 and ?̅? =
165° −  𝜑  with a phase shift (𝜑) of 10 to 70°. This pulse sequence was further employed to build 
supercycles of high decoupling efficiency known as SPINAL-X[131] (where X is number of 𝑃 or ?̅? pulses 
in the supercycle i.e., 16, 32, 64 or 128). 
B. Homonuclear decoupling 
Homonuclear dipolar coupling interactions are much more difficult to overcome due to the 
complexity of the spin term in the Hamiltonian equation. Similarly to the heteronuclear dipolar 
coupling Hamiltonian the geometric term of the equation can be eliminated by the application of 
‘magic angle’ spinning, however the spin term is much more difficult to overcome as the 
magnetisation of two interacting like nuclei cannot be manipulated independently. Many pulse 
sequences have been developed to average the spin term of the homonuclear dipolar Hamiltonian 
with two main decoupling methods based on multi-pulse or phase modulated sequences.  
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Figure 2-10. A. Schematic representation of LG conditions. An effective magnetic field is created 
along the ‘magic angle’ axis when the rf offset (Δω) and pulse amplitude (ω1) is set in the way it 
coincides with the ‘magic angle’ (Δω = ω1√2). B. FSLG pulse sequence for compensation of errors in 
magnetisation rejections by frequency switch. Adapted from [26,125]. 
 
In the frequently used multi-pulse sequence based on Lee-Goldburg (LG)[132] condition, i.e., 
Frequency-Switched-Lee-Goldburg (FSLG),[133] an off-resonance rf pulse is applied with the offset 
value: 
 
∆𝜔 = 𝜔1 tan 𝜃𝑚  (Eq. 2-18) 
 
where Δω is a LG offset and Ɵm is the ‘magic angle’. 
The applied rf pulse creates an effective rf field in the rotating frame which is aligned at the ‘magic 
angle’ with respect to the laboratory frame (B0). The efficiency of the LG sequence was further 
improved by the application of frequency switch from positive to negative (Δω; −Δω) to average 
out pulse imperfections. 
As simultaneous phase and frequency jumps were difficult to apply in many commercial 
spectrometers at the time of the development of the FSLG sequence, next generation of pulse 
sequences based on discrete phase modulation of on-resonance pulses were developed (PMLG[134] 
– phase modulated Lee-Goldburg, DUMBO[135] – decoupling using mind boggling optimisation). The 
homonuclear decoupling pulse sequences like PMLG and DUMBO show very good performance at 
relatively low MAS rates. At increased spinning speeds the decoupling performance of both pulse 
sequences diminishes, as the rf pulse cycling gets closer to the rotor periods. Both Lee-Goldburg 
based (FSLG[133] and PMLG[134]) homonuclear decoupling sequences were used throughout this work 
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to record high resolution 1H spectra of pharmaceutical polymorphs and in HETeronuclear 
CORelation experiments as a decoupling scheme within the indirect dimension. Furthermore, we 
were able to compare the decoupling performance of fast MAS (75 kHz) at 20.0 T with the PMLG 
pulse sequence used at 9.4 T and 6.8 kHz spinning speed, which happened to be extremely robust 
when properly optimised (Chapter 4).  
2.1.5 Cross polarisation (CP)[125,126,136,137] 
Cross polarisation is a double-resonance technique which is frequently used in solid-state NMR to 
increase sensitivity of dilute spins like 29Si (natural abundance (NA) = 4.7 %), 13C (NA = 1.1 %) and 
15N (NA = 0.03 %). Furthermore, the application of CP is particularly useful when dilute nuclei have 
a low gyromagnetic ratio, as the acquisition of good quality spectra of such nuclei is of significant 
challenge using the Bloch decay experiment. The second problem frequently encountered during 
the acquisition of spectra of low abundance spin ½ nuclei is their long relaxation time, in the order 
of tens second for 13C in organic solids and minutes for 29Si in framework materials. As relaxation is 
highly enhanced by homonuclear dipolar interactions, which are rarely observed for low abundance 
spins, only much less effective heteronuclear dipolar interactions participate in relaxation 
processes of dilute spins. The long spin-lattice relaxation times significantly increase the 
experimental time needed for acquisition of good quality spectra, as their recycle delay needs to 
be sufficiently long to allow longitudinal relaxation to occur. 
Therefore, the application of CP pulse sequence eliminates both problems, as the magnetisation is 
transferred from high abundant spins to low abundant spins through the cross polarisation step, 
effectively reducing the number of scans and the recycle delay required to acquire good quality 
spectrum.  
The transfer of magnetisation from high to low abundant spins is driven by dipolar couplings 
between both nuclei. Therefore, the local environment of the observed nuclei is very important. 
The principle of the CP experiment can be explained in a simplistic manner using the doubly rotating 
frame model (Figure 2-12). Within the first frame all I spins are processing at their Larmor frequency 
about B0, with all magnetic fields generated by I spins appearing static. Similarly, within the second 
laboratory frame all S spins rotating at their Larmor frequency about B0 appear to be static. Let us 
consider an initial I 90°x on-resonance pulse, which produces initial magnetisation along the -y axis 
in the I rotating frame. In the next step, the on-resonance -y I contact pulse is applied, which 
locks/holds the magnetisation along the -y axis and produces the so called spin lock field B1(I). When 
the contact pulse is applied, the spin locking field B1(I) is the only field acting on I spins so B0 effects 
on abundant spins vanishes. At the same time the contact pulse is applied on the S spins producing 
B1(S) field in a rotating frame.  
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Figure 2-11. The cross polarisation pulse sequence. Full description is given in the text. 
 
In order to transfer the magnetisation from abundant to dilute spins the amplitude of the contact 
pulses have to be carefully set in order to match the Hartmann-Hahn condition: 
 
𝛾𝐼𝐵1(𝐼) = 𝛾𝑆𝐵1(𝑆) ± 𝑛𝜔𝑟   (Eq. 2-19) 
 
where γI and γS is the gyromagnetic ratio of abundant and dilute nuclei and B1(I), B1(S) is the spin 
locking field in the rotating frame of I and S nuclei, and ωr is the frequency of MAS respectively. 
The Hartmann-Hahn match is met when both spins precess at the same rate in the rotating frame, 
i.e., when the energy gaps of both spin states of spin I and S is equal (irrespective of their Zeeman 
energies in the laboratory frame).  
 
 
Figure 2-12. Differences in the energy gaps between spins I and S in laboratory and rotating frame 
when the Hartmann-Hahn condition is met. Adapted from [125]. 
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The cross polarisation experiment can be explained using the dipolar-coupling operator describing 
the interaction between two spins S and I: 
 
?̂?𝐷
𝐼𝑆 = − (
𝜇0
4𝜋
) (
𝛾𝐼𝛾𝑆ħ
𝑟𝐼𝑆
3 ) (3𝑐𝑜𝑠
2Ɵ𝐼𝑆 − 1)𝐼𝑧𝑆𝑧  (Eq. 2-20) 
 
The Iz and Sz operators are not altered by the rotation about the z axis only, therefore the 
heteronuclear dipolar Hamiltonian does not change when transferred in the doubly rotating frame. 
At this moment, both I and S spins are aligned perpendicularly to the z axis in the xy plane in their 
individual rotating frames. At this condition, the dipole-dipole operator cannot affect the net 
energy of the spin system as it depends on the applied field B1 and on the magnetisation of spins 
aligned parallel to the quantisation axis. When the Hartmann-Hahn condition is met, the rotating 
frame energy gaps of spin I and S are equal, and dipolar interactions are possible. Hence, energy 
can be transferred between I and S spins in a conserving way that the total energy and polarisation 
of the system does not change.  
2.1.6 Analysis of molecular motions using solid-state NMR spectroscopy 
Analysis of molecular motions in solids is of huge interest in materials science as these may 
determine the properties of the materials, including stress resistance of polymers, physical stability 
and phase separation of drug-polymer amorphous solid dispersions[49] or understanding of phase 
transitions and stability of drug polymorphs. Solid-state NMR spectroscopy is a powerful method 
to probe molecular motions in solid-state at different time- and length scales, as different motional 
processes have an effect on the nuclear spins system on either the Larmor, spectral or relaxation 
timescales. These three characteristic timescales depend further on the sample, observed nuclei 
and physical parameters, i.e., temperature and magnetic field. 
There are several methods which can be used to probe dynamics in solid-state NMR. These include 
analysis of line shape, measurement of different relaxation times, exchange experiments or kinetics 
of polarisation transfer in CP experiments with different contact times. For better understanding of 
the experimental techniques that measure motional processes in solid-state NMR, relaxation 
phenomena are briefly described in this section. 
2.1.6.1 Nuclear relaxation 
For a particular spin system placed in the external magnetic field (for sufficiently long time) thermal 
equilibrium between spin populations in higher and lower energy levels is reached and can be 
predicted according to the Boltzmann distribution. After the application of a rf pulse, perturbation 
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of the distribution in the spin energy levels is observed and the system is no longer in equilibrium. 
Frequently, rf pulse generates spin coherence, which depends on the pulse magnitude, i.e., the π/2 
pulse transfers spins into the xy plane, while the π pulse inverts the spin system along the z axis.  
The perturbed spin system will seek an equilibrium through the nuclear relaxation processes. That 
occurs either through spin-spin interactions (T2 relaxation), or through energy (as heat) transfer to 
the surroundings, known as spin-lattice relaxation (T1 relaxation). 
 
 
Figure 2-13. Transverse T2 relaxation. Mutual exchange between spin levels and differences in local 
field results in loss of phase coherence leading to zero net magnetisation in the xy plane. Adapted 
from [124]. 
 
Spin-spin relaxation involves mutual exchange between the spin energy levels (α and β). That 
results in loss of coherence without change in the net energy of the system (Figure 2-13). Loss of 
the NMR signal related to T2 relaxation is due to repetition of the exchange processes, which will 
randomise the phase. Furthermore, slight inhomogeneities in the magnetic field result in 
differences in precession frequencies (fanning out) of spins. This, in turn, leads to loss of phase 
coherence without net energy changes. 
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Figure 2-14. A. Re-establishment of magnetisation equilibrium through T1. B. Effect of molecular 
motions on dipolar interactions between nuclei inducing fluctuations in the local magnetic field. 
Adapted from [26]. 
 
Spin-lattice relaxation (longitudinal relaxation) is a process in which Boltzmann distribution of spins 
is re-established through loss of heat energy to the surroundings (Figure 2-14). As the energy of the 
perturbed system is very small, no change in the temperature of the sample is observed due to this 
relaxation process. The T1 relaxation is predominately governed by dipolar interactions, however 
different relaxation mechanisms are also possible, including CSA, quadrupolar interactions and 
spin-rotation.  Dipolar interactions depend on molecular motions leading to fluctuations in the local 
magnetic field. These fluctuations can be in the order of the Larmor frequency of nucleus of 
interest, leading to mutual spin flips. As the interacting nuclei are not identical, a change in net 
energy is observed accompanying spin exchange. This process occurs until equilibrium is re-
established with a rate dependent on T1. 
2.1.6.2 Measurement of spin-lattice relaxation times 
The perturbed spin system goes back to thermal equilibrium following an exponential decay 
described by the Bloch equation: 
 
𝑑𝑀𝑧(𝑡)
𝑑𝑡
=
𝑀𝑧(𝑡)−𝑀0
𝑇1
  (Eq. 2-21) 
 
where M0 is the magnetisation at the thermal equilibrium, Mz(t) is the longitudinal magnetisation 
at time t and T1 is a time constant. According to Bloch’s theory, longitudinal relaxation follows first 
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order kinetics. Therefore, after application of π/2 pulse z-magnetisation at time t can be measured 
using the following equation: 
 
𝑀𝑧 = 𝑀0 (1 − 𝑒
𝑡
𝑇1)  (Eq. 2-22) 
 
In this work T1 relaxation was measured using the inversion recovery pulse sequence (see Chapter 
3). The measurement starts with the application of a π pulse, followed by the delay time (τ) during 
which the system relaxes. After the delay time (τ) a π/2 pulse is applied for detection of the 
remaining longitudinal magnetisation. During the set of experiments, the delay time (τ) is varied, 
which enables to plot the remaining z-magnetisation as a function of delay time.  
2.1.6.3 Measurement of spin-lattice relaxation times in the rotating frame 
As T1 is sensitive to fast motions (usually on the MHz timescale) spin-lattice relaxation in the rotating 
frame (T1ρ) is sensitive to slower motions (usually on the kHz timescale). Measurements of T1ρ are 
frequently applied in polymer science to determine the movement of backbone polymer chain.[49] 
We applied T1ρ measurements to detect motions of the aromatic ring in crystalline tolbutamide, 
which happened to be on the timescale of T1ρ. 
2.1.7 NMR crystallography for pharmaceutical solids 
Structural characterisation of pharmaceutical crystalline solids is of great interest for both academia 
and pharmaceutical industry as a different arrangement of atoms in the crystal lattice determines 
physical properties of a solid, including its melting temperature, density, stability, thermal 
conductivity, dissolution and compressibility. The ability to determine the three-dimensional 
structure of solids as complex as membrane proteins, virus particles or complex inorganic materials 
is a key achievement of the last decades in the field of single crystal X-ray diffraction.  
In contrast, determination of the atomic level structure for powdered materials is of significant 
challenge in diffraction studies and frequently requires application of other characterisation 
methods sensitive to the local environment of atoms, namely NMR spectroscopy. The wide variety 
of powdered samples including pharmaceutical polymorphs and co-crystals obtained by grinding 
methods or new low crystallinity phases gained recently much interest, bringing together 
experimentalists and computational chemists in the emerging field of NMR crystallography.  
Solid-state NMR spectroscopy shows advantages over X-ray diffraction based methods due to the 
wide range of structural information, accessed through the analysis of chemical shifts, or through 
the use of dipolar couplings in the determination of interatomic distances of crystalline solids. 
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Moreover, as NMR spectroscopy is sensitive to the local environment of atoms, it enables structural 
investigation of disordered systems, nanocrystalline solids or mixed composite materials, where 
amorphous and crystalline domains often coexist. Alongside structural information on the 
arrangement of atoms/molecules in the crystal, solid-state NMR can probe dynamical processes at 
different timescales. The analysis of molecular dynamics within the crystal, even if observed 
through the X-ray diffraction, is artificially modelled to give fractional probabilities for atomic 
positions. Information on the details of molecular motions in terms of correlation time and 
activation energy are difficult to obtain from X-ray diffraction studies.[138] These can be assessed 
accurately using NMR relaxation experiments and observed directly in the spectra as peak splitting 
or via the decrease of the signal intensity through their interference with decoupling.[139,140] In this 
section we will briefly summarise some advances in NMR crystallography for structural studies of 
pharmaceutical solids, as some detailed reviews for the combined use of NMR spectroscopy and 
first principles calculations of chemical shifts are now available for a wide range of materials and 
nuclei.[138,141–143] 
2.1.7.1 The use of chemical shifts[138]  
The isotropic chemical shifts are the easiest parameters to obtain from MAS NMR spectra for spin 
½ nuclei and they carry information on the position of atoms in the crystalline solid and fine 
interactions with their surroundings. Even without the application of more advanced solid-state 
NMR methods for the analysis of intermolecular distances through the dipolar couplings it is 
possible to gain an insight into the number of molecules in the asymmetric unit or possible 
hydrogen bonding patterns. 
2.1.7.1.1 Determination of the number of molecules in the asymmetric unit 
Molecules may form a crystal with more than one molecule in the asymmetric unit. Therefore, each 
molecule in the crystallographic site is in a different environment, which can be probed using solid-
state NMR. For pharmaceutical solids, 13C NMR is frequently used to observe single carbon peaks 
or peak splitting due to differences in chemical shifts for each 13C if more than one molecule is 
present in the asymmetric unit. This information is of great value to solve a crystal structure from 
both single crystal and powder diffraction data. For example, testosterone is known to form two 
different polymorphs (α- and β-testosterone) which have one (β-testosterone) or two (α-
testosterone) molecules in the asymmetric unit. The structure of α-testosterone was investigated 
by Harris et al. using solid-state NMR and computational methods (Figure 2-15 A and B). The authors 
were able to assign the 13C chemical shifts to individual testosterone molecules present in the 
asymmetric unit through the application of 13C INADEQUATE and CASTEP calculations. As 13C solid-
state NMR is highly sensitive to the local environment of atoms in the structure it can be used to 
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distinguish between different phases in heterogeneous materials. Nifedipine was shown to have 
three polymorphs labelled I, II and III according to Burger and Koller.[144,145] Nifedipine form I 
investigated by Harris et al. was shown to have two molecules in the asymmetric unit based on the 
1H-13C CP/MAS spectra. The concomitant presence of nifedipine forms I and II was identified by the 
authors in the 1H-13C CP/MAS spectrum during the crystallisation from the melt due to the presence 
of multiple 13C peaks highlighting the high sensitivity of solid-state NMR towards heterogeneous 
solids (Figure 2-15 C).  
 
 
Figure 2-15. Low frequency region of A. 1H-13C CP/MAS spectra of α-testosterone showing two 
peaks for each carbon due to the presence of two molecules in the asymmetric unit; B. 
INADEQUATE spectrum of α-testosterone, which enables to assign 13C sites from two different 
molecules (labelled in red and in blue) forming a crystal; C. Amorphous and crystalline nifedipine 
form I, with two molecules in the asymmetric unit. It is possible to distinguish a mixture of different 
phases in the material due to the high sensitivity of solid-state NMR to the local environment of 
atoms in the structure, resulting in multiple peaks in the spectra. Adapted from [144,146]. 
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2.1.7.1.2 NMR insight into hydrogen bonding pattern in the crystal 
The three dimensional structure of the crystal is frequently stabilised by the framework of hydrogen 
bonds, which determines molecular packing in the crystal. 1H and 13C chemical shifts are very 
sensitive to different hydrogen bonding patterns in the crystal, therefore for systems with multiple 
hydrogen donors and acceptors analysis of peak positions may give vital information on the possible 
packing scheme.  
 
 
Figure 2-16. A. Top: 1H MAS spectra of white and yellow polymorphs of methylnitroacetanilide 
showing differences in the 1H chemical shifts due to different hydrogen bonding between 
polymorphs. Bottom: DFT computed isotropic shielding constant (on an absolute scale) of the 
hydrogen bonded proton in the white form of methylnitroacetanilide, as a function of the N–H 
distance for the dimer, with all other atoms fixed at the positions given in the published crystal 
structure. B. 1H CRAMPS spectra of different crystalline forms of N-benzoyl-L-phenylalanine at 290 
K and after subsequent heating to 380 K. The differences in the hydrogen bonds between two forms 
of the amino acid were determined based on the distinct 1H chemical shifts between the OH groups 
involved in hydrogen bonds. Adapted from [147,148]. 
 
This is also of importance if several polymorphic forms can be present with different hydrogen 
bonding patterns. For example, Harris et al. demonstrated, using 1H MAS NMR, that two 
polymorphs of methylnitroacetanilide (white and yellow) have distinct hydrogen bonding patterns 
in the crystal, which are indicated by the small differences in the 1H chemical shifts assigned to the 
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NH···O hydrogen bond.[147] The authors also proved the sensitivity of the 1H chemical shift to the 
distance between interacting species forming the hydrogen bond. The dependence of the DFT 
calculated isotropic 1H chemical shifts as a function of N-H distance in methylnitroacetanilide crystal 
enabled to adjust the hydrogen bonding in the structure of the white polymorph (Figure 2-16A). 
The sensitivity of 1H chemical shifts to the interatomic distances of interacting species was also 
shown by Scott and co-workers using 1H CRAMPS spectroscopy for different crystalline forms of N-
benzoyl-L-phenylalanine. The authors demonstrated that in two crystalline forms of the amino acid 
two distinct types of -O-H···O= bonds are present with different distances between O···O atoms. In 
the symmetrically fused crystal structure (Form I) the O···O was determined as 2.5 Å resulting in a 
1H peak at 17.8 ppm, whilst in the asymmetrically bounded structure of Form II this distance was 
determined as 2.6 Å and assigned to the 1H peak at 13.8 ppm. 
2.1.7.1.3 Salt or co-crystal: problem of proton migration  
In the structural studies of multi component crystal systems the determination of the proton 
position in the hydrogen bond provides the ability to distinguish between salt or co-crystal. This 
somehow philosophical question on proton migration in solid state chemistry has its implications 
in solving the unknown structures using CSP (Crystal Structure Prediction) methods, as the acidic 
proton position was shown to have a significant effect on the relative energy ordering of different 
structures.[149,150] Therefore it is of great importance to determine the proton position in multi 
component systems experimentally prior to computational search. The high sensitivity of 15N 
chemical shifts towards the position of the acidic proton was shown by Jones and co-workers for 
model salts and co-crystals of caffeine with dicarboxylic acids, where ca. 50 ppm shift of the 15N 
peaks towards a higher field was observed for protonated nitrogen in caffeine salts as compared to 
the hydrogen bonded caffeine co-crystals (Figure 2-17).  
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Figure 2-17. A. High sensitivity of 15N chemical shifts in the 1H-15N CP/MAS NMR spectra to proton 
migration for model salts and co-crystals of caffeine with dicarboxylic acids. B. Difference in the 
position of the proton between salt and co-crystal (indicated with a circle) affects the relative 
energy ordering between predicted structures using CSP methods.  Adapted from [150,151]. 
 
2.1.8 First principles of calculations of NMR parameters[141,142] 
In order to calculate NMR parameters of a solid it is necessary to determine its total energy, from 
which the fundamental NMR interaction tensors can be derived. The total energy of the system can 
be obtained by solving the Schrödinger equation for a particular solid of interest. For a multi body 
system this requires a tremendous amount of computational effort, hence it is not possible to apply 
it for a real solid system (at this moment). Therefore, in the Quantum Mechanical model the 
nonrelativistic electronic Schrödinger equation for system of nuclei and electrons is solved using 
the Born-Oppenheimer approximation, which assumes that the motion of electrons in a molecule 
can be separated from motions of atomic nuclei [142]: 
 
𝐻(𝑅)𝛹(𝑟; 𝑅) = 𝐸(𝑅)𝛹(𝑟; 𝑅)  (Eq. 2-23) 
 
where the electronic Hamiltonian H(R) describes the kinetic energy of electrons together with their 
electrostatic interactions and depends parametrically on the nuclear positions (R). The many-body 
wave function Ψ(r; R) is a function of the electrons (r) and nuclei (R) coordinates in the system.[142] 
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To determine the electronic energy of the system one can use the knowledge of its electronic 
density (so called density functional theory, DFT).[152,153] This approach is used in most QM 
calculations, where the total ground state electronic energy of the system (E0) is calculated as a 
function of the electron density ρ(r): 
 
𝐸0[𝜌(𝑟)] = 𝐸𝑁𝑒[𝜌(𝑟)] + 𝑇𝑆[𝜌(𝑟)] + 𝐽[𝜌(𝑟)] + 𝐸𝑋𝐶[𝜌(𝑟)]  (Eq. 2-24) 
 
where the nucleus-electron interactions (ENe), kinetic energy of non-interacting electrons (Ts) and 
classical Coulomb interactions between electrons (J) can be efficiently determined and the only 
unknown factor is the exchange correlation energy (Exc), which needs to be approximated in order 
to calculate the electronic energy of the system (E0).  
There are many exchange-correlation functionals available to use in DFT calculations, however it is 
important to know the limitations of each with respect to the material under investigation. For 
example, LDA functional (local density approximation) considers the electron density to be constant 
at each spatial coordinate, which is only valid for uniform electron gas.[141] Therefore, LDA is known 
to overestimate atomisation energies and overbind resulting in short internuclear distances, 
especially for covalently bonded organic systems and molecular crystals, where hydrogen bonds 
and short contact interactions generate changes in the electron density.[141] For better 
approximation of the electron density in these systems GGA functional (general gradient 
approximation) can be used, which includes a gradient of the electron density, ∇ρ(r). The commonly 
used GGA function for molecular crystals is that of Perdew, Burke and Ernzerhof (PBE) and it is used 
throughout this work.[154] 
One of the properties of many solid materials is their periodic structure. This enables performing 
calculations only for a single unit cell, which in turn reduces significantly computational complexity. 
The periodicity of the structure allows the application of the Bloch theorem: 
 
𝑉(𝑟 + 𝐿) = 𝑉(𝑟)  (Eq. 2-25) 
 
where V(r) is the potential at r and V(r + L) is the potential at r displaced by the lattice vector L. This 
implies periodicity of the electron density ρ and, therefore, periodicity of the magnitude of the 
wavefunction Ψ(r). The Bloch theorem, however, does not assumes periodicity of the phase of the 
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wavefunction, therefore it is said that the wavefunction is quasi-periodic and can be written as 
follows: 
 
𝛹𝑘(𝑟) = 𝑒
𝑖𝑘∙𝑟𝑢𝑘(𝑟)  (Eq. 2-26) 
 
where eik·r is an arbitrary phase factor and uk(r) is a periodic function.  
The DFT codes applicable for calculation of solid-state electronic structures with the GIPAW 
technique (gauge including projector augmented wave) use planewaves as basis functions: 
 
𝑢𝑘(𝑟) = ∑ 𝑐𝐺𝑘𝑒
𝑖𝐺∙𝑟
𝐺   (Eq. 2-27) 
 
where cGk are the Fourier coefficients and G are the reciprocal lattice vectors. As the planewaves 
do not look like atomic or molecular orbitals in order to represent the wavefunction many basis 
functions are used. Therefore, the quality of planewave DFT calculations depends on two factors: 
(I) number of k indices (k-points) to sample the first Brillouin zone and (II) number of indices G (G-
vectors) for a number of planewave basis functions. Both of these parameters are optimised in the 
convergence tests in order to achieve the property of interest to be invariant with increasing 
number of k-points or G-vectors.[141]  
A drawback of the planewave basis is its inability to accurately represent the tightly bound core 
electrons, as a large number of planewave coefficients is required, increasing computational costs 
significantly. These are overcome by the application of pseudopotentials, which use two 
approximations to treat the core of atom: (I) the frozen core approximation assumes that electrons 
close to the core of atom (within a particular radius rcut) do not participate in bonding and therefore 
their environment is unchanged, and (II) the application of smoothed wavefunction, which is easier 
to represent by a planewave basis set instead of a valence wave function rapidly oscillating close to 
the nuclei.[141,142] 
The use of pseudopotentials allows accurate and efficient calculation of most properties of the 
material which relay on valence regions, however, for the calculation of NMR parameters, the 
electronic structure in close proximity to the nuclei is of high importance. The basis for the 
calculation of all-electron (AE) wavefunction from pseudo (PS)-wavefunction was provided by van 
de Walle and Blöchl: 
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𝛹𝐴𝐸(𝑟) = Ƭ𝛹𝑃𝑆(𝑟)  (Eq. 2-28) 
 
where the Projector Augmented Wave (PAW) transformation operator T is generated alongside the 
pseudopotential. The PAW transformation enables to compute a certain atomic-like state to be 
computed in a pseudo-wave function and to replace the ‘pseudised’ component with its all-electron 
form.[142] Further developments by Pickard and Mauri replaced the transformation operator T with 
the field-dependent transformation operator TB, which resolved the ‘gauge origin problem’ and 
enabled accurate calculation of the magnetic shielding for periodic systems.[155] 
GIPAW methodology enables the calculation of the absolute magnetic shielding tensor σ, which is 
the response of the electrons to an applied external magnetic field Bext.[141] This interaction is 
described by an effective Hamiltonian: 
 
𝐻 = − ∑ 𝛾𝐾𝐼𝐾(1 − 𝜎𝐾)𝐵𝑒𝑥𝑡𝐾   (Eq. 2-29) 
 
where γ and I are the gyromagnetic ratios and the spin angular momentum of K, respectively. 
Therefore, the response of the electrons to an external magnetic field results in an induced 
magnetic field Bind, which for a diamagnetic environment is mainly due to orbital currents: 
 
𝐵𝑖𝑛𝑑(𝑅𝐾) = −𝜎𝐾𝐵𝑒𝑥𝑡  (Eq. 2-30) 
 
The relationship between the absolute magnetic shielding tensor σ and the chemical shifts δ is given 
as follows: 
 
𝛿 =
𝜎𝑟𝑒𝑓−𝜎𝑠𝑎𝑚𝑝𝑙𝑒
1−𝜎𝑟𝑒𝑓
  (Eq. 2-31) 
 
where for all but heavy elements: 
 
|𝜎𝑟𝑒𝑓| ≪ 1  (Eq. 2-32) 
 
leading to: 
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𝛿 ≈ 𝜎𝑟𝑒𝑓 − 𝜎𝑠𝑎𝑚𝑝𝑙𝑒 . (Eq. 2-33) 
 
The agreement between the calculated and experimental absolute shielding is made through the 
use of a reference shielding σref, which can be determined by comparison of the computed magnetic 
shielding and the observed experimental chemical shifts. The accuracy of σref can be improved by 
using statistical approach; by plotting the calculated shielding −σiso
calc versus the experimental 
chemical shifts δiso
exp
 for a series of compounds. Therefore, the calculated chemical shift can be 
determined through: 
 
𝛿𝑖𝑠𝑜
𝑐𝑎𝑙𝑐 =
𝑐−𝜎𝑖𝑠𝑜
𝑐𝑎𝑙𝑐
𝑚
, (Eq. 2-34) 
 
Where m and c are the slope and the intercept, respectively. For well-defined systems m ≈ 1 and 
extrapolation of c to 0 allows to σref to be determined. For 13C NMR, the reference shielding was 
found between 169.2 and 178.9 ppm, which depends on the investigated system.[141] In our studies 
we used σref of 169.5 ppm for 13C in order to compare our results with those published by Brown 
and co-workers.[156] 
2.1.8.1 Structural models for NMR calculations 
In order to calculate NMR parameters, a three dimensional model of a structure is required. For 
molecular crystals of pharmaceutical solids, the structural models can be obtained from diffraction 
data. It is known that the positions of hydrogens in X-ray diffraction-based structures are not 
accurate and depend on the temperature of data acquisition and diffraction method – single crystal 
or PXRD. As DFT calculations are typically performed at 0 K and do not include temperature effects 
it is recommended to use geometry optimisation for diffraction-based structures prior to the 
calculation of NMR parameters in order to minimise the energy of the structure. The importance of 
this procedure has been highlighted in many papers and summarised recently by Ashbrook and 
McKay[141] and earlier by Harris and co-workers[143]. 
The structural models determined using diffraction based methods are frequently not available due 
to difficulties to produce significantly large crystals for single crystal diffraction or due to low 
crystallinity of the material. In order to generate the starting 3D configuration of atoms in the unit 
cell it is possible to ‘manually’ adopt the known structure through substitution of atoms, changes 
in molecular orientation or cell dimensions and removing parts of the molecule or solvent from the 
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structure.[141] All these operations significantly change the energy of the system as the positions of 
the atoms may be far from optimal, therefore they require geometry optimisation prior to NMR 
calculations. 
It is also possible to generate the structure using crystal structure prediction (CSP) methodology. 
Although this method is computationally expensive for molecular crystals, it is possible to make it 
feasible by the application of structural constraints (cell size, symmetry, stoichiometry or constraint 
conformation).[150,157,158] Several examples of combined application of CSP together with GIPAW 
calculations have been published for structural studies of pharmaceuticals[159–162], or more recently 
gels and large MOFs.[163,164]  
2.2 Powder X-ray Diffraction[53,165,166] 
2.2.1 Crystalline solids 
Powder X-ray diffraction is a widely used method to characterise materials with a three-
dimensional ordered structure, including crystalline pharmaceutical compounds and ordered 
porous materials (MCM-41, SBA-15). A crystalline solid can be defined as ‘a solid body having a 
characteristic internal structure and enclosed by symmetrically arranged plane surfaces, 
intersecting at deﬁnite and characteristic angles.’[52] A crystal can be thought as infinite 3D lattice 
of atoms (points) repeating periodically in all three dimensions. Atoms aligned in a particular 
pattern can be seen as forming small boxes (unit cells) of which the lattice is comprised. There are 
seven possible shapes of unit cells known as seven crystal systems, described in terms of three 
translational vectors a, b, c and intervector angles α, β, γ. The crystal systems can be classified into 
the 14 Bravais lattices based on the number of lattice points per unit cell including simple, body-
centred, face-centred and end-centred. The arrangement of atoms or scattering centres in the 
crystal can be determined through X-ray diffraction, as ordered array of atoms, ions or molecules 
in the crystal with spatial distribution in the range of 100 pm (1 Å) can be used as diffraction grating 
for X-rays. 
Differences in the arrangement of atoms in the three dimensional space for each crystalline 
material lead to unique diffraction patterns, characteristic of a particular solid. Two main 
techniques are employed to access structural information of ordered materials. These are single 
crystal X-ray diffraction and powder X-ray diffraction. The first is used frequently to obtain precise 
information about unit cell parameters, position of atoms, bond lengths and angles between them, 
and can only be applied for materials which are able to form crystals of sufficient size. The second 
method, which was used in this thesis, enables powdered materials including pharmaceuticals, or 
confined nanocrystals to be analysed, and allows a characteristic ‘fingerprint’ of the material to be 
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observed in the form of a PXRD pattern, where the X-ray intensities are plotted against the 
scattering angle.  
 
 
Figure 2-18. Seven crystal systems and related cell parameters. 
 
2.2.2 Generation of X-rays and interference 
To generate X-rays, the anode is bombarded with electrons emitted by an electrically heated 
filament (usually tungsten) and accelerated in vacuum by high potential voltage of 20-60 kV. The 
anode emits a ‘white radiation’ spectrum with two X-ray peaks (Kα and Kβ) superimposed at higher 
frequency, which depends on the metal used as anode (usually Cu or Mo). The electrons emitted 
by the filament knock out the electrons from the inner shell (K) of Cu making vacancies for electrons 
from the outer shell. As electrons from the outer shells descend, energy is emitted in the form of 
radiation. Kα is emitted by electrons descending from the L shell, while Kβ is emitted by electrons 
descending from the M shell. In practice the Kα and Kβ radiation is composed by doublets (Kα1, Kα2 
and Kβ1, Kβ2 – these are usually not resolved). The presence of the doublet Kα1, Kα2 is due to small 
splitting (0.020 keV) of LII and LIII energy levels of the 2p orbital in copper, leading to two 
wavelengths of Kα1= 1.54056 Å and Kα2= 1.54439 Å.  
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Figure 2-19. A. An X ray emission spectra of Cu. B. Generation of X-rays through changes in the 
electronic structure of Cu. Adapted from [53]. 
 
As X-rays are electromagnetic waves they can be classified as sine waves with a wavelength ranging 
from 0.01-10 nm. They can be scattered by a point object resulting in a new wave of the same 
frequency (if there is no loss in energy) spreading in all directions. When waves are scattered by 
two or more points, they all produce waves of the same wavelength which interfere with each other 
by adding they amplitudes. With two waves present the detected amplitude is not a simple sum of 
the amplitudes of the individual waves but depends on the phase shift δφ.  Two waves of the same 
wavelength can have a phase shift with respect to each other if they are not coincident. This can be 
described on a linear scale in wavelength units (Δ) or respectively as a phase shift (δφ) on an angular 
scale: 
 
∆
𝜆
=
𝛿𝜑
2𝜋
⇒ 𝛿𝜑 =
∆
𝜆
2𝜋   (Eq. 2-35) 
 
In two extreme examples, the detected intensity (I) of two sine waves (A1 and A2) being either of 
the same phase (δφ=0) or shifted by δφ=π constructive or destructive interference is observed, and 
can be written as: 
 
For δφ = 0 :       𝐼 = (𝐴1 + 𝐴2)
2 (Eq. 2-36) 
 
For δφ = π :     𝐼 = (𝐴1 − 𝐴2)
2  (Eq. 2-37) 
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In general terms the above equations for two and more (j) waves can be written as: 
 
𝐼 = (𝐴1 + 𝐴2 exp(𝑖𝛿𝜑))
2  (Eq. 2-38) 
 
𝐼 = [∑ 𝐴𝑗𝑒𝑥𝑝(𝑖𝜑𝑗)𝑗 ]
2
  (Eq. 2-39) 
 
In X-ray diffraction the measured intensity is the square of sum of the amplitudes of waves 
scattered by electrons bound to atoms distributed in the three dimensional space. Therefore, the 
detected waves arrive to the detector with a phase shift, which contains information about relative 
atomic positions. This feature with the application of Bragg’s Law is used to access the structural 
information of crystalline solids. 
2.2.3 Bragg’s Law 
Bragg’s Law treats crystals as built from planes of atoms acting as semi-transparent mirrors. The 
crystallographic planes are characterised by the Miller indices (hkl) and, if parallel, have the same 
Miller index and are equally spaced by the distance dhkl. 
 
 
Figure 2-20. Example of X-ray diffraction resulting in reflections at a particular angle θ used to derive 
Bragg’s equation (adapted from [53,165]). 
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When a monochromatic beam of parallel X-rays (ADI) is directed on a crystal (represented by green 
dots aligned in planes in Figure 2-20), at Ɵhkl the ray A is scattered by atom B, while ray D (and I) 
penetrates the material and is scattered by atom F (and J). Since both reflected waves (A and D) 
have the same direction, superposition of both rays occurs. It is evident from Figure 2-20 that ray 
D travels longer distance (EF) before and (FG) after being reflected. The constructive interference 
between reflected waves A and I occur only when the difference in distance Δ = EF + FG is a multiple 
(n) of wavelength (λ): 
 
∆= 𝐸𝐹 + 𝐹𝐺 = 𝑛𝜆        and      𝐸𝐹 = 𝐹𝐺  (Eq. 2-40) 
 
In geometrical terms (based on Figure 2-20): 
 
sin 𝛼 =
𝐸𝐹
𝑑ℎ𝑘𝑙
⇒ 𝐸𝐹 = 𝑑ℎ𝑘𝑙  sin 𝛼  (Eq. 2-41) 
 
∆= 𝐸𝐹 + 𝐹𝐺 = 2𝑑ℎ𝑘𝑙 sin 𝛼  (Eq. 2-42) 
 
𝑛𝜆 = 2𝑑ℎ𝑘𝑙 sin 𝛼  (Eq. 2-43) 
 
The above equation is known as Bragg’s equation and it relates the spacing between the particular 
planes (dhkl) with Bragg’s angle Ɵhkl at which the reflections from those particular planes are 
observed. The observed reflections in PXRD patterns are usually labelled using Miller indices (100), 
(110), (111), according to the plane from which they diffract. However, in some geometries 
systematic absences of reflections are observed due to destructive interferences of reflected waves 
from particular planes. 
2.3 Nitrogen adsorption isotherm analysis[13,167–169] 
Nitrogen adsorption at its boiling point at 77 K is a frequently used method for analysis of porous 
solids as it provides structural information of porous hosts, such as pore size distribution in the 
range from micro- to macropores, pores volume and surface area. Furthermore, it is a method of 
choice to confirm the intercalation of the organic phase inside the pores of the mesoporous 
scaffolds loaded with drug molecules, as a decrease of the total pore volume and surface is 
observed for the silica-drug composites when compared to the pure host. The measurements are 
usually performed by the application of volumetric or gravimetric methodology. In the case of 
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volumetric determination of an adsorption isotherm (as used in this study) a known quantity of gas 
is admitted to the confined volume containing the adsorbent at constant temperature. As gas is 
adsorbed at the materials surface the known gas pressure decreases until equilibrium is reached. 
The adsorbed amount of gas at a particular equilibrium pressure is determined as the difference 
between the admitted amount of gas and the amount of gas which is required to fill the space 
around the adsorbent. The shape of the isotherm depends on the structural features of the material 
under investigation, i.e., textural parameters, pores geometry and its chemical composition. Based 
on the recent IUPAC publication on physisorption of gases, eight distinct physisorption isotherms 
were proposed, with only type IV being common for mesoporous materials (highlighted in yellow 
in Figure 2-21).  
 
 
Figure 2-21. Types of nitrogen adsorption isotherms as proposed by IUPAC.  
 
The Type I physisorption isotherm is characteristic of microporous solids with relatively small 
external surface area, e.g., zeolites, certain porous oxides, microporous polymers or activated 
carbons. At low relative pressure (P/P0) steep uptake is observed due to increased interactions of 
the adsorbate with the micropores of molecular sizes resulting in fast filling of the accessible pores 
space. Based on the shape of the initial step of the adsorption isotherm, microporous materials can 
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be further divided into ultramicroporous with pore sizes smaller than 0.7 nm and wide microporous 
materials with pore sizes wider than 0.7 nm. 
Nonporous and macroporous materials display Type II and Type III adsorption isotherms. The shape 
of the reversible Type II isotherm indicates nonrestricted monolayer-multilayer coverage of the 
material surface up to relative pressure close to unity, while finite adsorption is observed in the 
Type III isotherm at high P/P0. The observed sharp B-point indicates completion of the formation of 
a monolayer and the start of multilayer adsorption. The overlap of the monolayer formation and 
multilayer adsorption processes is manifested as less pronounced B-point on the Type II isotherm. 
In cases of weak adsorbent-adsorbate interactions the B-point is not observed due to clustering of 
the adsorbate molecules at most favourable surface sites displayed in the Type III isotherm.  
Type V isotherm is very similar in shape to the Type III isotherm, due to the relatively weak 
adsorbate-adsorbent interactions and molecular clustering. At higher P/P0, pore filling is observed 
as a steep increase in the adsorbed amount of gas.  
Layer-by-layer adsorption of gas molecules at highly uniform nonporous surface is displayed by 
Type VI isotherm, where the height of the step describes adsorption capacity of each adsorbed 
layer. The steepness of the step is material and temperature dependent. Stepped adsorption is also 
possible for ultramicroporous solids with energetically different sites, e.g., zeolites with high 
crystallinity (Zeolite X) where each step is related to cavity filling.  
The Type IV isotherm is characteristic of mesoporous materials including mesoporous silica 
scaffolds. The adsorption branch of the isotherm at low P/P0 is similar to Type II isotherm and 
displays the monolayer-multilayer adsorption of nitrogen at the pore walls, which is followed by 
pore (capillary) condensation at P lower than P0. This phenomenon is related to condensation of 
gas to a liquid-like phase at relative pressure lower than the saturation pressure of the bulk liquid. 
A characteristic feature of Type IV isotherms is the plateau of the adsorbed amount of gas after the 
pore condensation step. Type IV isotherms can either show a hysteresis loop (Type IVa) for the 
mesoporous materials with pores wider than ca. 4 nm, or be fully reversible (Type IVb) for 
mesoporous materials with pores diameter narrower than ca.  4 nm. The relationship between the 
relative pressure at which the condensation step is observed and the size of the formed liquid-like 
meniscus of condensed gas can be explained by Kalvin equation (Eq. 2-44) and is used for 
mesopores size calculations.  
 
1
𝑟1
+
1
𝑟2
= −
𝑅𝑇
𝜎𝑉
𝑙𝑛 (
𝑃
𝑃0
)  (Eq. 2-44) 
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The equation correlates the principal radii of the meniscus curvature (r1 and r2) with the relative 
pressure (P/P0) at which condensation occurs; σ and V represent the surface tension of the liquid 
condensate and the molecular volume, respectively. To apply the Kalvin equation to obtain the pore 
radius or the pore width the pore shape model needs to be chosen and it is necessary to assume 
that the meniscus curvature is directly related to the pore width. In general, for spherical meniscus 
r1=r2=rk and the equation can be rearranged: 
 
𝑟𝑘 =
2𝜎𝑉
𝑅𝑇𝑙𝑛(
𝑃
𝑃0
)
  (Eq. 2-45) 
 
where rk is termed Kalvin radius. 
2.3.1 Desorption hysteresis in porous materials 
During the desorption step of an adsorbate from the surface of mesoporous materials a hysteresis 
loop is frequently observed. The size and shape of the hysteresis loop is related either to adsorption 
metastability or in more complex pores systems to network effects. In case of open cylindrical 
pores, for the adsorption branch of the isotherm the thermodynamic equilibrium is shifted towards 
higher P/P0 due to the metastability of the adsorption multilayer. As evaporation (desorption) of 
the liquid-like condensed gas from the pores does not include the nucleation step, the steep part 
of desorption isotherm reflects a reversible transition from liquid to gas phase, hence 
thermodynamic equilibration is established on the desorption branch of isotherm. Based on recent 
studies, IUPAC expanded the classification of hysteresis loops into six different types listed in Figure 2-22.  
The H1 type of isotherm is characteristic of materials which display narrow distribution of uniform 
mesopores including templated silicas (MCM-41, SBA-15), some controlled pore glasses and 
mesoporous carbons. Similar hysteresis loops can also be obtained for mesoporous materials with 
ink bottle pores where the neck diameter has a similar width as the diameter of the main 
pore/cavity. 
The H2 (a and b) isotherms are characteristic of more complex, usually interconnected pore 
systems, and are frequently observed for systems with ink bottle type of pores. The steep 
desorption branch of H2(a) type of hysteresis loop is related either to pore-blocking/percolation in 
narrow necks or cavitation-induced evaporation effects. These phenomena are observed for some 
silica gels, vycor glass or ordered mesoporous silica materials SBA-16 and KIT-5. When the sizes of 
the pores necks are distributed over wider ranges, the H2(b) loop is observed e.g., mesocellular 
silica foams. 
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Figure 2-22. Nitrogen adsorption isotherms based on IUPAC classification. The hysteresis loops 
observed in this study are highlighted in yellow. Adapted from [13] 
 
The H3 and H4 hysteresis loops display similar shape with H3 being characteristic of non-rigid 
aggregates of plate-like particles characteristic of clay materials. These can also be observed for 
macroporous or large mesoporous materials which are not completely filled with condensed 
adsorbate. The steep increase of adsorption at low relative pressure in the H4 loop is associated 
with micropores filling, hence this type of hysteresis loop is observed for aggregated zeolite crystals, 
mesoporous zeolites or hierarchical micro-mesoporous carbons. For mesoporous materials with 
partially blocked pores (e.g., plugged hexagonal templated silicas) type H5 hysteresis loop was 
recently identified by IUPAC.  
2.3.2 Determination of surface area, pores size diameter and pores volume of 
mesoporous materials 
The Brunauer, Emmet and Teller (BET)[170] method developed nearly 80 years ago to evaluate the 
surface area of porous materials is still widely used, despite of its simplified theoretical model of 
adsorption. The BET method for surface determination is based on the following assumptions: 
A. The heat of adsorption of the first monolayer is constant. 
B.  The lateral interaction of adsorbed molecules is negligible. 
C. The adsorbed molecules can act as a new adsorption surface. 
D. The heat of adsorption of all monolayers is the same apart from the first. 
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The determination of the volume of the monolayer coverage (Vm) and its use in the determination 
of the surface area (As) is based on the (Eq. 2-46): 
 
𝐴𝑠 = (𝑉𝑚/22414)𝑁𝐴𝜎  (Eq. 2-46) 
 
Where NA is the Avogadro number and σ represents the area covered by one nitrogen molecule 
(the accepted value is 0.162 nm2). The Vm can be estimated using three parameters BET equation 
(Eq. 2-47): 
 
𝑉𝑎𝑑𝑠 = 𝑉𝑚
𝑐
𝑃
𝑃0
1−
𝑃
𝑃0
      
1−(𝑛+1)(
𝑃
𝑃0
)
𝑛
+𝑛(
𝑃
𝑃0
)
𝑛+1
1+(𝑐−1)(
𝑃
𝑃0
)−𝑐(
𝑃
𝑃0
)
𝑛+1   (Eq. 2-47) 
 
where Vads is the adsorbed volume which depends on the relative pressure (P/P0), the c parameter 
which is related to the heat of adsorption of the first adsorbed layer and the n parameter, which 
describes the number of layers which can be adsorbed at the materials surface. The equation can 
be simplified to include only two parameters (Eq. 2-48), assuming n→∞: 
 
𝑉𝑎𝑑𝑠 = 𝑉𝑚
𝑐
𝑃
𝑃0
(1−
𝑃
𝑃0
)(1+(𝑐−1)
𝑃
𝑃0
)
  (Eq. 2-48) 
 
The BET equation can only be applied to the linear part of the isotherm due to other phenomena 
being observed at higher relative pressures e.g., pores condensation. The linearity of the adsorption 
branch of the isotherm is usually observed in the P/P0 range of 0.05 to 0.3. 
The pore size diameter and pore volume can be determined from the adsorption-desorption 
isotherm, which can be derived from the Kelvin equation (Eq. 2-49). For mesoporous materials 
which display finite adsorbed amount of the adsorbate the total pores volume can be derived at 
the relative pressure close to unity, based on the assumption that at P/P0 ≈ 1 the pores are filled 
with condensed liquid adsorbate. 
There are several models proposed for the determination of the pore size diameter including the 
most widely used Barrett, Joyner and Halenda (BJH method)[171]. The BJH method can be applied in 
the pore condensation region above P/P0 > 0.4 as it is based on the shift of the gas-liquid phase 
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transition of confined fluid compared to the bulk liquid, and for cylindrical pores it is described using 
the modified Kelvin equation: 
 
𝑙𝑛
𝑃
𝑃0
= −
2𝛾𝑉𝑚
𝑅𝑇(𝑟𝑝−𝑡𝑐)
  (Eq. 2-49) 
 
where rp is the pore radius, tc is the thickness of the adsorbed multilayer, γ is the surface tension of 
the bulk liquid and Vm is the molar liquid volume. For materials with pore size diameter below 10 
nm the validity of the Kelvin equation is debatable as macroscopic models are no longer valid to 
described adsorption phenomena. It was shown using highly ordered MCM-41 type of materials 
with different pores sizes, determined independently using PXRD and transmission microscopy, 
that adsorption methods based on the Kelvin equation underestimates pore size diameter of ca. 
20-30 %. For this type of materials, methods based on molecular simulation or DFT are now 
recommended for use, as they contain both thermodynamic and density information on confined 
fluids and are able to describe adsorption phenomena on the molecular level. For the small pores 
MCM-41 material (ca. 3.2 nm) synthesised in this study, reliable pore size diameter as corroborated 
using PXRD could only be obtain using the NLDFT model.  
2.4 Thermal analysis[172] 
2.4.1 Differential scanning calorimetry 
Differential scanning calorimetry (DSC) measures an uptake or release of thermal energy by a 
material which is subjected to linear heating or cooling, hence it enables to identify thermal 
transitional events including melting, crystallisation, glass transition or thermal decomposition. The 
energy uptake of a material closed in a metallic crucible is compared to the energy uptake of an 
empty reference pan, both placed in high accuracy furnace (Figure 2-23 in the case of heat flux DSC 
instrument).  
The material and the reference pans placed in the furnace are heated with the same linear heating 
rate. Due to the heat capacity (Cp) of the analysed sample it will heat slower (Ts) as compared to an 
empty reference pan (Tr), i.e., the temperature of the reference will increase slightly faster than the 
temperature of the analysed material. When the material melts (t1) the temperature of the sample 
Ts does not change until the process is completed, while the temperature of the reference Tr pan is 
still linearly increasing. As soon as melting is completed (t2) the temperature of both the reference 
and the sample increase linearly again. The differential signal ΔT of the two heating curves Ts and 
Tr gives rise to a peak in the DSC thermogram (ΔT = Ts − Tr), which represents an endothermic 
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melting process. The area of the peak is related to the heat of transition (enthalpy in J g−1). Example 
of a DSC thermogram is presented in Figure 2-24. 
 
 
Figure 2-23. Schematic representation of heat flux DSC calorimeter. Adapted from [172]. 
 
 
Figure 2-24. Example of a DSC thermogram with highlighted glass transition temperature (Tg), 
exothermic crystallisation (Tc) and endothermic melting (Tm) events. The points t1 and t2 represent 
the onset and the end of the melting transition, while peak area (shaded in blue) gives information 
on the heat of transition – detailed description in the text. Adapted from [49].  
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2.4.2 Thermogravimetric analysis 
Thermogravimetric analysis is an experimental method which enables the detection and used 
changes in mass of the material to describe chemical or physical processes that the reactant 
undergoes upon heating. The analysed sample placed in a metallic or ceramic crucible (depends on 
the temperature range) and situated on a microbalance is submitted to linear temperature increase 
and the resulting changes in the mass are measured as a function of temperature (or time at 
particular temperature in isothermal studies). 
This method has been widely used in studies of chemical processes that the materials undergo upon 
heating, including accurate measurement of reaction rates. In the pharmaceutical field it is 
frequently used to measure the loss of water and the temperature range at which dehydration 
occurs. In the case of pharmaceutical hydrates (or solvates) it enables a determination of the 
solvent:drug stoichiometry of the material or possible water uptake of pharmaceutical excipients 
during technological processes. Furthermore, it can be used to determine the composition of 
materials with significantly different degradation temperatures, e.g., organic-inorganic composite 
materials, as used in this thesis. 
 
 
Figure 2-25. Schematic representation of the thermobalance used for thermogravimetric analysis.  
 
Differences in the dehydration temperatures are frequently used to distinguish between surface 
and the crystalline water. Furthermore, many commercially available instruments enable to 
analysis to be performed in either inert gas atmosphere or oxidative conditions, which may have a 
significant impact on the analysed mass loss of the materials (Figure 2-26). It needs to be 
emphasised that TGA analysis needs to be complemented using other techniques, due to the 
complexity of the solid state reactions. 
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Figure 2-26. Example of the TGA curve of lactose monohydrate and Na-montmorillonite clay 
analysed under inert (N2) and oxidative (air) atmosphere. Several different phenomena are 
observed in the thermogram. 
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3 Experimental section 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3  
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3.1 Materials 
Indomethacin (IMC), flufenamic acid (FFA), tolbutamide (Tb), Pluronic P123, n-
hexadecyltrimethylammonium bromide 1,2,3-trimethylbenzene, tetraethylorthosilicate (TEOS), 
ammonium fluoride, sodium chloride, 37 wt. % hydrochloric acid, nitric acid, methanol, ethanol and 
acetonitrile were purchased from Sigma-Aldrich and used without further purification. 
3.2 Synthesis of porous solids 
3.2.1 MCM-41 silica host 
Spherical submicrometer mesoporous MCM-41 particles were synthesised according to the 
method previously described by Grün et al.[173] In a typical synthesis, 2.5 g of n-
hexadecyltrimethylammonium bromide was dissolved in miliQ quality water (50 mL). A solution of 
ammonia (37 wt. %, 13.2 g) and ethanol (60 g) was mixed with the solution of n-
hexadecyltrimethylammonium bromide. The resulting solution was stirred for 15 min and 4.7 g of 
TEOS was added leading to a synthesis mixture with the following composition: 1 TEOS : 0.3 
C16TMABr : 11 NH3 : 144 H2O : 58 EtOH. After stirring for 2 h, a precipitate was formed, filtered 
and washed using methanol and deionised water. The material was dried at 363 K overnight and 
calcined at 823 K for 5 h in air atmosphere. 
3.2.2 SBA-15 silica host 
The SBA-15 porous host was synthesised using the method reported by Zhao et al. with the addition 
of NaCl to obtain a highly ordered and hydrothermally stable material as described by Li et al. and 
Ryoo et al.[35,174,175] The triblock copolymer P-123 (2.0 g) and NaCl (5.5 g) were dissolved in 2M HCl 
aqueous solution (62.5 mL) at room temperature in a 250 mL polypropylene bottle to obtain a clear 
colourless solution. TEOS (4.23 mL) was then added dropwise and stirred at 313 K for 20 h. The final 
molar composition of the synthesis mixture was 1 TEOS : 0.017 P123 : 6.16 HCl : 4.6 NaCl : 165 H2O. 
This mixture was aged in an oven at 363 K for 24 h, filtered, washed with miliQ quality water and 
dried. The resulting dry white solid was then calcined at 823 K overnight in air atmosphere. 
3.2.3 MCF silica host 
Spherical particles of Mesostructured Cellular Foam (MCF) were synthesised using the method 
published by Han et al.[4] In a standard synthesis, 4 g of triblock co-polymer Pluronic P123 as a 
micellar template was dissolved in 75 mL of 1.5 M HCl at room temperature. Subsequently, 4 g of a 
swelling agent (1,3,5-trimethylbenzene) was added to swell the micelles and the resulting solution 
was heated to 313 K in a water bath and stirred vigorously for 2 h. Subsequently, 9.2 mL of TEOS as 
a source of silica was added dropwise to the polymer/1,3,5-trimethylbenzene mixture and stirred 
for another 5 min. The mixture was then transferred to a PTFE bottle and aged at 313 K for 20 h 
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without stirring. After that time 46 mg of NH4F was added to the mixture and further aged at 373 K 
for another 24 h. The resulting white solid was filtered, washed with miliQ quality water and ethanol 
and dried in an oven at 313 K for 24 h. The dried powder was then calcined in air at 1173 K for 10 
h. 
3.2.4 Controlled Pore Glass (CPG) 
Controlled Pore Glass (CPG), developed by Haller, is a rigid glass containing a network of 
interconnected pores.[11] The glass is formed by a phase rearrangement process of alkali borosilicate 
glasses at elevated temperatures.[176,177] Control of the time and the temperature of the process 
enables tailoring of the pore size diameter and leads to a narrow distribution of the pores. The 
product obtained after leaching forms a continuous, silica rich glass with a porous network of 
specified pore dimensions. The CPG material is used mainly in the exclusion and absorptive 
chromatography of biomolecules and, due to the possible organofunctionalisation of its internal 
surfaces, as a support for the immobilisation of bio-reactive molecules.[11] In our study, 
commercially available (Merck Millipore) CPG material with a pore size of 550 Å served as a nano-
size crystallisation chamber for the investigation of IMC phase changes under confinement. 
3.3 Drugs loading details 
3.3.1 Indomethacin 
Loading from the melt. The CPG or the MCF material (200 mg) was mixed with IMC in a glass vial 
(15 mL) for 3 min using a spatula to obtain host : drug weight ratios of 85-15, 80-20, 75-25, 70-30, 
50-50 and put into a vacuum oven (200 mbar) at 438 K for 2 h (i.e., a temperature above the melting 
point of -IMC). The loaded composites were then cooled to an ambient temperature and stored 
in a desiccator at 277 K. The presence of an amorphous phase was confirmed using DSC, PXRD and 
solid-state NMR. Composites loaded from the melt were labelled as follows: host–IMC (host is CPG 
or MCF) and host–guest ratio (e.g., CPG–IMC 85–15). 
Phase transformation of amorphous IMC under confinement. Typically, to drive IMC crystallisation 
from an amorphous phase, 280 mL of methanol were added dropwise to 200 mg of host-IMC 
composite loaded from the melt. The wetted samples were then mixed promptly and thoroughly 
with a spatula for 30 s to allow a uniform filling of the pores with the solvent and left on a bench at 
room temperature in sealed glass vials for 24 h. Subsequently, the materials were dried under 
vacuum at 313 K for 2 h and stored in a desiccator at 277 K. The volume and solvent addition 
procedure were carefully optimised. Composites loaded from the melt and subsequently treated 
with methanol were labelled as follows: host–IMC (CPG or MCF), host guest ratio + 0.28 mL MeOH 
(e.g., CPG–IMC 85–15 + 0.28 mL MeOH).  
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Incipient wetness loading method. Indomethacin loading solutions were prepared by dissolving 
the drug in a vial in hot methanol to obtain concentrations of 150, 200 and 250 mg mL−1. To 
investigate the effect of the volume and the concentration of the loading solution on the IMC phase 
formation, 120 mL or 150 mL of the IMC solution was then added dropwise to 200 mg of the CPG 
host and 160 mL of the same loading solution was added to the MCF material. The loaded host was 
mixed promptly and thoroughly with a spatula to obtain uniform loading and evaporate any excess 
of the solvent from the sample. 
3.3.2 Flufenamic acid 
The mesoporous host (MCM-41, SBA-15 or MCF) was mixed with gently grinded FFA at host:guest 
ratios of 85-15, 80-20, 75-25, 70-30, 60-40, 50-50 wt. wt.−1 inside an amber glass vial with a spatula 
for 60 s to allow uniform mixing of both compounds. Prepared physical mixtures were heated to 
423-428 K for 5 min on the hot plate, i.e., 288-293 K above the melting point of FFA acid (ca. 408 K 
for commercially available FFA form I) and mixed with a spatula. The resulting composite materials 
were labelled as follows: host name-FFA (host is MCM, SBA or MCF) and host-guest ratio, (e.g., 
MCM-FFA 85-15).  
3.3.3 Tolbutamide 
Tolbutamide was loaded into MCM-41 (host) using melt loading method. The drug and the material 
were mixed together in a glass vial for 3 min using a spatula in host:guest ratios of 85:15, 80:20, 
75:25, 70:30, 60:40 and 50:50 (wt. wt.−1). The obtained mixture of the powders was heated on a 
hot plate at 408 K, i.e., above the melting point of TB, and mixed with a spatula for 5 min, ensuring 
that the drug was adsorbed within the pores via capillary action. Once loaded, the samples were 
cooled to room temperature and stored within a desiccator. 
3.4 Preparation methods for reference polymorphic forms 
3.4.1 Indomethacin 
The indomethacin purchased from Sigma-Aldrich was the γ-IMC (form I[178]). The α-IMC (form II[179]) 
was formed by dissolving 300 mg of the drug in 40 mL of warm ethanol in a round bottom flask and 
promoting evaporation of the solvent using a rotary evaporator at 323 K. The resulting powder was 
then ground in a mortar and stored in the freezer. An IMC:MeOH (1:1) solvate was obtained using 
the method described by Joshi et al.[180] 500 mg of IMC was dissolved in 8 mL of methanol at 353 K 
and left on the bench at room temperature in a vial covered with parafilm to reduce evaporation. 
Fine needles were collected after two days and dried using filter paper. The stoichiometric ratio 
between the solvent and IMC was confirmed using thermogravimetric analysis. A reference sample 
of IMC form V was obtained by the slow desolvation of the IMC:MeOH (1:1) solvate at room 
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temperature for two months under a perforated parafilm cover. Indomethacin form IV was 
prepared by annealing of the intact IMC glass at temperatures from 333-363 K. The IMC glass was 
prepared by melting γ-IMC ca. 10 K above its melting point (γ-IMC m.p. = 433 K) and quench cooling 
on the cold metal block.  
3.4.2 Flufenamic acid 
FFA form I is the commercially available form from Sigma-Aldrich. FFA form III was obtained by 
dissolving 500 mg in 10 mL of ethanol and heating to 358 K until the drug is dissolved. The obtained 
solution was left on the bench at room temperature to cool down.[181] The FFA form III crystallises 
as yellow needles after a few days. We further made an attempt to obtain FFA form V using the 
method described by Lee et al. using salt additives to crystallisation solution.[182] In all attempts only 
FFA form III was obtained.  
3.4.3 Tolbutamide 
Tolbutamide form IL is the commercially available form. The phase transition of form IL to form IH 
happens at ca. 313 K. The Tb form IV was obtained as white needles on the surface of the 
crystallisation vial. 300 mg of Tb was dissolved in warm methanol and left on a bench at room 
temperature to crystallise. The white, fine needles of Tb form IV were formed on the walls of a glass 
vial. We observed that Tb form IV has a phase transition at 253 K. This form is further labelled Tb 
form IVL. The very unstable Tb form V was formed inside the MCM-41 and SBA-15 silicas loaded 
from the melt. Tb form V normally crystallises from methanol with traces of nitric acid according to 
Nath et al.[183]   
3.5 Computational details for chemical shift calculations 
All computations were performed using the CASTEP code (ver. 7.03) and on the fly ultrasoft 
pseudopotentials.[184] Calculations were performed for the crystal structures and isolated molecules 
of IMC (structure code: INDMET[178], INDMET02[179], BANMUZ[185]), crystal structures of FFA form I 
and FFA form III (structure code: FPAMCA11[186], FPAMCA[187]) and crystal structures of Tb form I, IV 
and V (structure code: ZZZPUS02[188], ZZZPUS04[189], ZZZPUS07[189], ZZZPUS10[183]) reported in CCDC. 
Geometry optimisations were carried out using the Perdew-Burke-Ernzerhof (PBE) generalised 
gradient approximation (GGA) exchange-correlation density functional[154], ultrasoft 
pseudopotentials[190], a k-point mp spacing of 0.05 Å−1 and a cut-off energy of 800 eV. Geometry 
optimisation was run with constrained cell dimensions and positions of all heavy atoms. 
Calculations of the NMR chemical shieldings were performed using the gauge including projector 
augmented wave approach (GIPAW) and on the fly pseudopotentials as implemented in CASTEP 
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code.[155,191] The computed isotropic NMR shieldings were converted to chemical shifts using the 
following equation: 
 
δcalc= σiso−σref (Eq. 3-1) 
 
where σiso is the isotropic chemical shielding generated from first-principles calculations and σref 
was chosen as the zero intercepts of the fits of the calculated shielding vs. experimental chemical 
shifts. 
3.6 Characterisation conditions 
3.6.1 Powder X-ray diffraction 
Powder X-ray diffraction patterns were measured using an ARLTM X’TRA Powder Diffractometer 
(Thermo Fisher Scientific Inc., Waltham, MA, U.S.) employing Cu Kα radiation source (λ = 0.1540562 
nm). The patterns were recorded in the range of 2θ from 5 to 36° applying a step size of 0.01° and 
a scanning rate of 6 s per step for loaded materials and 2 s per step for reference polymorphic 
forms. 
3.6.2 Nitrogen adsorption 
Adsorption-desorption isotherms of nitrogen were obtained using a Nova 2200e Surface Area and 
Pore Size Analyzer (Quantachrome, Hook, UK) at 77 K. All samples were outgassed prior to analysis 
under high vacuum at 313 K for 12 h. The pore size distribution analysis was performed using the 
Barrett–Joyner–Halenda (BJH) algorithm using the Broekhoff-de Boer method for the estimation of 
adsorbed statistical film thickness. The BET specific surface area was calculated using the molecular 
area of nitrogen of 0.162 nm2 over a relative pressure range from p/p0=0.05 to 0.20 assuming a 
monolayer coverage of the material surface. For all three hosts, the size of the pores was calculated 
from the adsorption branch of the isotherms. The size of the interconnecting pores windows of the 
MCF host was calculated from the desorption branch of the isotherms.[4,38,192] 
3.6.3 Electron microscopy 
Scanning electron micrographs were recorded to assess the size and morphology of porous hosts 
using a JSM 4900 LV (JEOL Ltd, Japan) electron microscope at accelerating voltage of 20 kV. Samples 
were deposited on an adhesive carbon foil and gold coated prior to the analysis. 
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3.6.4 Differential scanning calorimetry 
Differential scanning calorimetry measurements were performed with a Q 2000 MTDSC instrument 
(TA Instruments, New Castle, DE, U.S.) using standard crimped TA 100 μL aluminium pans. The 
sample weight of the loaded materials was 8-10 mg to increase detectability of the crystalline 
phase, while the sample weight of pure reference crystalline materials was 2-3 mg. The 
temperature and energy calibration was performed using indium, tin and n-octadecane. A heating 
rate of 5 K min−1 was applied in all the temperature ranges depending on the composite/reference 
sample under a nitrogen purge of 50 mL min−1. Results were analysed with the TA Instruments 
Universal Analysis 2000 software (TA Instruments-Waters LLC). 
3.6.5 Thermogravimetric analysis 
The content of the guest within the loaded materials was determined using a TQ 500 
thermogravimetric analyser (TA Instruments, New Castle, DE, U.S.). All samples (5-10 mg) were 
loaded on platinum pans and heated from room temperature to 383 K with a heating rate of 5 K 
min−1 to remove residual water. Subsequently, the samples were heated from 383 to 873 K using a 
heating rate of 30 K min−1 and left at 873 K for 15 min to ensure total decomposition of the loaded 
drug. Finally, the analysed samples were heated to 903 K and cooled to 298 K. A sample and balance 
nitrogen purge flow of 25 mL min-1 and 10 mL min−1, respectively, were applied. All results were 
analysed using the TA Instruments Universal Analysis 2000 software (TA Instruments-Waters LLC). 
3.6.6 THz spectroscopy 
Terahertz spectroscopy measurements were performed using Advantest TAS7500TS system with a 
broadband Cherenkov type THz wave source module TAS1130 based on LiNbO3 crystal. 20-50 mg 
(depending on sample) of sample material was mixed with 300 mg of PTFE powder, pressed into a 
pellet under 2 tons of pressure and mounted onto a copper sample holder. The copper holder was 
screwed on the cold finger of a modified continuous flow cryostat (ST-100 FTIR, Janis, Wilmington, 
MA, USA). The cryostat was operated under vacuum and the temperature was controlled using a 
temperature controller (Lake ShoreModel 331, Westerville, OH, USA). Samples were annealed for 
30 min at approximately 379 K inside the cryostat under vacuum in order to get rid of any adsorbed 
water vapour. In the next step the cryostat was filled with liquid nitrogen and the samples were 
cooled to 80 K in approximately 30 min. The system was left to equilibrate for 20 min before the 
measurements commenced. For all subsequent measurements the samples were heated in 20 K 
intervals and allowed to equilibrate for 5 min at each heating step. The estimated accuracy in 
temperature control is 1 K due to the rather robust metal sample holder. The data were analysed 
using Matlab.[193] The spectra for samples containing crystalline FFA were corrected for a 
background caused by particle scattering using an asymmetric least squares method with p = 0.008 
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and λ = 1x105.[194] Background correction was not possible for purely amorphous samples as it was 
not possible to distinguish between the absorption caused by particle scattering and the absorption 
caused by molecular interactions. 
3.6.7 Solid-state NMR spectroscopy 
29Si solid-state NMR spectra were acquired using a Bruker 300 MHz Avance III spectrometer with a 
double resonance probe operating at frequencies 300.13 MHz for 1H and 59.63 MHz for 29Si. The 
materials were packed into the 4 mm zirconia rotors and rotated using dry air. The 29Si chemical 
shifts are given in ppm with respect to external TMS. 
 1H, 19F, 13C and 15N NMR experiments were acquired using a 400 MHz Bruker AVANCE III solid-state 
NMR spectrometer equipped with a triple resonance probe operating at 400.23 MHz for 1H, 376.57 
MHz for 19F, 100.64 MHz for 13C and 40. 57 MHz for 15N. Materials were packed into 4 mm zirconia 
rotors and rotated using dry air. The 1H and 13C chemical shifts are given in ppm with respect to 
external TMS, the 19F chemical shifts were recorded with respect to CFCl3 setting PTFE peak to 
−122.0 ppm and the 15N chemical shifts are quoted with respect to liquid NH3 at 0 ppm by setting 
reference peak of glycine to 33.4 ppm.[195]  
Further 1H, 13C and 19F experiments were performed using a 850 MHz Bruker AVANCE III 
spectrometer equipped with a triple resonance probe operating at 850.22 MHz for 1H, 799.94 for 
19F and 213.81 for 13C. For 13C NMR experiments, materials were packed into 4 mm zirconia rotors 
and rotated at an MAS rates in the range from 10 to 13 kHz to avoid overlapping of spinning 
sidebands with 13C peaks. For 19F analysis, all materials were packed into 2.5 mm zirconia rotors and 
rotated at an MAS rate of 30 kHz. 1H analysis was performed using 1.0 mm double resonance probe 
operating at 850.22 MHz for 1H, all materials were packed into 1 mm zirconia rotors and rotated at 
an MAS rate of 78 kHz. 
3.6.7.1 One dimensional single pulse magic angle spinning (MAS) 
All 1D MAS experiments were acquired using a single pulse followed by acquisition of the FID.  
 
 
Figure 3-1. Representation of the pulse sequence for 1D MAS NMR experiment. 
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o 1H MAS NMR spectra were acquired using a 1H π/2 pulse length of 2.6 µs at an MAS rate of 
10 kHz or a 1H π/2 pulse length of 1.8 µs at an MAS rate of 78 kHz. The recycle delay was 
set based on the material 1H relaxation times.  
o 19F MAS NMR spectra were acquired using a 19F π/2 pulse length of 3.6 µs at an MAS rate 
of 10 kHz or a 19F π/2 pulse length of 4.0 µs at an MAS rate of 30 kHz and a recycle delay of 
10 s.  
o 29Si MAS NMR spectra were acquired using a 29Si π/2 pulse length of 4.1 µs at an MAS rate 
of 4 kHz and recycle delay of 240 s. Usually 2048 transients were acquired for all silica 
porous hosts. 
3.6.7.2 Single pulse 13C with high power decoupling (13C{1H} MAS NMR) 
13C{1H} MAS NMR spectra were acquired using a 13C π/2 pulse length of 3.5 µs at an MAS rate of 
10 kHz and recycle delay of 30 s using SPINAL64[131] heteronuclear 1H decoupling during acquisition 
with a rf field of 89 kHz. Typically 1024 scans were acquired with 30 s delay between scans.  
 
 
Figure 3-2. Representation of a 13C MAS NMR experiment with 1H high power decoupling (13C{1H} 
MAS NMR). 
 
3.6.7.3 One dimensional 1H CRAMPS MAS NMR 
High resolution 1H spectra were recorded using a PMLG[134] homonuclear decoupling pulse 
sequence at an MAS spinning rate of 6.8 kHz optimised for best decoupling performance. In 1H 1D 
CRAMPS, a 1H π/2 pulse length of 2.5 µs and 32 μs windowed PLMG1 cycle was applied with an 
effective rf decoupling power of 100 kHz. A short acquisition window (10−15 ms) was used in order 
to acquire a complete data set and to avoid probe overheating. Typically 16-64 transients were 
acquired with a recycle delay of 10 s. 
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Figure 3-3. Representation of a 1D 1H MAS NMR experiment with WPLMG CRAMPS decoupling. 
 
3.6.7.4 1H-X Cross-polarisation magic angle spinning (CP/MAS) 
All CP/MAS NMR experiments were acquired using ramp amplitude implemented on the 1H channel 
during the contact step and the SPINAL64[131] heteronuclear dipolar decoupling used during 
acquisition. 
 
 
Figure 3-4. Representation of a 1H-13C CP/MAS pulse sequence. 
 
o 1H-13C CP/MAS NMR spectra were acquired using a 1H π/2 pulse length of 3.2 μs and a CP 
contact time of 2 ms at an MAS rate of 10 kHz. The Hartman–Hahn conditions were set 
using hexamethylbenzene (HMB). Typically 1024 transients were acquired for loaded silica 
composites and 256 transients for reference crystalline materials with a recycle delay of 10 
s.  
o 1H-29Si CP/MAS NMR spectra were acquired using a 1H π/2 pulse length of 3.7 μs and a CP 
contact time of 2 ms at an MAS rate of 4 kHz. The Hartmann–Hahn match was set with 
kaolinite. Typically 1024 transients were acquired with a recycle delay of 30 s. The 1H-29Si 
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variable contact time CP/MAS NMR measurements used contact times ranging from 0.05 
to 10.0 ms.  
o 1H-15N CP/MAS NMR spectra were acquired using a 1H π/2 pulse length of 3.2 μs and a CP 
contact time of 2 ms at an MAS rate of 10 kHz. The Hartmann–Hahn match was set with 
glycine. Typically 256 transients were acquired with a recycle delay of 10 s. 
3.6.7.5 Non-quaternary suppression (Dipolar dephasing) experiment 
Distinction between protonated and quaternary carbons can be made using dipolar dephasing 1H-
13C CP/MAS NMR pulse sequence, which is a spectral editing method. During the dephasing delay 
implemented between the CP step and acquisition, 13C bound to the 1H lose their magnetisation 
due to strong heteronuclear dipolar interactions leading to absence of the signals. This enables to 
distinguish CH and CH2 functional groups from quaternary carbons. Usually the CH3 carbon peaks do 
not lose the intensity in the NQS experiment due to the fast mobility of the methyl group which is 
only slightly affected by heteronuclear dipolar interactions.  
 
 
Figure 3-5. Representation of a 1H-13C CP/MAS dipolar dephasing (DD) NMR experiment. 
 
The dephasing delay (DD) used in the experiment was 60 µs. Typically 256 transients were acquired 
for Z’=1 and Z’=2 structures and 1024 for Z’=3 (α-IMC) for better resolution.  
3.6.7.6 One dimensional 1H → 13C J-MAS-INEPT experiment 
The enhancement of 13C signal in solids with high mobility is very difficult to achieve using CP based 
methods due to efficiency loss of the cross polarisation step. For such systems enhancement of the 
13C signal can be achieved using transfer of nuclear spin polarisation from 1H spins by application of 
INEPT[196] pulse sequence under MAS conditions.[197,198] Furthermore, this method can be used to 
88 | P a g e  
detect through bond connections between heteronuclei.[197,199] The maximum signal enhancement 
for two coupled spin ½ nuclei is achieved when τ = 1/4J, assuming T2 >> 1/J.[197,198] It needs to be 
emphasised that for rigid solids with very short T2 relaxation times it is not possible to store the 
magnetisation in the xy plane for long enough to obtain sufficient polarisation transfer.[198] For such 
systems homonuclear dipolar decoupling needs to be applied during the τ evolution times.[198] 
Hence, we used the J-MAS-INEPT experiment as a probe of heterogenous solid materials which are 
composed of species with different mobility, which cannot be detect using CP based methods. 
 
 
Figure 3-6. Representation of a J-MAS-INEPT pulse sequence. 
 
All J-MAS INEPT experiments were acquired at an MAS rate of 10 kHz using a 1H π/2 pulse length of 
3.2 μs and 13C π/2 pulse length of 3.5 μs. The τ and τ’ delays were optimised for best signal 
enhancement and set to τ = 1.1 ms and τ’ = 0.9 ms. SPINAL64[131] heteronuclear dipolar decoupling 
was applied during acquisition. Typically 1024 scans were used for drug : silica composites with 
recycle delay of 10 s.  
3.6.7.7 Two dimensional 1H-X heteronuclear correlation (HETCOR) 
2D 1H-X HETCOR[200,201] NMR experiment enables to correlate the 1H chemical shifts recorded in the 
indirect dimension with the X nuclei chemical shifts in the direct dimension. The FSLG[133] 
homonuclear dipolar decoupling is applied during the t1 increment which enables 1H magnetisation 
to evolve only under the chemical shift Hamiltonian. By using short contact times during the CP step 
it can be assumed that only hydrogens covalently bound to carbons are correlated.  
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Figure 3-7. Representation of a 1H-X HETCOR pulse program.  
 
2D 1H-13C HETCOR[133,200] MAS NMR spectra were acquired using FSLG[201] homonuclear dipolar 
decoupling with a 1H rf field of ca. 92.6 kHz and CP contact time of 50 µs. SPINAL64[131] 
heteronuclear dipolar decoupling was used during acquisition. A recycle delay of 2 s and an MAS 
rate of 10 kHz were used. Typically 128 increments were recorded in the indirect dimension with 
192 transients per increment.  
3.6.7.8 Two dimensional 1H-1H spin diffusion experiment 
Close proximities between different 1H sites were probed using 2D 1H-1H spin diffusion experiment 
with windowed PMLG homonuclear decoupling reported by Leskes et al.[134] at 9.4 T and 6.8 kHz 
MAS rate or phase sensitive NOESY experiment (the same as for solution state spectrometers) at 
20 T and 78 kHz. The pulse program is composed by π/2 pulse, creating transverse magnetisation 
evolving during t1 followed by another π/2 pulse, which places the magnetisation along the z axis 
where it evolves for a fixed mixing time (tm). The last π/2 pulse moves back the magnetisation in 
the xy plane for acquisition. WPMLG homonuclear decoupling is used during t1 evolution and 
acquisition.  
 
 
Figure 3.5. Symbolic representation of the 1H spin diffusion pulse program. 
Figure 3-8. Representation of a 1H-1H NOESY experiment acquired with WPLMG decoupling at 9.4 T 
(left) and without decoupling at 20.0 T (right) spectrometers. 
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A 1H π/2 pulse lengths of 2.5 μs at 9.4 T and 1.8 μs at 20.0 T were applied, using recycle delays of 4 
and 5 s, respectively. 256 (9.4 T) and 512 (20.0 T) increments were acquired in t1 with 8 (9.4 T) or 4 
(20.0 T) scans per increment. Full build-up curves were constructed when analysing the IMC 
polymorphs at 9.4 T (from 0 – 2 ms in 20 experiments). Analyses at 20.0 T were performed at two 
mixing times of 50 and 150 ms.  
3.6.7.9 Two dimensional 1H-1H SQ DQ correlation experiment 
The high-resolution two-dimensional 1H-1H Double-Quantum CRAMPS NMR experiment at 9.4 T 
was performed using a pulse sequence previously published by Brown et al. (Figure 3-9).[202] The 
spectra were acquired at an MAS rate of 6.8 kHz optimised for best decoupling efficiency. The POST-
C7 pulse sequence was used to obtain double quantum coherences with an effective rf field of 7 x 
MAS rate, i.e., 47.6 kHz and a 1H π/2 pulse length of 2.5 μs. During the evolution period (t1) 32 μs 
windowed DUMBO cycle was applied, while 32 μs windowless DUMBO cycle was applied during the 
acquisition step, both with an effective rf decoupling power of 100 kHz. A short acquisition window 
(10−15 ms) was applied in order to acquire a complete data set and to avoid probe overheating. A 
total of 128 increments were acquired in the indirect dimension with 16 scans each.  
 
 
Figure 3-9. Representation of a 2D 1H-1H Double-Quantum CRAMPS experiment with POST-C7 
excitation reconversion pulse sequence and DUMBO decoupling. 
 
Application of additional homonuclear dipolar decoupling pulse sequences at high MAS rates (78 
kHz) and high field spectrometers (20.0 T) do not improve the resolution of the spectra but may 
lead to artefacts. In this case for the acquisition of 1H-1H Double-Quantum correlation spectra at 
20.0 T and at an MAS rate of 78 kHz we used BABA pulse sequence for excitation and recoupling 
and a 1H π/2 pulses of 1.8 μs (Figure 3-10). A total of 400 increments were acquired in the indirect 
dimension with 16 transients for each increment and a recycle delay of 5 s. 
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Figure 3-10. Representation of a 2D 1H-1H Double-Quantum pulse sequence using BABA excitation 
reconversion pulse sequence. 
 
3.6.8 Spin-lattice relaxation 
3.6.8.1 Spin-lattice relaxation in the laboratory frame T1 
All T1 relaxation experiments for both 1H and 19F nuclei were acquired using a standard inversion-
recovery (IR) pulse sequence (Figure 3-11).  
 
Figure 3-11. Representation of an inversion recovery pulse sequence. 
 
The first π pulse rotates the magnetisation to the −z axis followed by the evolution period τ and the 
second π/2 pulse rotates the magnetisation back to the −xy plane for detection of the remaining 
magnetisation. The 1H and 19F π/2 pulses used were 3.4 µs and 3.6 µs long, respectively. Typically, 
16 experiments were acquired with a τ delay in the range from 0.001 to 15 s for 19F T1 relaxation 
measurements and 0.01 to 30 s for 1H T1 relaxation measurements. The peaks intensities or 
integrations were plotted as a function of the delay time τ and fitted with the monoexponential 
equation (Eq. 3-2): 
 
𝑀𝑧(𝑡) = 𝑀0𝑧 [1 − 2𝑒𝑥𝑝 (−
𝑡
𝑇1
)]  (Eq. 3-2) 
 
where t is the delay time and Mz(t) is remaining net magnetisation after t delay. 
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3.6.8.2 Spin-lattice relaxation in the rotating frame T1ρ
H and T1ρ
C 
The modified CP pulse sequence was used to measure T1ρH and T1ρC . For T1ρH after the first π/2 pulse 
the spin-locking pulse is implemented, which locks the 1H magnetisation along the y axis for a set 
time τ between 0.01 and 20 ms. During this time 1H magnetisation evolves under homonuclear 
dipolar interactions resulting in decrease of net magnetisation, which depends on the 1H relaxation 
efficiency in the rotating frame. The remaining 1H magnetisation is detected via 13C using the 
standard CP step implemented after the spin-locking pulse (Figure 3-12).  
The indirect detection of T1ρH enables better resolution of different 1H sites through 13C spectrum. 
In all experiments a spin-locking power of 78 kHz, a CP contact pulse of 2 ms and a recycle delay of 
10 s were used. A total of 12 experiments were acquired varying the length τ of the spin locking 
pulse. The peak intensities were fitted to the exponential equation (Eq. 3-3): 
 
𝑀(𝑡) = 𝑀0𝑖𝑒𝑥𝑝 (−
𝑡
𝑇1𝜌𝑖
),  (Eq. 3-3) 
 
where t is the duration of spin locking pulse and M(t) is the peak intensity at time t. 
 
 
Figure 3-12. Representation of a T1ρH pulse sequence with spin-locking pulse applied on 1H channel. 
 
Similarly, it is possible to measure T1ρC relaxation times. The pulse sequence is composed of a π/2 
pulse followed by a CP step, after which the spin locking pulse is applied on the 13C channel locking 
the 13C magnetisation along y axis for set time (τ) between 0.01 to 20 ms (Figure 3-13). During this 
time the 13C magnetisation evolves under homonuclear spin-spin interactions resulting in decrease 
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of the net magnetisation similarly to T1ρH. A total of 12 experiments with different τ values were 
acquired. The peak intensities were fitted to the exponential equation (Eq. 3-3). A CP contact time 
of 2 ms and a recycle delay of 10 s were used. A spin locking rf pulse of 72 kHz was applied. 
 
 
Figure 3-13. Representation of a T1ρC pulse sequence with spin-locking pulse applied on 13C channel.  
 
3.6.9 Variable temperature (VT) experiments 
Typically, VT measurements were performed in the temperature range from 223 to 353 K in 10 K 
steps. The temperature control was achieved using the Bruker BCU II chilling unit or through the 
heating the sample using heater implemented in the probe. The temperature of the sample was 
stabilised for 5 min at set temperature before starting the measurement.  
3.6.10 Data processing 
All NMR spectra were acquired and processed using Bruker Topspin 3.1.7 software. Deconvolution 
of NMR peaks and relaxation data fitting was made using Origin Pro 8.5.1 software.  
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4 Indomethacin polymorphism: 
introducing solid state studies 
on indomethacin form IV and 
form V 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4  
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Findings from this chapter are partly published as: 
K. P. Nartowski, J. Tedder, D. E. Braun, L. Fábián and Y. Z. Khimyak, 2015, Building solids inside nano-space: from confined 
amorphous through confined solvate to confined ‘metastable’ polymorph, Phys. Chem. Chem. Phys., 17 (38), 24761-24773  
L. Fábián, K. P. Nartowski, Y. Z. Khimyak, 2015, Molecular dynamics of supersaturated indometacin-nicotinamide solutions, 
Act. Cryst. A71 s458. 
4.1 Introduction 
Indomethacin (IMC) (2-{1-[(4-Chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic 
acid) is a model pharmaceutical compound used frequently in crystallographic research due to its 
well-recognised polymorphism and complex phase behaviour.[59,156,179,203–216] The molecular 
flexibility of the 4-chlorophenyl ring, carboxylic acid motif and methoxy group makes it an 
interesting system for conformational studies (Figure 4-1 A and B). The conformational flexibility is 
demonstrated by the arrangement of the IMC molecules in the different crystal structures. 
 
 
Figure 4-1. A. Structure of IMC with numbering of carbon atoms. Red labels indicate quaternary 
carbons. B. Conformation flexibility of IMC in three different crystalline forms; most 
thermodynamically stable γ-IMC (yellow), IMC MeOH solvate (green) and α-IMC (molecule A – dark 
blue; molecule B – cyan; molecule C – light blue) structures are overlaid with carbons C5-C7. C. 
Crystals of IMC form IV – obtained by annealing of IMC glass and IMC form V formed after 
desolvation of MeOH solvate.   
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Therefore, by looking at molecular conformation in different solvents or in the amorphous state 
and comparing them with the IMC conformation within the crystal one can gain understanding of 
aggregation processes at the early stages of crystallisation from a solution or the amorphous state.  
The main focus of this chapter is the application of solid-state NMR spectroscopy to clarify 
molecular level arrangements in different solid forms of IMC, and to investigate structural 
differences between two polymorphic forms of IMC (Form IV and Form V). These forms have been 
incorrectly considered to be one crystalline phase (δ-IMC, Figure 4-1C). The story of δ-IMC began 
40 years ago, when Borka published the first paper on IMC polymorphism.[203] Due to small 
differences in the melting points between the two IMC forms (IV and V) (analysed at that time using 
hot stage microscopy) and poor IR spectroscopic data, the author specified that the crystalline form 
IV (δ-IMC) can be obtained from warm methanol or annealing of the IMC glass in the range of 
temperature from 343 to 363 K.[203] Despite a large volume of research published on its crystalline 
forms (including δ-IMC) there is a lack of understanding of the differences in the structure of these 
two forms.  
This chapter developed from a short study into systematic investigation of different IMC phases 
due to scientific curiosity to fundamentally understand the self-organisation of molecules from the 
solution or amorphous state into their solid form, and investigate opportunities to control these 
processes. IMC form IV and form V are not trivial examples of pharmaceutical polymorphism. The 
crystal structures of both the forms are yet to be determined, as single crystals are difficult to obtain 
and low crystallinity of the powders leads to significant broadening of the PXRD peaks. Additionally, 
the relatively large molecular weight of the compound (357.79 g mol −1), significant flexibility and 
Z’=2 (as determined using solid-state NMR) make the application of CSP methods challenging. IMC 
form IV and form V are therefore excellent examples of challenging problems to be solved by NMR 
crystallography. The ultimate goal of this study is to elucidate the structural reorganisation of the 
IMC methanol solvate upon desolvation, which forms a new crystalline form - IMC form V. 
Additionally, solid-state NMR methods were employed to obtain information on the conformation 
of molecules forming low crystallinity IMC form IV (obtained by annealing of IMC glass). This is of 
importance from a pharmaceutical perspective as IMC crystallisation from the amorphous state is 
a frequently discussed model in polymorphism and stability of organic glasses.  
This chapter is a part of collaboration between Universities in Innsbruck, Cambridge, UCL (London), 
Riga and Norwich and includes the following researchers: Dr Doris Braun (University of Innsbruck: 
crystal structure prediction, conformational analysis, indexing of IMC form V), Prof. Chris Pickard 
(University of Cambridge: crystal structure prediction), Dr Inese Sarcevice (University of Riga: VT 
PXRD studies). 
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4.1.1 Solvent mediated crystallisation 
The crystal structure of the most stable IMC polymorph (γ-IMC) was determined by Kistenmacher 
and Marsh in 1972.[178] Two years later, Borka studied the polymorphism of IMC extensively by 
isolating four forms of IMC including Form I (γ-IMC, m. p. 433 K), Form II (α-IMC, m. p. 427 K), Form 
III (m. p. 421 K), Form IV (m. p. 407 K) and several solvates, often labelled as β-IMC.[203] 
Crystallisation of IMC can result in the formation of different polymorphic forms depending on the 
level of supersaturation, solvent used and crystallisation method. There have been seven studies 
to date which focus on the crystallisation of IMC from different solvents[180,203,206,207,209,212,217] and 
one study discussing crystallisation from binary mixtures[218] of the solvents, reporting 
crystallisation from a total of 25 solvents. Solvents at high IMC supersaturation yield either solvates 
or α-IMC, indicating kinetically controlled crystallisation. Solvated forms of IMC can be obtained 
from tert-butanol, cyclohexanone, dichloromethane, chloroform, tetrachloromethane, benzene 
and tetrahydrofuran. IMC solvates are predominately formed at 0.5:1 solvent:IMC stoichiometric 
ratio, with only crystallisation from MeOH and tert-butanol yielding structures at 1:1 solvent:IMC 
stoichiometric ratios.[217] These two examples are the only fully solved crystalline IMC solvate 
structures to be reported in the CCDC.[185,219] The most thermodynamically stable γ-IMC was 
obtained at low supersaturation from 15 solvents indicating thermodynamically controlled 
crystallisation of IMC occurs under these conditions. The solvent mediated crystalline forms of IMC 
are summarised in Table 4-1.  
A hybrid approach to solvent mediated recrystallisation was recently proposed by Surwase et al.[220] 
The authors performed several recrystallisations from amorphous suspensions of IMC in water at 
different temperatures and pH, isolating and identifying seven different crystalline forms of 
indomethacin, including three new polymorphs with distinct PXRD, DSC, FTIR and Raman 
spectroscopic features.[220] 
4.1.2 Crystallisation from the amorphous state 
There are at least 11 reports on the recrystallisation of IMC from the amorphous state, including 
isothermal[204,213] and non-isothermal recrystallisation studies[59,208], molecular mobility and stability 
studies describing the effect of water on amorphous IMC[214,216] and, more recently, a study 
investigating the effect of preparation methods on stability, dissolution and recrystallisation 
behaviour of amorphous indomethacin[221,222].  
There are several methods for the preparation of amorphous indomethacin including melt 
quenching, spray drying and cryo- or ball milling.[212,221] The preparation method is known to affect 
the recrystallisation behaviour and stability of amorphous IMC.[60] It was shown in several studies 
that the most stable amorphous IMC is obtained by quenching of molten material.[58,59,204,213,221] 
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Table 4-1. Summary of literature data on crystalline forms of IMC obtained after crystallisation from 
different solvents. The table includes information from seven studies published on IMC 
polymorphism. 
Solvent Crystalline form of IMC Additional notes* 
Alcohols 
Methanol Form I (γ-IMC)[209] 
Form II (α-IMC)[203,217],  
solvate[180,203,212,217],  
Form IV (δ-IMC) [180,203,212],  
Solvate of IMC is formed at low supersaturations, while 
at higher supersaturations form II (α-IMC) or mixture of 
both forms can be obtained. Form IV (δ-IMC) is a 
desolvation product of methanol solvate. 
Ethanol Form II (α-IMC)[203,206,207,209,212,217],  
 
Form I (γ-IMC)[206,217] 
High supersaturation, slow evaporation or precipitation 
from warm ethanol using water as antisolvent,  
Low supersaturation 
1-Propanol Solvate[203,209,217] and/or Form II (α-
IMC); Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
2-Propanol Solvate and/or Form II (α-IMC);  
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
tert-Butanol Solvate[180,212,217] High and low supersaturation 
1-Butanol Solvate and/or Form II (α-IMC);  
Form I (γ-IMC)[217] 
High supersaturation,  
Low supersaturation 
Isobutanol Solvate and/or Form II (α-IMC);  
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Pentanol Solvate and/or Form II (α-IMC);  
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Isopentanol Solvate and/or Form II (α-IMC);  
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Octan-2-ol Solvate and/or Form II (α-IMC);  
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Cyclohexanol Solvate and/or Form II (α-IMC);  
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Ketones and ethers 
Acetone Solvate[203,209,217], Form II (α-IMC)[217],   
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Butan-2-on Solvate and/or Form II (α-IMC),  
 Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Cyclohexanone Solvate[217] High and low supersaturation 
Halogenated solvents 
Dichloromethane Solvate[203,209,217] High and low supersaturation 
Chloroform Solvate[203,209,217] High and low supersaturation 
Tetrachloromethane Solvate[217] High and low supersaturation 
Other   
Benzene Solvate[203,209,217] High and low supersaturation 
Toluene Solvate and/or Form II (α-IMC),   
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Dimethyl 
formamide 
Form II (α-IMC)[203]  
Glacial acetic acid Form II (α-IMC)[203]  
Acetonitrile Form II (α-IMC)[203,207,217] 
Form I (γ-IMC)[203,206,217],  
High supersaturation 
Low supersaturation 
Ethyl acetate Solvate and/or Form II (α-IMC)[203,217] 
Form I (γ-IMC)[217] 
High supersaturation 
Low supersaturation 
Diethylether Solvate[203,209,217], Form II (α-IMC)[209,217]  
Form I (γ-IMC)[203,217] 
High supersaturation 
Low supersaturation 
Tetrahydrofuran Solvate[209,217] High and low supersaturation 
Water Form II (α-IMC)[203], Form I (γ-
IMC)[207,209] 
Slow evaporation[207,209] 
* Additional notes highlight the crystallisation conditions, preparation methods or observations made by authors. In most 
studies crystallisation of IMC was carried out using slow evaporation method at high or low supersaturation of the drug 
in the solvent. Two papers describe antisolvent precipitation as a method to obtain α-IMC. 
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Furthermore, the cooling rate of molten IMC also determines the stability and recrystallisation 
behaviour of an amorphous drug.[59,208] The most pronounced effect was observed through the non-
isothermal crystallisation of amorphous IMC obtained by slow or quench cooling of molten 
material, where recrystallisation to either α- or γ-IMC was reported.[59] The processing of 
amorphous melt, i.e., mortar grinding of IMC glass, compared to un-triturated material, significantly 
reduced the stability of non-crystalline drug. Glassy IMC was reported to be stable for over 
2 years[58], while the 36 hours induction period prior to crystallisation of rapidly cooled, mortar 
grinded material was reported by Fukuoka et al. and later by Yoshioka et al.[58,59]  
All reports on crystallisation of amorphous IMC demonstrate the formation of either α- or γ-IMC. 
Kinetic studies of isothermal recrystallisation of amorphous IMC below the glass transition 
temperature (IMC Tg ca. 323 K) show the formation of the most stable γ-IMC, while α-IMC 
predominately crystallises at temperatures above 323 K.[59,204,213] Interestingly, there have been no 
further reports on the formation of IMC form IV from amorphous IMC as previously shown by 
Borka.[203] We therefore hypothesised that IMC form IV can only be formed from rapidly cooled, 
intact glass, as all previously described studies used ground amorphous drug. This hypothesis was 
evaluated in numerous experiments where the same isothermal crystallisation of IMC glass was 
performed in different laboratories at UEA, University of Riga, University of Innsbruck, UCL and 
University of Warwick.  
4.2 Results and discussion 
4.2.1 Solid state characterisation of IMC polymorphs and MeOH solvate 
4.2.1.1 Powder X-ray diffraction and differential scanning calorimetry studies 
 
Figure 4-2. A. PXRD traces and B. DSC thermograms of IMC polymorphs and MeOH solvate. 
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The thermodynamically most stable form of indomethacin (γ-IMC) has the space group symmetry 
𝑃1̅ with Z’ = 1. The γ-IMC crystal structure is stabilised by centrosymmetric 𝑅2
2(8) hydrogen bonded 
ring motifs,[223] formed between carboxylic acid groups. γ-IMC shows a melting point between 432.1 
to 434.3 K and an enthalpy of fusion of 110 J g−1.[178,207,224] Metastable α-IMC, another frequently 
occurring polymorph, crystallises in the monoclinic space group 𝑃21 with Z’ = 3 and has very 
different conformations compared to γ-IMC. α-IMC exhibits a melting point between 426.0 to 428.0 
K with an enthalpy of fusion of 97.5 J g−1.[207,215] The methanol solvate crystallises in the monoclinic 
space group 𝑃21/𝑛 (Z’ = 1), with a stoichiometric ratio of IMC:MeOH of 1:1 (BANMUZ
[185]). The 
solvate structure is stabilised by hydrogen bonds between the carboxylic acid groups of IMC and 
the alcohol groups of the methanol molecules, which form a 𝑅4
4(12) ring motif.[185] The solvent 
molecules are located in channels along the crystallographic b axis, from which they may easily 
escape during desolvation.[180] The DSC curve (open pan) of IMC methanol solvate shows an 
endothermic peak at an onset temperature of 357 K, which is in agreement with previous studies 
and corresponds to the desolvation of the solvate to IMC form V.[180,212] A second endothermic event 
at 404.4 K is related to the melting of form V and is followed by recrystallisation of the two more 
stable forms of IMC (α and γ). IMC form V, often incorrectly called δ or form IV, can be obtained via 
slow desolvation of the methanol solvate at room or elevated temperatures, or under 
vacuum.[180,220] Based on our experience, a slow desolvation process at room temperature may take 
up to 3 months, but leads to pure form V; while a much faster desolvation at elevated temperatures 
often leads to a mixture of polymorphs (V, γ, α). The crystal structure of IMC form V is yet to be 
determined, as this phase is a desolvation product exhibiting low crystallinity. The diffraction 
pattern of form V was indexed to a monoclinic unit cell (298 K: a = 18.5450 Å, b = 5.4032 Å, c = 
18.2967 Å, β = 95.6421) using the first twenty peaks with DICVOL04 with a space group 𝑃21 based 
on a statistical assessment of systematic absences, as implemented in the DASH structure solution 
package.[225,226] From the cell volume it was derived that there are two IMC molecules in the 
asymmetric unit (Z’ = 2). IMC form V shows small needles which melt between 403–404 K followed 
by recrystallisation directly into γ-IMC or α-IMC or mixture of both.[180] All DSC data of the reference 
samples are summarised in Figure 4-2B. The PXRD patterns of the reference samples (Figure 4-2A) 
are in good agreement with the simulated patterns for the IMC structures published in the CSD 
(Cambridge Structural Database) for structures INDMET (γ-IMC, form I), INDMET02 (α-IMC, form II) 
and BANMUZ (IMC methanol solvate).[178,179,185,227] The PXRD pattern of IMC:MeOH (1 : 1) solvate 
shows two strong intensity peaks with d(002) = 10.27 Å and d(004) = 5.15 Å, even after careful 
grinding, which may be related to preferred orientation of the fine needles. The PXRD pattern of 
form V IMC is in a good agreement with those published previously.[212,220]  
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Figure 4-3. Hydrogen bonding patterns in three different IMC crystal structures: γ-IMC, IMC MeOH 
solvate and α-IMC (CSD ref. INDMET, BANMUZ and INDMET02). 
 
There is only one previous report of IMC form IV (Borka, 1974), which includes only the preparation 
method and melting point of the material at ca. 407 K.[203] IMC form IV was formed from quenched 
cooled IMC glass after annealing at 343-363 K, which is in agreement with Borka’s results. The 
crystalline phase grows as a brownish opaque chunk from the IMC amorphous glass (Figure 4-1C). 
Pure IMC form IV was only formed when the IMC glass was fracture-free. Any visible imperfections 
in the IMC glass always resulted in concomitant crystallisation of IMC form IV and either α- or γ-
IMC. The cracks in the glass are easily introduced by quenching at very low temperatures, e.g. in an 
ice bath. The DSC thermogram of IMC form IV shows a broad melting event with an onset at 402.6 K 
and the fusion enthalpy of ca. 66 J g –1 (Figure 4-2B). There was no clear single crystal formed during 
the recrystallisation process. The PXRD pattern of the unground material shows very broad peaks 
indicating its low crystallinity (Figure 4-4). The crystallinity of the sample increased rapidly by 
crushing or scratching the surface, as shown in PXRD traces 2 and 3 in Figure 4-4. Unfortunately, 
indexing of the IMC form IV PXRD pattern was not possible due to low crystallinity of the sample 
and possible impurities from α-IMC (See Figure 4-4 traces 4, 6 and 7). There was no further increase 
in the crystallinity of the material after ball milling. Instead, the sample became amorphous, which 
is typical for all IMC polymorphs.[60,212] Further exposure of the amorphous material to the EtOH 
vapour led to formation of α-IMC.  
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Figure 4-4. PXRD traces of IMC form IV. 1) Chunk of IMC form IV without grinding; 2) ground IMC 
form IV and 3) sample 2) after 6 hours storage; 4) ground IMC form IV after overnight acquisition 
used for indexing; 5) PXRD of indomethacin IV after milling in ball mills (5 mL milling jars, 10 min, 
25 Hz, 1 × 8 mm ball); 6) material 5) after keeping it under the vapour of EtOH for 1 h; 7) simulated 
PXRD of INDMET02[179]. 
 
4.2.1.2 Solid-state NMR 
Indomethacin has been widely studied using solid-state NMR spectroscopy, as a complementary 
technique to single crystal structure determination of both the α- and γ-polymorphs. Advanced 
solid-state NMR methods focusing on detailed analysis of hydrogen bonding patterns and inter- and 
intramolecular distances within the crystal were supported by first principles 
calculations.[156,205,215,228] The analysis of the differences in 13C and 1H spectra between crystalline 
forms of IMC is presented in the following sections, starting with the well described model of γ-IMC 
to compare our experimental set up with previously published data. Inter- and intramolecular 
connectivity between nuclei were analysed using 1H-1H SQ-DQ and 1H-1H spin diffusion experiments 
and compared with available crystal structures in the CSD for γ-IMC, α-IMC and IMC MeOH solvate 
(INDMET[178], INDMET02[179], BANMUZ[185], respectively). All presented spectra were acquired at 
both 9.4 and 20.0 T using either fast MAS (78 kHz at 20.0 T) or CRAMPS experiments (6.8 kHz at 9.4 
T) with windowed PLMG decoupling (see experimental section for details).  
Structural analogies reflected in the changes of 13C and 1H spectra of known IMC polymorphs, due 
to the conformational differences of molecules in the unit cell, were used to gain structural 
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information of IMC forms IV and V. The methodology of experimental and computational studies is 
presented in the following steps: 
1. Acquisition of 13C spectra and identification of quaternary and non-quaternary carbons in a 
set of 13C and 1H-13C correlation experiments: 1H-13C CP/MAS, 1H-13C NQS CP/MAS, 
1H-13C HETCOR at short contact time (50 µs); 
2. Calculation of 1H and 13C chemical shifts of geometry optimised structures based on the 
GIPAW approach and comparison with experimental data; 
3. Detailed assignment of 1H spectrum based on GIPAW calculations and 1H-13C HETCOR 
spectrum; 
4. Acquisition of 1H spectra: 1H at fast MAS, 1H CRAMPS, and correlation experiments 
1H-1H SQ-DQ and set of 1H-1H spin diffusion experiments to evaluate molecular proximities 
between different 1H sites for IMC crystal structures. 
This approach was tested on the three known indomethacin structures and further applied to two 
unknown structures of IMC. Firstly, we focussed on γ-IMC and IMC MeOH solvate (Z’=1) which show 
significant conformational differences, in order to rationalise structurally related changes in the 
spectra. This information was used to analyse the more complex structure of α-IMC. Three main 
regions of the 13C spectrum, i.e., aliphatic region (0-60 ppm), aromatic region (90-145 ppm) and 
carbonyl and methoxy (C5) motifs (150-190 ppm) can be distinguished. To analyse conformational 
differences between IMC polymorphs, it is important to rationalise changes in the peak position 
(13C and 1H) related to the molecular conformation. The structural and spectral details gained from 
the known structures of IMC were applied to enable evaluation of conformational differences in 
IMC form IV and IMC form V. As IMC form V was obtained via desolvation of the IMC methanol 
solvate, we focused on changes in the peak positions and intensities for both forms and compared 
these to previously assigned peaks of the spectrum of γ-IMC. Here we report solid-state NMR 
spectra of the IMC methanol solvate and forms IV and V of IMC, the application of GIPAW 
calculations to a pharmaceutical molecule with Z’=3 (α-IMC) and detailed assignment of all 13C sites 
in the crystal structures of α-IMC and IMC MeOH solvate for the first time.  
4.2.1.3 Solid-state NMR of γ-IMC 
The most stable form of IMC (γ-IMC) has one molecule in the asymmetric unit which is in agreement 
with single, narrow peaks found in the 1H-13C CP/MAS NMR spectrum, where each peak 
corresponds to one 13C site in the IMC structure, in agreement with the spectra published previously 
(Figure 4-6).[205,210,228,229] The structure of IMC has both quaternary and non-quaternary carbons, 
which can be identified using the 1H-13C CP/MAS NQS or 1H-13C HETCOR experiments, respectively. 
In the NQS experiment, non-quaternary carbons are supressed due to strong dipolar couplings 
between 13C and 1H nuclei (see methods chapter for details). Only 13C sites with bound protons 
104 | P a g e  
undergoing fast motions (e.g., CH3 group) are still visible in the spectra due to the decreased 
strength of 1H-13C dipolar interactions. The 1H-13C HETCOR experiment uses dipolar couplings to 
provide the map of connections between different 1H and 13C sites. By using the HETCOR 
experiment at short contact time we were able to only detect 13C nuclei which are directly bound 
to 1H nuclei, hence distinguish the presence of quaternary carbons in the spectrum. The presented 
13C projection (Figure 4-6) and 2D HETCOR spectrum at short CP contact time (Figure 4-7) is in 
excellent agreement with the previously published 2D INEPT (insensitive nuclei enhanced by 
polarisation transfer) spectrum by Bradley et al.[156] The distinction between quaternary (red) and 
non-quaternary (blue) carbons in the 1H-13C CP/MAS spectrum of γ-IMC can be easily observed 
(Figure 4-6). By acquisition of the 1H-13C CP/MAS spectrum at high field (20 T) alongside application 
of the chemical shift calculations, we were able to gain sufficient separation of different 13C sites 
for complete assignment of the spectrum. With the exception of overlapping peaks for carbons C15, 
C19 and C2, C6, it was possible to distinguish all 13C sites and correlate them with 1H sites using 1H-
13C 2D HETCOR experiment (Figure 4-6, Figure 4-7).  
Interestingly, there was a large shift and splitting of the C17 peak between the spectra recorded at 
9.4 T (δC17=141.7 ppm) and 20.0 T (δC17=139.0 ppm). This can be explained by the second-order 
effects between 13C and 35Cl,37Cl due to large quadrupolar moments of chlorine isotopes. This effect 
was previously observed by Apperley et al. for γ-IMC and described in detail.[144] At high magnetic 
field (B0) the C-Cl site is predicted to be a 1:1 doublet composed of two powder patterns in 
agreement with our 13C spectra recorded at 20.0 T. Using perturbation theory, the authors 
calculated (C-Cl) the effective dipolar coupling constant (D’) of 576 Hz for 35Cl and quadrupole 
coupling constant (χ) of −67 MHz (assuming positive anisotropy of J in order of 100 Hz).[144] 
Additionally, at 16.4 T authors observed a splitting of one C17 site, which was explained as JCCl 
coupling of ca. −40 Hz. This value is in agreement with literature data of JCCl in range from −20 to 
−10 Hz.[230–232] Parameters (D’, χ) calculated by Apperley et al. are in excellent agreement with 
values obtained with MagresView[233] for geometry optimised γ-IMC (INDMET[178]) being χ=−67.5 
MHz and D’=570 Hz. The effect of chlorine on two other sites of chlorophenyl ring (C16 and C18) 
was displayed as peak broadening in 1H-13C CP/MAS spectrum acquired at 9.4 T and in 1H-13C 
HETCOR spectrum as clear doublet, likely due to better decoupling efficiency through the use of LG 
based heteronuclear decoupling pulse sequence in HETCOR experiment (Figure 4-6, Figure 4-7). 
Similar observation was made for the 1H-13C CP/MAS and 1H-13C HETCOR spectra of the IMC MeOH 
solvate (Figure 4-10, Figure 4-12).  
105 | P a g e  
 
Figure 4-5. Visualisation of EFG (blue ellipsoids) and dipolar couplings for γ-IMC from chlorine to 
three carbon atoms in the chlorophenyl ring, which are in 3 Å proximity from chlorine (marked as 
a grey sphere). The strengths of quadrupolar constant and dipolar couplings were calculated using 
MagresView.[233] 
 
Figure 4-6. From the top: 1H-13C CP/MAS solid-state NMR spectra of γ-IMC acquired at 20.0 and 9.4 
T, 1H-13C CP/MAS NQS and 13C projection of 1H-13C HETCOR solid-state NMR spectra of γ-IMC (9.4 
T). Spectra acquired at 10 kHz (9.4 T) and 13 kHz (20.0 T). Spinning sidebands are labelled with 
asterisks. Carbon labelling is based on GIPAW calculations (quaternary carbons are labelled in red 
and non-quaternary carbons are labelled in blue in agreement with scheme in Figure 4-1A). 
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There are two published 1H and 13C chemical shift GIPAW calculations of the γ-IMC structure which 
are in a very good agreement with our calculations (Table 4-2).[228,229] Ukmar et al. focused on 
general computational details, comparing different approaches in geometry optimisation and 
different types of pseudopotentials used in DFT calculations together with simplified assignment of 
the 1H and 13C spectra, but included no details on structural analysis.[228] Bradley et al. presented 
the differences in the calculated 1H chemical shifts of a single IMC molecule and full periodic crystal 
structure of γ-IMC, discussing in detail the effects of CH-π interactions on the differences between 
them. These authors used quantitative analysis of 1H DQ build-up curves to investigate subtle 
differences in the 1H-1H proximities in the crystal structure.[229] Neither group discussed changes in 
the 13C chemical shifts, which are a rich source of structural information. We therefore evaluated 
the use of both 1H and 13C chemical shifts to investigate structural relationships between different 
IMC polymorphs. For the conformational analysis, changes in the position of carbon peaks C4 and 
C6 (with respect to the position of methoxy group) and carbons C15-C19 (position of chlorophenyl) 
are of high importance, as these motifs differ significantly between the structures (Figure 4-1). As 
reported by Bradley et al. changes in the 1H chemical shifts can be directly related to CH-π 
interactions, hydrogen bonds or close interactions to the highly electronegative nuclei. It is 
important to note that the values of chemical shift of the methyl hydrogens H12 and H11 are 
calculated as an average of three chemical shifts of three different protons. The motional averaging 
of the CH3 motif is not implemented in GIPAW calculations and the calculated chemical shifts differ 
quite significantly (usually one 1H chemical shift differs ca. 1 ppm from the two others depending 
on its position with respect to the aromatic ring or electronegative nuclei in close proximity). To 
further evaluate the effect of the molecular conformation on the changes of the chemical shifts, 
we used geometry optimised isolated molecules of IMC extracted from three different crystal 
structures (INDMET[178]; INDMET02[179] and BANMUZ[185]) as models. 
The 1H CRAMPS spectrum of γ-IMC also agrees with the previously published spectra.[228,229] There 
are only four peaks in the spectrum making the assignment challenging (Figure 4-8), however 
combined analysis of the 1H-13C 2D HETCOR experiment and GIPAW calculations enabled the 
assignment of the different proton sites (Figure 4-7), which is in agreement with previously 
published data.[228,229] The first peak in the spectrum at ca. 2 ppm is assigned to aliphatic protons 
H9, H11 and H12; while the two peaks at ca. 6 and 7 ppm are due to the aromatic protons in the 
structure. The remaining peak at ca. 12 ppm can be assigned to the carboxylic motif. Hydrogen H16, 
which is a part of the chlorophenyl ring, has a significantly different value of chemical shift (ca. 1 
ppm) compared to three other protons in the same ring (Figure 4-7), which is due to the aromatic 
ring current interactions between H16 and the centre of the chlorophenyl ring of the neighbouring 
IMC molecule, which is in close proximity to H16 (3.42 Å).[156]  
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The other hydrogens of the chlorophenyl ring (H15; H18; H19) form close contact inter- and 
intramolecular interactions (ca. 2.6 Å) with oxygens, which may have a deshielding effect on the 
surrounding electronic cloud, leading to downfield shifts of the peaks. 
 
Table 4-2. Experimental (exp) and calculated (calc) 13C and 1H isotropic chemical shifts for γ-IMC. 
Nonquaternary carbons are labelled in blue. 
13C 
site 
δexp δcalca δcalcb δcalcc δmolb δmolc 
1H 
site 
δexp δcalca δcalcb δcalcc δmolb δmolc 
C1 136.7 138.4 140.0 138.1 140.2 138.7        
C2 112.7 111.9 115.2 111.2 114.9 113.8        
C3 131.0 132.0 132.4 131.3 131.5 130.4        
C4 98.0 95.5 95.6 94.4 92.6 91.8 H4 5.4 6.1 5.8 5.8 6.3 6.3 
C5 156.8 157.8 158.4 157.9 158.9 158.3        
C6 112.7 114.8 111.1 113.7 111.3 111.1 H7 5.9 6.2 5.9 5.8 5.8 5.8 
C7 115.8 115.0 115.4 114.2 113.6 112.9 H6 6.1 6.5 6.1 6.0 5.8 5.8 
C8 131.0 131.5 131.0 130.9 130.4 130.8        
C9 28.3 28.1 25.6 24.7 22.2 21.7 H9 1.8 
1.9; 
2.1 
1.4; 
1.7 
1.5; 
1.7 
3.3; 
3.6 
3.3; 
3.5 
C10 179.1 177.0 180.2 178.0 171.8 169.4        
C11 55.2 54.9 54.4 52.9 51.7 50.4 H11 2.4 2.5^ 2.3^ 2.3^ 3.5 3.5 
C12 13.7 14.1 11.2 10.5 6.9 6.3 H12 2.1 2.2^ 1.8^ 1.8^ 2.1 2.1 
C13 167.8 167.7 169.4 167.6 167.9 166.2        
C14 134.5 134.4 134.0 133.6 135.0 134.3        
C15 132.0 132.3 132.4 132.1 130.6 130.2 H15 7.2 7.5 7.2 7.1 6.8 6.8 
C16 127.2 126.6 128.0 126.2 128.6 128.4 H16 5.7 6.2 5.6 5.5 6.6 6.6 
C17 141.7 144.0 145.4 143.3 145.6 143.2        
C18 130.3 129.7 130.3 129.3 129.1 126.7 H18 7.1 7.4 7.0 6.9 6.9 6.8 
C19 132.0 133.1 134.1 132.9 132.2 131.4 H19 7.2 7.7 7.1 7.2 7.3 7.2 
       OH 12.8 14.4 14.4 14.1 7.2 7.3 
aUkmar et al.[228], bBradley et al.,[156] cour calculations,  
^average of three calculated 1H chemical shifts for CH3 groups 
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Figure 4-7. 1H-13C HETCOR spectrum of γ-IMC (9.4 T) acquired at 10 kHz. Cross-peaks between 1H 
and 13C enable to assignment of 1H spectra. 
 
Qualitative (and quantitative) information on the close proximities between different 1H sites in the 
crystal structure can be elucidated from both 1H SQ-1H DQ correlation and 1H-1H NOESY 
experiments in solid-state NMR. Spectral resolution is a highly important factor and determines the 
usefulness of 1H data in qualitative and quantitative analysis. Two approaches can be used to 
improve the resolution of 1H spectra; for “medium” field spectrometers moderate spinning rates 
and well optimised pulse sequences with CRAMPS decoupling gave excellent results (in our case 9.4 
T and 6.8 kHz spinning speed), while for high field spectrometers application of fast MAS probes 
eliminates the need for use multipulse sequences as CSA and dipolar interactions are partly 
overcome by MAS (in our case 20.0 T with 78 kHz spinning speed). We used both approaches; firstly, 
collecting the complete dataset at lower field using CRAMPS decoupling based pulse sequences and 
then validating the data using the UK 850 MHz Solid-State NMR Facility.  
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Figure 4-8. Top: 1H-1H SQ-DQ CRAMPS spectrum of γ-IMC (intramolecular short contacts are 
labelled in purple, while intermolecular short contacts are labelled in green). Bottom: 1H-1H 
CRAMPS NOESY spectrum of γ-IMC (cross-peaks between different 1H sites are labelled with 
different colours). Both spectra were acquired at 9.4 T, at an MAS rate of 6.8 kHz for the best 
decoupling performance determined experimentally. Labelling of 1H sites is based on GIPAW 
calculations and 1H-13C HETCOR experiment. 
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1H-1H SQ-DQ correlation spectroscopy is a powerful technique for structural studies, as it enables 
the determination of 1H sites in close proximity (up to 3.5 Å). The 1H SQ-1H DQ spectrum of γ-IMC 
(Figure 4-8) is in an excellent agreement with the spectra published previously by Bradley et al. and 
Pham et al.[69,229] There are four resolved resonances; one aliphatic, two aromatic and one for -OH 
protons. Due to the low resolution of the spectra, it is not possible to extract all structural 
information without knowing the crystal structure. The only well separated peak of the OH group 
gives a DQ peak at δDQ=25.0 ppm corresponding to the formation of a centrosymmetric discrete 
carboxylic acid homodimer synthon with O-H∙∙∙H-O proximity of 2.34 Å (for the geometry optimised 
structure). Two additional close intermolecular proximities of the OH group to H6 and H19 give DQ 
peaks at δDQ=19.8 ppm and 19.1 ppm, corresponding to the distances of 2.95 and 2.53 Å 
respectively. Other DQ correlations can be found at ca. δDQ=13.6 ppm, assigned to the 
intermolecular close contacts between aromatic protons H15 and H16 (2.43 Å) and H6 and H18 
(2.29 Å) of neighbouring molecules. The most intense aliphatic 1H peak at ca. δDQ=4 ppm is due to 
the close contact of the protons in two CH3 groups (H11 and H12). 
Complementary structural information can be extracted from the 1H-1H NOESY experiment in solid-
state NMR, which correlates hydrogen atoms in close contacts up to 4 Å.[234] The spectral resolution 
is lower compared to the 1H-1H SQ-DQ correlation experiment, due to the lack of chemical shift 
spread for DQ frequency in the F1 dimension of the spectrum. For the -OH group, it is possible to 
distinguish three cross-peaks: two with aromatic protons (H18 and H6), which were also observed 
in the 1H-1H SQ-DQ experiment, and one with aliphatic protons. The 1H-1H NOESY spectrum also 
shows correlations between both aromatic peaks (H15 and H16, H7 and H15/H19) at 5.8 ppm (F1) 
and 6.9 ppm (F2), and further between aliphatic peak at 2.0 ppm (F1) and both aromatic peaks at 
5.8 and 6.9 ppm (F2). These can be assigned based on the known structure of γ-IMC to 
intramolecular close contacts between H4 and H11 (2.37 Å) and H4 and one of the H9 hydrogens 
(2.55 Å), and intermolecular close contacts between hydrogens H11-H18; H12-H15 and H9-H19.  
In summary, we have shown that the results of our combined computational and solid-state NMR 
methodology to study structure of γ-IMC is in agreement with previously published data.[156,228] 
Therefore, this approach was applied to investigate structural and conformational differences 
between other forms of IMC presented in further sections. The correlation between the position of 
the methoxy group (C11) and the chlorophenyl ring in known structures of IMC and chemical shifts 
of carbons and hydrogens sensitive to conformational changes was applied to elucidate structural 
information for IMC form IV and IMC form V. The analysis of both 13C and 1H chemical shifts in this 
study enabled us to gain structural information for systems with low crystallinity and Z’>1, where 
application of only 1H NMR is difficult or not possible due to overlapping and broadening of the 
peaks.   
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4.2.1.4 Solid-state NMR of IMC methanol solvate 
The IMC methanol solvate has one indomethacin molecule in the asymmetric unit alongside an 
additional methanol molecule, leading to the same number of peaks in the 1H-13C CP/MAS NMR 
spectrum as for γ-IMC, with one additional peak at 49.3 ppm arising from the methanol carbon 
(Figure 4-10). The conformation of IMC in the crystal structure of the IMC MeOH solvate differs 
significantly from that in the structure of γ-IMC (Figure 4-1B; γ-IMC in yellow; IMC MeOH solvate in 
green). These differences include (i) position of the chlorophenyl ring with respect to the C12 and 
C7 sites, (ii) position of the methoxy group (C13) with respect to the carbons (and hydrogens) C6 
and C4 (H6 and H4) sites, and (iii) hydrogen bonding between the carboxylic acid motif involving 
the MeOH molecule and the carboxylic acid group of IMC. These structural changes can be deduced 
from the differences in the 1H and 13C chemical shifts between γ-IMC and IMC MeOH solvate (Figure 
4-6 and Figure 4-10). 
 
 
Figure 4-9. A. Hydrogen bonds between IMC MeOH solvate. B. View along crystallographic b axis. 
C. View along crystallographic c axis. Yellow boxes indicate channels in the structure. 
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Apart from the results of our recent studies there is no detailed structural or spectroscopic data on 
the IMC MeOH solvate.[88] The full assignment of the 1H-13C CP/MAS NMR spectrum was performed 
using the same method as for γ-IMC, using the BANMUZ[185] structure from the CCDC for CASTEP 
calculations (Figure 4-10, Table 4-3). Through acquisition of the 1H-13C CP/MAS NMR spectra at both 
9.4 and 20.0 T, it was possible to distinguish and assign all the 13C resonances, including a crowded 
aromatic region of the spectrum. The 1H and 13C chemical shifts calculated using GIPAW are in good 
agreement with the experimental data (Table 4-3). Compared to γ-IMC, the 1H-13C CP/MAS NMR 
spectrum of the IMC MeOH solvate shows several significant differences in the position of the 
13C peaks. The most pronounced change relates to the position of carbons C4 and C6, which 
undergo down- and upfield shifts of 7.5 and 6.9 ppm, respectively, compared to γ-IMC. Most likely, 
this is due to the change in the position of the methoxy group (C11) with respect to carbons C4 and 
C6. The differences between the conformation of the chlorophenyl ring with respect to the methyl 
group (C12) and carbon C7 were observed as a clear separation of the 13C sites of the chlorophenyl 
ring in the IMC MeOH solvate structure but not in γ-IMC. The two most significant changes in the 
IMC MeOH spectrum as compared to the γ-IMC structure are related to the position of carbons C16 
(upfield shift of 1.3 ppm) and C19 (downfield shift of 1.9 ppm). The change in the position of C16 
may be related to the position of this site with respect to the chlorophenyl ring of neighbouring 
IMC molecule as discussed by Bradley et al.[156] The position of H16 (and C16) in the IMC MeOH 
solvate is still in close proximity to the centre of the chlorophenyl ring (3.39 Å), however the 
geometry of the interaction is significantly different. The downfield shift of C19 can be attributed 
to inter- and intramolecular close contacts of this site to carbonyl C13 (2.22 and 2.73 Å, 
respectively). This is further corroborated by changes in peak positions in the 1H spectrum. The 
carboxylic acid carbon (C11) peak of the solvate undergoes three distinct changes: an upfield shift 
from 179.3 to 176.3 ppm, broadening, and decrease in intensity. The latter are most likely related to the 
close proximity of the methanol molecules in the solvate, forming the 𝑅4
4(12) ring motif, as shown in 
Figure 4-3. 
Assignment of 1H chemical shifts for the IMC MeOH solvate was carried out using the 1H-13C HETCOR 
spectrum and GIPAW chemical shifts calculations (Figure 4-12, Table 4-3). As solvent 1H peaks can 
overlap with the 1H spectrum of the drug, crystallisation of IMC from deuterated methanol was 
performed. The 1H spectrum shows excellent separation of different 1H sites at both fields (9.4 and 
20.0 T, Figure 4-12). There are only two overlapping peaks in the 1H spectrum acquired at 20.0 T 
(H16 and H18 at 6.0 ppm, and H4 and H15 at 6.9 (shoulder) and 6.6 ppm). The GIPAW calculated 1H 
chemical shifts are also in excellent agreement with the experimental data (Table 4-3). The 
comparison of 1H chemical shifts between IMC MeOH solvate and γ-IMC shows significant 
differences, again related to the different conformation of IMC molecules in each crystal structure. 
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In the GIPAW calculated 1H chemical shifts of isolated molecules, there was one large chemical shift 
difference (of 2 ppm) for the H7 peak, shifting upfield from 7.8 ppm (IMC MeOH solvate) to 5.8 ppm 
(γ-IMC). This change is likely due to the CH-π interaction between H7 and centre of the chlorophenyl 
ring (2.93 Å) as previously described by Bradley et al.[156] and is further corroborated by the 0.6 ppm 
change in the calculated chemical shifts of H12 between both conformations. Similar effects of the 
aromatic ring on 1H (and 13C) chemical shifts are frequently observed in solution-state NMR 
spectroscopy of organic molecules and are used in structural studies of substituted aromatic 
molecules.[235–237] The effect of the electric current of the ring on the chemical shift can be 
calculated using density functional theory and it is known as nucleus-independent chemical shift 
(NICS, Figure 4-10).[238,239]  
 
Table 4-3. Experimental (exp) and calculated (calc) 13C and 1H isotropic chemical shifts of IMC MeOH 
solvate. Nonquaternary carbons are labelled in blue. 
13C site δexp δcalc δmol 1H site δexp δcalc δmol 
C1 134.8 133.8 132.6     
C2 113.7 112.8 112.4     
C3 132.4 130.6 131.0     
C4 105.5 102.3 101.4 H4 6.9 6.8 6.4 
C5 156.7 158.0 159.2     
C6 105.8 103.2 103.0 H6 5.3 5.3 6.4 
C7 116.1 116.0 116.2 H7 8.4 8.3 7.8 
C8 133.0 132.5 133.4     
C9 29.8 27.6 26.5 H9 3.0;3.9 3.1;4.1 3.4;3.7 
C10 176.1 178.2 174.2     
C11 54.1 51.8 51.3 H11 2.2 2.3 3.5 
C12 14.5 10.7 8.4 H12 0.8 1.1 1.5 
C13 166.4 166.0 167.0     
C14 137.4 134.7 134.9     
C15 131.8 129.8 126.9 H15 6.6 6.5 7.1 
C16 125.9 123.5 126.1 H16 6.0 5.8 6.7 
C17 139.6 140.4 142.5     
C18 129.9 128.4 128.1 H18 6.0 6.0 6.8 
C19 133.9 133.6 130.7 H19 8.7 8.4 6.8 
MeOH 49.3 47.7 - OH 11.8 13.0 7.9 
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Figure 4-10. From the top: 1H-13C CP/MAS solid-state NMR spectra of IMC MeOH solvate acquired 
at 20.0 and 9.4 T, 1H-13C CP/MAS NQS and 13C projection of 1H-13C HETCOR solid-state NMR spectra 
of IMC MeOH solvate (9.4 T). Spectra acquired at 10 kHz (9.4 T) and 13 kHz (20.0 T). Spinning 
sidebands are labelled with asterisks. Carbon labelling is based on GIPAW calculations (quaternary 
carbons are labelled in red and non-quaternary carbons are labelled in blue in agreement with 
scheme in Figure 4-1A). 
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Figure 4-11. Nucleus-independent chemical-shift (NICS) map of a phenol. The colours reflect the 
chemical shift change of the nucleus, when placed in close proximity to the phenol ring. Different 
values are expected for IMC due to differences in the distribution of electronic cloud. Adapted from [239]. 
 
Although the effect of the aromatic ring current on the chemical shifts in 1H solution-state NMR is 
well recognised, similar observations in solids are not frequently described. The examples include 
supramolecular assembles of dendritic polymers and intercalated polymers in aromatic 
nanochannels.[239,240] The shielding effect of the ring in the IMC MeOH solvate on H12 is less 
pronounced when compared to the same effect on H7 in γ-IMC conformation due to the larger 
distance of H12 in the IMC MeOH solvate to the centre of the ring (3.30 Å) and different geometry 
of the interaction. Another significant change was related to the position of the H6 peak, which 
undergoes a downfield shift in the BANMUZ conformation, relating to the change of position of the 
methoxy group (C11) with respect to hydrogen H6. Both trends (for H12 and H6 chemical shifts) 
were confirmed in further conformational calculations of chemical shifts for isolated α-IMC 
molecules, which have similar conformations to either γ-IMC or IMC MeOH solvate (see Table 4-5). 
A difference between the calculated 1H chemical shifts for an isolated molecule and a molecule in 
the periodic crystal structure can be an indication of strong intermolecular interactions.[156]  
The calculated chemical shifts of four hydrogens of the isolated molecule (H6, H11, H19 and OH 
site) differ significantly (by more than 1ppm) from experimental and calculated data for the 
crystalline structure, which can be explained through the hydrogen bonding between the OH 
groups of IMC and MeOH in the crystal structure. The downfield shift of H19 (of ca. 2 ppm) can be 
attributed to close contact interactions between H19 and the three neighbouring carbonyl groups 
in the crystal structure. Additionally, the upfield shifts of H11 (2.64 Å from the indole ring centre) 
and H6 may be due to the shielding effect of the indole ring and close proximity of two chlorophenyl 
rings, respectively, when compared to calculated 1H chemical shifts for the isolated molecule. 
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Figure 4-12. Top: 1H-13C HETCOR spectrum of IMC MeOH solvate; bottom: 1H spectra of IMC MeOH 
solvate acquired at 20.0 T and an MAS rate 78 kHz and 1H CRAMPS spectrum acquired at 9.4 T and 
an MAS rate of 6.8 kHz. 
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Figure 4-13. Top: 1H-1H SQ-DQ CRAMPS spectrum of IMC MeOH solvate (intramolecular short 
contacts are labelled in purple, while intermolecular short contacts are labelled in green). Bottom: 
1H-1H CRAMPS NOESY spectrum of IMC MeOH solvate (cross-peaks between different 1H sites are 
labelled with different colours). Both spectra were acquired at 20.0 T, at an MAS rate of 78 kHz. 
Labelling of 1H sites is based on GIPAW calculations and 1H-13C HETCOR experiment. 
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1H-1H close contacts in the IMC MeOH solvate crystal structure were investigated further with 1H-
1H SQ-DQ and 1H-1H NOESY experiments (Figure 4-13). The map of 1H-1H connectivity becomes 
especially important for further studies of IMC form V, as this structure is formed during the 
removal of MeOH from the channels of the IMC solvate. In the 1H-1H SQ-DQ spectrum of the IMC 
MeOH solvate, nine distinct 1H sites were identified. However, due to the exchange of the OH 
hydrogens with deuterium (from deuterated methanol) correlations with the hydroxyl group were 
not visible in either the 1H-1H SQ-DQ or 1H-1H NOESY spectra (Figure 4-13). A distinct intermolecular 
correlation at δDQ=17.1 ppm (δSQ=8.7 + δSQ=8.4 : H7-H19) from three neighbouring IMC molecules 
in the close distance of ca. 3.1 Å was observed. Further intramolecular short contact interactions 
were seen for neighbouring protons of aromatic rings (H19- H18, δDQ=14.7 ppm; H6-H7, δDQ=13.7 
ppm; H15- H16, δDQ=12.6 ppm). An interesting correlation was highlighted between H4 and both 
H9a and H9b sites at δDQ=10.8 ppm and δDQ=9.9 ppm, respectively, assigned to the intramolecular 
close contacts between H4 and H9b (2.50 Å) and between H4 and both H9a and H9b sites (2.73 Å 
and 3.10 Å, respectively). The H4 site was further correlated with the H11 site of a neighbouring 
molecule, indicated by a peak at δDQ= 9.1 ppm. Assignment of the two inequivalent H9 sites was 
made through correlation of one site with H12 at δDQ= 3.9 ppm, and further correlation between 
both H9 sites at δDQ=6.9 ppm. The position of the methoxy group in close proximity to H6 (2.23 Å) 
was confirmed by a distinct peak at δDQ=7.4 ppm. The conformation of the chlorophenyl ring with 
respect to H12 was confirmed through correlation between H12 and H15 at δDQ= 7.4 ppm due to 
intra- (2.61 Å) and intermolecular (2.56 Å) close proximities. Structural information gained from the 
1H-1H SQ-DQ spectrum was further complemented by the 1H-1H NOESY spectrum (Figure 4-13). The 
low intensity cross-peak between H15 and H19 is due to overlay of the chlorophenyl rings of two 
neighbouring IMC molecules with both hydrogens almost parallel to each other, 3.83 Å apart. 
Further distinction between different H9 sites was made based on cross-peaks between H4 and 
H9b (in green) and H12 and H9a (in blue). The methoxy group hydrogens (H11) show several cross-
peaks between H6, both H9 sites and overlapping aromatic protons H16/18. The intramolecular 
close contact between H11 and H6 explains only one of the correlations. The additional cross-peaks 
are most likely due to intermolecular close contacts of IMC molecules aligned antiparallel to each 
other (H11 to H18 = 3.34 Å; H11 to H9b = 3.48 Å). The 1H-1H NOESY spectrum is however less 
informative due to lower resolution in the F1 dimension, overlapping peaks, and the presence of 
artefacts.  
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4.2.1.5 Solid-state NMR of α-IMC 
α-IMC is a frequently studied polymorph of IMC.[60,179,205,212,213,215,216,228,241] Partial assignment of the 
13C spectra was presented in initial solid-state NMR studies published by Masuda et al. and Ukmar 
et al.[205,228] To best of our knowledge, GIPAW computational studies of α-IMC have not been 
published due to the large number of atoms in the unit cell (246), which significantly increases 
computational time.[228] α-IMC has three molecules in the asymmetric unit (Molecule A, Molecule 
B and Molecule C - see Figure 4-3 and Figure 4-14 for details). The molecules A and B form a 
hydrogen-bonded carboxylic acid dimer; with molecule C forming a hydrogen bond between the 
carboxylic acid and the amide carbonyl (C13) of molecule B (Figure 4-3). All the three molecules are 
in different conformations. Molecule A follows a similar conformation to γ-IMC, whilst the 
conformation of molecule B is the same as the conformation found for the IMC MeOH solvate. The 
position of the methoxy group in the molecule C overlays with γ-IMC, but differs in the 
conformation of the chlorophenyl ring (see Figure 4-1 and Figure 4-14).  
We firstly compared the calculated 1H and 13C chemical shifts of isolated molecule A and molecule 
B with previously calculated 1H and 13C chemical shifts of isolated γ-IMC and IMC MeOH solvate, 
respectively, due to the conformational similarities between them. Based on the chemical shift 
calculations and experimental spectra we concluded that the position of the methoxy group (C11) 
is highly correlated with the 13C chemical shifts of C6 and C4. When the CH3 group is in close contact 
(ca. 2.1 Å) with H4 (for molecule A, molecule C and γ-IMC), the shielding effect of this motif gives a 
calculated C4 peak position at 91-95 ppm. The C6 carbon in this conformation has a chemical shift 
in the range of 108-111 ppm (see Table 4-2, Table 4-3 and Table 4-4). 
 
Figure 4-14. A. An overlay of molecule A, molecule B and molecule C forming crystal structure of α-
IMC; B. packing of α-IMC (INDMET02[179]) – molecules forming asymmetric unit are labelled in 
different shades of blue. 
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If the CH3 group (C11) is in close contact with C6 (ca. 2.1 Å) the calculated chemical shift of this site 
undergoes a dramatic upfield shift to 101-103 ppm with a concomitant shift of C4 by ca. 10 ppm to 
101-103 ppm. Understanding the correlation between the conformation of the chlorophenyl ring 
and 13C peak position changes is more challenging. The carbon sites which could be affected by 
close proximity of the ring (C12 and C7) do not show significant chemical shift differences between 
the conformations. However, the calculated chemical shift of C1 is sensitive to the position of the 
chlorophenyl ring: with molecule A and γ-IMC at ca. 138 ppm, molecule C at 143 ppm, and molecule 
B and BANMUZ conformations at a significant upfield shift of 132 ppm (see Table 4-2, Table 4-3 and 
Table 4-4). The conformational changes were correlated further with changes in the 1H chemical 
shifts. The most pronounced difference was related to the position of H7. If H7 is in close contact 
(ca. 2.9 Å) with the centre of the chlorophenyl ring (molecules A and C, γ-IMC); the calculated value 
of the H7 chemical shift is 5.6-5.8 ppm. A significant downfield shift (of 2 ppm) is observed when 
the chlorophenyl ring is no longer in close contact with H7. In this conformation the ring is close 
(ca. 3.1 Å) to H12, manifested in an upfield shift of H12 of ca. 1 ppm (see Table 4-2, Table 4-3 and 
Table 4-5). As indicated by Bradley et al. these changes can be used as a direct measure of the CH-
π interactions and can be further applied to obtain structural information in other systems where 
aliphatic and aromatic motifs can be present in close proximity. [156] 
Changes in calculated 13C and 1H chemical shifts due to molecular flexibility can be used further to 
help assign the complex 1H-13C CP/MAS NMR spectrum of α-IMC. The acquired spectrum of α-IMC 
is in agreement with previously published spectra.[205,228] Three molecules in the asymmetric unit of 
α-IMC result in three peaks in the 13C spectrum for each carbon atom (Figure 4-15). To distinguish 
between different molecules in the asymmetric unit, we used the following peak labelling system 
for 13C sites: CX_Y, where X is the carbon number according to the labelling in Figure 4-1, and Y 
indicates molecule A, molecule B or molecule C according to the labelling in Figure 4-3 and Figure 
4-14.  
There are nine well resolved peaks from the three different molecules in the asymmetric unit in 
aliphatic region of the spectrum (0-60 ppm). The assignment of these sites were based on GIPAW 
calculations. Due to small differences in the calculated chemical shifts for carbon C11, it was not 
possible to distinguish clearly between the three different IMC molecules using calculated and 
experimental 13C chemical shifts. In this case the 1H-13C HETCOR experiment alongside GIPAW 
calculated 1H chemical shifts were used, and showed that H11_A site was shifted upfield (1.4 ppm) 
compared to H11_B and H11_C (2.1 ppm). The carbonyl region of the 1H-13C CP/MAS NMR spectrum 
(150-190 ppm) has only one overlapping peak, which was assigned to C10_C and C13_C. All peaks 
in this part of the spectrum are in good agreement with calculated chemical shifts for the 
INDMET02[179] crystal structure. There was a significant difference between the experimental 
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position of the carbonyl peaks of the crystalline material and calculated 13C chemical shifts for 
isolated molecules. These changes are due to the formation of hydrogen bonds between a) the 
carboxylic motif (C10_A, C10_B), which shift downfield by 12 and 6 ppm, respectively, and b) C13_B, 
which shifts 6 ppm downfield due to hydrogen bonding with molecule C.  
 
Table 4-4. Experimental (exp) and calculated (calc) 13C isotropic chemical shifts of α-IMC and 
calculated 13C chemical shifts of isolated molecules (mol) A, B and C. Non-quaternary carbons are 
labelled in blue. 
13C site 
 δexp   δcalc   δmol  
Mol A Mol B Mol C Mol A Mol B Mol C Mol A Mol B Mol C 
C1 137.6 133.2 137.6 139.7 134.0 143.0 138.4 131.4 143.0 
C2 110.5 115.5 111.8 113.3 118.0 114.5 113.8 116.5 113.7 
C3 130.5 134.9 133.2 131.3 135.1 133.9 130.6 134.2 132.3 
C4 97.1 105.8 97.8 95.7 105.5 96.5 95.1 103.4 92.0 
C5 155.5 156.8 154.5 156.6 157.9 155.8 158.8 158.1 157.1 
C6 111.2 104.7 110.5 110.5 101.4 106.9 111.3 101.3 107.9 
C7 114.9 114.9 114.9 115.0 115.2 113.9 114.4 115.3 113.8 
C8 130.5 130.5 130.5 129.1 132.0 132.9 128.0 133.2 131.9 
C9 30.9 28.4 27.4 28.0 25.3 24.6 23.9 21.4 21.6 
C10 179.1 180.3 166.0 176.6 183.3 168.0 167.1 174.0 163.5 
C11 51.2 53.4 52.0 50.7 50.7 50.2 51.7 51.2 50.7 
C12 12.9 11.2 13.6 9.0 8.4 11.2 6.9 8.5 8.7 
C13 170.1 171.4 166.0 169.5 169.9 164.1 170.0 168.2 165.0 
C14 133.2 133.2 136.4 134.2 135.0 137.8 136.1 138.3 138.8 
C15 131.0 129.9 129.9 132.2 130.6 130.9 128.5 129.8 129.0 
C16 129.5 128.6 128.7 129.6 127.7 128.9 127.8 126.9 127.5 
C17 140.9 137.6 140.9 144.2 142.7 144.7 142.8 140.6 146.6 
C18 127.7 129.9 131.5 127.6 130.4 134.5 127.4 128.4 131.6 
C19 129.5 131.0 131.0 130.2 132.8 133.2 128.1 129.1 129.9 
 
The most difficult region of the spectrum to assign is the crowded and highly overlapping aromatic 
part between 120 and 140 ppm. The peaks in this region describe 27 carbons from three different 
molecules making the assignment difficult. Better resolution was achieved in the aromatic part of 
the spectrum from 90 to 120 ppm, where it was possible to identify and assign the position of 
important carbons C6 and C4. The calculated 13C chemical shifts for the crystalline structure are in 
agreement with the data for isolated molecules. Based on the conformational studies we were able to 
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distinguish two molecules (A and C) with the CH3 group in close contact to C4 (H4) and one molecule (B) 
with the methoxy group in close proximity to C6 (H6) (Figure 4-15).  
 
Figure 4-15. From the top: 1H-13C CP/MAS solid-state NMR spectra of α-IMC acquired at 20.0 and 
9.4 T, 1H-13C CP/MAS NQS and 13C projection of 1H-13C HETCOR solid-state NMR spectra of α-IMC 
(9.4 T). Spectra acquired at 10 kHz (9.4 T) and 13 kHz (20.0 T). Spinning sidebands are labelled with 
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asterisks. Carbon labelling is based on GIPAW calculations (quaternary carbons are labelled in red 
and non-quaternary carbons are labelled in blue in agreement with scheme in Figure 4-1A). 
 
Figure 4-16. Top: 1H-13C HETCOR spectrum of α-IMC; bottom: 1H spectra of α-IMC acquired at 20.0 
T and spinning speed of 78 kHz and 1H CRAMPS spectrum acquired at 9.4 T and spinning speed of 
6.8 kHz. The assignment of proton spectra was made based on 1H-13C HETCOR spectrum of α-IMC 
and CASTEP calculations. 
 
Assignment of the 1H spectrum was based on the 1H-13C HETCOR experiment and GIPAW chemical 
shift calculations for α-IMC (Figure 4-16, Table 4-5). The calculated and experimental chemical shifts 
are in good agreement. There are nine peaks in the 1H spectrum acquired at 20.0 T (78 kHz MAS 
rate), with a similar number of sites observed in the 1H CRAMPS spectrum recorded at 9.4 T (6.8 
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kHz MAS rate). The majority of the peaks overlap but there is good separation for the OH groups 
indicating high sensitivity of 1H solid-state NMR spectroscopy to different hydrogen bonding 
patterns. Separation of H12_B was achieved due to its close contact with the centre of the 
chlorophenyl ring leading to a significant (ca. 2 ppm) upfield shift of this site compared to molecules 
A and C. Further understanding of the α-IMC crystal packing was gained through the comparison of 
calculated and experimental 1H chemical shift changes between isolated molecules and molecules 
forming a crystal (Table 4-5). Significant differences were found between calculated chemical shifts 
of the OH groups between isolated molecules and molecules in α-IMC structure (4.3-5.7 ppm), 
explained due to OH groups forming hydrogen bonds between IMC molecules in the crystal 
structure. Further differences were highlighted between hydrogens H19_B, H18_A and H18_B, 
(downfield shift of ca. 1 ppm as compared to the calculated 1H chemical shifts for isolated 
molecules), due to short contact interactions with the electronegative oxygen from the 
neighbouring molecules. Similar changes were observed in the spectra of γ-IMC and IMC MeOH 
solvate. The differences between the calculated 1H chemical shifts for H11 of isolated molecules 
and molecules forming the crystal structure can be related to the short contact (ca. 2.8 Å) 
interaction of the centre of the six carbon part of the indole ring with the CH3 group. Interestingly, 
all three molecules in the unit cell show almost identical stacking interactions, where the C11 
methoxy group is located below the six carbon part of the indole ring. Additionally, an upfield shift 
of 1.2 ppm (H12_B) when compared to the calculated 1H chemical shift of the isolated molecule 
may be related to similar CH-π interactions, as this motif forms short contact interactions with the 
indole ring in the crystal structure.  
 
Table 4-5. Experimental (exp) and calculated (calc) 1H isotropic chemical shifts of α-IMC and 
molecules isolated from α-IMC crystal structure. 
1H site 
 δexp   δcalc   δmol  
Mol A Mol B Mol C Mol A Mol B Mol C Mol A Mol B Mol C 
H4 6.0 6.8 6.8 5.6 6.4 6.4 6.8 6.3 6.4 
H6 6.0 6.0 6.0 4.8 5.2 5.6 5.8 6.4 5.7 
H7 6.0 8.2 6.0 5.3 8.6 5.8 5.6 8.0 5.7 
H9 4.0 4.0 4.4 3.7;4.0 2.7;3.7 3.9;4.3 3.1;3.6 3.3;3.5 3.5;3.7 
H11 1.4 2.0 2.0 1.4 2.1 2.1 3.6 3.5 3.5 
H12 2.3 0.0 2.3 2.3 -0.1 2.0 2.4 1.2 2.1 
H15 6.8 6.0 6.8 6.6 5.7 6.5 6.5 6.6 6.6 
H16 6.0 6.8 6.0 4.7 6.7 5.5 6.6 6.6 6.6 
H18 8.2 6.0 8.2 7.8 6.1 7.9 6.9 6.8 7.0 
H19 6.8 8.2 6.8 6.1 8.1 6.5 7.0 7.0 7.2 
OH 12.5 12.5 11.0 14.5 13.5 12.0 6.8 7.3 6.7 
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Figure 4-17. Top: 1H-1H SQ-DQ CRAMPS spectrum of α-IMC (intramolecular short contacts are 
labelled in purple, while intermolecular short contacts are labelled in green). Bottom: 1H-1H 
CRAMPS NOESY spectrum of α-IMC (cross-peaks between different 1H sites are labelled with 
different colours). Both spectra were acquired at 20.0 T, at an MAS rate of 78 kHz. Labelling of 1H 
sites is based on GIPAW calculations and 1H-13C HETCOR experiment. 
 
126 | P a g e  
Further structural analysis of α-IMC crystal packing was based on the 1H-1H SQ-DQ and 1H-1H NOESY 
experiments (Figure 4-17). It is possible to distinguish nine 1H sites in the F2 dimension in the 
1H-1H SQ-DQ spectrum, which shows good separation of the OH group of molecule C (δSQ=11.0 ppm) 
and OH groups from both molecules A and B (δSQ=12.5 ppm). Similarly to the 1H-1H SQ DQ spectrum 
of γ-IMC, correlations between both OH groups of molecule A and molecule B due to hydrogen-
bonded carboxylic acid dimer were observed at δDQ=25.0 ppm. 
Additional intermolecular correlations of both OH_A and OH_B hydroxyl groups were observed at 
δDQ=19.0 ppm (OH_B-H19_C;H7_C; ca. 3.2 Å), δDQ=16.8 ppm (OH_B-H9_A; 3.25 Å), δDQ=15.3 ppm 
(OH_A-H9_B; 2.85 Å), δDQ=14.3 ppm (OH_A-H11_A; 3.13 Å) and δDQ=12.8 ppm (OH_A-H12_B; 2.73 
Å). The hydroxyl group of molecule C had only one clear correlation at δDQ=20.0 ppm, assigned to a 
short contact with hydrogen H19_B of the neighbouring IMC molecule. Two short intermolecular 
contacts of H7_B with H19_B (3.11 Å) and H18_A (2.69 Å) were observed at δDQ=17.1 ppm. The 
intramolecular interactions between aromatic ring hydrogens (H15, H16, H18, H19) are grouped in 
two correlated peaks at δDQ=15.1 and 13.1 ppm. An intramolecular short contact between H7_B 
and H6_B can be observed at δDQ=14.4 ppm. It is also possible to correlate hydrogens H18_A/C with 
H16_A/C of neighbouring molecules, which form stacked layers with chlorophenyl rings in close 
proximity (these inter- and intramolecular correlations overlap, hence they are labelled with 
dashed lines in Figure 4-17). The hydrogens of the H12_B form a well separated peak at δSQ=0.0 
ppm, which has clear correlations with four other sites including the previously described OH_A 
peak. This correlation was used to confirm the position of one of the H9_B sites at δSQ=2.8 ppm, 
which is in agreement with the GIPAW calculated 1H chemical shift (2.7 ppm). The close proximity 
of H12_B with the chlorophenyl ring hydrogens H15_B (2.75 Å) and H19_B (3.22 Å) is reflected in 
correlated peaks at δSQ=5.9 and δSQ=8.5 ppm, respectively; in agreement with calculated values. 
Based on the information from the H12_B correlations, we were able to confirm the position of the 
second H9_B site at δSQ=4.0, δDQ=6.8 ppm, and also H4_B site at δDQ=10.6 ppm, which is close to 
H9_B hydrogen (2.57 Å). The two peaks overlap with a correlated pair of hydrogens (H9_C and 
H4_C), which have very similar chemical shift values (Table 4-5). Similarly, the well separated peak 
of H11_A (δSQ=1.4 ppm) also confirms the conformation of the methoxy group with respect to H4_A 
at ca. δDQ=7 ppm, as this site overlaps with H12_A/C and H11_A/C, resulting in a broad peak centred 
at δDQ=7.8 ppm. Due to the highly overlapping aromatic part of the spectra centred at δSQ=6.0 and 
6.8 ppm, it is not possible to unequivocally isolate correlations of all individual 1H sites. 
The 1H-1H NOESY spectrum recorded at relatively short mixing time (150 ms) is easier to interpret 
(Figure 4-17). Under these conditions, there were no hydroxyl cross-peaks. The cross-peak at δ= 8.1 
ppm (F1) and δ=7.0 ppm (F2) between aromatic sites H19_B-H18_B and H18_A/C-H19_A/C 
(labelled in light blue) was similar to the 1H-1H SQ-DQ spectrum. Further short contacts between 
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aromatic protons were observed as a cross-peak at δ=6.7 ppm (F1) and δ=6.0 ppm (F2) (labelled in 
red). Intramolecular short contacts between hydrogens H9_A/C and H4_A/C were shown as a cross-
peak at δ=4.1 ppm (F1) and δ=6.0 ppm (F2) and δ=6.7 ppm (F2), respectively. There was a strong 
correlation (cross-peak at δ=2.4 ppm (F1) and δ=4.0 ppm (F2)) between the aliphatic protons 
(H12_A/C, H11_A/C) and H9_A/C due to short intramolecular distances. The methyl protons 
showed two further correlations with aromatic sites at δ=6.0 ppm and δ=6.5 ppm (F2) due to 
intramolecular contacts with protons H4_A/C and H6_B, and several intermolecular contacts with 
neighbouring molecules. The separated H12_B site had two correlations, i.e., an intramolecular 
cross-peak with one of the H9_B protons (2.09 Å) and an intermolecular correlation with H11_A 
site (2.87 Å) at δ=0.0 ppm (F1) and δ=1.6 ppm (F2). 
In summary, we have presented for the first time detailed structural and computational studies for 
α-IMC. We proposed full assignment of 1H and 13C spectra based on the chemical shift calculations 
and 1H-13C HETCOR experiment. It needs to be emphasised that experimental identification of the 
13C peaks from independent molecules forming the structure is required to confirm the spectral 
assignment. This can be achieved using 13C-13C INADEQUATE experiment at natural abundance and 
will be a part of future work. Conformational studies of isolated molecules forming α-IMC using 
CASTP were in agreement with the results from γ-IMC and the IMC MeOH solvate. This enabled us 
to confirm the 1H and 13C sites in the IMC structure, which highly sensitive to the conformational 
changes. 
4.2.1.6 Solid-state NMR of IMC form V 
Careful desolvation of the IMC MeOH solvate yielded IMC form V. The solvent escaped from the 
crystal structure at room temperature over a period of a couple days or weeks depending on the 
sample size and desolvation conditions. The process can be accelerated at elevated temperatures, 
as described by Joshi et al.[180] Based on our experience, the desolvation at elevated temperatures 
often led to concomitant crystallisation of IMC form V alongside two other thermodynamically 
more stable forms (α- and γ-IMC). It was possible to monitor this process using solid-state NMR and 
hot stage microscopy. The room temperature transition of the IMC MeOH solvate to IMC form V 
occurred without an intermediate phase which was confirmed using 1H-13C CP/MAS NMR (Figure 
4-18). New peaks of IMC form V appeared and the intensity of IMC MeOH solvate peaks decreased 
gradually, with decreasing solvent content.  
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Figure 4-18. 1H-13C CP/MAS NMR spectra of IMC MeOH solvate recorded during desolvation at room 
temperature. The content of MeOH was measured using TGA analysis. Numbers in brackets indicate 
the stoichiometric ratio. Arrows indicate most pronounced changes in the spectrum. 
 
 
 
Figure 4-19. A. Hot stage microscopy images and showing desolvation process of IMC MeOH solvate 
and formation of IMC form V.  
 
Hot stage microscopy showed the presence of fine fine shiny needles of the IMC MeOH solvate, 
which upon desolvation became more opaque (Figure 4-19 A) and their melting at ca. 403-408 K, 
in line with the melting temperature of IMC form V.[88,180] Again, no other intermediate phase was 
detected.  
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As IMC form V is formed via desolvation of the IMC MeOH solvate, the 1H and 13C spectra of this 
polymorph will be discussed in comparison with the spectrum of the IMC MeOH solvate. There are 
several differences in the spectrum of IMC form V as compared to the IMC MeOH solvate. Firstly, 
the methanol carbon peak disappears and the C11 peak undergoes downfield shift from 54.1 to 
ca. 56 ppm. Secondly, splitting of different carbon sites indicates the presence of two molecules in 
the asymmetric unit, in agreement with the space group and unit cell parameters derived from 
PXRD data (Figure 4-20). C10, which is involved in the hydrogen bonding of the solvate, undergoes 
a downfield shift and splitting, indicating the presence of two magnetically non-equivalent 
carboxylic acid motifs. As shown above, the position of the C4 and C6 peaks are good indicators for 
the conformation of the methoxy group (C11) with respect to both C4 (H4) and C6 (H6) sites.  
 
Table 4-6. Experimental (exp) 1H and 13C chemical shifts of IMC form V compared with experimental 
1H and 13C chemical shifts of IMC MeOH solvate. Non-quaternary carbons are labelled in blue. 
13C site δexp (MeOH) δexp (form V) 1H site δexp (MeOH) δexp (form V) 
C1 134.8 130-135    
C2 113.7 112.9;113.6    
C3 132.4 130-135    
C4 105.5 104.4;105.0 H4 6.9 6.1;7.1 
C5 156.7 156.3;156.6    
C6 105.8 106.1;106.7 H6 5.3 5.0 
C7 116.1 116.4 H7 8.4 8.4 
C8 133.0 130-135    
C9 29.8 28.4;29.8 H9 3.0;3.9 2.2;2.7;3.8 
C10 176.1 179.8;180.7    
C11 54.1 55.8;56.1 H11 2.2 2.2;2.7 
C12 14.5 13.1;13.7 H12 0.8 0.6 
C13 166.4 167.1;167.5    
C14 137.4 136.8    
C15 131.8 125-134 H15 6.6 6.1-8.4 
C16 125.9 125-134 H16 6.0 6.1-8.4 
C17 139.6 136.8    
C18 129.9 125-134 H18 6.0 6.1-8.4 
C19 133.9 125-134 H19 8.7 6.1-8.4 
MeOH 49.3 - OH 11.8 12.4 
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Figure 4-20. From the top: 1H-13C CP/MAS solid-state NMR spectra of IMC form V acquired at 20.0 
and 9.4 T, 1H-13C CP/MAS NQS and 13C projection of 1H-13C HETCOR solid-state NMR spectra of IMC 
form V (9.4 T). Spectra acquired at 10 kHz (9.4 T) and 13 kHz (20.0 T). Spinning sidebands are labelled 
with asterisks. Carbon labelling is based on similarities with previously assigned spectra of IMC 
polymorphs and MeOH solvate (quaternary carbons are labelled in red and non-quaternary carbons 
are labelled in blue in agreement with scheme in Figure 4-1A). The numbers in the zoomed region 
of the spectrum indicate integration of different 13C sites. 
131 | P a g e  
The C4 peaks and C6 peaks at ca. 105 ppm and 106 ppm, respectively, indicate that the 
conformation of methoxy group (C11) does not change significantly upon desolvation and transition 
to IMC form V in both inequivalent molecules in the asymmetric unit. Although the considerably 
complex aromatic region of the 1H-13C spectrum (125 ppm to 140 ppm) could not be assigned fully, 
it was possible to distinguish between the non-quaternary carbons of the chlorophenyl ring (125-
134 ppm), quaternary carbons of the indole ring and carbons C14 and C17 of the chlorophenyl ring 
(130-140 ppm).  
Through assignment of the 1H-13C CP/MAS and 1H-13C HETCOR spectra it was possible to partly 
assign the 1H spectrum of IMC form V (Figure 4-21). The 1H spectrum of IMC form V shows nine 
peaks which are broadened in comparison to the 1H spectrum of the IMC MeOH solvate, due to the 
presence of two inequivalent molecules in the asymmetric unit and low crystallinity of the material, 
leading to an increased distribution of 1H sites. The peak positions are similar to those for the IMC 
MeOH solvate. There are several important features in the spectrum which enable the 
identification of the conformation of IMC molecules in the asymmetric unit. The highest sensitivity 
indicator for the position of the chlorophenyl ring with respect to H7 and H12 is the chemical shift 
value of H7 (and H12). The shielding effect of the chlorophenyl ring leads to a significant upfield 
shift of H7 if in close proximity. A similar, but less pronounced effect, is observed for the H12 site. 
Based on the 1H-13C HETCOR spectrum and similarities between the 1H-13C CP/MAS spectra of 
different IMC polymorphs, it was possible to assign the C7 site at 116.4 ppm and correlate it with 
the H7 site at ca. 8.4 ppm. The peak position of the H7 site in IMC form V was very similar to that 
of H7 in the 1H spectrum of the IMC MeOH solvate indicating close proximity of the chlorophenyl 
ring to the methyl H12. This is further corroborated by only a minor shift of 0.2 ppm for the H12 
peak towards a lower field in the 1H spectrum of IMC form V as compared to IMC MeOH solvate 1H 
spectrum (Figure 4-21).  
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Figure 4-21. Top: 1H-13C HETCOR spectrum of IMC form V; bottom: 1H spectra of IMC form V and 
IMC MeOH solvate acquired at 20.0 T and spinning speed of 78 kHz and 1H CRAMPS spectrum of 
IMC form V acquired at 9.4 T and spinning speed of 6.8 kHz. 
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Figure 4-22. Top: 1H-1H SQ-DQ CRAMPS spectrum of IMC form V (intramolecular short contacts are 
labelled in purple, while intermolecular short contacts are labelled in green). Bottom: 1H-1H 
CRAMPS NOESY spectrum of IMC from V (cross-peaks between different 1H sites are labelled with 
different colours). Both spectra were acquired at 20.0 T, at an MAS rate of 78 kHz. Labelling of 1H 
sites is based on 1H-13C HETCOR experiment. 
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Additional information on the intra- and intermolecular close proximities for the IMC form V 
structure can be extracted from 1H-1H SQ-DQ and 1H-1H NOESY spectra (Figure 4-22). The 1H-1H SQ-
DQ spectrum of IMC form V showed correlation between the OH groups at δDQ=24.8 ppm, which 
indicates that molecules in the crystal structure are stabilised by a carboxylic acid dimer similarly to 
the α- and γ-IMC structures. The OH site also showed two intermolecular close contacts between 
H6 and H9/H11 at ca. δDQ=17.4 ppm and δDQ=14.8 ppm, which were previously observed in the 1H-
1H SQ-DQ spectra of α- and γ-IMC. 
Clear correlation between neighbouring H6 and H7 sites were observed at δDQ=12.7 ppm and 
δDQ=13.3 ppm due to interactions with both methyl sites (H11 and H12 at δDQ=12.7 ppm and 
δDQ=13.3 ppm). The position of H6, and its close proximity to the H11 site, was confirmed by a 
correlation peak at δDQ=7.4 ppm. Three intramolecular close contacts of H9 were observed in the 
spectrum: H9 correlation with H12 at δDQ=3.25; correlation between inequivalent H9 (a and b) sites 
at δDQ=6.4 ppm; and correlation with aromatic protons (H4) at δDQ=10.3 and δDQ=11.0 ppm, which 
is in agreement with the position of two H4 sites determined using 1H-13C HETCOR. Further 
correlations between different aromatic sites in the highly overlapped region between 6.1 and 8.4 
ppm were also found.  
Two distinct correlations between the OH group and both methyl sites and H9 were observed in 
the 1H-1H NOESY spectrum (labelled in blue and yellow - Figure 4-22). The correlations may indicate 
further similarities between the desolvated crystal (IMC form V) and the IMC MeOH solvate; where 
the OH group is in close proximity to one of the H9 protons (3.16 Å), the two methyl protons H11 
and H12 (2.93 and 3.41 Å) and the H12 motif. The H7 site had correlations between aromatic 
protons at 6.1 and 7.0 ppm, and one isolated correlation with H6 at 5.0 ppm. The H6 site was shown 
to be in intermolecular close contact with other aromatic hydrogens of the chlorophenyl ring 
through cross-peaks at 6.1 and 7.0 ppm.  The correlation between H9/H11 sites with H6 site was 
also clearly visible in the 1H-1H NOESY spectrum providing further evidence of the conformation of 
the methoxy group in the structure. Additionally, the aliphatic H9/H11 site shows an intense cross-
peak with the aromatic site at 6.1 ppm, and smaller shoulder at 7.0 ppm, which is likely due to 
intramolecular close contact of the H9 site with H4 and intermolecular close contacts of both 
H9/H11 with neighbouring molecules.   
The solid-state NMR analysis of IMC form V indicates that there are two molecules in the 
asymmetric unit, which show similar conformations to the IMC MeOH solvate structure. The 
similarities between the 1H-13C CP/MAS spectra and 1H MAS spectra of IMC form V and IMC MeOH 
solvate suggest the desolvation of the structure leads to changes in the packing of the molecules 
rather than changes in the molecular conformation. We were able to confirm the conformations of 
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the methoxy group C11 and the chlorophenyl ring through analysis of the position of C6 and C4 
sites in the 1H-13C CP/MAS spectrum and the H7 site in 1H MAS spectrum. Additionally, the 1H-1H 
SQ-DQ spectra enabled us to confirm the assignment of the 1H spectrum through the dipolar 
correlations, and provided evidence for structure stabilisation through the hydrogen bonded 
carboxylic acid dimer, to α- and γ-IMC, as correlation between OH groups in the spectrum was 
observed.  
4.2.1.7 Solid-state NMR of IMC form IV 
To best of our knowledge the existence of IMC form IV has been reported only once in 1974 by 
Borka.[203] Form IV has been frequently confused with the already described IMC form V (δ) due to 
their similar melting points. 
 
Table 4-7. Experimental (exp) 1H and 13C chemical shifts of IMC form IV compared with experimental 
1H and 13C chemical shifts of γ-IMC. Non-quaternary carbons are labelled in blue. 
13C site δexp (γ-IMC) δexp (form IV) 1H site δexp (γ-IMC) δexp (form IV) 
C1 136.7 128.0-140.0    
C2 112.7 112.0;113.2    
C3 131.0 128.0-140.0    
C4 98.0 98.8 H4 5.4 4.7;6.1 
C5 156.8 155.4    
C6 112.7 112.0;113.2 H6 5.9 4.7;5.4 
C7 115.8 112.0;113.2 H7 6.1 4.7;5.4 
C8 131.0 128.0-140.0    
C9 28.3 29.1;30.0 H9 1.8 2.1 
C10 179.1 178.8;180.4    
C11 55.2 55.1;56.2 H11 2.4 3.1 
C12 13.7 13.1;13.9 H12 2.1 0.7;1.3 
C13 167.8 167.6;168.3    
C14 134.5 128.0-140.0    
C15 132.0 127.0-133.0 H15 7.2 4.7-7.2 
C16 127.2 127.0-133.0 H16 5.7 4.7-7.2 
C17 141.7 128.0-140.0    
C18 130.3 127.0-133.0 H18 7.1 4.7-7.2 
C19 132.0 127.0-133.0 H19 7.2 4.7-7.2 
  - OH 12.8 12.0 
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Figure 4-23. From the top: 1H-13C CP/MAS solid-state NMR spectra of IMC form IV acquired at 20.0 
and 9.4 T, 1H-13C CP/MAS NQS and 13C projection of 1H-13C HETCOR solid-state NMR spectra of IMC 
form IV (9.4 T). Spectra acquired at MAS rates of 10 kHz (9.4 T) and 13 kHz (20.0 T). Spinning 
sidebands are labelled with asterisks. Carbon labelling is based on similarities with previously 
assigned spectra of IMC polymorphs and MeOH solvate (quaternary carbons are labelled in red and 
non-quaternary carbons are labelled in blue in agreement with scheme in Figure 4-1A). The 
numbers in the zoomed spectra indicate integration of different 13C sites. 
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Although we attempted to obtain the structural parameters of this form from PXRD data it was not 
possible to index the highly broadened PXRD pattern. However, we were able to obtain some 
structural information through solid-state NMR spectroscopy. The 1H-13C CP/MAS spectrum of IMC 
form IV showed two peaks for each carbon site indicating the presence of two non-equivalent 
molecules in the asymmetric unit. The close proximity of the methoxy group C11 to the carbon C4 
was confirmed through the values of chemical shift of carbons C4 and C6 at ca. 99 and 112 ppm, 
respectively, which were similar to the C4 and C6 values for γ-IMC and molecules A and C of α-IMC 
(Figure 4-23, Table 4-7). The 13C aromatic peaks of the chlorophenyl ring were in similar position 
compared to the position of the same motif in the γ-IMC, indicating further structural similarities 
(Figure 4-23, Table 4-7).  
The assignment of different 1H sites was conducted based on the 1H-13C HETCOR experiment (Figure 
4-24). The 1H spectrum of IMC form IV shows three distinct regions. Firstly, the aliphatic protons 
(H9, H12 and H11) are observed as a highly overlapping set of four peaks grouped between 0.8 and 
3.5 ppm. The aromatic protons of the indole ring (H4, H6 and H7) have a broad peak between 4.5 
and 5.5 ppm; and the chlorophenyl ring protons are grouped together as two peaks at ca. 6 ppm 
with two deshielded sites at ca. 7 ppm. The conformation of the chlorophenyl ring can be 
determined based on the chemical shift value of the H7 site.  
As discussed previously, the CH-π shielding interactions between H7 and the chlorophenyl ring lead 
to a drastic upfield shift of the H7 peak from 8.4 ppm to ca. 5 ppm. The position of the H7 site for 
IMC form IV structure (as observed in the 1H-13C HETCOR experiment) indicated a close proximity 
between the chlorophenyl ring and H7 site.  
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Figure 4-24. Top: 1H-13C HETCOR spectrum of IMC form IV; bottom: 1H spectra of IMC form IV 
acquired at 20.0 T and spinning speed of 78 kHz and 1H CRAMPS spectrum of IMC form IV acquired 
at 9.4 T and MAS rate of 6.8 kHz. 
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Figure 4-25. Top: 1H-1H SQ-DQ CRAMPS spectrum of IMC form IV (intramolecular short contacts are 
labelled in purple, while intermolecular short contacts are labelled in green). Bottom: 1H-1H 
CRAMPS NOESY spectrum of IMC from IV (cross-peaks between different 1H sites are labelled with 
different colours). Both spectra were acquired at 20.0 T, at an MAS rate of 78 kHz. Labelling of 1H 
sites is based on 1H-13C HETCOR experiment. 
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Unfortunately, little information could be extracted from the 1H-1H SQ-DQ and 1H-1H NOESY 
experiments due to overlapping peaks (Figure 4-25). The correlation peak between OH groups from 
two different molecules at δDQ=24.0 ppm indicates the formation of the carboxylic acid dimer, 
which may stabilise the structure in a similar way to γ-IMC. Splitting of the chlorophenyl ring 
protons into two peaks at ca. 6 and 7 ppm, as determined through 1H-13C HETCOR experiment, was 
confirmed by both the 1H-1H SQ-DQ correlation peak at δDQ=13.3 ppm and the distinct correlation 
in 1H-1H NOESY spectrum (labelled in red - Figure 4-25). The chlorophenyl ring was confirmed as 
being in close proximity to the H7 and H6 site, through correlation of these sites with aromatic 
protons at δDQ=11.8 and δDQ=11.0 ppm, and through the NOESY correlation peak at ca. 6 ppm (F2) 
and 5 ppm (F1) (labelled in light blue - Figure 4-25). Although the intramolecular correlation 
between H4 and H11 and H9 can be observed in both the 1H-1H SQ-DQ and 1H-1H NOESY spectra, it 
is also possible that other hydrogens in close proximity participate in the interaction due to 
overlapping peaks in both spectra.  
The 13C spectral analysis of IMC form IV suggests the presence of two IMC molecules in the 
asymmetric unit with similar conformation to γ-IMC. The chemical shifts of carbons C4 and C6 
indicate close proximity of the methoxy group (C11) to C4, whilst chemical shift of hydrogen H7 to 
ca. 5 ppm confirmed its close proximity to the chlorophenyl ring. The highly overlapping 1H 
spectrum of IMC form V was not very informative, however the visible correlation peak of both OH 
groups did indicate stabilisation of the structure via carboxylic acid dimer.  
4.2.2 Summary of the solid-state NMR structural studies on IMC form IV and form V 
IMC form V formed through the desolvation of the IMC MeOH solvate has been confused frequently 
in the scientific literature with IMC form IV, obtained by annealing of the amorphous glass, due to 
the similar melting temperature of both crystals at ca. 403 K. In our spectroscopic and diffraction 
studies significant differences between both structures have been demonstrated, unequivocally 
proving structural differences between both crystal forms. The combined use of computational and 
spectroscopic approaches for five different forms of IMC enabled significant understanding of the 
structures. Both molecules in the asymmetric unit of IMC form V were found to be closely related 
to the conformation of the IMC MeOH solvate. Methanol escaping from the crystal may induce 
some disorder. Changes in hydrogen bonding patterns and conformation of the carboxylic acid 
motif were reflected by significant differences in the position of both H9 and C10 peaks between 
the solvate and IMC form V. The presence of two molecules in the asymmetric unit, as determined 
with solid-state NMR, is in line with previous structural studies based on the PXRD.  
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Figure 4-26. Summary of the conformational analysis of IMC form IV and IMC form V based on the 
combined experimental and computational 1H and 13C chemical shifts. Chemical shifts of different 
1H and 13C sites sensitive to the conformation of chlorophenyl ring and methoxy group are labelled 
with red dots together with experimental chemical shift values.  
 
IMC form IV has two molecules in the asymmetric unit which are related conformationally to γ-IMC. 
Both γ-IMC and IMC form IV can be obtained by annealing of the amorphous IMC glass. IMC form IV 
was formed by annealing of quenched, intact glass below 363 K: all other conditions lead to the 
formation of γ-IMC. This indicates that overcoming an energy barrier is required to form the 
thermodynamically most stable γ-IMC. Taking into account the crystallisation procedure of both 
IMC forms (γ-IMC and IMC form IV) from the amorphous state, it is not surprising that a) they are 
conformationally related and b) they are both stabilised through the formation of a carboxylic acid 
dimer. Detailed structural analysis of IMC polymorphs is of importance in a pharmaceutical field as 
IMC is frequently investigated model in crystallisation research. Furthermore, IMC is widely used as 
a model for poorly soluble compound in studies of amorphous solid dispersions. Due to this it is of 
importance to investigate possible crystallisation pathways of IMC from an amorphous state for 
better understanding of stability and nucleation processes in glassy solids. 
4.2.3 Future work and concluding remarks 
Although significant progress has been made towards understanding structures of IMC form IV and 
form V through the application of the combined computational and solid-state NMR approach 
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presented in this chapter, the ultimate goal of solving the crystal structures of both polymorphs is 
yet to be achieved. The mechanism of the IMC MeOH solvate desolvation and its effect on the 
decreased crystallinity of the material will be investigated further through the combined application 
of computational and experimental methods sensitive to local environment of atoms (solid-state 
NMR) and long range ordering (PXRD). This approach was recently demonstrated to be successful 
in investigation of structural disorder of orotic acid, which shows a significant decrease of 
crystallinity upon desolvation (DMSO solvate) and dehydration of the crystal.[242]  
4.2.3.1 NMR studies 
In order to fully assign IMC structures with Z’>1 it is essential to distinguish 13C peaks from different 
molecules in the asymmetric unit. This can be achieved by correlating neighbouring carbon atoms 
through the use of J-couplings. In order to do that, it is possible to use INADEQUATE experiment in 
solid-state NMR, even at natural abundance.[146,243,244] Our attempt to record the INADEQUATE 
spectrum at UK 850 MHz Solid-State NMR Facility using a sample with natural abundance was not 
successful. This is likely due to fast decay of transverse magnetisation, which in turn is related to a 
short T2 relaxation time. We are now in the process of applying for instrumental time at Nottingham 
DNP MAS NMR Facility in order to enhance the detection of 13C-13C J-coupling correlations at natural 
abundance, as was shown recently by Pinon et al.[245] The identification of 13C signals from 
independent molecules in the IMC crystals with Z’>1 would enable complete assignment of the 13C 
and 1H spectra based on the combined experimental and computational approach and gain a 
detailed knowledge of the structure of IMC, which is an important model in crystallisation research. 
The detailed structural information would enable us to confirm that some parts of the IMC are 
highly sensitive towards conformational changes, which could have more general application in 
NMR crystallography.   
4.2.3.1 Computational studies 
In collaboration with Prof. Chris Pickard at Cambridge University we used AIRSS[246] (Ab Inition 
Random Structure Searching) methodology in order to find possible structures of IMC form V. 4000 
structures were generated using as constraints space group and cell parameters obtained from 
indexed PXRD pattern, and IMC MeOH solvate without methanol molecules as a starting structure. 
The 20 lowest energy structures predicted using AIRSS, and geometry optimised with CASTEP, did 
not match any of the experimental PXRD patterns. Although the conformation of IMC in the 
predicted structures was in agreement with IMC conformation determined using NMR studies 
presented in this chapter, none of the structures was stabilised through the hydrogen-bonded 
carboxylic acid dimer. With structural information obtained from solid-state NMR and 
conformational studies and new developments in AIRSS, we expect to repeat structures search 
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using additional constraints. Additionally, in collaboration with Dr Doris Braun at University of 
Innsbruck, we are going to perform a crystal search using similar approach as presented for orotic 
acid. This is only possible due to the conformational information elucidated with solid-state NMR, 
as computations for flexible molecules in large unit cells and with Z’>1 are very expensive.  
Through the application of structural information obtained from solid-state NMR we believe it will 
be possible to use CSP methods in order to find feasible structures for both IMC crystals. This in 
turn will enable us to explain in details the process of desolvation of IMC.  This will be relevant to 
other systems, where new low crystallinity polymorphs are formed after desolvation.  
Even more challenging is the explanation of nucleation processes in amorphous glasses, which, as 
was shown for IMC, lead to formation of either γ-IMC or IMC form IV depending on annealing 
conditions. Through the comparison of molecular packing and hydrogen bonding patterns in both 
IMC polymorphs (γ-IMC and IMC form IV), it might be possible to find spectral features in 
amorphous materials which would enable us to gain in depth understanding of this process.  
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5 Controlled crystallisation and 
stabilisation of IMC form V 
within MCF and CPG porous 
solids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5  
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Findings from this chapter are published as: 
K. P. Nartowski, J. Tedder, D. E. Braun, L. Fábián and Y. Z. Khimyak, 2015, Building solids inside nano-space: from confined 
amorphous through confined solvate to confined ‘metastable’ polymorph, Phys. Chem. Chem. Phys., 17 (38), 24761-24773  
5.1 Introduction 
In the previous chapter we discussed polymorphism of a frequently used model drug IMC and its 
detailed structural and conformational flexibility using solid-state NMR spectroscopy. Furthermore, 
we proved structural differences between two metastable IMC polymorphs, i.e., form IV and form 
V. In this work we have studied nano-crystallisation of IMC encapsulated within MCF and CPG 
porous solids via careful control of the confined structures from amorphous to crystalline states. 
With its well described polymorphism and phase transitions IMC is an excellent model compound 
for nano-crystallisation research.  
 
 
 
Figure 5-1. Multi-step phase transformation of confined IMC; from confined amorphous IMC to a 
stabilised metastable IMC form V, via a confined solvate. 
 
Recently, SBA-15 mesoporous silica has been demonstrated to be a suitable host for the 
stabilisation of amorphous IMC loaded via an incipient wetness method.[41] An attempt to crystallise 
IMC ‘inside’ the pores of MCM-41 and SBA-15 materials was recently made by Ukmar et al.[86,87,247] 
Although the authors suggested selective crystallisation of one of the IMC polymorphs under 
mesoscopic confinement, the presented data show no decrease or broadening in the melting point 
of loaded drug, therefore cannot be described as confined crystallisation.[87] Moreover, the 
spectroscopic data are consistent with the presence of amorphous IMC in the pores, in agreement 
with Van Speybroeck et al.[41] In this work, for the first time we have shown multiple phase 
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transformations of the confined solids assuring in a critical and comprehensive way that all 
transitions take place inside the nanopores. Starting from confined amorphous IMC, through a 
confined IMC MeOH solvate, we show a novel method to crystallise and stabilise the rare and highly 
metastable IMC form V, a desolvation product.[180,185,220] We further demonstrate methods to 
control the drug phase through the effect of the pore size, loading procedure and guest content, 
which is of paramount importance for further industrial development. 
5.2 Results and discussion 
5.2.1 Loading efficiency and textural parameters of loaded materials 
Several methods have been applied for loading drug molecules into the porous silica hosts, 
including impregnation, incipient wetness, rotary evaporation, immersion, spray drying and melt 
loading.[39,40,73,85,248,249] The studies of crystallisation in the confined space require accurate control 
of experimental protocols to prevent the loading of the drug outside the pores. Furthermore, it is 
important to note that distinguishing between the confined drug species and the bulk phase outside 
the pore space often presents a significant characterisation challenge. We used two loading 
methods, i.e., incipient wetness and the melt loading method, for the encapsulation of 
indomethacin, and two different types of the silica hosts. The first one was the spherical (particle 
size 3-5 µm) MCF with ink-bottle like pores of 29.6 nm (Figure 5-2) in diameter interconnected by 
smaller windows (necks) of 11 nm as determined using nitrogen adsorption analysis (Figure 5-3). 
The second material was the commercially available unstructured CPG host with a mean pore size 
diameter of 55 nm and particle size of ca. 100-200 µm (Figure 5-2).  
 
 
Figure 5-2. SEM images of A. MCF host and B. CPG host. 
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5.2.1.1 N2 Adsorption-desorption isotherms 
When the MCF silica host is loaded from the melt a gradual decrease of the total pore volume and 
surface area as a function of an increasing drug content are observed from nitrogen adsorption–
desorption isotherms, indicating loading of the drug inside the pores. When the concentration of 
the embedded drug reaches 50 wt. % (MCF–IMC 50–50) the pores seem to be fully filled with the 
guest molecules (Figure 5-3, Table 5-1).  
 
Figure 5-3. Nitrogen adsorption–desorption isotherms of MCF host loaded with different ratios of 
IMC using the melting method. The isotherms are offset by 100 cm3 g−1. 
 
Table 5-1. Drug content in the MCF and CPG hosts and structural parameters of the hosts after melt 
loading. a 
Host-guest composite IMC (g g−1) Vtotal [cm3 g−1] dpore [nm] SBET [m2g−1] 
MCF N/A 1.613 29.6 333.2 
MCF-IMC 85-15 0.151 ± 0.003 1.290 26.2 233.9 
MCF-IMC 80-20 0.199 ± 0.010 1.225 30.0 220.1 
MCF-IMC 75-25 0.243 ± 0.016 1.134 23.3 203.0 
MCF-IMC 70-30 0.294 ± 0.010 0.880 25.8 167.8 
MCF-IMC 50-50 0.494 ± 0.013 0.056 N/A 28.1 
CPG N/A 1.2b 55.0b 50.4 
CPG-IMC 85-15 0.169 ± 0.010 - - 30.4 
CPG-IMC 80-20 0.218 ± 0.008 - - 33.3 
CPG-IMC 75-25 0.267 ± 0.018 - - 33.7 
CPG-IMC 70-30 0.285 ± 0.024 - - 15.4 
CPG-IMC 50-50 0.482 ± 0.032  - N/A 
a Vtotal – total pore volume calculated at P/P0 of 0.99, dpore – pore size diameter calculated from the 
adsorption branch using the BJH (Barrett–Jotyner–Halenda) method, SBET – the BET specific surface 
area. b data from the manufacturer. 
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The CPG host with large pores of 55 nm in diameter can be classified as being on the boundary 
between mesoporous and macroporous silica materials. The combination of melting point 
depression (onset and heat of fusion) and changes in N2 adsorption properties serve as a proof of 
the guest confinement. The loaded CPG silicas show some decrease of the BET specific surface area 
compared to the pure host (Table 5-1). However, the correlation between the drug content and 
decrease of surface area is not straightforward due to the relatively low value of the BET surface 
area of the host (i.e., for the CPG material it is ca. 49.5 m2 g−1 compared to 333.2 m2 g−1 for the MCF 
host). The presence of crystalline guest embedded within the CPG host can be illustrated by the 
broadening and decrease of the IMC melting point, which is indicative of small crystals.[93,106,115] 
5.2.2 Pore size diameter dependence of IMC recrystallisation from confined 
amorphous phase 
The MCF and CPG hosts loaded using the melting method at different drug to host ratios do not 
show signs of a crystalline phase, only a broad ‘halo’ signifying the lack of long range order is visible 
in the PXRD patterns. These results are corroborated by the solid-state NMR spectra of confined 
IMC within both the MCF and CPG hosts (Figure 5-4). The broadening of the indomethacin peaks is 
due to the increased distribution of possible orientations and magnetically non-equivalent 
environments of carbon atoms, typical of amorphous solids. The significant broadening of the 
spectra from 160 to 180 ppm, corresponding to the carboxylic acid carbon, may be related to the 
presence of a variety of hydrogen bonding environments and orientations. This could also be 
related to an increased mobility.[74,77]  
 
 
Figure 5-4. 1H–13C CP MAS NMR spectra of MCF and CPG hosts loaded with IMC using melting 
method at different host-drug ratios. 
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Although thermal properties and phase transitions of confined gases and liquids have been studied 
extensively, the effect of confinement on solids is still not understood fully. It is known that nano-
size crystals show a decrease and broadening of the melting point and the melting enthalpy of 
confined crystals is smaller in comparison to the bulk phase.[106,110,114,115] Upon heating, bulk 
amorphous indomethacin shows a glass transition (Tg) at ca. 310 K followed by recrystallisation of 
α- and γ-IMC at 373-473 K and the melting of the latter two polymorphs.[59] DSC thermograms of 
the MCF host loaded with indomethacin using the melting method do not show any crystallisation 
and melting processes, proving it is in an amorphous state and the size of the pores of MCF (ca. 30 
nm) prevents the thermally induced recrystallisation of indomethacin.  
 
Figure 5-5. DSC thermograms of CPG host loaded with IMC using melting method at different 
host:drug ratios. 
 
Interestingly, indomethacin confined within the larger pores of the CPG host (ca. 55 nm) shows a 
concentration dependent thermally induced crystallisation (Figure 5-5). No thermal transitions 
were observed at low concentrations of IMC (up to 25 wt. %). However, when the drug content 
reached 30 wt. %, recrystallisation of the amorphous indomethacin into both α- and γ-IMC is 
observed. Such recrystallisation occurs inside the pores, as confirmed by a decrease of the melting 
temperature and broadening of the melting peak (for CPG–IMC 70–30 Tm is 420.5 K, for CPG–IMC 
50–50 Tm is 419.8 K). Nevertheless, the two other peaks present on the DSC thermogram for the 
materials loaded with IMC at concentrations of 30 and 50 wt. % indicate the presence of the bulk 
crystalline α- and γ-IMC, which again signifies the importance of the loading protocol on the 
crystallisation outcome. 
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5.2.3 Solvent driven recrystallisation of confined amorphous IMC and stabilisation 
of confined IMC form V 
5.2.3.1 Changes in the textural properties of the host upon addition of the solvent 
A substantial increase in the total pore volume and the surface area of the products loaded with 
high concentration of the drug (MCF–IMC 70–30 and MCF–IMC 50–50) was observed after addition 
of the solvent (Figure 5-6, Figure 5-7, Table 5-2). This may indicate dissolution and rearrangement 
of the confined amorphous phase prior to further crystallisation or some leakage of the drug from 
the pores as melting of bulk crystalline IMC was detected in DSC studies of the composites loaded 
with 30 and 50 wt. % IMC (see section 5.2.3.2.2 and related figures). It is important to mention that 
careful control over the solvent volume (lower than Vtotal) and total content of the drug within the 
pores is crucial to avoid leakage of the drug. Large volumes of solvent and high drug content 
increase the risk of the drug leakage leading to inhomogeneous composites. This is discussed in 
details in section 5.2.3.2.1. 
 
 
 
Figure 5-6. Nitrogen adsorption–desorption isotherms of MCF host loaded with different ratios of 
IMC using the melting method and subsequently treated with MeOH. The isotherms are offset by 
100 cm3 g−1. 
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Table 5-2. Drug content in the MCF and CPG hosts and structural parameters of the hosts loaded 
using melting method and subsequently treated with MeOH. a 
Host-guest composite IMC (g g−1) Vtotal [cm3 g−1] dpore [nm] SBET [m2g−1] 
MCF N/A 1.613 29.6 333.2 
MCF-IMC 85-15 + 0.28 mL MeOH 0.161 ± 0.012 1.322 26.1 251.2 
MCF-IMC 80-20 + 0.28 mL MeOH 0.191 ± 0.070 1.206 23.1 260.0 
MCF-IMC 75-25 + 0.28 mL MeOH 0.245 ± 0.041 1.109 26.1 214.3 
MCF-IMC 70-30 + 0.28 mL MeOH 0.261 ± 0.027 1.042 26.0 204.8 
MCF-IMC 50-50 + 0.28 mL MeOH 0.471 ± 0.073 0.725 23.1 126.7 
CPG N/A 1.2b 55.0b 50.4 
CPG-IMC 85-15 + 0.28 mL MeOH 0.150 ± 0.001 - - 38.4 
CPG-IMC 80-20 + 0.28 mL MeOH 0.198 ± 0.003 - - 22.4 
CPG-IMC 75-25 + 0.28 mL MeOH 0.231 ± 0.002 - - 35.3 
CPG-IMC 70-30 + 0.28 mL MeOH 0.291 ± 0.003 - - 29.1 
CPG-IMC 50-50 + 0.28 mL MeOH 0.484 ± 0.012 - - 3.3 
a Vtotal – total pore volume calculated at P/P0 of 0.99, dpore – pore size diameter calculated from the 
adsorption branch using the BJH (Barrett–Jotyner–Halenda) method, SBET – the BET specific surface 
area. b data from the manufacturer. 
 
 
 
 
Figure 5-7. Total pore volume and BET surface area of MCF–IMC melt loaded samples before and 
after addition of the solvent. The total amount of IMC within the materials was determined using 
TG analysis. 
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5.2.3.2 Solvent induced amorphous to crystalline phase transition in confined space. 
To drive indomethacin crystallisation from an amorphous phase embedded within the porous MCF 
and CPG hosts, three organic solvents, i.e., methanol, ethanol and acetonitrile were used. It was 
reported previously that IMC crystallisation from acetonitrile always leads to the formation of γ-
IMC, while crystallisation from ethanol may yield either the α- or the γ-polymorph depending on 
the supersaturation ratio.[203,206] Borka’s first paper on indomethacin polymorphs indicated the 
formation of γ-IMC in a bulk acetonitrile solution and α-IMC on the walls of the crystallisation 
vial.[203] Crowley and Zografi reported the formation of IMC : methanol (1:1) solvate from hot 
methanol at a low supersaturation ratio.[212] As demonstrated by Joshi et al. and later by Surwase 
et al. this solvate may yield the metastable form V of IMC under careful desolvation. This form was 
reported to recrystallise subsequently into more stable polymorphs.[180,220] Using CPG host loaded 
with molten IMC at concentrations 15–25 % we were able to obtain exclusively γ-IMC after the 
addition of ethanol or acetonitrile as a crystallisation driving solvent. When methanol was used to 
drive IMC crystallisation, either pure IMC form V, with the methanol solvate as an intermediate, or 
a mixture of both γ-IMC and IMC form V were obtained (see next section 5.2.3.2.1). 
 
5.2.3.2.1 Optimisation of volume and solvent addition to CPG melt loaded materials 
To optimise the loading and phase transformation procedure we used the CPG porous host due to 
its previous application in crystallisation studies and commercial availability.[93,114,115,119,250] To 
investigate the impact of the solvent on the recrystallisation from an amorphous phase under 
confinement, we loaded the CPG material with indomethacin at the 85-15, 80-20 and 75-25 
host:guest ratios, followed by the addition of three different solvents: methanol, ethanol and 
acetonitrile. After loading, the materials were dried under vacuum at 310 K for 2 hours. In the first 
series of experiments the volume of the solvent was adjusted to enable total filling of the pores i.e., 
1.4 mL g−1 of the material (i.e., 0.28 mL of the solvent per 200 mg of the material used during the 
screening). The phase composition of the loaded indomethacin was assessed using PXRD. In the 
cases of using acetonitrile or ethanol as the crystallisation driving solvent, exclusive formation of 
γ-IMC was observed (Figure 5-8). In the case of using methanol as the crystallisation driving solvent 
we obtained the metastable IMC form V as confirmed during further studies (Figure 5-9).  
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Figure 5-8. PXRD patterns of CPG material loaded with different ratios of indomethacin and 
subsequently treated with ethanol (EtOH) and acetonitrile (ACN). 
 
 
 
Figure 5-9. PXRD patterns of CPG material loaded with different amounts of indomethacin and 
subsequently treated with 0.28 mL of MeOH. 
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In the next step we optimised the volume of methanol required to form a pure crystalline phase of 
IMC form V in the pores. In this experiment, 0.140 or 0.560 mL of methanol were added to 200 mg 
of melt loaded CPG host. These volumes of the solvent were chosen to allow only a partial wetting 
of the pores (0.140 mL) and total overloading of the material with the solvent (0.560 mL). Both used 
volumes lead to the formation of the composites with two phases of indomethacin i.e., γ-IMC and 
IMC form V. Only the host loaded with 20 % drug shows a PXRD pattern characteristic exclusively 
of the IMC form V after addition of 0.140 mL of methanol (Figure 5-10). Further confirmation of the 
concomitant crystallisation of γ-IMC and IMC form V was made using DSC analysis (Figure 5-11). It 
further confirmed partial leakage of IMC from the pores at high solvent volumes.   
 
 
Figure 5-10. PXRD patterns of CPG material loaded with different ratios of indomethacin and 
subsequently treated with different volumes of methanol (peaks due to γ-IMC are indicated by 
asterisks). 
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Figure 5-11. DSC thermograms of CPG material loaded with different ratios of indomethacin and 
subsequently treated with different volumes of methanol. The arrows indicate melting of bulk IMC 
outside the pores. 
 
5.2.3.2.2 Deposition of indomethacin outside the pores of MCF and CPG composites at high 
drug loadings (30 and 50 %) after methanol addition 
As shown in the Figure 5-5, the CPG host loaded with high drug contents of 30 and 50 wt. % shows 
thermally driven recrystallisation of IMC loaded outside the pores as confirmed by observation of 
the bulk melting temperature of both IMC polymorphs (α- and γ-). When IMC was loaded from the 
melt into the MCF host, no signs of drug loaded outside the pores could be detected using DSC, 
PXRD and solid-state NMR (Figure 5-4). The amorphous drug loaded within the MCF host at the 
concentration of 30 and 50 wt. % crystallises into a mixture of IMC phases after addition of 
methanol, which are partly loaded outside the pores. The DSC thermograms of both composites 
with the highest loadings show the melting peaks of bulk γ-IMC (Figure 5-12). This can be related 
to a leakage of the dissolved drug from the pores after addition of the solvent and recrystallisation 
on the external surface of the host, since the presence of the bulk crystalline phase in the highly 
concentrated samples could not be detected before the addition of the solvent. Similar findings 
regarding ibuprofen confined within MCM-41 were recently published by Skorupska et al.[79]  
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Figure 5-12. DSC thermograms of MCF and CPG hosts loaded with IMC using melting method at 
concentrations of 30 and 50 wt. % after the addition of methanol. 
 
 
 
Figure 5-13. PXRD patterns of IMC loaded into MCF and CPG host from the melt at concentrations 
of 30 and 50 wt. % after addition of methanol (peaks showing the presence of γ-IMC are labelled 
with asterisks whereas peaks showing α-IMC are labelled with hash marks). 
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Figure 5-14. 1H-13C CP/MAS solid-state NMR spectra of MCF and CPG hosts loaded with IMC using 
melting method at concentrations of 30 and 50 wt. % after addition of methanol (peaks showing 
the presence of γ-IMC are labelled with asterisks whereas peaks showing α-IMC are labelled with 
hash marks). 
 
Solvent driven recrystallisation of the IMC loaded within MCF and CPG hosts at high IMC 
concentrations leads to a mixture of phases which are loaded inside and outside the pores. The 
presence of either α-, γ- and form V IMC was detected using PXRD and solid-state NMR (Figure 5-13, 
Figure 5-14), however, due to the complex thermal transitions it is difficult to state unequivocally 
which phase is formed due to the confinement or which is loaded outside the pores. Further 
investigation of concomitant crystallisation of non-confined systems is beyond the scope of this 
work. 
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5.2.3.2.3 Stabilisation of metastable IMC form V inside the pores of the MCF host 
The DSC thermograms of IMC confined within the MCF pores show a decrease of the melting 
temperature and broadening of the melting peak indicating the presence of nanosize crystals 
(Figure 5-15).  
 
 
Figure 5-15. DSC thermograms of MCF and CPG hosts loaded with IMC from the melt after addition 
of methanol. 
 
Table 5-3. Thermal transitions corresponding to confined IMC form V in MCF and CPG hosts loaded 
from the melt after addition of the solvent. 
Host-guest composite Melting onset (K) ΔHfusion (J g−1) 
MCF-IMC 85-15 + 0.28 mL MeOH - - 
MCF-IMC 80-20 + 0.28 mL MeOH 383.0 (form V) 18.3 (form V)a 
MCF-IMC 75-25 + 0.28 mL MeOH 384.9 (form V) 35.8 (form V) 
CPG-IMC 85-15 + 0.28 mL MeOH 395.6 (form V) 425.1 (γ-IMC) 31.6 (form V) 18.6 (γ-IMC) 
CPG-IMC 80-20 + 0.28 mL MeOH 385.3 (form V) 423.1 (γ-IMC) 25.6 (form V)b 26.5 (γ-IMC) 
CPG-IMC 75-25 + 0.28 mL MeOH 383.5 (form V) 422.6 (γ-IMC) 24.1 (form V)b 25.9 (γ-IMC) 
a The lower measured heat of fusion value, compared to ‘MCF–IMC 75–25 + 0.28 mL MeOH’, 
indicates the presence of amorphous IMC. b Melting of form V and recrystallisation of α- and γ-IMC 
overlap, thus, the stated ΔHfusion values are too low. 
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The host loaded with 15 wt. % of IMC shows no recrystallisation in the temperature range from 20 
to 453 K confirming the presence of an amorphous phase, which is in agreement with the PXRD 
data (Figure 5-16). Increasing the guest loading to 20 % results in a mixture of amorphous and IMC 
form V. The composites loaded with 20 and 25 wt. % of IMC, after treatment with methanol, show 
a single melting point of form V IMC. This may indicate that spatial constraints of ca. 30 nm prevent 
the concomitant crystallisation of form V and other phase impurities (α- and γ-IMC). Thus, phase 
pure form V can be obtained.  
 
 
Figure 5-16. PXRD patterns of MCF and CPG hosts loaded with indomethacin using melting method 
and subsequently treated with methanol (peaks showing the presence of γ-IMC are labelled with 
asterisks). 
 
The CPG–IMC composite loaded with 15 wt. % of IMC shows the PXRD pattern and solid-state NMR 
spectrum of the pure IMC form V (Figure 5-16, Figure 5-17). At host–guest ratio of the CPG–IMC 
80–20 and the CPG–IMC 75–25, predominately indomethacin form V with a small amount of γ-IMC 
is formed (confirmed by the PXRD and solid-state NMR). Further increase of the IMC content to 30 
and 50 wt. % leads to the increase of the proportion of the drug loaded outside the pores. The DSC 
thermograms of the CPG host loaded with IMC from the melt and subsequently treated with 
methanol show several thermal events, which may be assigned to the melting of IMC form V (below 
398 K), recrystallisation of α- and γ-IMC, corresponding to the only exothermic event following the 
form V melting process, and finally the melting of α- (shoulder) and γ-IMC (ca. 430 K). Broadening 
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and decrease of the melting peaks of form V, as well as α- and γ-IMC, indicates that all observed 
phases are not bulk material, but are in the confined space (Figure 5-15, Table 5-3).  
 
 
Figure 5-17. 1H–13C CP/MAS NMR spectra of MCF and CPG hosts loaded with molten IMC at 
different host:drug ratios subsequently treated with methanol (peaks assigned to γ-IMC are 
labelled with asterisks). 
 
Neither solid-state NMR nor PXRD indicated the formation of γ- or α-IMC within the CPG–IMC 85-15 
composite after addition of methanol, suggesting that the presence of the melting peaks at 419.5 K 
(shoulder) and 425.1 K are due to recrystallisation of the α- and γ-IMC forms above the form V 
melting point. Seeds of γ- and α-IMC may be present below the PXRD and NMR detection limit and 
trigger the recrystallisation. A decrease of the melting peak onset temperature of IMC form V with 
increasing drug concentration in the CPG host is evident, indicating a decrease of the size of the 
crystals. Full understanding of the mechanism of thermal events in silica host loaded with large 
amounts of IMC is beyond the scope of this work. 
5.2.3.2.4 IMC–silica composites obtained via incipient wetness method. 
Indomethacin loaded using the incipient wetness method into both silica hosts shows different 
crystallisation products in comparison to melt loaded composites. The presence of metastable form 
V within loaded hosts was proven using PXRD, DSC and solid-state NMR. To investigate the impact 
of the added volume of the loading solution on the final composition of the loaded hosts we used 
0.6 and 0.75 mL g−1 of a loading solution for the CPG and 0.8 mL g−1 for the MCF material. These 
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values were chosen taking into account the total pore volume of the CPG and the MCF hosts used 
in the study (1.18 and 1.61 cm3 g−1 respectively).  
 
 
Figure 5-18. PXRD patterns of CPG host and MCF materials loaded with IMC using IW method with 
0.6 mL g−1 of the solvent for CPG and 0.8 mL g−1 of the solvent for MCF. 
 
PXRD patterns of the composites loaded with solutions of different indomethacin concentrations 
show peaks characteristic for IMC form V (and γ) (Figure 5-18). Due to overlapping and broadening 
of the peaks only traces of γ-IMC within the MCF composites can be detected, which is corroborated 
by DSC results. The DSC thermograms of CPG composites loaded using lower volumes (150 and 
200 mg mL−1) of the loading solution show a slightly broader melting endotherm of IMC form V and 
traces of bulk α- and γ-polymorphs of IMC (0.05–1.0 % as determined from melting point onset 
temperatures and heat of fusion). Furthermore, there is no exothermic recrystallisation event after 
the melting of IMC form V. This indicates the formation of confined IMC form V and the importance 
of the spatial constrains of silica walls in preventing the crystallisation of other IMC polymorphs in 
the temperature range 293 to 443 K. The 250 mg mL−1 sample shows a distinct γ-IMC melting peak. 
Loading from the solution with the highest concentration of IMC in methanol gives sharper form V 
melting peaks and a slightly lower decrease of the melting onset which may indicate that IMC 
form V is partly loaded outside the pores (Figure 5-19, Table 5-4). 
The MCF host loaded with IMC from methanol using the IW method shows the presence of confined 
form V IMC, bulk γ-IMC and small amounts of α-IMC. Although the loading volume was much 
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smaller than the total pore volume of the MCF host, crystallisation outside the pores could not be 
avoided. Similarly to the CPG hosts loaded with higher volumes of loading solution (Figure 5-21), 
the DSC thermograms of MCF composites loaded with higher concentrations of IMC loading 
solution (200 and 250 mg mL−1 MeOH) show melting of form V IMC was preceded by a small 
endothermic event at ca. 358 K. This may be related to the presence of IMC methanol solvate 
(Figure 5-19). The endotherm below 353 K is related to the evaporation of water from the silica 
surface, as water sorption from the air may happen during sample preparation. 
 
 
Figure 5-19. DSC thermograms of CPG and MCF hosts loaded with IMC using IW method. 
 
Table 5-4. Thermal parameters of CPG and MCF hosts loaded using IW method from methanol. 
Host-guest composite Melting onset (K) Melting peak (K) 
CPG 150 mg mL−1 MeOH 399.9 (form V) 403.6 
CPG 200 mg mL−1 MeOH 399.7 (form V) 403.4 
CPG 250 mg mL−1 MeOH 402.9 (form V) 405.1 
MCF 150 mg mL−1 MeOH 
401.3 (form V) 
432.7 (γ-IMC) 
404.4 
433.1 
MCF 200 mg mL−1 MeOH 
400.6 (form V) 
432.5 (γ-IMC) 
405.1 
433.1 
MCF 250 mg mL−1 MeOH 
400.5 (form V) 
432.5 (γ-IMC) 
404.7 
433.1 
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Solid-state NMR spectra of both hosts loaded using the IW method at IMC concentration of 
200 mg mL−1 in methanol are consistent with the presence of pure IMC form V within the 
composites. No peaks of other IMC crystalline phases could be detected, indicating that the 
presence of the γ-IMC peak at high loading concentrations of the MCF material is most likely due 
to temperature induced recrystallisation of the bulk drug phase loaded on the external surface of 
the host (Figure 5-19, Figure 5-20). 
 
 
Figure 5-20. 1H–13C CP/MAS NMR spectra of CPG and MCF hosts loaded using IW method at 
indomethacin concentration in methanol of 200 mg mL−1. 
 
The outcome of the deposition of the drug on the external surface of the material is related to the 
concentration of the loading solution. A high concentration of the guest molecules in the loading 
solution (250 mg mL−1) allows reaching reasonable API content within the composite. This, 
however, leads to the risk of some that the drug to be loaded outside the pores, as crystallisation 
of the supersaturated solution may start in contact with the external surface of silica.  
CPG hosts loaded with a higher volume of the loading solution (0.75 mL g−1) show distinct peaks of 
both crystalline phases (Figure 5-21). This is corroborated by DSC analysis, where thermograms 
show peaks of bulk crystalline phases of IMC (Figure 5-21). 
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Figure 5-21. PXRD pattern (left) of the CPG material loaded with IMC using the IW method at the 
higher volume (0.75 mL g−1) of loading solution. Asterisks and hash marks indicate peaks of the γ- 
and α-forms, respectively. DSC thermograms (right) of the CPG host loaded with IMC using the IW 
method with the higher volume (0.75 mL g−1) of loading solution. 
 
5.3 Summary 
In this chapter we demonstrate the impact of mesoscopic confinement, loading method, drug 
content within the pores and subsequent solvent treatment of melt loaded composites on the 
formation of the nano-size crystals of the model pharmaceutical compound indomethacin 
(Scheme 1). It is possible to prevent the thermally induced recrystallisation of the amorphous 
indomethacin confined within the pores of the MCF host using a whole range of host guest ratios 
(up to 50 % of drug content).  
Thermally induced recrystallisation of indomethacin confined within the CPG host was prevented 
at up to 30 wt. % drug content within the pores. This indicates an increased possibility for molecules 
to form different supramolecular assemblies within the pores, which can lead to polycrystalline 
composites.[87] Addition of methanol to the melt loaded MCF composites drives the crystallisation 
of the methanol solvate and upon vacuum drying IMC form V is obtained (at drug concentrations 
within the silica pores from 20 to 25 wt. %). Interestingly, confined form V does not show any 
recrystallisation upon heating, indicating that spatial constraints and the crystallisation method 
allowed us to readily produce phase pure methanol solvate and phase pure form V. Phase purity of 
the intermediate solvate and form V is crucial if one aims at preventing/slowing down the 
transformation to any of the other more stable IMC polymorphs.  
The addition of the solvent to the MCF composite loaded with IMC at a concentration of 15 % does 
not drive crystallisation into any of crystalline forms of IMC. This may indicate both strong 
interactions between the drug and the silica walls and/or the insufficient number of drug molecules 
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to form nuclei large enough to form a crystal. Methanol driven crystallisation of amorphous 
indomethacin inside the larger pores of the CPG host shows the formation of a mixture of forms 
within the whole range of investigated host–guest ratios. However, a proportional preference 
towards the most stable γ-IMC with an increase in drug content is observed. The addition of either 
ethanol or acetonitrile to the melt loaded CPG composites leads to an exclusive recrystallisation 
into the most stable γ-IMC. This highlights the importance of both the nature of the confinement 
medium and the solvent on the formation of nanoscale confined crystals. 
 
 
 
Figure 5-22. Summary of possible amorphous to crystalline transformations of melt loaded 
indomethacin under confinement of MCF and CPG hosts. 
 
The amount of guest molecules that can be successfully embedded within the silica hosts depends 
on a careful design of the loading procedure. The maximum loading capacity of the host might be 
overestimated due to the obstruction of the pores, especially when high drug loading is needed. 
166 | P a g e  
A uniform distribution of the drug within the host material during mixing helps to avoid the 
presence of drug rich domains which cannot be loaded fully into the pores by a capillary action and 
may lead to some drug being left on the external surface. Finally, the heating temperature needs 
to be sufficiently high to melt the guest, while avoiding its decomposition. The incipient wetness 
method is one of the solvent mediated methods for drug loading into the mesoporous silica hosts. 
However, it is much more difficult to control as increasing drug concentration within the loading 
solution increases risk of the spontaneous crystallisation of the supersaturated solution outside the 
pores. In the case of indomethacin, it can even lead to the formation of an elusive polymorph, IMC 
form V. 
Mesoporous silica materials with pore diameters of up to 8 nm (MCM-41 and SBA-15) have been 
widely studied as drug delivery systems to stabilise amorphous phases. We have demonstrated that 
an increase in the pore size diameter of mesoporous silicas may lead to exciting changes in the 
crystallisation behaviour of a widely studied pharmaceutical compound indomethacin. Amorphous 
IMC can be stabilised when embedded within pores of ca. 30 nm using the melting method, 
whereas the CPG host with pores of ca. 55 nm can stabilise the amorphous phase only at low drug 
content within the composite. Furthermore, addition of a solvent to the melt loaded systems leads 
to the formation of nano-scale crystals inside the pores. The polymorphic phase formed under 
confinement depends on the pore size, embedded drug content and crystallisation solvent. Guest 
loading using the IW method leads directly to the formation of a crystalline phase. Thus, by choosing 
the right conditions it is possible to increase the solubility, which might be crucial for a poorly water 
soluble compound as indomethacin.  
5.4 Conclusions 
In this study, we have used a novel approach to investigate phase transitions inside silica based, 
nano-scale crystallisation chambers with well organised systems of pores, i.e., MCF hosts. 
Combined application of nitrogen adsorption–desorption analysis, thermal and diffraction methods 
and solid-state NMR enabled much better control over the phase and transformations of the guest 
in the final products, which may lead to a better understanding of host guest interactions within 
drug delivery systems based on mesoporous silica composites. Furthermore, we have 
demonstrated a new method for the formation and stabilisation of IMC form V using mesopores to 
prevent recrystallisation into more stable IMC polymorphs. This should enable further studies of 
MCF based nano-crystalline drug delivery systems and highlights the importance of loading 
methods and laboratory procedures on the final product, which is of the interest for the 
pharmaceutical industry. 13C solid-state NMR spectra of IMC methanol solvate and IMC form V were 
presented for the first time, highlighting the main structural changes related to the desolvation. 
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Mesoporous silicas with large pores are not only promising systems for nano-crystalline drug 
delivery systems, but are also well defined model materials for the investigation of early stages of 
crystallisation. Possible tailoring of the pore size diameter may enable effective control of the 
maximum size of critical nucleus during crystal formation. Furthermore, functionalisation of the 
internal surface of the silica host may target a particular hydrogen bonding motif on crystallisation 
outcome. 
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6 19F NMR as a Highly Sensitive 
Probe Towards Understanding 
and Direct Monitoring of 
Confined Crystallisation 
within Nanoporous Materials 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6  
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6.1 Introduction 
Incorporation of fluorine in the structure of pharmaceuticals has been an effective strategy for 
tuning their pharmacodynamic properties with more than 40 new drugs accessing the market in 
the last 15 years. In this context, 19F NMR can be viewed as a useful probe for investigating the host-
guest chemistry of pharmaceuticals in nanosize drug delivery systems. Although the interest in 
confined crystallisation, nanosize devices and porous catalysts is gradually increasing, 
understanding of the complex phase behaviour of organic molecules confined within nano-
chambers or nano-reactors is still lacking. Using 19F MAS NMR, we achieved detailed mechanistic 
insight into the crystallisation of flufenamic acid (FFA) in a confined environment of mesoporous 
silicas with different pore diameters (3.2 to 29 nm), providing a direct experimental proof of the 
formation of a molecular liquid-like layer in addition to the crystalline confined FFA form I. 
 
 
Figure 6-1. Schematic representation of FFA in three different molecular environments and mobility 
regimes from liquid-like species at the silica surface to confined nanocrystals as probed using 19F 
MAS NMR. 
 
The engineering of nanocrystals confined within nanosize chambers of controlled pore glasses has 
yielded new crystalline structures, stabilised metastable polymorphs or helped the formulation of 
amorphous drug delivery systems.[93,110,111,250] Although the number of studies aimed at new 
applications of porous silicas is rising, there is a considerable lack of molecular level understanding 
of the phenomena which govern the self-assembly in such systems. Thus, ibuprofen, benzoic acid 
and lauric acid confined within MCM-41 silicas (pore diameter ca. 3-4 nm) have been found in a 
highly mobile state, as liquid-like behaviour was observed with solid-state NMR.[74,75,77–79,251] The 
high mobility of confined ibuprofen (IBU) was confirmed indirectly with hyperpolarised 129Xe NMR 
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spectroscopy and MAS-PFG NMR, where two different diffusion coefficients were observed for the 
guest.[78] Dielectric relaxation spectroscopy studies of the IBU/MCM-41 confirmed two different 
motional regimes for IBU, assigned to its populations in the pore voids and at the silica surface; this 
was corroborated with molecular dynamics simulations.[112] Detailed quantum mechanical 
modelling of the adsorption of clotrimazole and IBU in porous silicas confirmed very high mobility 
of these guests at silica surfaces, in good agreement with IR and solid-state NMR spectroscopic 
data.[80,81,252] As fluorinated pharmaceuticals are currently in the spotlight of drug discovery,[253] it is 
possible to take advantage of the high sensitivity of 19F nuclei to changes in local environment and 
probe the nanoscale organisation of such molecules confined in porous hosts. In this work, we 
demonstrate that 19F solid-state NMR can be used to detect the presence of confined molecules of 
the model pharmaceutical (flufenamic acid, FFA) in different environments and motional regimes. 
By encapsulation of FFA in three different silica scaffolds with pore diameters from 3.2 to 29 nm, 
we were able to fully control the confined crystallisation of FFA form I, gaining mechanistic insight 
of the self-assembly at different length scales. The combined use of 19F MAS NMR and other 
characterisation tools enabled us to monitor the processes in the confined space in situ.  
Using a variety of techniques (N2 adsorption, PXRD, DSC, solid-state NMR and THz spectroscopy[254]) 
we have shown that FFA has been encapsulated inside the pores of the three silica scaffolds via the 
melt loading method. We gradually increased the guest loading to achieve gradual filling of the 
pores with different diameters. The materials are labelled as host:FFA X-Y, where the host is MCM-
41, SBA-15 or MCF and X-Y is host:guest ratio in wt. %. It is important to note that stabilisation of 
the extremely unstable amorphous FFA (Tg = 286 K) was achieved for over a year inside the pores 
of the MCM-41 and SBA-15 hosts. 
6.1.1 Polymorphism of Flufenamic acid 
Flufenamic acid (FFA, 2-{[3-(Trifluoromethyl)phenyl]amino}benzoic acid) is a non-steroidal anti-
inflammatory drug (NSAID) which up to date has the highest number of different crystalline 
structures reported in CCDC (The Cambridge Crystallographic Data Centre).[181] Based on a recent 
study by López-Mejías et al. nine polymorphs were proposed; eight structures elucidated with X-
ray diffraction and a ninth elusive polymorph characterised with PXRD and Raman spectroscopy 
(Figure 6-3).[181] The high number of crystalline structures of FFA is not only of the interest from the 
pharmaceutical perspective, its supramolecular chemistry enabled authors to probe the concept of 
the polymorphophor in the group of fenamic acids.[181,255,256] In that case, a monocarboxylated 
diphenyl amine nucleus is a structural element, which promotes formation of multiple crystalline 
structures.[181] 
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The first crystal structure of FFA form III was published by McConnell in 1973 followed by the report 
on seven polymorphic forms of FFA by Krc and elucidation of the second well known polymorph, 
FFA form I, by Murthy et al. in 1982.[186,187,257] Although polymorphism of FFA has been known for 
the last 40 years, major progress in understanding the differences in structural conformations and 
transitions of FFA was made only recently.1,4,5–11  Frequently occurring, commercially available, FFA 
form I crystallises as white needles in the P21/c space group, while FFA form III forms yellow needles 
and crystallises in the C2/c space group.[181,186,187,260,263] Both forms of FFA are enantiotropically 
related to each other with FFA form III being most stable below transition temperature at 315.5 K. 
[257,260,261,264] The phase transformation from form I to form III is faster for large crystals due to an 
increased number of surface defects in larger crystals.[260] Furthermore, it was demonstrated that 
FFA form I compared with form III shows an increased reactivity in the solid state with both 
ammonia gas and MgO due to packing differences leading to higher accessibility of the carboxylic 
acid motif in FFA form I.[258,261] Recently, Delaney et al. using  periodic DFT analysis suggested that 
polymorphic order between FFA form I and FFA form III is the result of strong dipolar interactions 
related to presence of CF3 motif in the structure.[263]  
The presence of at least seven polymorphs of FFA was suggested by Krc in 1977 and only 35 years 
later López-Mejías et al. were able to obtain single crystals of the six new crystalline phases of FFA 
using polymer induced heteronucleation (Figure 6-3).[181] Lee et al. were able to stabilise FFA form 
V by addition of ammonium chloride.[182] Conformational analysis of FFA in different crystalline 
forms revealed that the main difference between building molecules lies in changes in the torsion 
angles τ2 and τ3 defined as planes connected by the biphenyl amine (Figure 6-2).[181]  
 
 
 
Figure 6-2 A. Structure of FFA with torsion angles τ2 and τ3 varying between the structures labelled 
in green. B. Example of conformational polymorphism between FFA form I and FFA form III (adapted 
from [181,263]). 
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Figure 6-3. Molecular packing of FFA polymorphs. A. FFA form I (CSD ref. code FPAMCA11[186]), B. 
FFA form II (CSD ref. code FPAMCA17[181]), C. FFA form III (CSD ref. code FPAMCA[187]), D. FFA form 
IV (CSD ref. code FPAMCA15[181]), E. FFA form V (CSD ref. code FPAMCA16[181]), F. FFA form IV (CSD 
ref. code FPAMCA14[181]), G. FFA form VII (CSD ref. code FPAMCA12[181]), H. FFA form VIII (CSD ref. 
code FPAMCA13[181]). Forms I, II, III, V, VII and VIII are shown along b crystallographic axis, forms IV 
and VI are shown along a crystallographic axis.  
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Formation of intramolecular hydrogen bond between the carboxylic acid oxygen and the amino 
group in all conformers leads to a coplanar arrangement of the carboxylic group with the phenyl 
ring, hence small differences in the torsion angle τ1 between the conformers.[181] Newly obtained 
forms II, V and VII of FFA similarly to FFA form I crystallise in the space group P21/c with Z’=1, Z’=4 
and Z’=2, respectively. Forms IV, VI and VIII crystallise in triclinic space group 𝑃1̅ with 3, 6 and 9.5 
molecules in the asymmetric unit, respectively. It is worth noting that there are less than 200 
structures with Z’=6 reported in CSD and none of the reported structures has 9.5 molecules in an 
asymmetric unit.[181]   
6.2 Results and discussion 
6.2.1 Solid state characterisation of FFA form I and FFA form III 
FFA form I is the commercially available form of FFA, while FFA form III was crystallised from 
ethanol. The experimental PXRD patterns of both investigated FFA polymorphs are in good 
agreement with simulated PXRD patterns based on the CSD reference structures FPAMCA11[186] 
(FFA form I) and FPAMCA[187] (FFA form III). FFA form I melts at 406.8 K while FFA form III melts at 
399.2 K followed by its recrystallisation to the most stable form I. 
 
 
Figure 6-4. Simulated and experimental PXRD patterns of FFA form I (CSD ref. code FPAMCA11) and 
FFA form III (CSD ref. code FPAMCA) (left); DSC thermograms of FFA form I and FFA form III (right). 
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Figure 6-5. A. 1H-13C CP/MAS and 1H-13C CP/MAS NQS spectra of FFA form I and FFA form III recorded 
at 9.4 T; B. Experimental and CASTEP calculated 13C chemical shifts of FFA form I (CSD ref. code 
FPAMCA11) and FFA form III (CSD ref. code FPAMCA); the dashed line shows perfect fit; C. 19F MAS 
NMR spectrum of FFA form I and FFA form III recorded at 9.4 T. The 13C numbering was made based 
on CASTEP calculations. The 13C numbering is in agreement with the carbon numbers in the FFA 
structure presented in the figure.  
 
The 1H-13C CP/MAS NMR spectra of FFA form I show 14 carbon peaks which can be assigned to all 
13C sites in the FFA structure indicating the presence of one molecule in the asymmetric unit (Figure 
6-5 A.). The CASTEP calculated and experimental 13C chemical shifts are in good agreement (Figure 
6-5 B., Table 6-1). The assignment of the 13C spectrum based on CASTEP calculations is further 
confirmed by 1H-13C CP/MAS NQS spectrum where only peaks from quaternary carbons can be 
observed. The low intensity of the carbon C6 peak is due to lack of 1H in close proximity from which 
magnetisation could be gained during cross polarisation step in the 1H-13C CP/MAS NMR 
experiment.  
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Table 6-1. Comparison of experimental and CASTEP calculated 13C chemical shifts of FFA form I and 
FFA form III. Non-quaternary carbons are labelled in blue. 
13C site 
FFA form I FFA form III 
δexp δcalc δexp δcal 
C1 175.1 175.2 174.8 173.7 
C2 149.4 151.8 145.9 146.3 
C3 140.1 140.8 142.0 141.8 
C4 136.4 137.2 137.2 137.8 
C5 133.0 135.5 133.3 134.5 
C6 124.0 127.5 125.1 126.8 
C7 129.5 129.4 131.0 131.5 
C8 128.2 128.3 122.3 122.0 
C9 119.9 119.7 120.2 120.2 
C10 117.4 117.6 120.2 120.2 
C11 121.8 122.0 108.0 107.1 
C12 112.2 113.6 117.9 118.0 
C13 109.8 110.3 114.1 113.9 
C14 131.8 133.7 133.3 134.5 
 
Similarly, the 1H-13C CP/MAS NMR spectrum of FFA form III indicates the presence of one molecule 
in asymmetric unit which is in agreement with crystallographic data. The 13C spectrum shows 12 
peaks with overlapping peaks for carbons C5, C14 and C9, C10. The CASTEP calculated 13C chemical 
shifts are in excellent agreement with the experimental data (Figure 6-5 B., Table 6-1). Molecules 
in the asymmetric units of FFA form I and FFA form III structures are in very different conformations 
(Figure 6-2), leading to significant differences in the position of some 13C peaks in the spectra. The 
torsion angles τ2 and τ3 of the FFA molecule differs significantly between both structures, i.e., FFA 
form I: τ2= 53.94°, τ3 =1.76°, FFA form III τ2= 8.72°, τ3 =37.09°. These lead to very different 
conformations of the phenyl ring bearing fluoromethyl group in both structures. The differences 
are accompanied by significant changes in the positions of 13C peaks C2 and C3 i.e., up-field (C2) 
and down-field (C3) shift of both peaks by ca. 4 and 2 ppm, respectively. The most pronounced 
changes in the 13C peak position can be observed for carbons C8, C11 and C12 as intramolecular 
interactions between these three sites are significantly different in both structures. Carbons C11 
and C8 of FFA form I structure undergo significant up-field shift of ca. 14 and 5 ppm, respectively, 
in comparison to the peaks position in the FFA form III structure. In contrast, the C12 site in FFA 
form III undergoes down-field shift of ca. 5 ppm compared to the peak position in FFA form I structure.   
One peak can be observed in the 19F MAS NMR of FFA form I and FFA form III indicating all three 
fluorine atoms are in the same local environment. Sensitivity of fluorine to changes in the long-
range electrostatic interactions enable the different FFA polymorphs to be distinguished, as FFA 
form I shows the 19F MAS NMR peak at −60.0 ppm in comparison to −62.0 ppm for FFA form III 
(Figure 6-5 C.). To the best of our knowledge this is the first report of a full experimental and 
computational assignment of FFA form I and FFA form III 13C solid-state NMR spectra.  
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6.2.2 Local structure of mesoporous silica hosts 
The 29Si solid-state NMR data show three characteristic peaks of silicon atoms in three different 
environments, i.e., Q4 site Si(OSi)4 at ca. −110 ppm and two OH ended sites Q2 (HO)2Si(OSi)2 and Q3 
(HO)Si(OSi)3 at ca. −90 and −100 ppm, respectively. The degree of silica condensation determined 
as the ratio between ‘surface’ related sites (Q2, Q3) and bulk Q4 (i.e., Q2+Q3/Q4) indicates similar 
population of the OH groups at the silica surface (Figure 6-6, Table 6-2).  
 
 
Figure 6-6. 29Si MAS NMR spectra and deconvoluted peaks of mesoporous silica hosts MCM-41, 
SBA-15 and MCF. 
 
Table 6-2. The deconvolution parameters of different silicon sites in the 29Si MAS solid-state NMR 
spectrum and condensation parameter determined based on the integration of different Q sites. 
Material 
2Q 3Q 4Q 
R2 (2Q+3Q)/4Q 
Integral FWHM Integral FWHM Integral FWHM 
MCM-41 0.82 9.93 3.51 7.7 10.67 10.7 0.997 0.41 
SBA-15 0.67 10.5 2.85 9.1 11.43 11.2 0.991 0.31 
MCF 0.96 11.5 2.79 9.1 11.53 11.6 0.983 0.33 
 
Very similar population of OH bearing 3Q and 2Q silicon sites in the SBA-15 and MCF hosts suggests 
that the pore surfaces in such hosts are very similar. This is also confirmed by the 1H-29Si CP/MAS 
NMR spectra which in some publications are interpreted as more surface specific than 29Si MAS 
NMR spectra (Figure 6-7).[5] Both MCF and SBA-15 silica hosts were synthesised using silica 
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condensation in acidic conditions hence both materials have very similar properties. The slightly 
higher value of the condensation parameter of a MCM-41 silica host may be related to differences 
in synthetic conditions, i.e., basic conditions and different templating agent. 
 
 
Figure 6-7. 1H-29Si CP/MAS NMR spectra and deconvoluted peaks of mesoporous silica hosts MCM-
41, SBA-15 and MCF. 
Several reports on the studies of surface in porous silicas assign different types of surface hydroxyls 
and water species depending on the density of silanols on the surface as manifested by the changes 
in 1H chemical shifts.[265,266] The comparison of 1H spectra reported for SBA-15 and MCM-41 hosts 
indicate that, in our hosts, the surface is dominated by regions with 3-4 Si-OH groups expected per 
nm2 with 1H chemical shifts in the range of 4.5-5.5 ppm. We also detected isolated very small 
amount of Si-OH species (ca. 2 ppm).[265,266] The similarity of 1H spectra of FFA-loaded silicas 
supports our assumption of a similar level of OH-coverage between the three silica hosts. 
6.2.3 Textural parameters of silica scaffolds and identification of FFA loaded 
outside the pores 
Melt loading of FFA within mesoporous silicas resulted in a gradual decrease of the total pore 
volume and the BET surface area of the loaded composites as compared to unloaded porous 
scaffolds, consistent with the incorporation of the drug inside the pores of the hosts (Table 6-3, 
Figure 6-8 and Figure 6-9).  
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Table 6-3. FFA content within different hosts and structural parameters of the hosts after loading. 
Host-guest composite FFA (g g−1) aVtotal [cm3 g−1] bdpore [nm] cSBET [m2 g−1] 
MCF N/A 1.796 29.5 (14.9) 356.2 
MCF-FFA 85-15 0.145 1.441 29.5 (15.0) 275.1 
MCF-FFA 80-20 0.184 1.350 29.5 (14.0) 254.0 
MCF-FFA 75-25 0.253 1.266 29.6 (11.7) 235.8 
MCF-FFA 70-30 0.301 1.186 29.7 (13.8) 218.7 
MCF-FFA 60-40 0.401 1.043 29.7 (13.0) 181.8 
MCF-FFA 50-50 0.494 0.747 26.6 (13.1) 129.7 
SBA-15 N/A 0.809 7.1 571.2 
SBA-FFA 85-15 0.131 0.588 7.1 367.2 
SBA-FFA 80-20 0.210 0.507 6.4 315.8 
SBA-FFA 75-25 0.238 0.441 6.2 278.2 
SBA-FFA 70-30 0.294 0.354 5.6 235.4 
SBA-FFA 60-40 0.372 0.234 5.6 156.3 
SBA-FFA 50-50 0.485 0.125 5.6 81.0 
MCM-41 N/A 0.654 3.2 1370.4 
MCM-FFA 85-15 0.145 0.434 3.2 872.7 
MCM-FFA 80-20 0.214 0.341 3.1 715.4 
MCM-FFA 75-25 0.259 0.277 3.2 563.8 
MCM-FFA 70-30 0.309 0.178 3.1 361.6 
MCM-FFA 60-40 0.399 0.162 3.2 306.6 
MCM-FFA 50-50 0.525 0.056 3.2 89.1 
a Vtotal – total pore volume calculated at P/P0 of 0.99, b dpore – pore size diameter calculated from the 
adsorption branch of the isotherm using the BJH method, values in the brackets for MCF material 
indicate size of pores windows calculated using desorption branch of the isotherm, c SBET – the BET 
specific surface area 
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Figure 6-8. Nitrogen adsorption/desorption isotherms (left) and pore size distribution curves (right) 
of A. MCF, B. SBA-15, C. MCM-41 at different FFA loadings. Closed symbols indicate adsorption and 
open symbols indicate desorption of nitrogen. MCM-41 isotherms were offset by 50 cm3 g−1, SBA-15 
isotherms are offset by 150 cm3 g−1 and MCF isotherms are offset by 600 cm3 g−1. 
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Figure 6-9. Linear relationship between the total pores volume and drug content in MCM-FFA, SBA-
FFA and MCF FFA composites. Improved correlations can be observed for MCM-FFA composites, 
when the two last points (i.e., when drug is loaded outside the pores) are excluded from the fit. 
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Figure 6-10. Low angle PXRD patterns of A. MCM-FFA and B. SBA-FFA (B) composites at different 
host:guest ratios (w/w). 
 
A gradual decrease of the intensity of the [100] peak in the PXRD patterns of MCM-41 and SBA-15 
materials loaded with FFA as compared to unloaded materials further corroborates the N2 
adsorption results and confirms the deposition of the loaded drug inside the pores of silica hosts. 
6.3 Pore size dependent amorphous to crystalline transition of 
confined flufenamic acid 
The encapsulation of organic guest molecules within the silica scaffolds leads to either the 
formation of confined crystals, or stabilisation of the confined amorphous phase, depending on the 
properties of the host (mainly pore size) and the guest molecules (size, flexibility and thermal 
behaviour).  
 
Figure 6-11. DSC thermogram of FFA form I during heat-cool-reheat cycle shows several transitions 
during cooling and subsequent reheating of the material indicating formation of mixture of 
different crystalline phases after melting and subsequent cooling. 
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As it is demonstrated in the previous chapter, it is of paramount importance in confined 
crystallisation research to ensure that all observed phases and transitions are due to confinement 
effect. As melting point depression is a good indicator of the formation of confined crystals, DSC 
analysis was carried out to identify non-uniformly loaded composites, where a bulk melting point 
is observed. FFA is highly unstable in the amorphous state (Tg = 286 K) and crystallises on cooling to 
a mixture of polymorphs (Figure 6-11).[267] DSC analysis enabled us to immediately identify the 
composites with FFA loaded outside the pores, due to the presence of melting points of the bulk 
FFA polymorphs (Figure 6-11).  
 
 
Figure 6-12. DSC thermograms of MCM-FFA and SBA-FFA composites at different host:guest ratios 
(w/w). 
 
The two outcomes observed for confined FFA were directed primarily by silica pore size. Firstly, the 
encapsulation in MCM-41 (3.2 nm) or SBA-15 (7.1 nm) results in the stabilisation of amorphous FFA 
across all studied host:guest ratios. No melting point in the DSC thermograms and a broad ‘halo’ in 
the PXRD traces are characteristic of amorphous solids (Figure 6-12). The crystalline phase detected 
at high host:guest ratios can be assigned to FFA form I loaded outside the pores, as no decrease or 
broadening of the melting peak characteristic for confined crystals is observed in 
DSC.[93,106,110,115,116,250] The presence of the bulk FFA form I is corroborated by PXRD and solid-state 
NMR data (Figure 6-13, Figure 6-14) indicating a partial deposition of the drug outside the pores. 
This may be related to the complete filling of the available pore volume of the material as 
determined using N2 adsorption measurements. 
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Figure 6-13. PXRD patterns of MCM-FFA and SBA-FFA composites at different host:guest ratios 
(w/w). 
 
13C solid-state NMR spectra of the MCM-FFA and SBA-FFA materials show very broad peaks and low 
signal intensity, especially at low guest contents (Figure 6-14). Such effects, characteristic of 
confined amorphous solids, can be attributed to the increased mobility of the guests, reducing the 
efficiency of 1H-13C cross-polarisation.[74,75,77,136]  
 
 
Figure 6-14. 1H-13C CP/MAS solid-state NMR spectra of MCM-FFA and SBA-FFA composites at 
different host:guest ratios (w/w). 
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Figure 6-15. A. DSC thermograms, B. PXRD patterns and C. 1H-13C CP/MAS solid-state NMR spectra 
of MCF loaded with FFA at different host:drug ratios. Increase of the melting onset with increasing 
drug content (A.) indicates a gradual growth of the confined crystal in agreement with the Gibbs-
Thomson relationship.[93,110] The samples are labelled accordingly with the host:FFA ratios (in wt. %). 
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In contrast to MCM-41 and SBA-15, the formation of crystalline FFA is observed in the pores of MCF 
silica (pore diameter ca. 29 nm). This effect was dependent on the loading level of FFA, with the 
drug remaining amorphous at low loadings (up to 20 wt. %) and crystallising into FFA form I at 
higher loadings. Crystallisation into FFA form I is confirmed by both PXRD and solid-state NMR. DSC 
thermograms show the broadening of the melting peak and lowering of the melting point of FFA 
form I, proving unequivocally the presence of the confined crystalline phase (Figure 6-15). 
 
 
Figure 6-16. Variable temperature (VT) THz spectra of A. FFA form I confined within MCF (MCF-FFA 
60-40) and B. FFA form I. Differences in peak positions and intensities between bulk and confined 
FFA form I can be observed for all spectral features. The peak at ca. 2.3 THz is due to the nano-
porous silicas. Data acquired in collaboration with Dr Axel Zeitler and Dr Juraj Sibik. 
 
Due to the high sensitivity of THz spectroscopy to molecular organisation in organic solids it can be 
used to show fine differences between bulk and confined FFA.[268,269] Changes in the peak positions 
and intensities can be observed in the VT THz spectra of both phases alongside peak broadening 
for the confined FFA compared to the bulk crystalline material (Figure 6-16). The blue shifts of the 
vibrational modes for spectra acquired at the same temperatures for FFA confined in MCF 
compared to the bulk FFA form I are in line with the previous observations using waveguide 
spectroscopy and can be viewed as a further signature of the confinement. The decreased melting 
point of the confined FFA form I is reflected in the loss of the THz signal between 400 and 420 K, 
which is in agreement with DSC data. The peak of FFA at 1.6 THz becomes attenuated upon loading 
FFA into nano-pores: this peak is distinct in the low temperature spectra of the pure crystalline FFA, 
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but is barely visible for the FFA confined in MCF (see Figure 6-28). This highlights the sensitivity of 
THz spectroscopy towards subtle changes in local ordering: it is exactly this feature that disappears 
completely upon heating, an effect which is indicative of an increased crystalline disorder, often 
due to intramolecular flexibility or rotator phases. It is not surprising that it is this spectral signature 
that exhibits the most pronounced difference between the bulk and confined FFA as the 
confinement will limit the degrees of freedom for the FFA molecule to form ordered domains.[269] 
6.4 Directing the organisation of encapsulated flufenamic acid 
Changes in the pore diameters upon encapsulation along with 19F solid-state MAS NMR 
measurements indicate possible differences in the mechanism of drug encapsulation inside the 
pores of silica scaffolds, which depends on the size of the pore. The analysis of the changes in BET 
surface area and pore size distribution after loading FFA inside different silica scaffolds, along with 
the calculations of the expected surface area available for drug adsorption (Table 6-4), enabled us 
to postulate the loading and crystallisation mechanism illustrated in Figure 6-17. The values of 
available pore surface area and pore volume were calculated based on the N2 adsorption isotherm 
data and the mass of the porous host used for drug loading (Table 6-4, see footnote for details). 
Similarly, the number of FFA molecules was calculated using the number of moles of FFA loaded 
inside the porous hosts. The suggested mechanism of the organisation of FFA molecules inside the 
hosts with different pore sizes is presented in Figure 6-17. 
 
Table 6-4. Calculated surface area and pore volume available for FFA molecules, total volume of 
FFA molecules and maximum surface covered by FFA molecular monolayer. a 
Mass (g) 
Available pore surface 
(m2) 
Available pore volume 
(cm3) 
Surface covered 
by FFA 
monolayer (m2) 
Total FFA 
volume 
(cm3) 
Total box 
FFA volume 
(cm3) 
Total cryst 
FFA volume 
(cm3) host drug MCM-41 SBA-15 MCF MCM-41 SBA-15 MCF 
0.085 0.015 116.4 48.5 30.3 0.0556 0.0688 0.1527 34.3 0.0072 0.0214 0.0101 
0.080 0.020 109.6 45.7 28.5 0.0523 0.0647 0.1437 45.8 0.0097 0.0286 0.0135 
0.075 0.025 102.7 42.8 26.7 0.0490 0.0607 0.1347 57.2 0.0121 0.0357 0.0169 
0.070 0.030 95.9 40.0 24.9 0.0458 0.0566 0.1257 68.7 0.0145 0.0429 0.0203 
0.060 0.040 82.2 34.3 21.4 0.0392 0.0485 0.1078 91.6 0.0193 0.0572 0.0270 
0.050 0.050 68.5 28.5 17.8 0.0327 0.0404 0.0898 114.4 0.0242 0.0715 0.0338 
a Surface area and pore volume were calculated based on the content of the material multiplied by the BET surface area 
and the total pore volume at P/P0=0.99. The total pore volume is derived from the amount of vapour adsorbed at a 
relative pressure close to unity, by assuming that the pores are then filled with liquid adsorbate. Monolayer surface 
covered by FFA molecules was estimated based on the surface of the largest rectangle of single molecule as determined 
by the wrapping box tool in Olex2 software (OlexSys Ltd, Durham, UK), i.e., 12 Å × 8 Å and multiplied by theoretical number 
of molecules. Total FFA volume refers to an average van der Waals volume of a single FFA molecule multiplied by the 
theoretical number of molecules, total box FFA volume refers to an average volume of the wrapping box multiplied by 
theoretical number of molecules and total cryst volume refers to crystallographic volume of single FFA molecule in the 
FPAMCA11 structure (i.e., unit cell volume/4 molecules). The realistic volume of the FFA molecules can be found between 
the box FFA volume (considered as maximum volume) and cryst FFA volume, as both values reflect the molecular 
flexibility, possible distances between molecules and packing density. 
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Figure 6-17. Proposed mechanism of drug loading and formation of confined crystalline phase 
based on the N2 adsorption data, theoretical calculations and 19F NMR analysis. 
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Figure 6-18. High-field 19F{1H} solid-state MAS NMR spectra (20.0 T) of A. MCF-FFA, B. SBA-FFA, C. 
MCM-FFA.  The samples are labelled accordingly with the host:FFA ratios (in wt. %). Growth of the 
main peaks at −60, −62 and −64 ppm with FFA content is consistent with the pore loading pathways 
indicated in Figure 6-17. The high-field spectra are in full agreement with the data recorded at 9.4 
T (Figure 6-23).   
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Molecules confined within mesopores of silicas can be present in several different environments, 
i.e., confined crystals, amorphous aggregates and species interacting with the surface of the host. 
The 100 % natural abundance of 19F and its high sensitivity to changes in the long-range electrostatic 
interactions[162] enabled us to detect the differences between these environments of FFA. 
Advantageously, crystalline FFA form I has one molecule in the asymmetric unit and three 
magnetically equivalent fluorine atoms in the structure, leading to a single peak at −60.1 ppm in 
the 19F solid-state NMR spectra recorded both at 9.4 and 20.0 T (Figure 6-18, Figure 6-23).  
19F solid-state NMR spectra of FFA confined in the MCF host show that the guest species reside in 
two different environments with populations dependent on the host:guest ratios. A sharp peak at 
−65.0 ppm is present at the lowest loading. Increasing FFA content leads to the gradual growth of 
the broad peak at −60.1 ppm, attributable to FFA form I (Figure 6-18) which is also confirmed by 13C 
NMR spectra (Figure 6-15). Two additional features of the peak at −65.0 ppm are important for 
further understanding of the spectra. Firstly, there are no spinning sidebands even at very slow 
MAS rates (1 kHz), indicating very low chemical shift anisotropy (Figure 6-25). This may be related 
to an increased molecular mobility for this population, which is further corroborated by 19F T1 
relaxation times (Figure 6-19). Secondly, the intensity of this peak shows only minor changes across 
all host:guest ratios reaching saturation at 15 wt. % FFA. This is in agreement with the expected 
values for full surface coverage of the pores by a molecular monolayer. Linear increase of the 
intensity of the peak at ca. −60 ppm (FFA form I) with increasing content of FFA indicates a gradual 
growth of the crystalline phase inside the pores (Figure 6-18, Figure 6-21, Figure 6-23). Interestingly, 
it was possible to detect the confined crystalline phase using 19F NMR at loadings as low as 15 wt. %, 
below the threshold of either DSC or PXRD. This may indicate formation of small nucleating clusters 
with only local ordering. 
The presence of molecules in two distinct environments with different relaxation rates (19F T1 is 
ca. 3.5 s for the confined phase and 0.7 s for the liquid-like surface layer) supports the concept of a 
highly dynamic liquid-like molecular layer formed on the internal surface of the pores (Figure 
6-19).[80,81,252] The presence of the liquid-like layer of FFA layer on the silica surface is not surprising, 
as host-guest interactions between the hydrophobic FFA guest and the silica surface of the  host 
with a high content of 3Q [((SiO)3SiOH) ] sites (see section 6.2.2) are expected to be weak. Similar 
phenomena have been suggested by the DFT and MD simulations of ibuprofen and clotrimazole 
encapsulated in MCM-41 and MSU silicas.[80,81,252] Importantly, these molecules share similar 
properties with FFA (i.e., hydrophobicity and the presence of a carboxyl group for IBU).  
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Figure 6-19. 19F T1 relaxation measurements of MCF-FFA composites at different drug loadings from 
15-50 wt. %. The expected errors for the method are between 5 to 10 %. 
 
Similarly to MCF-FFA materials, two different environments of FFA molecules can be detected when 
confined in MCM-41 and SBA-15. For SBA-FFA composites, a peak at −64.8 ppm is observed at low 
loading levels. The increasing FFA content leads to its downfield shift and the growth of a peak of 
confined amorphous drug at −62.6 ppm. 19F NMR spectra of MCM-FFA composites show the two 
(merged) peaks at −63.5 and −64.4 ppm, which undergo a downfield shift with increasing drug 
content. The very low intensity of spinning sidebands in both SBA-FFA and MCM-FFA with up to 30 
wt. % of FFA is consistent with the presence of a disordered amorphous guest phase along with the 
liquid-like layer of FFA, also confirmed by the 19F T1 relaxation times. 
19F T1 relaxation measurements of confined FFA in both MCM-41 and SBA-15 hosts indicate the 
presence of highly mobile species, in a similar mobility regime to the amorphous/surface FFA 
confined in the MCF host (Figure 6-19). A gradual increase of the relaxation times with increasing 
drug content may indicate the formation of densely packed amorphous plugs of FFA with restricted 
mobility inside the pore voids. The presence of a distinct crystalline component (FFA form I) loaded 
outside the pores in MCM-FFA 50-50 composite affects the relaxation measurements significantly, 
leading to increased 19F T1 relaxation time.  
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Figure 6-20. 19F MAS NMR T1 relaxation times of FFA confined inside MCM-41 (left) and SBA-15 
(right) materials at different drug content. Presence of large crystalline component loaded outside 
the pores of MCM-FFA 50-50 significantly affects the 19F T1 relaxation time. The expected errors for 
the method are between 5 to 10 %. 
 
The two distinct peaks observed in the 19F MAS NMR spectra of SBA-FFA 60-40 and SBA-FFA 50-50 
enable us to determine differences in the 19F T1 relaxation times of molecules in the high mobility 
regime; and the densely packed amorphous FFA molecules in the pore voids (Figure 6-20). The 
highly mobile species have relaxation times of ca. 0.85 and 0.9 s, whilst the amorphous plugs have 
relaxation times of 1.0 and 1.15 s for SBA-FFA 60-40 and SBA-FFA 50-50 composites, respectively. 
Furthermore, the presence of crystalline FFA loaded outside the pores (shoulder at ca. −60 ppm) 
may slightly increase the relaxation time of the FFA peak at ca. −62 ppm for SBA-FFA 50-50. The 19F 
relaxation time measurements confirm the general model of pore loading, in which the presence 
of confined molecules in two different environments and motional regimes can be detected. 
The 19F spectra acquired at lower field (9.4 T) show sufficient resolution to identify FFA molecules 
in three different environment. Further deconvolution of different 19F sites of the spectra acquired 
at lower field shows very good agreement with 19F spectra acquired at 20.0 T proving sensitivity of 
19F NMR towards monitoring of confined crystallisation within nanoporous systems (Figure 6-23).  
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Figure 6-21. Deconvoluted 19F MAS NMR spectra (recorded at 20.0 T) of A. MCM-FFA, B. SBA-FFA 
and C. MCF-FFA composites at different FFA loadings and evolution of the changes in deconvoluted 
peaks intensity (integration) for crystalline, amorphous and surface components. 
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Figure 6-22. 19F MAS NMR spectra (20.0 T) of A. MCM-FFA, B. SBA-FFA and C. MCF-FFA composites 
at different FFA loadings including the region of first spinning sidebands (labelled with asterisks). 
Spinning sidebands can be observed only from crystalline FFA form I. 
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Figure 6-23. Deconvoluted 19F MAS NMR spectra (recorded at 9.4 T) of A. MCM-FFA, B. SBA-FFA 
and C. MCF FFA composites at different FFA loadings and evolution of the changes in deconvoluted 
peaks intensity (integration) for crystalline, amorphous and surface components. 
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The sideband pattern in the 19F NMR spectra was used to estimate the 19F CSA parameters using 
the SOLA Solid Lineshape Analysis software (version 2.2.3) implemented in the Topspin 3.2 (Bruker 
Biospin, Germany). For FFA form I, we used a single site model for data fitting. Due to the presence 
of the two peaks in the spectrum, i.e., the peak of FFA form I at ca. −60 ppm and the isotropic peak 
of a highly mobile species at ca. −65 ppm, the fitting of the 19F spectra of the FFA-MCF 60-40 
composite required the use of a two site model. The strength of dipolar couplings was not included 
in the model, as 19F nuclei in the CF3 motif are not strongly coupled to 1H nuclei due to spatial 
separation. This was confirmed by comparison of 19F and 19F{1H} NMR spectra FFA form I spectra 
recorded at 20.0 T, which show no differences in linewidths between both spectra. Furthermore, 
the implementation of additional variables for each site may lead to non-comparable data.  
 
We used Haeberlen conventions for shielding parameters, with the relation between them 
described as follows: 
Isotropic shielding: σiso = (σ11 + σ22 + σ33)/3       (2) 
Anisotropy: ζ = σ33 – σiso         (3) 
Asymmetry: η = (σ22 – σ11)/ζ       (4) 
The isotropic chemical shift, δiso is given by: 
δiso = – (σiso – σref),       (5) 
where σref  is the shielding of a nucleus in a reference system as described by Yates et al.[270]  
The three tensor components are given as follows: 
|σ33 – σiso| ≥ |σ11 – σiso| ≥ | σ22 – σiso|.       (6) 
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Figure 6-24. 19F solid-state NMR spectra of FFA form I recorded at 20.0 T with and without 1H 
decoupling. Spectra acquired at an MAS rate of 30 kHz. 
 
 
Figure 6-25. 19F solid-state NMR spectra of FFA form I (spectra in light shade) and MCF-FFA 60-40 
composite (spectra in dark shade) at different spinning speeds. Spectra at an MAS rate of 1 and 2 
kHz are not shown for clarity. 
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Figure 6-26. 19F solid-state NMR spectra recorded at 9.4 T (dark shade) and fitted CSA models 
(light shade) of FFA form I and MCF-FFA 60-40 composite at an MAS rate of 10, 8 and 7 kHz. 
 
Minor differences are observed in the spinning sideband patterns of the 19F spectra for FFA form I 
in the bulk and confined nanocrystalline phases, which may be related to preferable growth of the 
confined crystal. Analysis of the CSA parameters shows slightly higher anisotropy of the bulk FFA 
form I as compared to the confined crystalline phase. Differences in anisotropy are followed by 
minor changes in asymmetry between the bulk and nanocrystalline FFA form I (Figure 6-24, Figure 
6-26). The second component of the spectra of the MCF-FFA 60-40 composite at ca. −65 ppm 
(assigned to highly mobile FFA species) shows an absence of spinning sidebands and little 
broadening at spinning speeds as low as 3 kHz, indicating very small chemical shift anisotropy 
(Figure 6-25).  
Table 6-5. Experimental 19F NMR shielding tensor parameters for FFA form I as bulk and confined 
in MCF porous silica host. All parameters are referenced to CFCl3 signal. 
Spin 
rate 
Material |σ11 – σref| |σ22 – σref| |σ33 – σref| 
δiso 
[ppm] 
ζ η 
Best 
fit1 
10 kHz 
FFA form I 31.7 12.6 44.3 -60.3 44.3 0.43 0.902 
MCF-FFA 60-
40 
30.1 11.1 41.2 -60.3 41.2 0.46 0.918 
8 kHz 
FFA form I 30.6 12.5 43.1 -60.2 43.1 0.42 0.908 
MCFFFA 6040 29.3 11.1 40.4 -60.3 40.4 0.45 0.912 
7 kHz 
FFA form I 29.7 12.4 42.2 -60.2 42.2 0.41 0.908 
MCFFFA 6040 28.9 10.9 39.8 -60.2 39.8 0.45 0.928 
1Best overlap calculated as a difference between the experimental spectrum and the superimposed simulated spectra in 
the range of chemical shifts from 100 to -150 ppm.  
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6.5 Monitoring of confined crystallisation in situ using 19F NMR 
FFA loaded into the MCF host crystallises into FFA form I after a couple of hours. We prepared 
amorphous FFA inside the pores of the MCF scaffold and monitored the crystallisation of confined 
FFA form I between 293 and 333 K in situ. At 293 K two broad peaks are observed at ca. −65 and 
−62 ppm, indicating the presence of a highly mobile species of FFA alongside amorphous plugs of 
the drug in the pore voids. An Increase in temperature leads to the narrowing of both peaks due to 
increased mobility. At 323 K, the growth of an additional broad peak of crystalline FFA form I is 
observed at −60.0 ppm. The three different environments of FFA in the MCF host can be assigned 
as follows: confined crystalline FFA (form I) at −60.0 ppm; confined amorphous FFA at ca. −62.3 
ppm; and highly mobile FFA adsorbed on the silica surface at ca. −65 ppm (Figure 6-27). 
The intensity of the FFA form I peak (−60 ppm) during isothermal recrystallisation reached the 
maximum at 333 K after 60 minutes (Figure 6-27). Similarly, the intensity of the peak at −62.3 ppm 
(assigned to the confined amorphous FFA) reached a minimum and subsequently stabilised at the 
same temperature.  
Interestingly, there was only a slight change to the intensity of the peak at ca. −65 ppm, which 
displayed only a minor change at the beginning of the experiment, indicating that the population 
of FFA molecules that are adsorbed at the silica surface is practically unaffected by crystallisation. 
At the end of the in situ crystallisation experiment at 333 K three different environments of FFA in 
the confined space were still observed. The spectrum acquired at room temperature following the 
whole recrystallisation experiment showed only two peaks - a broad peak at ca. −60 ppm (FFA form 
I) and a sharper peak at ca. -65 ppm (highly mobile FFA species). 
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Figure 6-27. A. Kinetics (333 K) of confined crystallisation of FFA within MCF material at 60-40 
host:guest ratio, 19F solid-state NMR spectra (9.4 T) recorded at variable temperatures of FFA 
confined within B. MCF and C. SBA-15  porous hosts. 
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Figure 6-28. THz spectra of amorphous FFA confined in SBA-15 mesoporous silica at drug loading of 
40 wt. % recorded at different temperatures. Lack of the peaks in the spectra reflects the 
amorphous nature of the analysed material. The THz spectra of crystalline FFA form I and FFA form 
I confined in the MCF material at 40 wt. % are shown for comparison (acquired at 100 K). 
 
The amorphous SBA-FFA composite shows very different behaviour at elevated temperatures. Two 
19F NMR peaks are observed throughout the range of applied temperatures, which narrowed with 
increasing temperature. No crystallisation was observed during the experiment, indicating an 
efficient stabilisation of confined amorphous FFA (Figure 6-27). This was confirmed further using 
variable temperature THz spectroscopy, which is highly sensitive to the presence of crystalline 
phase within the material (Figure 6-28). It is interesting to note the significantly reduced baseline 
in the THz spectra of amorphous FFA molecules confined within SBA-15 material relative to the bulk 
drug. The reduction of the baseline has been reported previously for organic molecular crystals that 
were confined on the surface of single-mode metal parallel plate waveguide.[268] Given our 
observation of the spectra in SBA host we believe that this is a signature of molecular confinement, 
as the vibrational motions cannot be perturbed by disorder in the polycrystalline environment 
typically encountered in bulk transmission measurements, where the disorder at grain boundaries 
will have a significant effect on the complex motions that are observed in the far-infrared. We 
believe that the THz spectra of FFA in the SBA host are a result of a similar phenomenon, where the 
surface effects increase the global molecular mobility of the FFA. 
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Figure 6-29. 19F solid-state NMR spectra (9.4 T) recorded during isothermal crystallisation at A. 313 
K and B. 323 K of FFA confined within MCF silica scaffold at 60:40 host:guest ratio.  
 
To further investigate the distribution of FFA molecules in different environments we performed 
isothermal crystallisation of FFA confined within the MCF host at 313 and 323 K. Differences in the 
peak widths due to the changes in mobility and slower crystallisation rate was observed during 
crystallisation at lower temperatures (Figure 7-29). Similar distribution of the FFA molecules in 
three environments was observed for materials crystallised at 333 and 323 K. In the spectra of the 
material crystallised at 313 K, the induction period could be observed during first 15 minutes of the 
experiment where slow growth of FFA form I is observed. Furthermore, slight differences in the 
surface peak intensity (at ca. −65 ppm) between materials crystallised at different temperatures 
indicate dynamics of the highly mobile FFA molecules at the surface.  
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Figure 6-30. Kinetics of confined crystallisation of FFA within MCF material at 60-40 host:guest ratio 
at A. 313 and B. 323K. 
 
6.6 Conclusion 
In this work we demonstrated that 19F NMR is a highly sensitive tool to probe the local environments 
of molecules confined within porous hosts. We were able to distinguish between molecules of the 
model pharmaceutical compound present in the pores as confined crystalline, confined amorphous 
and highly mobile species. The observation of the latter is consistent with the formation of a 
molecular liquid-like layer at the silica surface. To the best of our knowledge this is the first direct 
experimental proof of the presence of a liquid like layer of molecules on the silica surface. 
Simultaneous quantification of the three environments allowed us to use 19F solid-state NMR to 
monitor the kinetics of confined crystallisation in situ. We have demonstrated that confined FFA 
(either amorphous in SBA-15 and MCM-41 or nano-crystalline in MCF) has very different dynamical 
properties as compared to bulk FFA form I. All the presented studies allow us to gain a better 
understanding of the fundamental processes of molecular aggregation at the nanoscale. 
Considering that 25 % of all marketed drugs are fluorinated molecules[253], these findings offer a 
fast and direct diagnostic tool for developing of novel nano-confined pharmaceutical formulations. 
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7 Controlled crystallisation, 
phase transitions and 
mobility of confined 
tolbutamide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7  
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7.1 Introduction 
Tolbutamide (1-butyl-3-(4-methylphenylsulfonyl) urea, TB) is an example of a sulfonylurea 
derivative, pioneer of the first-generation potassium channel blockers used in type II diabetes as an 
oral hypoglycaemic drug. Its flexible structure makes it an excellent model compound for studies of 
conformational polymorphism as up to date seven polymorphic forms of TB have been reported 
(including low temperature structures of TB form III2 and high temperature TB form IH).[183,189,271–273] 
In this chapter we begin with an introduction to TB polymorphism, followed by the characterisation 
of different TB polymorphs including TB form I, TB form IV and TB form V (confined in the MCM-41 
scaffold). The 13C NMR spectra of TB form V with full assignment based on the DFT calculations of 
chemical shifts using CASTEP code is presented for the first time, together with high-resolution 1H 
CRAMPS spectra of TB forms IL, IH, IV and V. The NMR experiments are accompanied by 
computational studies of isotropic 1H and 13C NMR chemical shielding tensors of all investigated TB 
polymorphs using the CASTEP code. Through the acquisition of variable temperature 1H-13C CP/MAS 
NMR spectra and 1H T1, T1ρ and 13C T1ρ relaxation measurements, we were able to investigate 
mobility of the aromatic ring of TB in both TB form I and TB form IV. Additionally, the new low 
temperature TB form IV with Z’>1 was observed using 1H-13C CP/MAS and 1H CRAMPS NMR spectra 
below 283 K. The studies of TB polymorphism are followed by a structural and dynamical 
investigation of the drug encapsulated within the MCM-41 host at loading levels up to 50 wt. %, 
where selective crystallisation of TB form V was observed. We used 1H-13C CP/MAS NMR to monitor 
phase transitions of confined TB within the MCM-41 material in situ. Using 1H-13C CP/MAS NMR at 
low temperatures, we were able to prove TB is encapsulated as a solid, crystalline phase coexisting 
with highly mobile amorphous drug.  To best of our knowledge, the encapsulation and 
crystallisation of TB molecules inside pores as small as ca. 3 nm has not been reported previously.  
As the effect of humidity on drug molecules encapsulated within mesoporous silica based materials 
for drug delivery is poorly understood, in the last section, we present a set of NMR based methods 
designed to gain in-depth understanding of the physical state of confined TB using two model 
MCM-TB systems loaded at either low (20 wt. %) or high (50 wt. %) drug contents and different 13C 
signal enhancement methods sensitive to molecular mobility. 
The aim of this chapter is to understand crystallisation and phase transitions of the highly flexible 
TB molecule as a bulk drug, and encapsulated inside the small pores (3.2 nm) of a MCM-41 silica 
scaffold. The effect of storage conditions on the state of confined TB molecules was investigated 
extensively using a wide range of NMR methods alongside PXRD and DSC studies. Furthermore, 
through the application of NMR relaxation measurements we were able to gain better 
understanding of the molecular dynamics of the phenyl ring for a group of TB polymorphs. 
205 | P a g e  
7.1.1 Polymorphism of tolbutamide 
Tolbutamide contains a rigid benzene ring and a highly mobile aliphatic chain with seven bonds that 
can rotate freely. The high flexibility of this structure has led to a large number of TB polymorphs 
reported in the CCDC (6 structures including a high Z’ form III). Further understanding of TB 
polymorphism may serve as a base for structural studies of other (sulfonyl) urea derivatives, which 
are an important group of compounds in materials science, used frequently as low molecular weight 
gelators.[183,189,271,274] 
The polymorphism of TB was firstly investigated in 1969, when three forms were reported by 
Kuhnert-Brandstätter and Wunsch[189,275]. Further investigation of TB crystal structures was carried 
out by Simmons et al. who obtained two TB structures – forms A and B.[189,276] The preparation of 
four forms of TB, i.e., forms I-IV (known as Burger’s forms), was carried out by Burger in 1975.[189,277] 
Six years later the first structure of TB form I with atomic coordinates was reported independently 
by both Nirmala et al. and Donaldson et al. (CSD ref. codes ZZZPUS01, ZZZPUS02).[188,278] Thirty years 
later, the detailed structural analysis of four Burger’s TB polymorphs was reported by Thirunahari 
et al. (CSD ref. codes: ZZZPUS04 (form I), ZZZPUS05 (form II), ZZZPUS06 (form III), ZZZPUS07 (form 
IV)).[189]  
The temperature driven conformational changes within the TB form I were reported for the first 
time by Hasegawa et al. who identified that TB form IL (low temperature TB form I) was stable below 
the transition temperature of ca. 310 K and TB form IH (high temperature TB form I) was stable 
above ca. 310 K.[273] The identification of a low temperature (100 K) TB form III (known as TB form 
III2) was carried out independently by both Nath et al. and Drebushchak et al. in 2011 (CSD ref. 
codes ZZZPUS08[183], ZZZPUS11[271]).[183,271] TB form III2 was found to have three molecules in the 
asymmetric unit as compared to one molecule in TB form III. The reversible transition between form 
III and form III2 is accompanied by the elongation of the b axis of the unit cell of TB form III and an 
increase in the unit cell volume from ca. 1439.2 to ca. 4155.2 Å3 at 100 K.[183,271] Furthermore, 
Nath et al. reported a highly unstable (2 hours at room temperature) TB form V, which could only 
be prepared by recrystallisation from acidified methanol (CSD ref. code ZZZPUS10).[183] The 
structural parameters of the different TB polymorphs are listed in Table 7-1. 
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Figure 7-1. A. Numbering of carbon and nitrogen atoms; B. PXRD patterns of TB forms IL and IH; C. 
conformational changes in the structure of TB form IL and TB form IH; D. changes in the aliphatic 
region of TB form IL upon heating and transition to TB form IH. Adapted from [273]. 
 
Table 7-1. Crystallographic data of TB forms I-V reported by Thirunahari et al. and Nath et al.[183,189] 
 Form IL Form IH Form II Form III Form III2 Form IV Form V 
Crystal habit Prism  Plate Needle Needle Needle Plate 
Colour Colourless  Colourless Colourless  White Colourless 
Crystal system Orthorhombic Orthorhombic Monoclinic Monoclinic Monoclinic Monoclinic Orthorhombic 
Temp. of 
structure 
determination 
(K) 
153 363 153 153 100 298 298 
Space group Pna21 Pna21 Pc P21/n P21/n P21/c Pbcn 
a (Å) 19.626(9) 20.8095(4) 9.087(8) 11.787(5) 11.5613(7) 10.091 15.851(6) 
b (Å) 7.803(4) 7.9323(2) 17.228(3) 9.043(4) 27.189(4) 15.646 9.288(4) 
c (Å) 9.058(4) 9.0610(2) 17.951(4) 13.955(6) 13.556(2) 9.261 19.691(8) 
α (°) 90 90 90 90 90 90 90 
β (°) 90 90 95.01(3) 104.644(7) 102.803(2) 100.49 90 
γ (°) 90 90 90 90 90 90 90 
V (Å3) 1387.3(11) 1494.67(5) 2799.8(10) 1439.2(10) 4155.2(11) 1438.9 2899.2(19) 
Z/Z’ 4/1 4/1 8/4 4/1 12/3 4/1 8/1 
CSD ref. code ZZZPUS04 N/A ZZZPUS05 ZZZPUS06 ZZZPUS08 ZZZPUS07 ZZZPUS10 
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Figure 7-2. Conformations and packing arrangement of TB molecules in TB forms I-V based on the 
CSD structures ZZZPUS04 (form I), ZZZPUS05 (form II), ZZZPUS06 (form III), ZZZPUS07 (form IV), 
ZZZPUS10 (form V) (adopted from [189]). 
 
Due to its high flexibility, TB adopts different conformations in different crystal forms and is 
therefore a representative example of conformational polymorphism. There are two types of 
conformations found within the crystalline structures of TB: the U-type and chair type. These 
conformations reflect the position of the phenyl ring and butyl tail with respect to the 
S-N1-C8-N2-C9 plane (Figure 7-2). In the U-type conformation the phenyl ring and the butyl chain 
are both at the same site of the S-N1-C8-N2-C9 plane, while in the chair type conformation the 
phenyl ring and the butyl tail are on the opposite sites of the sulfonylurea tape.[189] Based on the 
two conformation types, Thirunahari et al. proposed four packing schemes summarised in Figure 
7-2. The proposed schemes take into account the relative orientation of the phenyl ring and butyl 
chain in adjacent molecules. For example, in the first packing scheme of TB forms I and III the two 
TB molecules lie on opposite sides of the urea tape bonding motif, while in the second packing 
scheme both the phenyl ring and the butyl chain are on the same side of the S-N1-C8-N2-C9 plane. 
Furthermore, similarly to other urea based compounds, the ‘head-to-tail’ (phenyl ring-to-butyl 
chain) packing mode is dominant in all TB polymorphs and stabilised by the bifurcated N-H∙∙∙O 
hydrogen bonding synthon formed between two NH hydrogen donors and carbonyl acceptor.[183,189] 
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7.2 Results and discussion 
7.2.1 Thermal, spectroscopic and computational studies of TB polymorphs 
Variable temperature 1H-13C CP/MAS NMR studies of the phase transition between TB forms IL and 
IH were begun by Dr Lucy Hawarden as a part of her PhD program. Significant broadening of the 
aromatic carbon peaks was observed upon cooling of TB form IL, however, due to time constrains 
this was not investigated further. In this section we aim to elucidate the motional processes within 
TB polymorphs (form IL, form IV and confined forms IL and form V). We made several attempts to 
crystallise pure TB forms II and III, but these forms were consistently obtained concomitantly with 
other structures. Using the method described by Nath et al. (crystallisation of form V from acidified 
methanol), we obtained colourless highly unstable crystals, which only formed on the vial walls, 
and quickly recrystallised to TB form IL when scratched for analysis.  In our experiments, TB form V 
was obtained inside the pores of the MCM-41 host (pores of ca. 2.6 nm in diameter - see section 
7.2.3). Interestingly, in a control experiment (crystallisation from methanol without nitric acid), we 
always obtained fine white needles of TB form IV on the vial walls. These polymorphs were 
identified using a combination of PXRD, DSC and solid-state NMR (Figure 7-3, Figure 7-4). 
 
 
Figure 7-3. A. DSC thermograms; B. experimental and simulated PXRD patterns of TB form I (CSD 
ref. code ZZZPUS04[189]), form IV (CSD ref. code ZZZPUS07[189]) and form V (CSD ref. code 
ZZZPUS10[183]). 
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The PXRD patterns of TB forms used in this study (TB forms I, IV and V) were in good agreement 
with simulated PXRD patterns for CSD structures ZZZPUS04[189] (TB form I), ZZZPUS07[189] (TB form 
IV) and ZZZPUS10[183] (TB form V). The TB form IV crystallises as very fine, white needles which, even 
after grinding, displayed preferred orientation in PXRD patterns, manifested as strong intensity 
peaks with d(110) = 10.65 Å and d(210) = 18.72 Å. The stability order of TB polymorphs has been 
discussed separately by Burger, Kimura et al. and Thirunahari et al.[189,274,277] Although the latest 
comprehensive thermodynamic stability analysis by Thirunahari et al. showed TB form II to be the 
most stable form below ca. 353 K and TB form IH the most stable form above ca. 353 K, we did not 
detect formation of TB form II at any stage of our studies. The analysed materials either 
recrystallised to TB form IL when stored below ca. 315 K, or to TB form IH upon heating. Based on 
our DSC studies, the clear transition of TB form IL to TB form IH was observed at ca. 315 K followed 
by melting of TB form IH at ca. 399 K. TB form IV shows two transitions on heating – an exothermic 
transition with onset at 336 K followed by an endothermic transition with onset at 366.8 K. The VT 
solid-state NMR spectra of this material indicate that these changes could be related to a phase 
transition of TB form IV to TB form IH (see section 7.2.2). There are some discrepancies between the 
DSC thermograms published by Thirunahari et al. and Kimura et al. which may be related to the 
analysis conditions, which are not fully specified by Kimura et al.[189,274] The DSC thermograms 
presented in this chapter  were measured on multiple occasions using either crystallisation from 
methanol or the method described by Thirunahari et al. (crystallisation from acetonitrile).[189] The 
TB form V was formed from the melt inside the pores of MCM-41 material (see section 7.2.3). The 
PXRD pattern of TB form V shows a broad ‘halo’ peak of amorphous silica walls and slightly 
broadened peaks of TB form V due to size constraints for the confined crystals. There are no DSC 
data published on TB form V due to its thermodynamic instability. TB form V as a confined crystal 
shows an endothermic transition at ca. 333 K followed by melting of confined TB form IH at ca. 373 
K, proving the formation of confined crystals (see section 7.2.4). 
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Figure 7-4. 1H-13C CP/MAS NMR spectra of TB forms IL, IH, IV and form V confined within MCM-41 
pores (spectra acquired at 298 K). 
 
1H-13C CP/MAS solid-state NMR spectra of TB forms IL, IH IV and V show 10 peaks for 12 carbon 
atoms in the TB structure grouped in 2 regions (aromatic and aliphatic). The number of peaks in the 
spectra indicates the presence of one molecule in the asymmetric unit, in agreement with 
crystallographic data. There are five well-separated peaks in the aliphatic region of the spectra 
between 10 and 45 ppm, while the aromatic and carbonyl carbons are grouped into the spectral 
region between 120 to 160 ppm as five separate peaks. The aromatic carbons C3/C7 and C4/C6 
overlap to give a single peak at ca. 130 (C3/C7) and 126 (C4/C6) ppm, respectively (Figure 7-4). The 
13C chemical shifts (listed in Table 7-2) are in excellent agreement with the 13C chemical shifts 
published by Kimura et al. for form IL and form IV and Hasegawa et al. for forms IL and IH.[273,274] The 
presented 1H-13C CP/MAS NMR spectra are also in agreement with the spectra published by 
Thirunahari et al.[189] The phase transition between TB forms IL and TB form IH is detected  by the  
changes in the 13C peaks positions of the spectra recorded at 283 K and 333 K, in agreement with 
the 1H-13C CP/MAS spectra published by Hasegawa et al.[273] Additionally, a substantial narrowing 
of the peaks at 131.2 and 125.5 ppm is observed upon heating, which has not been previously 
discussed in any of the published papers and will be discussed in detail from a dynamical 
perspective in section 7.2.2.  
The 1H-13C CP/MAS solid-state NMR spectrum of TB form V is shown in Figure 7-4 for the first time. 
As discussed in the previous chapters, the confined crystalline phase is usually present together 
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with confined amorphous species, therefore both components are observed in the spectrum. The 
13C spectrum of TB form V is composed of sharp resonances of the crystalline phase superimposed 
on slightly broadened peaks of the disordered species. There is an extra peak of amorphous TB 
present at ca. 12 ppm, observed previously in our group during analysis of amorphous solid 
dispersions of TB in a polymer matrix (Figure 7-4).[49] 
The carbon peaks were assigned based on the papers of Kimura et al., Thirunahri et al. and 
Hasegawa et al. Independently, we performed calculations of chemical shifts using CASTEP code for 
the TB structures reported in the CSD by Thirunahari et al. and Nath et al. (structures ZZZPUS04[189] 
(TB form I), ZZZPUS07[189] (TB form IV), ZZZPUS10[183] (TB form V)). The calculated 13C chemical shifts 
are in very good agreement for all the three structures (Table 7-2; Figure 7-5). Contrary to the 
assignment proposed by Kimura et al., the peak at ca. 130 ppm was assigned to sites C3/C7 and the 
peak at ca. 125 ppm was assigned to carbons C4/C6 based on the CASTEP results. 
 
Table 7-2. Experimental and CASTEP calculated 13C and 1H chemical shifts of different TB 
polymorphs. 13C experimental chemical shifts are compared to these published by Kimura et al. for 
TB form IL and IV and Hasegawa et al. for TB form IH. 
13C site TB form IL TB form IH TB form IV TB form V 
δexp δexp[274] δcalc δexp δexp[273] δexp δexp[274] δcalc δexp δcal 
C1 21.9 21.8 19.6 21.4 20.9 22.3 22.1 19.5 21.7 19.7 
C2 145.4 145.8 149.2 145.6 145.1 145.4 144.8 148.5 144.3 147.9 
C3 131.3 126.2 133.9 131.2 125.1 130.4 127.2 133.4 130.0 133.3 
C4 125.6 131.8 127.0 125.5 130.7 126.3 130.4 126.6 126.8 129.3 
C5 138.0 138.1 140.8 138.2 137.8 137.9 137.5 141.8 137.2 139.5 
C6 125.6 131.8 127.0 125.5 130.7 126.3 130.4 126.6 126.8 129.3 
C7 131.3 126.2 133.9 131.2 125.1 130.4 127.2 133.4 130.3 133.3 
C8 155.0 155.0 152.0 154.5 154.2 154.2 154.0 153.8 153.6 153.9 
C9 40.1 40.1 37.3 40.3 40.0 41.5 41.5 39.9 41.2 40.0 
C10 31.6 31.8 29.5 32.6 32.2 34.4 33.8 33.8 33.5 33.0 
C11 19.3 19.4 15.5 19.7 19.3 20.9 20.7 18.3 20.4 18.7 
C12 13.4 13.6 8.8 14.3 13.9 16.9 16.1 15.5 15.9 15.0 
 
1H site TB form IL TB form IV 
δexp δcal δexp δcal 
H1 1.9 2.1 1.9 2.2 
H3;H7 7.6;7.6 7.7 6.1;6.6 6.5 
H4;H6 7.2;7.4 7.3 6.3;6.9 6.5 
H9a;b 2.5;3.2 3.1 3.5;3.5 3.3;3.3 
H10a;b 0.0;1.3 0.4;0.8 1.1 0.7;0.8 
H11a;b 1.4 1.3 1.1;1.9 1.0;1.5 
H12 0.0 -0.4 0.2 0.1 
NH1 10.8 11.3 10.2 11.3 
NH2 7.6 7.9 7.7 7.8 
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Figure 7-5. Comparison of experimental and CASTEP calculated A. 13C and B. 1H chemical shifts; the 
dashed line shows the perfect fit.  
 
 
Figure 7-6. A. 1H-15N CP/MAS NMR spectra of TB forms IL and IH; B. 1H CRAMPS spectra of TB forms 
IL, IH and TB form IV; the spectra were recorded at an MAS rate of 6.8 kHz.  
 
The structural differences between TB form IL and IH can be visualised using 1H-15N CP/MAS spectra 
and 1H CRAMPS spectra (Figure 7-6). The two 15N sites in the TB structure result in two peaks in the 
1H-15N CP/MAS spectra of TB form IL at 100.8 ppm (N2) and 133.3 ppm (N1). Both peaks undergo 
an up-field shift of ca. 3 and 2 ppm, respectively, upon heating to 333 K due to the transition to TB 
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form IH. The assignment of both nitrogen sites was based on CASTEP calculations. The differences 
between TB polymorphs were investigated further using 1H CRAMPS spectroscopy. The aromatic 
hydrogens of TB form IL were observed as a single peak at 7.6 ppm, while the aliphatic hydrogens 
lead to at least four peaks between 0 and 4 ppm. The conformational differences due to the TB 
form IL  TB form IH phase transition were reflected by a change in the aliphatic part of the 
spectrum, where three resonances can be seen. Although the U-shape conformation of TB form IV 
is similar to the conformation of TB form IL and TB form IH, the differences in the packing scheme 
(see Figure 7-2) are highlighted by ca. 1 ppm up-field shift of the aromatic peak from 7.6 ppm in TB 
forms IL and IH to 6.5 ppm in TB form IV. All three structures show a similar urea tape hydrogen 
bonding pattern, reflected in only a slight up-field shift of the NH1 hydrogen peak (0.6 ppm) in the 
TB form IV spectrum compared to TB IL spectrum. The NH2 proton peak is observed as a part of the 
aromatic peak in the spectra of both TB form IL and TB form IH, appearing as a small shoulder peak 
in the TB form IV spectrum at ca. 7.6 ppm. All peaks observed in the 1H CRAMPS spectra of TB form 
IL and form IV are in good agreement with CASTEP calculations of 1H chemical shifts.  
7.2.2 Variable temperature solid-state NMR studies of TB form I and TB form IV 
 
NMR spectroscopy is a powerful and unique tool to study molecular dynamics over a wide range of 
timescales from 101 to 10−10 s, due to the sensitivity of magnetic interactions for molecular 
motions.[139,140,279] The possible molecular motions observed in solids include conformational 
changes, fluxionality, molecular reorientation and pseudorotations, and can be divided into slow < 
103 Hz, intermediate 103 – 106 Hz and fast > 106 Hz.[139,140,279] These are manifested as changes in 
NMR relaxation properties and NMR parameters sensitive to motional averaging, including CSA and 
dipolar interactions.[279] Importantly, some of the molecular motions detected using NMR 
spectroscopy are undetectable using diffraction based techniques, unless they lead to positional 
disorder.[279] This is due to differences in the timescale of diffraction processes, which are very fast 
(10−18 s) compared to the broad timescale of interactions which are possible to analyse using NMR 
spectroscopy.[279] Detailed studies of TB form I were started recently in our group due to the 
detection of unusual dynamic behaviour of the phenyl carbons C3/C7 and C4/C6 in the 1H-13C 
CP/MAS NMR spectra at low temperatures (Figure 7-7). These changes could be explained as either 
thermally induced disorder around the aromatic part of TB or dynamics of the aromatic ring, which 
at lower temperatures may be manifested as loss of structural equivalence of different aromatic 
carbon sites leading to distribution of 13C chemical shifts.[49]  
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Figure 7-7. 1H-13C VT CP/MAS NMR spectra of TB form IL (all spectra acquired at an MAS rate of 10 kHz). 
 
It was shown recently by Nath et al. and Drebushchak et al. using diffraction studies that TB form 
III undergoes structural changes at temperatures below 150 K, where one of the cell parameters (b) 
triples, leading to a structure with Z’=3 compared to Z’=1 structure at room temperature.[183,271] 
Furthermore, room temperature TB form III shows a significant disorder of the butyl chain. Based 
on this result, Drebushchak et al. performed a similar study for TB form I and TB form II. As reported 
by these authors, the two forms do not change upon cooling to 100 K.[271] In relation to the 
crystallographic data from Drebushchak et al., the gradual broadening and loss of intensity of 
aromatic carbons observed in our 1H-13C CP/MAS spectra of TB form I is  unlikely to be a result of 
major structural rearrangements within the crystal. Thirunahari et al. described significant changes 
in the calculated and experimental PXRD patterns of TB form I at room temperature and at 153 K, 
which were explained by thermal effects on the lattice parameters and anisotropy of the lattice 
contractions at low temperature. The redetermination of the crystal structure at room temperature 
revealed slight torsional changes in the butyl chain of TB, while the aromatic part of the molecule 
was not affected.[189] 
Substantial broadening and loss of signal intensity of phenyl carbons undergoing a 180° 
reorientation or ‘flip’ motions in 1H-13C CP/MAS NMR spectra were observed for several crystalline 
penicillin salts, ibuprofen-Na salt and L-phenylalanine HCl salt (Figure 7-8).[139,279–281] Such dynamics 
of the phenyl ring lead to equivalence of ortho (C3/C7) and meta (C4/C6) carbon peaks in the fast 
limit on the broadening-exchange timescale, while carbons in the ipso (C2) and para (C5) positions 
are unaffected by this motion.[279] The possible mechanisms of line broadening in the 1H-13C CP/MAS 
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NMR spectra under MAS and 1H decoupling were investigated in details by Vanderhart et al. who 
indicated that molecular motions in solids at the frequencies of the 1H decoupling can cause line 
broadening due to enhanced relaxation for transverse 13C magnetisation.[282] Rothwell and Waugh 
showed that the temperature dependence of the broadening enables determination of the rates 
and types of rotational motions in solids using examples of hexamethylbenzene, hexamethyletane 
and adamantane.[283] The mechanism of broadening was explained to be due to enhanced 
relaxation of S spins in the presence of molecular motions (incoherent averaging), which reduces 
the efficiency of rf decoupling (coherent averaging), particularly when both processes are on the 
same timescale.[283] It was further shown by Long, Bowen and Griffin that molecular motions may 
interfere with particular frequencies of the pulse trains and rf fields leading to ‘disappearing lines’. 
This was shown for labelled alanine using VT 1H spectra under CRAMPS decoupling and 15N{1H} 
under CW decoupling.[284] The interference of the TB phenyl ring motions with 1H-13C dipolar 
decoupling frequencies (here ca. 80 kHz) resulted in substantial broadening of the aromatic peaks 
C3/C7 and C4/C6 in the spectra. [279,280] This indicates motion of the phenyl ring in the crystal 
structure in the range of kHz or tens of kHz.[139] 
 
 
Figure 7-8. A. An overlay of different potassium penicillin salt structures, which undergo dynamical 
interchange and effect of motion on the aromatic region of VT 1H-13C CP/MAS spectra. B. Structure 
of ibuprofen and an effect of aromatic ring motions on VT 1H-13C CP/MAS spectra. Adapted from 
[139,279]. 
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Very recently (June 2016) Drebushchak et al. published detailed structural analysis of the TB IL 
TB IH phase transition, which was described as single crystal to single crystal conformation 
transformation between two phases using variable temperature single crystal X-ray studies.[285] The 
authors solved the crystal structure of TB form IH, which is now deposited in CSD database. The unit 
cell parameters and the space group of newly solved structure is in agreement with the data 
published previously by Hasegawa et al. if taking into account the thermal expansion. Based on the 
recent structural studies by Drebushchak et al., the ordered aliphatic tail of TB form IL is disordered 
in the TB form IH, split between two positions. The size of thermal ellipsoids of carbons C10 and C12 
increases significantly, while the position of carbon C11 is split into two ellipsoids with occupancies 
of 0.59(3) and 0.41(3) (Figure 7-9). Despite of the disorder of the alkyl tail, the space group remains 
unchanged and molecular pacing and hydrogen bonding is largely unaffected by the TB form ILTB 
form IH polymorphic transformation.[285] 
 
 
Figure 7-9. The asymmetric unit of TB form I at different temperatures. The displacement ellipsoids 
are drawn with 50 % probability. The disordered aliphatic tail at 330 K is highlighted in the box. 
Adapted from [285]. 
 
The structural studies of Drebushchak et al. highlight that, as observed by our group, the 
disappearance of the aromatic 13C peaks in the VT 1H-13C CP/MAS experiment is not related to the 
structural disorder in the aromatic part of the molecules, but as discussed previously it is likely due 
to the mobility of the aromatic ring interfering with the rf field of heteronuclear dipolar decoupling. 
The structural disorder of the aliphatic part of the molecule above the TB form ILTB form IH phase 
transition may explain the differences in the 1H T1ρ and 1H T1 times above the phase transition 
temperature, which are likely to be related to the molecular motions being dominated by the 
dynamics of aliphatic tail of the molecule (Figure 7-11, Figure 7-12).  
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Figure 7-10. 1H VT CRAMPS spectra of TB form IL (all spectra acquired at 6.8 kHz). 
 
The phase transition of TB form IL to TB form IH and broadening of the aromatic carbons C3/C7 and 
C4/C6 in the 1H-13C CP/MAS spectra are corroborated by VT 1H CRAMPS spectra (Figure 7-10). 
Significant broadening (FWHM = 945 Hz) of the aromatic peak of the spectrum at ca. 7.5 ppm was 
observed at 253 K as compared to the spectrum recorded at 323 K (FWHM = 349 Hz). The 
broadening of the peak may indicate an increased distribution of possible 1H chemical shifts of the 
hydrogens H3/H7 and H4/H6 due to the loss of equivalence between different proton sites due to 
slowing the motion of the aromatic ring. The aliphatic component of the spectra broadens to a 
much lesser extent with decreasing temperature, indicating only minor structural changes in the 
butyl chain of TB at low temperatures. In contrast to this, an increase in temperature above the 
phase transition of TB form IL TB form IH results in the merging of two peaks at 0.0 ppm and 
1.9 ppm in a one broad resonance at 0.3 ppm in the 1H CRAMPS spectra, related to conformational 
changes of the butyl chain between TB form IL and TB form IH. 
Variable temperature measurements of 1H T1 and 1H T1ρ relaxation times of the TB form I were 
started in our group by Dr Lucy Hawarden and highlighted the differences in dynamics between TB 
form IL and TB form IH.[49] Here we have continued this work by performing the measurements for 
TB form IV and expanding the temperature scale of the experiments for TB form I. 1H relaxation is 
dominated by homonuclear dipolar interactions, averaging T1 and T1ρ relaxation times of different 
protons to a single value.[139,140]  
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Figure 7-11. Variable temperature 1H T1ρ times of TB form IL. The expected errors for the method 
are between 5 to 10 %. 
 
VT 1H T1ρ relaxation time measurements of TB form I show two types of behaviour. Below the phase 
transition at 313 K, single values of 1H T1ρ times were observed for all proton sites, with a clear 
minimum at ca. 263 K. Above the phase transition, a substantial increase in distribution of the 1H 
T1ρ relaxation times was observed, with values too long to be determined accurately (above 
70 ms).[139,140,279] The parameters of the motions calculated previously in our group indicate a τc of 
5.6 x 10−4 s with an activation energy of 56.6 kJ mol−1.[49] The substantial differences in the 1H T1ρ 
relaxation times between TB form IL and TB form IH indicate that both structures have very different 
dynamic behaviour despite their structural similarities. 
 
 
Figure 7-12. Variable temperature A. 13C T1ρ times and B. 1H T1 times of TB form IL. The expected 
errors for the method are between 5 to 10 %. 
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The VT 1H T1 relaxation times show slight differences between aromatic and aliphatic hydrogens in 
the temperature range from 253 to 293 K which may indicate that both sites are in slightly different 
motional regimes. The 1H T1 relaxation times measured as a function of increasing temperature 
show a substantial drop in the relaxation times values from ca. 2.2 s to 1.7 s around the TB form IL 
 TB form IH transition temperature at ca. 313 K. This indicates a dramatic change in the dynamics 
of TB form IL above its phase transition temperature. The 1H T1 relaxation times for both aromatic 
and aliphatic sites are equal above the phase transition temperature, indicating a sufficient 
averaging of the relaxation times through the spin diffusion phenomenon. The 1H T1 relaxation time 
minimum at ca. 318 K, slightly above the phase transition temperature, describes molecular 
motions of TB on the MHz timescale, which are likely to be dominated by the movement of butyl 
tail. The activation energy of this motion was previously calculated to be 6.77 kJ mol−1.[49] 
The interpretation of 13C T1ρ relaxation (13C T1ρexp) times is not straightforward, as it does not only 
represent a purely dynamical contribution from the spin-lattice relaxation in the rotating frame 
(13C T1ρdyn), but it can also be affected by spin-spin interactions between thermally coupled 13C and 
1H spins (TCHD). Furthermore, the 1H-13C dipolar interaction (TCHD) relaxes to the lattice with the time 
constant T1D, hence the observed 13C T1ρexp relaxation times includes contributions from TCHD, T1D 
and the heat capacity of proton dipolar reservoir.[140,286]  
Both aromatic 13C sites (C3/C7 and C4/C6) have relatively short (up to 70 ms) and similar 13C T1ρ 
relaxation times as compared to other 13C sites, which show a wide distribution of experimental 13C 
T1ρ relaxation times. The temperature dependence of the 13C T1ρ relaxation times of both aromatic 
carbon sites showed a broad minimum at 253-263 K (due to the low resolution of the spectra 
acquired at 253 K, the 13C T1ρ times could not be measured accurately) and a substantial increase in 
the 13C T1ρ relaxation times above the TB form ILTB form IH phase transition temperature. 
Interestingly, the substantial increase in relaxation times of both aromatic carbon sites was 
observed above the phase transition temperature at ca. 313 K. This is another proof of drastic 
change in dynamic properties between TB form IL and TB form IH, which is likely due to the structural 
disorder of the aliphatic tail for TB form IH as compared to TB form IL. The structural changes 
observed by Drebushchak et al. using single crystal X-ray diffraction may indicate the dynamics of 
TB above the phase transition temperature (ca. 313 K) is dominated by the fast motions of the 
aliphatic part of the molecule, which is expected to be on the MHz timescale.[285] The increased 
disorder of the butyl tail at room temperature was also observed by the same group for TB form III. 
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Figure 7-13. 1H-13C VT CP/MAS NMR spectra of TB form IV (all spectra acquired at an MAS rate of 
10 kHz). 
 
As at least two TB polymorphs (TB form I and TB form III) show unusual structural and dynamic 
behaviour at low temperatures, we decided to expand the VT solid-state NMR studies to include TB 
form IV.[183,271,273] It is known that TB form IV undergoes a phase transition to TB form IH in the range 
of temperatures between 343 and 373 K.[61,189,287] These changes were monitored using 1H-13C 
CP/MAS NMR spectra at 343 and 353 K, where peaks from TB form IV and TB form IH are observable 
(Figure 7-13). Following cooling of the sample back to room temperature, the spectrum attributable 
to TB form IL was obtained, indicating that the phase transition from TB form IV TB form IH is 
irreversible. This is in agreement with previous reports, as TB form IH is the most stable form above 
ca. 343 K.[189] During the gradual cooling of TB form IV to 223 K, significant broadening and a 
decrease of the intensity of the aromatic carbons C3/C7 and C4/C6 peaks was observed, with a 
minimum at ca. 243 K (20 K below the minimum observed in the spectra of Tb form IL). Additionally, 
line broadening (C8, C2, C1, C11) or growth of new carbon peaks (C9, C10, C12) were observed in 
the spectra below 283 K, indicating a loss of chemical equivalence of TB molecules in the crystal 
structure.  This is likely due to a low temperature phase transition of TB form IV below 283 K. The 
TB form IVTB form IVL transition may be similar the TB form IIITB form III2 at low temperatures, 
where the translational symmetry changes due to the changes in the conformation of every third 
molecule leading to Z’=3 structure with two molecules in a gauche conformation and one molecule 
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with a trans conformation of the butyl tail.  As this is the first observation of TB form IV undergoing 
structural changes at low temperatures, we will refer to it as low temperature TB form IV: TB form IVL. 
 
 
Figure 7-14. 1H VT CRAMPS spectra of TB form IV (all spectra acquired at an MAS rate of 6.8 kHz). 
 
The structural changes observed in the 1H-13C CP/MAS spectra are corroborated by VT 1H CRAMPS 
spectra. Firstly, the phase transition between TB form IV and TB form IH was successfully monitored 
using 1H CRAMPS. The substantial differences in the aromatic region of the spectra are observed 
between 343 and 353 K, where the two aromatic peaks at ca. 6.5 ppm (TB form IV) and ca. 7.5 ppm 
(TB form IH) indicate the simultaneous presence of both TB forms. The low temperature transition, 
clearly observed in the 13C spectra is not so evident in the 1H CRAMPS spectra. At temperatures 
below 283 K, the broadening of all 1H sites may indicate structural changes displayed as a 
distribution of 1H chemical shifts of different hydrogen sites. Additional broadening of the aromatic 
peak in the spectrum may be related to the dynamics of aromatic ring, as observed previously for 
TB form IL.  
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Figure 7-15. Variable temperature 1H T1ρ and 13C T1ρ times of TB form IV (left) and zoomed 
temperature region (right) with uniform relaxation times for all 1H sites. The expected errors for 
the method are between 5 to 10 %. 
 
The VT 1H T1ρ measurements of TB form IV showed averaged relaxation times across all 1H sites with 
a clear minimum at ca. 243 K, which is 20 K lower than the minimum observed for VT 1H T1ρ times 
for TB form IL. The distribution of measured 1H T1ρ relaxation times for all 1H sites is evident at 
temperatures above 303 K. This is indicative of the start of TB form IV  TB form IH phase transition 
as small peaks of TB form IH are displayed in the 1H-13C CP/MAS spectrum acquired at 323 K. The VT 
13C T1ρ times of aromatic carbons C3/C7 and C4/C6 of TB form IV show the start of a broad minimum 
at ca. 223-243 K, with an increase in relaxation times with increasing temperature, similar to the 
effects observed for TB form IL. The 13C T1ρ relaxation times for other carbon sites of TB form IV 
showed very long values, with a wide distribution of relaxation times, hence were not used for 
comparison. The 13C T1ρ relaxation is driven mostly by heteronuclear dipolar interactions, therefore 
relaxation processes of quaternary carbons are complex and cannot be assessed accurately using 
simple models. In the case of the aliphatic carbons of TB, their relaxation is dominated by the fast 
motions of the aliphatic part of molecule (MHz timescale) therefore cannot be measured through 
13C T1ρ relaxation measurements.  
The structural and dynamical studies of two TB polymorphs, i.e., TB form I and TB form IV, using VT 
1H CRAMPS and 1H-13C CP/MAS solid-state NMR spectroscopy and relaxation measurements have 
shown the molecular motions at low temperatures are likely to be dominated by dynamics of the 
aromatic ring in both TB structures. To fully understand the motions of the phenyl ring of crystalline 
TB, it is important to use more sophisticated solid-state NMR methods including observation of 2H 
nuclei, 2D exchange or CODEX experiments.[125,126,281]  
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Solid-state 2H NMR (I = 1) is a widely used method to probe dynamics in the solids due to relatively 
small (ca. 250 kHz) first-order quadrupolar coupling interaction, which allows probing molecular 
motions in a timescale between 10-4 and 10-7 s.[126,288] The appearance of the 2H NMR static 
spectrum is affected by molecular motions due to partial averaging of the 2H quadrupolar 
interactions and changes in the line shapes. Furthermore, the quadrupolar coupling in 2H NMR is 
highly sensitive to internal molecular motions with respect to the external magnetic field. 
Therefore, the analysis of static lineshapes enables an insight into the mechanism and timescale of 
atomic and molecular motions in solids. In addition to quadrupolar couplings, 2H T1 relaxation 
measurements may be used to calculate the rate of molecular motions.[125,126,289,290] 2H MAS NMR 
has gained much interest in the last decade due to its increased sensitivity and resolution based on 
the distinct chemical shift of different 2H sites and possibility to probe the motions on the 
microsecond timescale.[266,288,291,292]  The solid-state 2H NMR was applied successfully to probe 
molecular motions of the ring in poly(L-phenylalanine),[290] dynamics of polymers,[289] hydrated 
clays[288,291] and encapsulated molecules within the porous solids.[91,266,289,292–294] 
 
 
Figure 7-16. A. 2D exchange spectrum of 13C sites in phenylalanine – two sites undergoing 180° flip 
exchange are shown as cross peaks circled in yellow and green. B. Calculated 2H solid-state NMR 
line shapes for static carbon-deuterium pair or undergoing different motions. Adapted from [281,289]. 
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The dynamics of different sites of the molecule can be probed using 2D exchange experiment. 
Although this method enables the identification of the motional model and calculation of motion 
rates, its full evaluation requires chemical shift separation between exchanging sites and large 
amount of spectrometer time for acquisition of multiple 2D spectra.[281] As an alternative, the 1D 
centerband-only detection of exchange (CODEX) experiment was proposed, which enables to 
determine both the exchange rate and amplitude of motion on the ms to s timescale. CODEX uses 
anisotropic interactions (chemical shift anisotropy or heteronuclear dipolar interactions) to encode 
the molecular orientation and monitor the ability to refocus the spatially dependent interaction as 
a function of mixing time.[281,295,296] Examples of NMR methods to probe molecular motions are 
highlighted in Figure 7-16. 
The low temperature TB form IVL with Z’ > 1 was detected below 283 K using VT 1H-13C CP/MAS 
experiments. Although the peak splitting observed may indicate this structure has two molecules 
in the asymmetric unit, relative intensities between different13C sites suggest the Z’ = 3 structure is 
also possible.  To answer this question, it would be necessary to perform additional experiments at 
higher magnetic field, to achieve a better resolution in the 1H-13C CP/MAS spectrum and acquire 
single pulse 13C spectra below the transition temperature for precise quantification of different 13C 
sites. Full proof of this transition is the subject of further research using VT PXRD and VT IR studies 
in collaboration with Dr Doris Braun at the University of Innsbruck and VT THz studies in 
collaboration with Dr J. Axel Zeitler at Cambridge University. PXRD would unequivocally prove 
changes in the long-range ordering of the TB form IV crystal at low temperatures. Furthermore, 
both vibrational spectroscopies, frequently used in the characterisation of pharmaceutical 
polymorphism, may provide additional information on changes in hydrogen bonding and changes 
in lattice vibrations upon cooling, which could be correlated with the dynamics of phenyl ring.[297–299] 
In summary, it was shown using VT 1H-13C CP/MAS, 1H CRAMPS, 1H T1 and 1H T1ρ relaxation 
measurements that two different polymorphs of tolbutamide TB form I and TB form IV have similar 
dynamics of the aromatic ring, which was found to be on the kHz timescale. The molecular motions 
below the temperature of the TB form ILTB form IH and TB form IVTB form IH phase transitions 
are dominated by the ring dynamics in both TB crystals, as minima in the temperature dependence 
of 1H T1ρ were detected for both phases. The disorder of the butyl tail in TB form IH reported recently 
by Drebushchak et al. may explain the drastic change in the dynamics of the system above the phase 
transition temperature, which is dominated by fast motions, observed as a minimum at ca. 313 K 
in the temperature dependence of 1H T1 relaxation times. Additionally, we reported new low 
temperature phase of TB form IV (TB form IVL), detected below 283 K, which will be the subject of 
further structural studies. 
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7.2.3 Formation of nano-crystalline metastable TB form V within mesoporous 
MCM-41 material 
7.2.3.1 Textural properties of TB loaded materials 
Synthesised sub-micrometre spherical particles of the MCM-41 host with pore size diameter of ca. 
3.2 nm were loaded with tolbutamide using the melting method (Figure 7-17). Loaded composites 
analysed with nitrogen adsorption/desorption isotherms showed a gradual decrease of the total 
pore volume and surface area with increasing drug content (Figure 7-18, Table 7-3).  
 
 
Figure 7-17. A. Low angle PXRD patterns of MCM-TB composites at different loading levels. B. SEM 
micrograph of MCM-41 particles. 
 
These results are corroborated by low angle PXRD, where a gradual decrease of the d[100] peak 
intensity was observed with increasing drug content (Figure 7-17), indicating a gradual deposition 
of the drug molecules within the pores of the MCM-41 host. Thermogravimetric analysis of the 
drug-SiO2 composites confirmed that the expected drug content was achieved during loading (Table 
7-3). It is important to mention that the water content of the final composites was ca. 1-2 %, as 
determined by TGA (see section 7.2.6 for detailed studies of water effects on the drug phase inside 
the pores of silica).  
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Figure 7-18. Nitrogen adsorption-desorption isotherms (left) and pores size distribution curves 
(right) of MCM-TB composites at different drug loadings (the isotherms are offset by 50 cm3 g−1). 
 
Table 7-3. Drug content and structural parameters of MCM-41 host and loaded composites. 
Host-guest composite TB (g g−1) Vtotal [cm3 g−1] dpore [Å] SBET [m2 g−1] 
MCM-41 N/A 398 31.8 1277.1 
MCM-TB 85-15 0.163 254 31.8 780.3 
MCM-TB 80-20 0.211 213 30.6 614.4 
MCM-TB 75-25 0.254 166 30.6 484.6 
MCM-TB 70-30 0.317 78.8 28.2 176.2 
MCM-TB 60-40 0.420 24.5 N/A 34.6 
MCM-TB 50-50 0.504 10.6 N/A 2.1 
 
 
7.2.3.2 Powder X-ray diffraction and differential scanning calorimetry results 
Amorphous tolbutamide has a low glass transition temperature (Tg = 277 K) and is included in the 
first class of glass forming agents based on the classification system implemented by Taylor et al.[267] 
Compounds in this class recrystallise during cooling from the undercooled melt state, regardless of 
cooling rate, and therefore the crystallisation process is dominated by thermodynamics.[61,267] Based 
on the results reported by Kawakmi et al., amorphous TB recrystallises to form IV on cooling with a 
further recrystallisation to form III observed during subsequent heating.[61] Tolbutamide 
encapsulated inside the silica scaffolds using the melting method displayed a very different 
behaviour compared to the bulk drug cooled from the melt. We found that TB remained amorphous 
at loading levels up to 30 wt. %, with crystallisation into the highly metastable TB form V occurring 
at higher drug loadings (40-50 wt. %), confirmed using a combination of PXRD, DSC and solid-state NMR. 
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Figure 7-19. DSC thermograms and PXRD patterns of MCM-TB composites at different drug 
loadings. The PXRD pattern of TB form V was simulated using ZZZPUS10[183] CSD structure. 
 
PXRD patterns (Figure 7-19) show a broad ‘halo’ peak due to the presence of amorphous MCM-TB 
composites at drug concentrations up to 30 wt. %. The small reflection at d = 8.39 Å observed for 
composites loaded with TB at 20 and 25 wt. % may indicate the confined guest is a mixture of 
amorphous and partially crystalline TB form V. The PXRD patterns of the host loaded at 40 and 50 
wt. % are in agreement with the simulated PXRD pattern of the highly unstable crystalline TB form 
V, which has only previously been formed through crystallisation from acidified methanol.[183]  
DSC analysis (Figure 7-19) of MCM-TB composites with drug content up to 30 wt. % does not show 
the melting peaks characteristic of TB polymorphs. The broad endotherm observed here may be 
related to the evaporation of loosely bound surface water as this is a frequently reported 
phenomenon for mesoporous silica based drug delivery systems.[41] At drug loadings of 40 and 50 
wt. %, a broad melting endotherm of confined TB form V was observed at 339.9 K followed by 
recrystallisation and melting of TB form IH at 364.2 K. Due to the broadening and decrease of the 
melting point expected with confined crystalline material, TB form IH was identified only using 
variable temperature 13C solid-state NMR spectroscopy (see section 7.2.4). This method enabled us 
to provide additional information on the supramolecular organisation of tolbutamide in the pores, 
and to monitor the phase transition of confined drug in situ (Figure 7-22).  
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7.2.3.3 Solid-state NMR studies 
 
Figure 7-20. 1H-13C CP/MAS solid-state NMR spectra of MCM-TB composites with different drug 
loadings. 
 
1H-13C CP/MAS NMR spectra of confined tolbutamide indicate the presence of amorphous drug at 
drug loading up to 30 wt. % (Figure 7-20). The peak broadening is due to the presence of 
magnetically non-equivalent environments of the carbon atoms alongside increased distribution of 
possible orientations, typical of amorphous solids. At the higher drug content of 40 and 50 wt. %, 
much sharper 13C peaks are observed, which indicates the presence of crystalline TB form V 
confined within the porous MCM-41 host, in agreement with PXRD data. The 1H-13C CP/MAS NMR 
spectrum of TB form V confined within MCM-41 is in agreement with the 13C chemical shifts 
calculated with CASTEP, based on the ZZZPUS10[183] structure reported in the CSD (see section 
7.2.1). Additionally, a decrease in the peak intensity of the amorphous TB (6144 transients 
averaged) as compared to crystalline TB (1024 transients averaged) may indicate increased mobility 
of the confined amorphous drug, resulting in the inefficient transfer of magnetisation during the 
cross-polarisation. This explanation was corroborated by 1H T1 relaxation measurements of 
confined crystalline and amorphous TB/MCM-41 composites compared to bulk crystalline TB. In the 
1H-13C CP/MAS spectra of MCM-TB 50-50 composite it was possible to observe, not only the peaks 
of TB form V, but also broad peaks of the confined amorphous species at ca. 12 and 30 ppm. The 
broadening of the base of the aromatic peaks of carbons C3/C7 and C4/C6, together with the slight 
asymmetry of the C9 peak, provide a further proof of both the presence of amorphous and 
crystalline species confined within the pores of MCM-41. 
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Figure 7-21. 1H MAS NMR spectra of MCM-TB composites with different drug loadings. Spectra 
acquired at an MAS rate of 10 kHz. 
 
1H MAS NMR spectra of rigid solids usually show very broad peaks due to the presence of strong 
homonuclear 1H-1H dipolar interactions. To partially overcome these interactions in 1H solid-state 
NMR, fast MAS (up to 120 kHz) and/or 1H-1H homonuclear decoupling sequences are used.[133–135] 
In the case of confined TB at drug contents up to 30 wt. %, five different proton sites were identified, 
indicating that the confined drug is in a highly dynamic state. These sites were assigned to the 
protons of aromatic ring (H4, H7 and H3, H6) and to two CH3 groups (H1 and H12). The assignment 
was carried out based on both 1H solution NMR spectra of TB, and CASTEP calculations. Further 
increase of the drug content within the material (40-50 wt. % drug loading) lead to crystallisation 
of TB inside the pores. This was confirmed by the broadening of the 1H peaks, consistent with the 
presence of enhanced 1H-1H dipolar interactions, which are expected for rigid crystalline solids 
(Figure 7-21). 
7.2.4 Solid-state NMR in situ monitoring of TB form V phase transformation under 
confinement  
The investigation of phase transitions of confined solids is a considerable analytical challenge due 
to decrease and broadening of the melting peak in DSC and broadening of PXRD peaks for nano-
size crystals.[93,106,110] In such cases, full understanding of the phase transitions in confinement 
requires application of methods sensitive to the local environment of atoms, therefore solid-state 
NMR is essential to probe both structure and dynamics.  
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Figure 7-22. 1H-13C VT CP/MAS NMR spectra of MCM-TB 50-50 composite with confined TB form V. 
 
At temperatures up to 333 K there was no change observed in the spectra of the MCM-TB 50-50 
composite, which is in agreement with DSC analysis. At 333 K peak splitting was detected, which 
indicated the presence of two crystalline phases. This agrees well with DSC results, where the first 
transition onset was observed at ca. 339 K. With increasing temperature further (up to 343 K) 
recrystallisation was observed through growth of the peaks associated with form IH, resulting in 
only one phase being detected by 353 K, as the confined metastable TB form V underwent a phase 
transition to TB form IH. This transition was in agreement with the DSC data, which demonstrated 
that there is a narrow temperature range at which TB form IH can be present before it melts at 366 
K. When the temperature reached 373 K, the confined drug melted. This was confirmed firstly by a 
loss of the CP efficiency observed as a substantial decrease of the peaks intensity in the 1H-13C 
CP/MAS spectrum (Figure 7-22), and secondly by the significant narrowing of lines in the 1H 
spectrum at 373 K, due to an increased mobility (Figure 7-23). To the best of our knowledge, this is 
the first attempt to monitor the crystallisation of a confined pharmaceutical molecule within the 
mesopores of MCM-41 scaffold.  
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Figure 7-23. 1H VT MAS NMR spectra of MCM-TB 50-50 composite with confined TB form V. 
 
The VT 1H MAS spectra of the MCM-TB 50-50 composite with confined TB form V showed a gradual 
narrowing of proton peaks H1, H3, H4, H6 and H7 with increasing temperature. The gradual 
narrowing of the peaks was attributed to increased dynamics of the aromatic ring of tolbutamide 
with increasing temperature. This is not unexpected as all TB polymorphs are stabilised through the 
rigid sulfonylurea bonding motif, hence the aromatic ring of tolbutamide may be in a different 
motional regime compared to the aliphatic part of the molecule. 
7.2.5 Structure and dynamics of TB form I confined within MCM-41 host: NMR 
studies 
7.2.5.1 Preparation of confined TB form IL 
Confined TB form IL was obtained by heating the MCM-TB 50-50 composite loaded with confined 
TB form V above its phase transition to TB form IH at ca. 333-343 K in situ within the spectrometer, 
followed by subsequent cooling of the sample to 293 K. The rotor with the converted material was 
removed from the spectrometer and stored at room temperature in a desiccator for a week to allow 
further recrystallisation of residual amorphous drug to TB form IL.  
7.2.5.2 Variable temperature solid-state NMR studies 
The 1H-13C CP/MAS NMR spectrum of the MCM-TB 50-50 composite loaded with TB form IL, 
acquired at 293 K, shows peaks of TB form IL built on the broad peaks of amorphous TB. The 
presence of the disordered phase inside the pores becomes more evident upon gradual cooling, 
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which results in a gradual increase of 1H-13C dipolar interactions leading to an increased CP 
efficiency.  
 
 
Figure 7-24. 1H-13C VT CP/MAS NMR spectra of MCM-TB 50-50 composite with confined TB form I. 
Amorphous TB peaks are indicated by arrows. 
 
In this regime, the broad amorphous TB peaks, (indicated by arrows in Figure 7-24) present either 
as a shoulder (C8, C9, C12) or as a broad base (C2, C5, both aromatic peaks, C9, C1, C11), were 
observed under the sharper peaks of crystalline TB form IL. The substantial decrease and broadening 
of both aromatic peaks (carbons C3/C7 and C4/C6) of TB form IL was observed in the spectra below 
283 K, in agreement with data for bulk TB form IL. Interestingly, the aromatic peaks (C3/C7 and 
C4/C6) of confined amorphous TB display a very different behaviour when compared to the 
crystalline material. The presence of both aromatic peaks of amorphous TB at decreased 
temperatures may indicate substantial differences in the mobility of the confined amorphous drug 
as compared to crystalline TB form IL. The absence of the peaks of amorphous TB in the 1H-13C 
CP/MAS spectra at increased temperatures may indicate it is in liquid like state, similarly to 
ibuprofen confined in MCM-41 as reported by Azais et al. and Skorupska et al. The decrease in the 
temperature may result in vitrification of liquid like TB into a glassy state observed as broad peaks 
in 1H-13C CP/MAS spectra. Similar observation was made by Azais et al. for confined ibuprofen at 
223 K (discussed further in General discussion chapter). The differences in the dynamics between 
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confined amorphous and crystalline drug are corroborated by measurements of relaxation time 
(Figure 7-26, Figure 7-27). Gradual heating of the material from 293 to 303 K led to a decrease in 
the peak intensity of confined amorphous TB, and narrowing of the peaks of confined TB form IL. 
This is particularly well illustrated for both aromatic carbons of TB highlighted in the blue box in 
Figure 7-24.  The confined TB form IL undergoes a phase transition to TB form IH above ca. 313 K, 
close to the transition temperature of bulk TB form IL (indicated by dashed lines in Figure 7-24). 
The 1H CRAMPS spectra of the MCM-TB 50-50 composite loaded with confined TB form IL indicate 
the presence of two superimposed components. This was highlighted by the asymmetry of the 
aromatic peak at temperatures below 283 K and a shoulder peak (shown by arrows in Figure 7-25) 
at temperatures of 303 K and above, due to increased distribution of 1H chemical shifts.  
 
 
Figure 7-25. 1H CRAMPS VT MAS NMR spectra of MCM-TB 50-50 composite with confined TB form 
I. The arrows indicate a shoulder peak, which suggests the presence of more than one component 
in the spectrum. 
 
This is in agreement with the broadening of the aliphatic part of the 1H CRAMPS spectra of the 
confined TB form IL. The spectrum of bulk drug is composed of four distinguishable peaks (see 
Figure 7-6 for comparison), while the spectra of confined TB form IL acquired at 303 K and below 
show only two broad resonances. The changes in the aliphatic part of the spectra between 303 and 
313 K indicate the presence of confined TB form IL to TB form IH, highlighting the sensitivity of this 
method towards subtle structural changes in crystalline/amorphous composite systems. 
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7.2.5.3 Relaxation time measurements of confined TB form IL within MCM-TB 50-50 
composite 
Substantial differences were observed in the VT 1H T1 and 1H T1ρ relaxation times of confined TB 
form IL in comparison to bulk drug. The temperature dependence of the 1H T1ρ values shows a clear 
minimum at ca. 263 K, which is likely to be related to the dynamics of the aromatic ring of TB form 
IL. Interestingly, the values of 1H T1ρ times for carbons C3/C7 and C4/C6 at temperatures below 283 
K are slightly longer compared to the values for other hydrogens of confined TB. These differences 
could be the result of a decreased intensity of the peaks for carbons C4/C6 and C3/C7 at 
temperatures below 283 K, alongside an increased intensity of the peaks of the amorphous 
component in the spectra. Therefore, the measured 1H T1ρ times for the aromatic carbons 
represents a mixture of relaxation times of the two components (crystalline and amorphous TB). 
The 1H T1ρ relaxation time of amorphous TB incorporated in the PVP-VA polymer matrix was 
measured previously as ca. 12 ms (at 263 K)[49], which is in agreement with data presented for 
amorphous TB encapsulated in the MCM-41 scaffold and significantly longer (3 times) than for the 
crystalline TB form IL at 263 K. 
 
 
Figure 7-26. Variable temperature 1H T1ρ data of MCM-TB 50-50 composite with confined TB form I. 
The expected errors for the method are between 5 to 10 %. 
 
At temperatures close to the TB form IL  TB form IH phase transition (ca. 313 K) the separation of 
1H T1ρ relaxation times becomes pronounced. A similar phenomenon was observed for bulk TB form 
I, but to greater extent as 1H T1ρ relaxation times well above 70 ms could not be measured 
accurately. This is either due to the differences in dynamics of confined crystalline TB form I in 
comparison to bulk, or to the presence of two components with very different dynamics inside the 
pores.  
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Figure 7-27. Variable temperature 1H T1 data of MCM-TB 50-50 composite with confined TB form I. 
The expected errors for the method are between 5 to 10 %.  
 
The analysis of the VT 1H T1 times recorded for the MCM-TB 50-50 composite with confined TB 
form IL shows a very different behaviour as compared to bulk TB form I. There was a clear minimum 
observed in the temperature dependence of the 1H T1 values for bulk TB form I, centred at the 
phase transition temperature at ca. 313 K (Figure 7-12), while an increase in the 1H T1 relaxation 
times with increasing temperature was observed for confined TB form IL. Further differences were 
observed between the relaxation times for aromatic and aliphatic peaks of TB with increasing 
temperature. While the 1H T1 values for the aliphatic hydrogens increase almost linearly with 
increasing temperature, the 1H T1 values for aromatic hydrogens increase linearly up to 283 K, then 
plateau and go through a local minimum at ca. 313 K (the phase transition temperature between 
TB form IL and TB form IH). As confined TB in the MCM-TB 50-50 composite has both the crystalline 
and amorphous drug, we measured 1H T1 relaxation times for only amorphous drug confined within 
the MCM-41 pores at 20 wt. % (Figure 7-27). An almost linear increase in the 1H T1 relaxation times 
was observed with increasing temperature with absolute 1H T1 values being significantly smaller 
than those observed for the MCM-TB 50-50 composite. Additionally, the measured values of 1H T1 
relaxation for amorphous confined TB are unlikely to be affected by the 1H T1 relaxation of the 
population of silanol protons, which were determined by Hansen et al. and Overloop et al. as equal 
to 3 and 4 s, respectively.[300]  Furthermore, the linear increase of the 1H T1 relaxation time with 
increasing temperature was observed by Aksnes and co-workers for cyclohexane and 
cylopentane[301,302] and  Hansen et al. for silanol protons of the MCM-41 pore wall.[300] A similar 
observation was made by the Navrotsky group for organic solid N,N,N-trimethyl-1-
adamantammonium iodide confined within silica scaffolds with pore sizes between 0.8 and 20 
nm.[303] 
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An increase in the 1H T1 values was observed by Aksnes and co-workers with increasing content of 
confined organic liquids (cyclohexane and cyclopentane). This observation was explained due to 
the increased contribution of the ‘bulk’ liquid in the middle of the pore to the overall 1H T1 relaxation 
time of the surface species. These were measured to have six times lower 1H T1 relaxation time 
compared to the ‘bulk’ species located in the pores centre. Porion et al. reported similar findings 
for T1 relaxation of confined water, where 1H T1 relaxation times were increasing with increasing 
water content.[304] This observation is in agreement with our 1H T1 relaxation studies for confined 
TB at 20 wt. % and 50 wt. % and earlier 19F T1 relaxation times of FFA-MCM and FFA-SBA composites 
at different loading levels.[301,302] 
 In summary, significant differences in mobility between bulk and confined TB crystals have been 
observed using 1H T1 and 1H T1ρ measurements. The observed changes in the dynamics of bulk and 
confined TB form I may be the result of the biphasic nature of the confined drug molecules. As it 
was indicated throughout this section using VT NMR studies, the TB molecules are present inside 
the pores as both confined crystals and confined amorphous species, both shown to be in two 
different motional regimes. The observed 1H MAS spectrum was an average of all TB molecules 
present in all different environments and motional regimes, therefore the measured 1H T1 values 
are likely to be an overall average of different motional processes of confined TB molecules.  
The equation for the calculation of the average T1 of confined water was established for 
macroporous solids and further applied for organic liquids, assuming the molecules reside either at 
the surface of the pores, with particular relaxation time T1S, or in the pore void, with relaxation time 
equal T1B.[305] Therefore, if the two-site fast exchange model for relaxation is still valid for the 
system, the overall relaxation time is expressed as: 
 
1
𝑇1
=
𝑥
𝑇1𝑆
+
(1−𝑥)
𝑇1𝐵
,  (Eq. 7-1) 
 
Where x is the fraction of molecules present at the surface sites. This model was applied 
successfully for cyclohexane and cyclopentane confined within the MCM-41 host to determine the 
thickness of the molecular layer of highly mobile species at the pores surface.[301] Our results were 
in agreement with the model assuming the material is dominated by amorphous species (x = 0.8), 
and T1S = 0.36 s at 253 K and T1B = 3.42 s for confined amorphous TB at 20 wt. % loading and bulk 
TB, respectively. The mechanism of increased dipolar relaxation of the surface species was 
explained by both translational diffusion at the surface or bulk-mediated surface diffusion through 
the Levy walk mechanism of desorption and readsorption of the surface species.[305] 
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7.2.6 Changes of the structure and dynamics of confined tolbutamide during 
storage at dry and humid conditions (75 % RH) 
 
Understanding the changes to the structure and dynamics of confined pharmaceuticals upon 
storage is of paramount importance from an industrial and regulatory perspective. Recently we 
have shown that the crystallisation of FFA can be inhibited inside the pores of MCM-41 and SBA-15 
(pore size diameters ca. 3 and 8 nm, respectively), whilst FFA form I is formed inside the pores of 
MCF (pore size diameter ca. 29 nm).[306] In another study we have shown that IMC crystallisation 
can be driven inside the pores through the addition of organic solvents (MeOH, EtOH or ACN). These 
findings enable the prediction of the material’s performance during pharmaceutical processing 
such as wet granulation, coating or spray drying.[88] 
The effect of water on the mesoporous silica-drug composites is very poorly understood and is 
rarely addressed in the scientific literature. To date, there is only one study by Skorupska et al. 
showing a molecular level understanding of water and ethanol effects on confined ibuprofen 
loaded inside the pores of MCM-41 material at high drug contents (50 and 60 wt. %).[79] The study 
presented in this section was developed based on two observations regarding MCM-TB composites. 
Firstly, at low drug contents (for amorphous materials), the 1H and 13C MAS NMR spectra differed 
for the same sample depending on the storage conditions: narrowing of the 1H peaks and 
substantial decrease of the 1H-13C CP/MAS NMR signal were observed during the analysis 
performed at high ambient humidity. Secondly, the formation and stability of TB form V confined 
within MCM-41 scaffolds was affected by residual water content and storage conditions. This is not 
surprising as Nath et al. have highlighted decreased stability of bulk TB form V under increased 
humidity.[183] In the following study we chose two model MCM-TB composites loaded with 20 and 
50 wt. % of the drug to show the effect of water on the structural and dynamical properties of 
confined molecules. We further showed application of different NMR methods to gain a better 
understanding of the structure and mobility of confined tolbutamide. 
7.2.6.1 Effect of storage conditions on the state of amorphous TB confined within MCM-41 
silica scaffold loaded at 20 wt. % using melting method 
 
The MCM-41 material loaded with 20 wt. % of TB yields amorphous composite as determined by 
the broad ‘halo’ in the PXRD pattern and absence of melting endotherm in the DSC thermogram 
(week 0 - Figure 7-28).  
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Figure 7-28. A. PXRD patterns and B. DSC thermograms of MCM-TB 80-20 composite stored at dry 
and humid (75 % RH) conditions over a period of four weeks.  
 
The material stored over a period of 4 weeks in either dry or humid conditions remained amorphous 
as determined using PXRD and DSC analysis (Figure 7-28). The DSC thermograms of the material 
stored at 75 % RH show a broad endotherm in the temperature range from ca. 323 to 403 K, which 
may be related to the evaporation of loosely adsorbed water during storage. These endotherms are less 
pronounced and centred between 300-370 K for the composite stored at dry conditions (Figure 7-28). 
DSC and PXRD methods could only confirm that the TB confined within the MCM-41 host at low 
loading levels (20 wt. %) remained amorphous over a period of four weeks, regardless of the storage 
conditions. Additional information on the state of the drug confined within the nanopores was 
obtained using solid-state NMR. The 1H MAS NMR spectra of the composite stored at dry conditions 
show three broad peaks attributable to aromatic (at ca. 8 ppm) and aliphatic (at ca. 1 and 2 ppm) 
hydrogens of TB (Figure 7-29) and did not change over a period of four weeks. In contrast, the 1H 
MAS NMR spectra of the material stored at 75 % RH showed substantial narrowing of the peaks 
after one week of storage.  
The spectra show eight peaks, assigned to both aromatic sites (H3/H7 and H4/H6) at 7.6 and 7.0 ppm, 
intense water peak at 5.2 ppm, H9 site at 2.9 ppm, and intense H1 methyl peak at 2.1 ppm (Figure 
7-29). Interestingly, the H12 site has two peaks (0.6 and 0.8 ppm), which is evident from the HSQC 
spectrum (Figure 7-30) and hydrogens H10 and H11 were observed as a broad shoulder centred at 
1.1 ppm. The two peaks for the H12 site, with an integral equal to an integral of H1 methyl site 
along with the broadening of the H9-H11 protons of butyl tail, may indicate that the flexible aliphatic 
part of tolbutamide is present in more than one conformation inside the pores of MCM-41. 
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Figure 7-29. 1H MAS solid-state NMR spectra of MCM-TB 80-20 composite stored at A. dry and B. 
humid (75 % RH)  conditions over four weeks. 
 
 
 
Figure 7-30. 1H-13C HR-MAS HSQC spectrum of MCM-TB 80-20 after a week of storage at 75 % RH 
acquired at 18.8 T using MAS rate of 8 kHz. 
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The 1H-13C CP/MAS NMR spectrum of the MCM-TB composite loaded with 20 wt. % shows five 
broad low intensity peaks, indicating the presence of amorphous TB inside the pores. The 1H-13C CP 
spectra of the material stored in dry conditions did not change over four weeks. However, the 
formulation stored at 75 % RH showed significant narrowing, and substantial decrease in peak 
intensity as compared to the starting material (week 0) after the first week of storage. Decrease in 
signal intensity in CP/MAS spectra was previously observed by Azais et al. and Skorupska et al. for 
small organic molecules (ibuprofen, benzoic acid, lauric acid) and can be a result of an increased 
mobility of confined TB stored in humid conditions.[74,75,77,79] Furthermore, eight different 
resonances were identified in the 1H-13C CP/MAS spectra of the materials stored in humid 
conditions compared to the five resonances for the compound stored in dry conditions. These are 
the carbons with directly bonded hydrogens including aromatic carbons C3/C7 and C4/C6 at 130.1 
and 126.7 ppm, respectively, and aliphatic carbons C1, C9-C12 in the range from 13.9 to 40.7 ppm. 
Interestingly there are two peaks at 29.8 and 32.1 ppm, which can be assigned to carbon C10 in the 
material stored at 75 % RH. The methyl C12 can be found in at least two different environments in 
the starting material at 12.5 and 13.9 ppm and has relatively low intensity in the spectra of the TB-
MCM-41 stored at 75 % RH. This is in agreement with the 1H MAS NMR spectra (Figure 7-29) and J-
MAS-INEPT (Figure 7-32) spectra, indicating that the butyl chain of TB could be present in more 
than one conformation. This hypothesis is based on recent single crystal X-ray studies by 
Drebushchak et al. for TB form IL and IH, where substantial disorder in the aliphatic tail was observed 
with site C11 being present in two different positions.[285] The disorder of the aliphatic part of TB 
was also observed earlier by the same group for TB form III above 150 K or freezing of the molecules 
below 150 K in either gauche or trans conformation of the butyl tail in TB form III2 structure.[271] 
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Figure 7-31. 1H-13C CP/MAS NMR spectra of MCM-TB 80-20 composite stored at dry and humid 
(75 % RH) conditions over four weeks.  
 
The application of 1H-13C INEPT experiments in ‘true’ solids is limited due to the rapid decay of 1H 
transverse magnetisation coherences. As MAS does not average 1H-1H dipolar couplings fully, [125,126] 
the effective transverse dephasing times are very short, therefore the application of multi-pulse 
homonuclear decoupling sequences is required during the polarisation transfer times in the INEPT 
pulse sequence.[198] Application of solution-state INEPT pulse sequence (without proton decoupling) 
under MAS conditions has been reported only for poorly coupled nuclei of inorganic solids or mobile 
systems such as inorganic gels and drugs or surfactants confined in MCM-41 silica 
scaffold.[74,77,197,199,307] In the latter case, there are only two model systems studied using J-MAS-
INEPT (ibuprofen and benzoic acid confined in MCM-41 material).[74,75,77,79] It important to note that 
ibuprofen has a low melting temperature (351 K), hence it is expected to be present in the liquid 
state in confined media due to the effect of melting point depression related to 
confinement.[74,75,77,79] 
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Figure 7-32. 13C J-MAS-INEPT spectra of TB-MCM 80-20 composite stored at dry and humid 
(75 % RH) conditions over a period of four weeks. 
 
The starting material loaded with 20 wt. % of TB did not show any peaks in the 13C J-MAS-INEPT 
spectrum, indicating the inefficiency of the polarisation transfer through the scalar couplings. 
Similarly, there was no signal in the 13C J-MAS-INEPT spectra of the materials stored in dry 
conditions over four weeks due to formation of amorphous TB inside the pores (Figure 7-32). The 
TB-MCM-41 stored at 75 % RH showed four resonances in the 13C J-MAS-INEPT spectra, which can 
be assigned to aromatic carbons (C3/C7 at 130.3 ppm and C4/C6 at 126.6 ppm) and methyl sites 
(C1 at 21.5 ppm and C12 at 13.8 ppm). There are two interesting features in these 13C J-MAS-INEPT 
spectra. Firstly, the intensity of the methyl C12 is around half that of the methyl C1, and the C12 
site is almost twice as broad as the C1 site. Secondly, there are no CH2 resonances present in the 
spectra (Figure 7-32). The broadening and decrease of the intensity of the C12 peak could be 
another proof of the aliphatic chain being present in more than one conformation in confined TB, 
due to increased distribution of possible orientations of the C12, which resulted in peak broadening. 
The absence of CH2 peaks was observed in the 13C J-MAS-INEPT and 1H-13C HSQC spectra, both 
recorded at different fields. It is known that CH2 groups in solid state have very short 1H to 13C 
transverse coherence lifetimes and are difficult to decouple.[198] In our case, all 1H peaks (H9-H11) 
of the three CH2 groups were broadened in the 1H MAS spectra, indicating reduced mobility, which 
may explain the lack of CH2 peaks in the J-MAS-INEPT spectra.   
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Figure 7-33. 13C{1H} MAS NMR spectra of MCM-TB 80-20 at week 0 and after 4 weeks of storage at 
dry and humid conditions (75 % RH); the J-MAS-INEPT and CP/MAS spectra of MCM-TB 80-20 after 
4 weeks of storage at 75 % RH conditions are added on the top for comparison. The orange dashed 
lines indicate peaks present in both J-MAS-INEPT and 13C{1H} spectra, while green dashed lines 
indicate peaks present in both CP/MAS and 13C{1H} spectra.  
 
In the last set of experiments, we recorded 13C{1H} MAS NMR spectra, which in principle should 
provide information on all the TB species confined in the MCM-41 scaffold (Figure 7-33). The 
spectrum of the starting material (week 0) shows four broad resonances in the aliphatic region, and 
two very broad peaks covering the full aromatic and carbonyl spectral range from 120 to 165 ppm. 
An almost identical spectrum was measured after four weeks of storage in dry conditions. The 
13C{1H} MAS NMR spectrum of the MCM-TB 80-20 composite stored at 75 % RH shows substantial 
differences as compared to the spectrum of the material stored in dry conditions and the starting 
material. Here we observed all 11 resonances of the different TB carbon sites. The aromatic region 
showed a peak for each carbon site C2, C5, C4/C6 and C3/C7, similarly to the spectrum of crystalline 
TB. The carbonyl carbon C8 underwent an unusual downfield shift of ca. 5 ppm as compared to the 
spectra of the TB polymorphs. Additionally, the peak intensity was half of the other peaks, which 
may indicate broadening of the peak at ca. 152 ppm (indicated by arrow), possibly assigned to an 
additional C8 site. The aliphatic region of the spectrum shows four peaks (for sites C1, C9, C11 and 
C12) and again two peaks at 30.1 and 32.4 ppm (for carbon C10). The carbon C12 of the material 
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stored at increased humidity underwent down-field shift of ca. 1 ppm compared to the starting 
material. Furthermore, the asymmetry of the C12 peak in the spectrum of the starting material may 
indicate the presence of two C12 sites of TB in the silica pores. Similarly, splitting of C10 carbon 
indicates it is present in two different environments.  
 
 
Figure 7-34. 1H T1 relaxation times for MCM-TB 80-20 composite stored in dry and humid conditions 
over a period of four weeks. The expected errors for the method are between 5 to 10 %. 
 
The 1H T1 relaxation times (Figure 7-34) highlight differences in the mobility of MCM-TB 80-20 
composite stored in either dry or humid conditions. Clear separation between 1H T1 relaxation times 
of the aliphatic and aromatic 1H sites in the material stored at 75 % RH highlights differences in 
mobility across both parts of the molecule. A gradual decrease in 1H T1 relaxation times with storage 
was observed for this material, which may be related to progressing dissolution and/or increasing 
content of water inside the pores. The material stored in dry conditions does not show significant 
differences in 1H T1 values over the four weeks of storage as shown in Figure 7-34.   
7.2.6.2 Effect of storage conditions on the TB confined within MCM-41 silica scaffold 
loaded at 50 wt. % using melting method 
TB loaded into the MCM-41 silica host at 50 wt. % underwent complex phase transitions upon 
storage at room temperature in both dry and humid conditions. It is important to emphasise that 
TB form V described previously can only be formed by slow crystallisation under dry conditions at 
277 K. When the MCM-TB 50-50 composite was stored at RT and above, a mixture of phases, or 
only TB form I, was formed. The 1H-13C CP/MAS spectrum of the MCM-TB 50-50 composite (week 
0) shows broad resonances of amorphous drug inside the pores (Figure 7-35).  
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Figure 7-35. Variable-temperature 1H-13C CP/MAS spectra of as synthesised MCM-TB 50-50 
composite and TB form IH. The spectra show growth of TB form IH followed by its melting at 343K 
and formation of amorphous confined TB after cooling to 273 K. 
 
 Gradual in situ heating of the MCM-TB 50-50 composite led to an increased population of 
TB form IH as significant narrowing of the 13C peaks was observed in the VT 1H-13C CP/MAS spectra 
(Figure 7-35). The decrease of the peak intensity in the spectrum acquired at ca. 343 K indicates 
melting of confined TB form IH. The increased mobility of molten drug leads to a decrease in the CP 
efficiency, resulting in decreased peak intensity (Figure 7-35). When the sample was cooled to 
273 K, broad peaks of confined amorphous TB, formed after melting at 343 K, were observed.  
Although the 1H-13C CP/MAS NMR spectrum of the freshly loaded material (week 0) indicated 
formation of amorphous TB inside the pores, the PXRD pattern of this composite shows four broad 
peaks, which do not match any of the known TB polymorphs (Figure 7-36 A). The PXRD peaks display 
significant narrowing upon storage at both the dry and 75 % RH conditions, indicating a growth of 
the confined crystallites (Figure 7-36). The PXRD peaks may be due to the formation of an 
intermediate disordered phase, which upon heating transforms directly into stable TB form IH, as 
confirmed with VT 1H-13C NMR studies. The DSC thermogram of the starting material (MCM-TB 
50-50, week 0) showed a single melting peak at ca. 353 K (Figure 7-36). This endotherm displayed 
the melting of TB form IH in agreement with melting of this form observed through VT 1H-13C 
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CP/MAS spectra (Figure 7-35). It is important to note the depression of the melting point of 
confined TB form IH by ca. 40 K compared to the bulk drug. Furthermore, a lack of the transition 
peak at ca. 313 K indicates there was no confined TB form IL in the starting material (Figure 7-36).  
 
 
Figure 7-36. A. PXRD patterns and B. DSC thermograms of MCM-TB 50-50 composite stored at dry 
and humid (75 % RH) conditions over a period of four weeks. The PXRD patterns of TB form IL and 
form V are shown for comparison. Different phases are indicated by dashed lines in green (TB form IL), 
orange and pink. 
 
The phase stability of TB confined inside the pores of the MCM-41 silica host at 50 wt. % was highly 
affected by storage conditions. The accelerated growth of crystalline phases, including TB form IL in 
the materials stored at 75 % RH was demonstrated using PXRD, DSC and solid-state NMR 
spectroscopy (Figure 7-36, Figure 7-37). Three distinct endothermic transitions were seen in the 
DSC thermograms of the materials stored at increased humidity, indicating the presence of three 
phases inside the pores of the silica host (Figure 7-36, indicated by arrows). This is in agreement 
with PXRD data, where three different phases were indicated. Due to similarities in PXRD patterns 
and overlapping of the peaks, it was difficult to state unequivocally which phases were present 
within the material. Only TB form IL could be recognised easily based on the PXRD pattern of the 
reference material (indicated by green dashed lines). In contrast, the DSC thermograms of the 
material stored in dry conditions showed only two distinct endotherms indicating the presence of 
only two phases inside the pores. The DSC data is in good agreement with the PXRD patterns, which 
show only two distinct phases labelled with orange and green (TB form IL) dashed lines in Figure 7-36. 
 
247 | P a g e  
 
Figure 7-37. 1H-13C CP/MAS solid-state NMR spectra of MCM-TB 50-50 composite stored at dry and 
humid (75 % RH) conditions over four weeks. 
 
The 1H-13C CP/MAS NMR spectra of the material stored in dry conditions were dominated by broad 
peaks characteristic of amorphous disordered TB (Figure 7-37). The significant distribution of the 
13C chemical shifts of the aromatic carbons in the spectra of amorphous TB (stored at dry conditions) 
led to only two broad peaks of the six aromatic carbons in the spectrum. The presence of a 
crystalline component was detected by the presence of sharper peaks superimposed with the broad 
component of the spectrum. The peaks in the spectra of the MCM-TB composite stored at 75 % RH 
had 2-3 times lower intensity compared to the spectra of the MCM-TB 50-50 composite stored in 
dry conditions. Additionally, significant narrowing of multiple peaks in the spectra indicates the 
presence of more than one crystalline phase. TB form IL was identified in the spectra of the materials 
stored at increased humidity (Figure 7-37), labelled with green dashed lines, in agreement with the 
PXRD patterns. An additional crystalline component identified in the spectra has been labelled with 
pink dashed lines, but could not be assigned to any of the referenced TB polymorphs described in 
this chapter. The broadening of the peaks indicated that amorphous TB was still present inside the 
pores of the material stored at increased humidity. Furthermore, the 1H MAS spectra of the MCM-
TB 50-50 composite stored at 75 % RH were also indicative of the presence of multiple components 
in the material, as substantial broadening of the peaks was observed (Figure 7-38).  
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Figure 7-38. 1H MAS solid-state NMR spectra of MCM-TB 50-50 composite stored at A. dry and B. 
humid (75 % RH) conditions over four weeks. 
 
 
Figure 7-39. 1H T1 relaxation times for MCM-TB 50-50 composite stored in dry and humid conditions 
over a period of four weeks. The expected errors for the method are between 5 to 10 %. 
 
The slight increase in mobility of confined TB loaded within the MCM-41 silica scaffold at 50 wt. % 
stored at 75 % RH was evident from the 1H T1 relaxation measurements. The 1H T1 relaxation times 
of the MCM-TB 50-50 composite stored in dry conditions remained constant (at ca. 1.15 s) 
throughout the four weeks, whilst decrease of TB relaxation times (ca. 0.9 s) was observed for the 
material stored at 75 % RH (Figure 7-39). The substantial differences (ca. 0.4 s) in the 1H T1 
relaxation times between the confined TB loaded at 20 wt. % and 50 wt. % indicate increased 
mobility of the amorphous TB species loaded inside the pores at 20 wt. %, compared to the 
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crystalline/amorphous composites loaded at 50 wt. %. This may be due to the presence of the free 
space available for reorientation of TB molecules at lower loadings compared to the densely packed 
molecules within the pores at 50 wt. % loading.  The small changes in the 1H T1 relaxation times of 
MCM-TB 50-50 composites compared to the distinct changes in dynamics of TB confined within 
MCM-TB 80-20 host may be related to the differences in filling of the pores. As seen from the 
nitrogen adsorption analysis (Figure 7-18) at 20 wt. % drug loading, there is still enough space within 
the pores for water vapour to enter and dissolve the drug molecules. However, at 50 wt. % loading, 
pores seem to be completely filled with drug molecules, seen through the almost flat nitrogen 
adsorption isotherm (type II isotherm) (Figure 7-18), which is characteristic of nonporous solids. 
Therefore, most of the drug molecules encapsulated deeper within the pores are not accessible for 
water due to limited penetration.  
The 1H T1 relaxation times of both MCM-TB 50-50 and MCM-TB 80-20 composites stored in dry 
conditions indicate a higher mobility of TB molecules in fully amorphous composites (MCM-TB 80-
20) compared to the silica host loaded with crystalline drug. Similar differences were demonstrated 
in materials stored at 75 % RH humidity, where composites loaded at 20 wt. % displayed lower 1H 
T1 relaxation times (Figure 7-34) compared to MCM-TB scaffolds loaded at 50 wt. % (Figure 7-39). 
These differences may be due to packing density of TB within the pores: as TB loaded at 20 wt. % 
has more space for reorientation, it undergoes faster motions, compared to the more densely 
packed crystalline TB encapsulated inside mesopores of MCM-41 at higher loading level. 
To summarise, we have demonstrated that the state of encapsulated TB depends on the drug 
content within the pores and relative humidity storage conditions. We were able to distinguish TB 
confined in the pores of MCM-41 material in different local environments with different dynamics 
using both 1H and 13C NMR experiments. The application of different 13C signal enhancement 
methodologies, sensitive to either solid or liquid like environments, enabled us to distinguish both 
rigid and highly mobile components of the confined TB at low loading levels.  TB loaded at 20 wt. % 
within the MCM-41 silica host and stored at 75 % RH was found to reside in more than one 
environment, as highly mobile liquid like species. The composites stored in dry conditions remained 
amorphous and did not change over a period of four weeks, as demonstrated using PXRD, DSC and 
solid-state NMR. The materials loaded with 50 wt. % of TB and stored at 75 % RH displayed 
accelerated crystallisation towards two TB polymorphs including TB form IL as compared to the 
predominately amorphous material stored in dry conditions. These findings have implications for 
the pharmaceutical industry regarding the effect of storage conditions on the phase stability of 
encapsulated drug molecules. In depth, understanding of such processes is of paramount 
importance from an industrial perspective, as it enables knowledge-based design of drug delivery 
systems.    
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7.3 Conclusions 
In this chapter we gained in-depth understanding of possible phase transitions of the flexible 
molecule TB encapsulated inside very small pores of MCM-41 silica host (ca. 2.6 nm).  
Firstly, we focused on the detailed characterisation of model TB polymorphs (forms IL, IH, IV and V) 
and detected dynamics of the TB phenyl ring in three different crystalline forms using VT solid-state 
NMR studies. We further have identified low temperature phase transition of TB form IV (TB form 
IVL). The dynamics of the phenyl ring may be linked with the relative phase stability order and 
transitions between different TB forms. The new TB form IVL and ring dynamics in a series of TB 
crystals will be the subjects of further structural and spectroscopic studies.  
Detailed investigation of TB confined within MCM-41 pores enabled us to develop a new method 
to crystallise highly unstable TB form V inside the mesopores of ca. 2.6 nm. The crystallisation of 
the relatively large model pharmaceutical TB (270.35 g mol−1) is very unusual in small pores and to 
the best of our knowledge this is the first report of such a phenomenon. We believe this may be 
related to the flexibility of the molecule, which enables it to be packed more efficiently in confined 
geometries. For comparison, flufenamic acid (281.23 g mol−1) can be crystallised only in ten times 
larger pores[306]. The in situ monitoring of the confined phase transitions of TB form V  Tb form IH 
and TB form ILTB form IH was demonstrated for the first time. By application of VT 1H-13C CP/MAS 
NMR studies we have proven that at high drug loadings, TB molecules are present as both confined 
crystals and amorphous drug molecules. 
Finally, confined TB loaded at 20 wt. % was shown to undergo dissolution inside the silica pores 
when exposed to 75 % RH. The dissolved molecules were in at least two different environments, 
detected through the application of different 13C NMR methods. In contrast, at 50 wt. % drug 
loading, accelerated crystallisation into the more stable TB polymorphs was detected. In these 
studies, we developed an experimental approach towards molecular level understanding of 
dissolution processes of drug delivery systems using NMR based methods.    
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8 General discussion and 
conclusions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 8 
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8.1 Knowledge based design of mesoporous silica based systems for 
drug delivery – from amorphous to nano-crystalline composites 
In formulation science it is of paramount importance to prepare uniformly loaded composites, 
which are physically stable over a storage time. To design the mesoporous silica based composites 
for drug delivery one needs to consider several factors affecting the final state of the confined drug. 
These factors are:  
A. Structure of the drug and its physicochemical properties; 
B. Type of mesoporous silica – pore diameter, total pore volume and surface area, pores 
architecture; 
C. Loading method and desired drug content within the pores. 
 
These three main factors affect the expected phase of confined drug, which in turn may affect 
important pharmaceutical properties including dissolution or phase stability. Herein we present 
general approach for the design of silica-drug scaffolds based on our findings in context of other 
work published to date. 
8.1.1 Structure of the loaded drug and its physicochemical properties 
In our study, we used three model drugs (FFA, TB, IMC), which differ in molecular size, flexibility 
and physicochemical properties. Both FFA and TB have similar glass forming ability i.e., they 
recrystallise on cooling from the melt and are difficult to stabilise in an amorphous state due to low 
Tg (ca. 278 K for TB and ca. 290 K for FFA). Additionally, both are of similar size but differ in molecular 
flexibility; as FFA has a more rigid structure with only three bonds that can differ between the 
conformers whilst TB has a flexible structure with seven bonds that can rotate freely. IMC has 
significantly higher Tg (ca. 323 K) and it is known to stay amorphous for at least 36 h when stored 
at 303 K prior to crystallisation to its thermodynamically most stable form γ-IMC.[59,204] The core of 
the IMC molecule is an indole ring which has three flexible motifs attached to it: a chlorophenyl 
ring, a methoxy group and an acetic acid motif and the position of these three components with 
respect to the indole ring differs between the crystal structures (Figure 8-1).  
In order to make sure that the drug is loaded inside the pores of the silica host, the size of the 
molecule needs to be smaller than the size of the pores. This is not difficult to achieve for small 
pharmaceutical molecules, with the longest dimension usually shorter than 20 Å, however for 
delivery of peptides or small proteins size constraints need to be considered.  
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Figure 8-1. Top. Size of FFA, TB and IMC determined using the bounding box tool in Olex2 software. 
Bottom: comparison of physicochemical properties of TB, FFA and IMC. 
 
Molecular size is also important for the phase prediction of the loaded drug, as critical nucleus size 
(r*) needs to be achieved for crystallisation to occur. If the nucleus size is smaller than r*, it will 
dissolve spontaneously; whilst nuclei larger than r* will grow spontaneously.[93,308] The critical 
nucleus size is considered to be on the nm scale, however the absolute values for r* are related to 
the solid/liquid interfacial energy and the difference between the Gibbs free energy per unit volume 
of solids and liquids. It is therefore not surprising that different critical nucleus sizes are expected 
for different molecules. For example, it was shown by Pradzynski et al. that a cluster of 275 water 
molecules was required to form an ice crystal [309] which represents an 18 × 18 × 18 Å cube, which 
is in excellent agreement with the critical size of an ice nucleus (12 – 18 Å) as determined by Cooper 
and co-workers.[310] Davey et al. (2013) gave examples of experimentally determined 20 nm sized 
nucleating clusters in solution for alanine and citric acid.[308] Much smaller sizes of 1-3 nm were 
reported by Ginde and Myerson for glycine, citric acid and urea.[308,311] This agrees with the results 
of Ward and co-workers who crystallised β-glycine inside 7.5 nm CPG pores.[250] In recent work, 
Navrotsky et al. showed that for the  confined crystallisation of N,N,N-trimethyl-1-
adamantammonium iodide within porous silicas, the volume of one unit cell size was sufficient for 
molecules to crystallise.[303] 
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We showed that molecular size, structural flexibility and glass forming ability are all important 
factors to consider for the prediction of crystallisation outcome inside porous hosts. In our studies, 
we used the melting method to incorporate drug molecules inside the pores. This method was 
successfully used by Beiner et al. to load paracetamol into CPG hosts with different pore size 
diameters. Additionally, it allowed direct differentiation between the bulk and confined species 
based on the melting point depression for compounds which recrystallise on cooling, or subsequent 
reheating.[114] For relatively large IMC (MW=357.8 g/mol), which forms a well-documented 
amorphous solid, we did not observe crystallisation inside the pores of MCM-41 and SBA-15 
materials (pore size ca. 3 and 8 nm respectively). This was in agreement with data published by 
Lehto[85] and Van den Mooter[41]. We only observed the thermal recrystallisation of IMC at high drug 
contents inside the large pores of the CPG host (ca. 55 nm), while inside the pores of the slightly 
smaller MCF host (ca. 30 nm), thermal recrystallisation of IMC was again supressed. Crystallisation 
to either γ-IMC or the IMC MeOH solvate was only driven by the addition of organic solvents into 
the IMC loaded MCF hosts, indicating the enhanced structural rearrangement of the confined 
species, likely due to increased mobility following solvent addition.    
TB and FFA were used as model compounds as they are both unstable in the amorphous state, 
recrystallising quickly following cooling. When FFA was confined inside the pores of MCM-41 and 
SBA-15 hosts, it remained amorphous during heating. The thermally induced recrystallisation of this 
compound was only observed inside the 30 nm pores of the MCF host at loadings above 20 wt. %.  
In contrast, the highly flexible TB molecule crystallised inside the 3 nm pores of MCM-41. Our results 
therefore suggest that it is not only the molecular size, but also structural flexibility which is 
important in predicting the phase of the confined drug, as the presence of multiple freely rotating 
bonds plays an important role in confined crystallisation.  
Finally, it is important to discuss our results in the context of other low melting point compounds 
described in the literature (ibuprofen, IBU Tm = 351 K, fenofibrate, FEN Tm = 353 K and coumarin, 
COU Tm = 345 K) (Figure 8-2). Ibuprofen is a well known model drug used in nanoconfinement 
research.[75,79,112] It is relatively small (MW = 206 g/mol) and highly unstable in the amorphous state 
(Tg = 228 K). Therefore, we can expect IBU to crystallise inside the small pores of MCM-41 in a similar 
way to TB. IBU loaded inside MCM-41 scaffolds (ca. 3-4 nm) was investigated by both Azais et al. 
and Skorupska et al.[77,79] Azais et al. showed that confined IBU stayed in a highly mobile liquid-like 
state at room temperature and vitrified at 223 K, using solid-state NMR spectroscopy.[77,79] The lack 
of crystallisation was thought to be due to spatial constraints, preventing nucleation of the confined 
drug.[77] Conversely, Skorupska et al. observed peaks due to both crystalline and amorphous drug 
in the 13C spectra and explained that amorphous IBU was formed inside the pores, whilst crystalline 
drug was present outside the pores.[79] Unfortunately, both studies lacked DSC and PXRD data, and 
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therefore it is difficult to state unequivocally whether the crystalline species observed by Skorupska 
et al. was due to bulk drug loaded outside the pores, or confined crystalline IBU. When IBU was 
loaded inside the large pores of MCM-41 (ca. 12 nm), Azais et al. observed crystallisation of the 
drug at 223 K, well below its bulk melting point.[77] The confined crystallisation of IBU inside porous 
silicon was observed by Lehto et al.[312] Although the size of the pores was not specified by the 
authors, the presence of a hysteresis loop at a high relative pressure in the N2 
adsorption/desorption data indicates they used pore sizes of 20-30 nm.[312]  
 
 
Figure 8-2. Top. Size of COU, IBU and FEN determined using the bounding box tool in Olex2 
software. Bottom: comparison of physicochemical properties of COU, IBU and FEN. 
 
Fenofibrate has a similar molecular weight to IMC (MW = 360.8 g/mol), but due to its linear 
structure, it is more flexible than IMC. Recently, Myerson et al. showed that FEN crystallised inside 
ca. 20 nm pores when loaded from solution, whilst further decrease of pore size to ca. 13 nm led 
to stabilisation of the amorphous drug.[111] These findings are in agreement with our results for IMC, 
as we observed the formation of crystalline drug inside 29 nm pores. The additional degree of 
structural flexibility for FEN enabled the formation of confined crystals inside smaller 20 nm pores, 
but as with IMC, its large molecular size prevented the formation of a critical nucleus inside the 13 
nm pores.[111] 
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Coumarin is small rigid compound (MW = 146.2 g/mol) used frequently in perfumes and its 
derivatives are known as laser dyes.[115] It crystallises as α-coumarin in the orthorhombic Pca21 
space group with four molecules in the unit cell (Z’=1).[313,314] Ward and co-workers obtained a new 
polymorphic form of COU (β-coumarin) inside the pores of a CPG host (pore size less than 23 nm) 
using the melting method for encapsulation.[115] The group identified both α and β COU inside 7.5 
nm CPG pores using PXRD, which were measured at 278 K due to the partial melting of COU crystals 
at room temperature.[115] The photo-physical and photo-luminescence properties of COU 
derivatives encapsulated in ca. 4 nm MCM-41 hosts using the melting method were investigated by 
Li et al. and Zhao et al.[315,316] Based on the absorption, emission[315] and fluorescence[316] spectra, 
both groups stated that encapsulated COU derivatives formed a monomolecular dispersion.[315,316] 
These findings are in agreement with the results of the Ward group, as due to the decrease of the 
melting point (due to encapsulation), COU would be expected to remain as a liquid inside the 4 nm 
pores of the MCM-41 host. 
In summary, to predict the phase of drug molecules confined within mesoporous silica based 
scaffolds, it is important to consider both the size and structural flexibility of the molecule of 
interest, as these parameters influence the resulting phase of loaded drug. Other important 
predictors are Tg and Tm, as these can also determine whether the loaded drug will crystallise, 
remain amorphous or form a highly mobile liquid-like species at room temperature.  For the design 
of mesoporous silica based DDS, it is additionally necessary to know the properties of the silica 
scaffold and required drug loading level within the pores. These factors are discussed in 
section 8.1.2.  
8.1.2 Type of mesoporous silica – pore diameter, total pore volume and surface 
area, pores architecture 
In this section, I will highlight the properties of mesoporous silicas, which can be synthetically 
tailored to provide unique features required for the encapsulation of the pharmaceutical molecule 
of interest.  
For standard sol-gel synthesis of ordered mesoporous silicas, the pore size determines the available 
scaffold surface and volume. Hosts with small pores will have a large surface area and relatively 
small pore volume (per mass unit). This is important for the adsorption of drug molecules, as the 
encapsulation process inside the pores of such hosts (e.g., SBA and MCF) begins on the pore surface 
and proceeds after the saturation of the surface: a plug of drug molecules is formed in the pore 
void, which subsequently grows along the pores, filling the available pore volume (Figure 8-3). This 
mechanism was suggested by Ukmar et al. for IMC encapsulation in SBA-15[87] and was recently 
proven by our group using 19F NMR and FFA as a model compound.[306] 
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Figure 8-3. Top right:  Average dimensions of the FFA molecule and the three different states of 
FFA species inside the pores. A) and B) Different mechanisms for FFA adsorption and stabilization 
of the amorphous state. C) Mechanism of the formation of crystalline FFA form I in MCF (for a 
detailed description, see Chapter 6). Adapted from [306]. 
 
To understand how differences in the surface area of the porous host can affect the final state of 
confined drug, both size and molecular flexibility of the drug must be considered alongside the 
required drug loading level and material properties. For a system of a small MW drug encapsulated 
in pores larger than 7 nm with a drug loading below 25 wt. %, we expect only the presence of 
species adsorbed at the pore surface. Crystallisation of the drug in this case would be unlikely, as 
sufficiently large nuclei of drug molecules cannot be formed in the pore void. Based on our studies, 
the encapsulation mechanism is different for systems with small pores (MCM-41, ca. 3 nm) as 
compared to systems with larger pores (SBA-15 and MCF), as the plug of drug inside the pores is 
formed even at low drug loadings. The crystallisation is the effect of molecular properties, including 
flexibility (important for efficient packing) and minimal size of nucleus (r*) required for crystal 
growth.  
Total pore volume is another parameter that determines the maximum loading capacity of the host. 
The total pore volume for mesoporous silicas synthesised using standard sol-gel procedures 
increases with increasing pore size diameter. Therefore, loading capacity of large pore scaffolds is 
higher compared to hosts with smaller pores (e.g., Vtotal MCF = 1.8 cm3/g, Vtotal MCM-41 = 0.65 
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cm3/g). This parameter is a crucial consideration for larger drug molecules, or when high drug 
loading needs to be achieved. We have shown for FFA that exclusive drug loading within the pores 
of MCF was achieved at 50 wt. %, whilst for scaffolds with smaller pores (MCM-41 and SBA-15), 
crystallisation outside the pores was detected above 40 wt. % drug loading. 
8.1.3 Loading method and desired drug content within the pores 
There are two frequently used methods for loading pharmaceutical molecules into mesoporous 
silicas: the impregnation method and the melting method. For efficient loading from the solvent, 
high concentration of the solute in the loading solution must be achieved, and impregnation is 
required to be repeated three to four times, to obtain sufficient drug content within the pores. This 
procedure often leads to the deposition of the loaded drug on the external surface of the silica 
particles, therefore additional washing of the material is required.[74,317] The maximum drug loading 
using the impregnation method does not usually exceed 30 wt. %, with many reported systems not 
reaching 20 wt. %.[39,40] The loading efficiency can be solvent dependent, therefore the correct 
choice of solvent is important to achieve the desired drug loading. 
We used the impregnation method to load IMC into the MCF and CPG scaffolds (pore size of ca. 30 
and 55 nm respectively).[88] We used concentrated IMC in MeOH solutions (150, 200 and 250 
mg/mL) with a lower solvent volume than the available pore volume, in order to obtain reasonable 
drug loading and avoid deposition of the drug outside the pores of the silica hosts. The obtained 
drug loading did not exceed 15 wt. % and crystallisation of IMC form V (and γ-IMC) was observed 
within all composites. Deposition of the drug outside the pores was evident for the materials loaded 
from the solution of highest concentration (250 mg/mL), due to fast recrystallisation of IMC upon 
contact with the silica surface. Additionally, if the volume of loading solution exceeded the pore 
volume, a significant increase if the population of bulk IMC crystals was observed with PXRD and 
DSC.[88] We tried solvent mediated loading for two other model APIs (TB and FFA), however due to 
the formation of heterogeneous composites with crystalline drug loaded outside the pores we 
decided to focus on the more reliable melting method for drug encapsulation. 
There is very little data in the literature describing the effect of the solvent impregnation method 
on confined crystallisation. For the majority of the published systems, where either MCM or SBA 
silicas were used, the confined drug was amorphous, or not described.[41,70,83,89] Myerson and co-
workers used solvent impregnation to incorporate model compounds (IBU, FEN, IMC and 
griseofulvin) into large pores (40 nm) of commercially available silica (AEROPERL® 300 Pharma). A 
loading efficiency below 10 wt. % was achieved after washing the drug from the external surface. 
The presence of a crystalline phase was only detected for FEN and griseofulvin using solid-state 
NMR, with PXRD not detecting crystalline material. However, due to the low signal intensity for 
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CP/MAS experiments, the solid-state NMR required 80 000 scans (4.5 days of spectrometer time) 
for one sample.[317] The same group investigated the confined crystallisation of FEN loaded using 
the impregnation method for a broad range of CPG scaffolds (pore sizes between ca. 13 and 300 
nm). A drug content of ca. 25-30 wt. % was achieved, with crystallisation of FEN form I detected 
inside pores of 20 nm and larger.[111] Wang et al. used MCF (pore size diameter ca. 28 nm) to load 
two large drugs: simvastatin (SIM, MW = 418.6 g/mol) and telmisartan (TEL, MW = 514.6 g/mol) by 
soaking the porous scaffold in concentrated ethanol and acetic acid solutions respectively.[249,318] 
Amorphous composites were obtained at lower drug loadings, but at drug loadings above 40 wt. %, 
crystalline component loaded outside the pores was detected using both PXRD and DSC.[249,318]  
In this work we extensively used the melting method to load model pharmaceuticals (TB, FFA and 
IMC) into different mesoporous silica scaffolds, achieving a high level of control over the drug 
phase, distribution and its loading level within the pores. Compared to the impregnation method, 
the melting method enabled much better control over drug loading level within the pores, as a 
physical mixture of the drug and the silica scaffold was prepared prior to loading. The main 
drawback of this procedure was the requirement for the loaded compound to be thermally stable 
at the loading temperature, which was around 5-10 K higher than the melting point of the drug. We 
found that amorphous composites were likely to be formed at low drug loadings (below 20-25 wt. 
%), whilst crystallisation of the API was observed at higher drug loadings. The melting method has 
been applied successfully in other literature studies for loading paracetamol into CPG glasses and 
AAO (anodic aluminum oxide) membranes,[113,114,117,119] ibuprofen and itraconazole into MCM-41 
scaffolds and porous silicon[79,83,84,312] and dicarboxylic acids and coumarin into CPG glasses and 
polymeric monoliths.[115,118] Recently, Skorupska et al. used the melting method for the 
encapsulation of benzoic acid/fluorinated benzoic acid and naproxen/picolinamide co-crystals into 
MCM-41 and SBA-15 materials.[91,92]  
It is important to choose the correct encapsulation method to ensure phase control of the resulting 
solid. We showed that the melting method enables sufficient phase control of encapsulated API. 
Firstly, we were able to obtain the highly unstable TB form V by encapsulation within the MCM-41 
scaffold using the melting method. Previously, this polymorph had only been crystallised from 
acidified methanol.[183] We were also able to stabilise metastable IMC form V within ca. 30 nm pores 
of MCF using a hybrid approach for crystallisation. We encapsulated amorphous IMC within the 
silica pores using the melting method, then drove the crystallisation of encapsulated drug into the 
metastable IMC form V through the addition of methanol.[88] Furthermore, through careful choice 
of pore size of the silica hosts, and manipulation of the drug content within the pores, we were able 
to stabilise amorphous FFA within MCM-41 and SBA-15 scaffolds, amorphous TB within MCM-41 at 
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low drug loadings and amorphous IMC within both MCF and CPG porous hosts at loading levels 
below 25 wt. %.[88,306]  
The use of the melt loading method for encapsulation and formation of crystalline organic 
molecules confined within nanoporous materials has also been described by other authors. It was 
shown by Beiner and co-workers that it was possible to obtain usually inaccessible paracetamol 
form III within a CPG host with pore sizes between 22 and 103 nm, when crystallising form the 
melt.[114] The same group reported stabilisation of amorphous paracetamol inside 10 nm pores of 
CPG and significant depression of Tg of the confined drug (ca. 20 K) in comparison to bulk 
paracetamol, which indicates increased mobility of confined drug.[114,117] Unfortunately, the loading 
level of the drug inside the pores was not specified by the authors. 
 
 
Figure 8-4. PXRD patterns (top) and DSC thermograms (bottom) for glutaric acid loaded within the 
CPG pores of 7.5, 23, and 55 nm using the melting method and methanol solution. The vertical 
dashed lines indicate the melting of α-glutaric acid, and the vertical solid lines indicate the β → α 
phase transition. Adapted from [115]. 
 
Ward and co-workers performed crystallisation of dicarboxylic acids inside CPG hosts loaded using 
both melting and solvent based methods.[115] They achieved much higher drug loading with the 
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melting method, as compared to solvent mediated loading. Furthermore, the observed 
crystallisation outcome was found to be dependent on the loading method. For example, it was 
shown that glutaric acid formed a mixture of α and β polymorphs when crystallised from a methanol 
solution within the CPG scaffolds, but when using the melt loading method only the metastable α 
polymorph was observed, and remained stable within the CPG pores for months (not specified).[115] 
The melting method was also used by Skorupska et al. for loading IBU and two model co-crystals 
(benzoic acid/fluorinated benzoic acid and naproxen/picolinamide) into MCM-41 and SBA-15 
hosts.[79,91,319] The authors demonstrated that although high drug loadings of IBU and co-crystals 
could be achieved using the melting method, part of the drugs remained in their crystalline phase 
outside the pores, highlighting the importance of optimisation of drug loading capacity within the 
mesoporous scaffolds.[79,92,319] Interestingly, the authors demonstrated that for the 
naproxen/picolinamide system it was possible to overcome the limitations of thermal instability of 
the drug (in this case naproxen) through the formation of co-crystals, which had a lower melting 
point compared to bulk drug prior its loading using the melting method.[319]  
In summary, we have demonstrated the importance of several parameters that need to be taken 
into account to design mesoporous silica based materials for drug delivery. Efficient drug 
encapsulation and control over the physical state of confined molecules is a balancing act between 
molecular and host properties, alongside experimental protocols for drug encapsulation i.e., the 
loading method. It is important to emphasise that small and flexible molecules tend to crystallise 
inside the silica pores more easily as compared to relatively large drugs. Nevertheless, the drug 
content within the pores is of importance, as a sufficiently large and densely packed plug of 
molecules inside the pore void must be formed for crystal nuclei to grow. Finally, as it is possible to 
tailor the properties of the silica scaffolds synthetically, the materials can be designed for a 
particular molecule or a group of compounds.  
8.2 Probing structural heterogeneities in confined pharmaceutical 
systems – the role of solid state NMR 
The investigation of the structure of multicomponent materials is a significant challenge, frequently 
requiring the use of several analytical techniques to gain molecular level understanding of 
heterogeneous solids. Pharmaceuticals encapsulated within mesoporous silicas are one example of 
a multicomponent solid, where the drug molecules are confined within the pores of the porous 
silica scaffold, or loaded outside the pores. We have shown throughout this work that drug 
molecules can reside in more than one physical state within the pores, ranging from highly mobile 
liquid-like species to rigid nano-crystalline solids. This section highlights the importance of solid-
state NMR in the structural studies of amorphous and amorphous/crystalline composite materials. 
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Solid-state NMR spectroscopy is a powerful method for the analysis of amorphous solids, as it 
enables molecular level structural information to be gained through the analysis of the local 
environment of atoms in solids. Pharmaceutical formulations are frequently developed as 
amorphous systems, due to the improved dissolution of API as compared to crystalline drugs. A 
detailed structural and dynamical investigation of drug/polymer amorphous solid dispersions was 
recently carried out by Dr Lucy Hawarden[49]. Here we present a structural and dynamical 
investigation of amorphous/nanocrystalline mesoporous silica-drug composites, using similar 
methods  
Although PXRD and DSC are often used to assess the crystallinity of materials, or determine the 
glass transition temperature of amorphous solids, they have very limited use in detailed structure 
elucidation of non-crystalline materials. In this work we have shown several examples of seemingly 
identical amorphous systems (determined using DSC and PXRD), which through analysis with 
solid-state NMR, were shown to be structurally and dynamically heterogeneous. The amorphous 
MCM-FFA and SBA-FFA composites were shown to have very different distributions of confined 
molecules within the pores of silica scaffolds, and significantly different drug loading mechanisms 
(Figure 8-3). Using 19F MAS NMR, FFA loaded within the 29 nm pores of the MCF scaffold was proven 
to be present inside the pores as both a crystalline solid and a highly mobile amorphous species, 
likely located at the pore surface. Additionally the high sensitivity of 19F MAS NMR enabled us to 
differentiate between crystalline, amorphous and surface species during the in situ crystallisation 
experiment.[306] 
The simultaneous presence of a highly mobile species located at the silica surface and amorphous, 
or nanocrystalline plugs in the pore voids has been postulated by several research groups, and was 
recently confirmed by our group using 19F MAS NMR.[78,87,110,112,117,303,306] Interestingly, very similar 
behaviour for the confined mixture of amorphous benzoic acid/fluorinated benzoic acid within a 
SBA-15 host was shown by the Potrzebowski group using 19F NMR (Figure 8-5).[91] 
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Figure 8-5. 1H and 19F MAS NMR spectra of benzoic acid/fluorinated benzoic acid confined within 
SBA-15 with (Top) small water content and (Bottom) large water content. Adapted from [91]. 
 
Two distinct 19F peaks were observed for each fluorine site of fluorinated benzoic acid and the 
relative population of both peaks was shown to change upon exposure to water.[91] Although this 
phenomenon was not investigated in detail, and not fully explained by the authors, it does 
corroborate our findings for the presence of confined molecules in different local environments 
inside the silica pores.  
The identification of species in different environments and motional regimes becomes more 
complex for molecules that do not contain 19F, or similar high sensitivity nuclei. One of the examples 
used in this study was confined TB, which was shown to be present in different environments and 
motional regimes using 1H T1 and T1ρ relaxation time measurements alongside with 1H and 13C NMR 
methods sensitive to dynamics on different timescales.  
Confined TB loaded within MCM-41 at 20 wt. % and stored at 75 % RH was shown to be amorphous 
using PXRD and DSC. However, solid-state NMR spectroscopy identified a highly mobile liquid-like 
species inside the silica pores, using 1H MAS NMR, 1H-13C J-MAS-INEPT and 1H-13C HSQC HR/MAS 
experiments. The presence of 13C NMR peaks in INEPT based experiments without 1H decoupling 
between the pulses indicates the presence of a highly mobile liquid-like species, as these have 
sufficiently long T2 relaxation for efficient polarisation transfer through the j-couplings. In contrast, 
in the CP/MAS experiment, using 1H-13C dipolar couplings for polarisation of 13C signal is not efficient 
for highly mobile systems, as increased mobility decreases the strength of dipolar couplings, leading 
to inefficient magnetisation transfer, therefore only rigid components of the material are observed. 
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The combined application of NMR methods sensitive to different mobility regimes enabled us to 
identify the co-existence of both highly mobile and rigid TB inside the silica pores.  
Confined TB at high drug loadings (50 wt. %) formed confined crystals inside the pores, identified 
using PXRD, DSC and 1H-13C CP/MAS NMR. The application of the 1H-13C J-MAS-INEPT experiment 
for this composite did not successfully identify mobile TB species confined within the pores, most 
likely due to the viscous/rubbery state of the API, which was too rigid to be observed with J-MAS-
INEPT. In order to detect the amorphous drug in an intermediate mobility regime (between rigid 
and liquid states), we re-introduced dipolar interactions by decreasing the temperature during 
acquisition of 1H-13C CP/MAS spectra, which highlighted broad peaks of non-crystalline TB species 
alongside crystalline peaks of TB form IL. The similar use of different 13C excitation methods was 
described by other authors for the low melting point drug IBU confined within 3.5 and 11.6 nm 
MCM-41 silica hosts (Figure 8-6).[77]  
 
 
Figure 8-6. A. 1H-13C CP/MAS and 13C MAS spectra of viscous IBU melt and IBU confined within the 
MCM-41 host at different temperatures; B. PFG-MAS 1H NMR echo attenuation curve for IBU 
confined within the large pores MCM-41 scaffold (ca. 12 nm). The solid line represents bimodal fit 
to the experimental data. Adapted from [77,78]. 
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Babonneau et al identified confined IBU in 3.5 nm MCM-41 scaffolds as either liquid-like species or 
vitrified drug using 13C NMR (Figure 8-6). Narrow peaks in the 13C MAS NMR spectrum were 
observed for confined IBU at room temperature, assigned to the presence of a liquid-like species, 
corroborated by the substantial decrease of signal in 1H-13C CP/MAS NMR, and sharp peaks in the 
1H-13C J-MAS-INEPT due to increased mobility and decreased strength of dipolar couplings. At 223 
K, significant broadening of the 13C peaks characteristic for amorphous drug was observed using 1H-
13C CP/MAS, due to decreased mobility of the drug at low temperatures, corroborated by the 
gradual broadening of 1H peaks with decreasing temperature.[77] Low temperature crystallisation of 
IBU confined within the large pores of MCM-41 (11.6 nm) was also observed by Babonneau and co-
workers using 1H-13C CP/MAS NMR. The authors observed the coexistence of amorphous and 
crystalline species through the presence of sharp 13C NMR peaks of crystalline IBU superimposed 
on the broad peaks of amorphous component (Figure 8-7 A).[77] Additionally, the application of 1H 
MAS PFG NMR for the amorphous IBU-MCM system with large pores (11.6 nm) revealed the 
presence of confined molecules in two different motional regimes, assigned again to species at the 
silica surface and in the pore void.[78]  
 
 
Figure 8-7. A. Crystallisation of IBU within the 11.6 nm pores of the MCM-41 host at 223 K; B. 
Formation of amorphous and crystalline species of the TMAAI inside the pores of different silica 
frameworks. The arrows indicate the presence of amorphous component. Adapted from [77,303].  
 
The group of Navrotsky investigated in depth host-guest interactions of N,N,N-trimethyl-1-
adamantammonium iodide (TMAAI) encapsulated within porous silica scaffolds with pore sizes 
between 0.8 to 20 nm.[303] The authors observed crystallisation of the TMAAI inside the SBA-15 
pores larger than 12 nm, while encapsulation within the smaller pores resulted in the formation of 
amorphous systems. Using selective 13C labelling, the authors identified the coexistence of 
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amorphous and crystalline species inside the pores larger than 12 nm (Figure 8-7 B). Using the 
Scherrer formula, the size of the confined crystals was determined as 11.6 nm for the 12.8 nm pore 
size of SBA-15, and 18.3 nm for the 20.0 nm pore size of SBA-15, indicating the single nanocrystal 
filled the pore. Based on these results, and further calculations with Gibbs-Thomson equation, the 
authors indicated the presence of a molecular layer of a disordered species at the silica surface and 
a single crystal in or close to the pore centre. This hypothesis is in agreement with our findings from 
19F MAS NMR of confined FFA, alongside low temperature 1H-13C CP/MAS NMR studies of confined 
crystalline TB, where the presence of both amorphous and crystalline species were identified.  
The structural investigation of heterogeneous composite materials is analytically challenging due 
to the presence of multiple components, which could be either an integral part of the structure or 
phase contamination, which does not carry real structural information for the system. Therefore, 
for complex materials, it is important to rely on more than one complementary analytical method 
for structure elucidation, which differ between the confined and bulk species e.g. melting point 
depression for confined crystals or differences in the relaxation times between bulk and confined 
species.  
For heterogeneous composites of FFA confined within both MCM-41 and SBA-15 silica scaffolds at 
high drug loadings, we observed a substantial increase in the 19F T1 relaxation times due to the 
presence of crystalline FFA species loaded outside the pores with significantly longer 19F T1 
relaxation times. Here, differences in the mobility between the confined and bulk species were used 
to determine whether the formation of a crystalline phase occurred within the silica pore or outside 
the pore as bulk crystallisation. 
The mobility based approach was used by Potrzebowski and co-workers to distinguish between 
crystalline IBU loaded outside the pores and a highly mobile species of the drug confined within the 
MCM-41 pores with the application of variable contact time CP/MAS NMR and dipolar dephasing 
experiments (Figure 8-8 A).[79] 
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Figure 8-8. A. Variable contact time 1H-13C CP/MAS spectra and dipolar dephasing (DD) spectra of 
IBU confined within MCM-41 at high drug loadings – the peaks of the species located inside and 
outside the silica pores re labelled with red dashed lines; B. 19F MAS NMR spectra of fluorinated 
benzoic acid confined within the MCM-41 host at different recycle delay times. The sharp isotropic 
peaks indicate highly mobile species confined within the MCM-41 pores while low intensity peaks 
are due to crystalline species loaded outside the pores. Adapted from [79,91]. 
 
In the CP/MAS experiment with 10 ms contact time, the highly mobile species had lower peak 
intensity compared to the rigid component due to shorter relaxation times. On the other hand, in 
the dipolar dephasing experiment, the highly mobile drug molecules had intense peaks, due to 
decreased strength of 1H-13C dipolar couplings. The rigid species loaded outside the pores 
disappeared in the spectrum due to enhanced relaxation through the dipolar interactions during 
the dephasing delay in the pulse program. In another example, the authors used a 19F MAS T1 filter 
to distinguish between fluorinated benzoic acid species loaded within the pores of MCM-41, and a 
crystalline species present outside the pores (Figure 8-8 B).[91] The sharp isotropic 19F peaks of the 
loaded compound with much faster relaxation times were observed after a 5 s recycle delay, while 
the broader peaks of the crystalline component were only present after a recycle delay of 1000 s.[91] 
In summary, solid-state NMR spectroscopy enabled us to gain an insight into the molecular level 
structure of fully amorphous composites, identifying molecules in different local environments and 
motional regimes. The application of this method for heterogeneous crystalline/amorphous 
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composites is not straightforward, as it requires the distinction between crystalline species loaded 
inside or outside the pores. For these materials, it is extremely important to apply a multi-technique 
approach using a combination of DSC, PXRD and N2 physisorption analysis prior to NMR 
investigation, as the combined use of these methods enable to confirm that all the observed 
phenomena are due to the molecules confined within the pores. 
8.3 Confined crystallisation from the amorphous state 
In-depth understanding of nucleation and crystallisation from the amorphous state is a significant 
challenge in academic and industrial research, as it ultimately enables control over the structure of 
the resulting solid. The application of nanoscale confinement offers a unique opportunity to gain 
insight into the early stages of crystallisation, where small crystalline species have high surface-to-
volume ratio.[117] As indicated by Beiner and co-workers the main difference between the 
crystallisation model based on mesoporous silica and the formation of nano-crystals in the bulk 
melt is the nature of the interface.[117] The authors suggest that the presence of a layer of 
amorphous drug molecules at the silica surface is similar to the bulk nanocrystal/melt interface, 
with the only difference being the mobility and density of the amorphous drug interface.[117]   
Mesoporous materials are attractive models, which can be used to gain insight into the transient 
structure of the nucleus and the origin of the crystal/melt interface. There are several open 
questions that need answering in order to fully understand confined crystallisation. These questions 
concern: the effect of the pore surface on the spatial distribution of molecules inside the pore; the 
different molecular environments of confined amorphous molecules, the thickness of the 
amorphous layer at the pore surface and how the amorphous layer and the pore directs the 
crystallisation process or the growth of the crystal. 
In this work we demonstrated that confined FFA and TB molecules can be present as either fully 
amorphous or a mixture of amorphous and crystalline forms inside the silica pores. The confined 
non-crystalline API can be further divided into either highly-mobile surface species, or amorphous 
species forming a plug in the pore centre. The mechanism of confined crystallisation is not 
straightforward and depends on the space accessible for the formation of critical nuclei. We 
showed for all three investigated APIs confined within pores of different sizes that it is not only the 
size of the pores which are important in confined crystallisation, but also the content of the drug 
and its distribution within the pores. For example, the thermally induced crystallisation of confined 
amorphous IMC inside the 29 nm pores of MCF was suppressed up to 50 wt. % drug loading, whilst 
recrystallisation inside the 55 nm pores of CPG was observed at 30 and 50 wt% loadings.[88] The 
recrystallisation of confined FFA inside the 29 nm pores of the MCF host detected at drug loadings 
of 25 wt. % and above, whilst FFA remained amorphous at 15 and 20 wt. % loadings.[306] Similarly, 
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we were able to crystallise confined TB inside a 3.2 nm MCM-41 silica host, but only at drug loadings 
of 40 and 50 wt. %. These findings proved the deposition of the drug species at the pore surface 
prior to the plug formation in the pore void. 
 
 
Figure 8-9. A. Summary of the fundamental questions for fully understanding the confined 
crystallisation from the amorphous state; B. Two possibilities for the crystal growth along the pores 
of the material.  
 
Beiner and co-workers demonstrated that it was possible to estimate the critical size of the pores 
(d*) inside which the crystallisation was suppressed, due to the higher surface energy contribution 
as compared to the energetically advantageous release of internal energy upon crystallisation. The 
critical pore size is described as follows:  
 
d∗ =
4σclTm
∞
(Tm
∞−T)∆Hmρc
,  (Eq. 8-1) 
 
where σcl is surface energy between crystal and melt, 𝑇𝑚
∞is the bulk melting temperature, ΔHm is 
the heat of melting and ρc is the density of the crystal. This model assumes the pores are fully filled 
with drug, therefore for systems with low drug loadings, crystallisation might not be observed due 
to the distribution of the drug molecules at the silica surface.  
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Figure 8-10. A. Similarities between early stages of crystallisation within the melt loaded CPG 
porous hosts and in the bulk. The red circle represents the nanocrystal/melt interface, dark blue 
circle represents the hydroxyl terminated silica interface, orange represents amorphous drug and 
light blue represents the silica wall; B. The model of benzene confined within a 30 nm MCF scaffold 
and 2H NMR spectra of benzene-d6 loaded within MCF silica host showing the presence of 
crystalline and glassy benzene inside the pores; the spectra of bulk crystalline and glassy (confined 
in SBA-15) benzene are given for comparison; C. The relaxation time distribution g[log10(τ)] 
corresponding to different relaxational processes; an interfacial relaxation process is present for 
salol confined in the 7.5 nm pores with surface rich in OH groups. Adapted from [117,293,320–322] 
 
The presence of confined molecules distributed at both the silica surface and in the pore void has 
been proposed in the literature by many authors.[112,117,293,303,306,320] Nevertheless, it is not fully 
understood: what directs the molecules towards the silica surface; what is the thickness of the 
adsorbed molecular layer; are the surface/drug interactions characteristic for particular systems? 
Based on both the 19F NMR and nitrogen physisorption, we were able to determine the thickness 
of the liquid-like drug layer at the surface of SBA-15 porous host prior to the drug deposition in the 
pore void (ca. 12 Å).[306] We observed similar phenomenon for drug deposition in the MCF scaffold, 
prior to its crystallisation in the pore void. Using 2H NMR, Buntkowsky and co-workers identified 
two amorphous solid components for benzene confined in SBA-15 material,[321] and highly mobile 
and crystalline benzene confined in a 30 nm MCF silica host.[320] The authors determined that the 
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surface phase had an average thickness of 2-3 molecular layers of benzene.[320] Aksnes et al. 
determined the thickness of cyclohexane and cyclopentane adsorbed onto MCM-41 as 0.65 and 
0.51 nm respectively.[301] Navrotsky and co-workers indirectly determined the thickness of the 
surface phase of confined TMAAI as 1.2-1.6 nm through the determination of the nanocrystal size 
using the Scherrer formula.[303] Based on the above examples it could be hypothesised that the 
formation of a highly mobile molecular layer at the silica surface is a general phenomenon for 
nanoencapsulation within silica pores. However, as the majority of the reports investigated 
adsorption onto the surfaces rich in silanol groups this could still be a system specific phenomenon. 
Kremer et al. elegantly showed the effect of the surface properties (hydrophilic or hydrophobic) on 
the adsorption of salol at the pore surface. The authors observed two populations of molecules 
assigned to the surface species, and molecules in the pore void upon confinement inside the OH 
group rich material. When salol was confined inside the material with a hydrophobic surface, 
functionalised with (CH3)3Si- groups only one population of molecules assigned to the species 
distributed in the pore centre was observed.[322]  
In summary, the confined crystallisation from the amorphous state is a complex process dependent 
on the size of the pores, nature of confined molecules, properties of the silica surface and interfacial 
interactions as shown in Figure 8-9 and Figure 8-10. Despite the complexity of the systems, and the 
several remaining unanswered questions, mesoporous silicas remain attractive models which can 
be used to gain molecular level insight into the early stages of crystallisation. Recent developments 
in solid-state NMR methods for probing the local environment of confined species including 2H NMR 
(widely used by the Buntkowsky group), selective 13C labelling (used by Navrotsky and co-workers) 
and mobility sensitive 1H-13C NMR experiments, together with 19F NMR (used in this work) will help 
to answer some of the questions regarding confined crystallisation and the nature of the critical 
nucleus. 
 
8.4 NMR insight into structural reorganisation of pharmaceuticals 
This project focussed on the application of NMR spectroscopy, supported by complementary 
techniques (PXRD, DSC, microscopy) and DFT calculations, in understanding the structural 
reorganisation of pharmaceuticals, in particular confine nanocrystalline and amorphous species 
present in mesoporous silicas. We were particularly interested in understanding the structural 
reorganisation in pharmaceutical crystalline solids, including solvates and co-crystals, and 
identifying the discrete intermediate phases, which are important in so called ‘spontaneous 
reactions’ in the solid state. Therefore, the findings from previously published research on co-
crystallisation processes[323,324] and disordered crystals[242] have been discussed here. 
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The importance of co-crystals in pharmaceutical drug delivery is gradually increasing, as these novel 
materials show promise in providing improved stability, increased dissolution rates and 
bioavailability compared to the parent crystalline drug. There are several methods for co-crystals 
formation including crystallisation from solvents, melting, crystallisation through spray drying or 
mechanical treatment. Some co-crystals can form ‘spontaneously’ in a physical mixture of each 
compounds, but sometimes this process is activated with pre-grinding of the physical mixture.[323] 
The ‘spontaneity’ of co-crystallisation is frequently related to the presence of intermediate phases 
or reactions, which are difficult to investigate using standard research procedures.  
 
 
Figure 8-11. A. The schematic mechanism of benzoic acid : isoniazid co-crystallisation reaction; B. 
Normalized intensity of the benzoic acid carbonyl peak during co-crystallisation under 5 and 10 kHz 
MAS spinning rates. 
 
The isoniazid-benzoic acid co-crystal is an example of a solid, which forms spontaneously from the 
physical mixture of the compounds. This reaction is accelerated by elevated temperature and 
humidity or mechanochemical activation.[323] To gain a molecular level understanding of the 
co-crystallisation process, we used solid-state NMR to support the hypothesis that the 
crystallisation process is driven by the deposition of highly volatile benzoic acid on the soft surface 
of hydrophilic isoniazid. In agreement with the results from other methods, we observed no 
changes in the spectra for the simple physical mixtures of the compounds over an experiment time 
of 18 h. However, for mechanochemically activated samples, a substantial increase in the reaction 
rate was observed due to the 10 kHz MAS rate during spectral acquisition. These findings were 
further confirmed at a slower MAS rate of 5 kHz, where relatively slower conversion was 
observed.[323] The effect of sample spinning on the material properties is frequently discussed in 
the literature for fragile samples analysed under fast MAS conditions. Here the increase of sample 
temperature due to frictional heating and heating through the high power rf irradiation can change 
the temperature inside the rotor.[325–327] We presented direct evidence that fast sample spinning 
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can accelerate the co-crystallisation reaction rate and therefore significantly alter reaction 
conditions, likely due to increased frictional forces. Similar observations were made by Harris and 
co-workers, who noted that fast sample rotation (7 kHz) under MAS conditions can alter the 
dehydration process of sodium acetate trihydrate, and consequently the polymorphic product of 
dehydration.[328]  
 
 
Figure 8-12. A. 1H-13C CP/MAS solid-state NMR spectra of malonic acid, caffeine anhydrous, caffeine 
monohydrate, caffeine:malonic acid physical mixture and caffeine:malonic acid co-crystal; B. 1H-13C 
CP/MAS NMR spectra showing the effect of water on the rate of formation of the caffeine:malonic 
acid co-crystal; C. 1H MAS NMR spectra of malonic acid after 24 and 48 hours of storage at 75 % RH 
and [caffeine:caffeine hydrate] 20 : 1 mixture with malonic acid. 
 
The accelerating effect of water on the spontaneity of the co-crystallisation process of caffeine and 
malonic acid was investigated by our group using solid-state NMR. We outlined that it was possible 
to tune the kinetics of spontaneous co-crystal formation through the control of water content in 
the sample. The mechanism of the reaction was understood with the aid of 1H MAS NMR, as we 
observed sharp 1H peaks of a highly mobile species of malonic acid after storage of the compound 
at 75 % RH and in the mixture of the reacting compounds, which was assigned to the dissolved 
species at the crystal surface.[324]  
The effect of solvents on the crystallisation is of high importance in materials science, as it can drive 
structural reorganisation of solids towards materials with new properties. We demonstrated that 
water dissolved TB confined in MCM-41 material, and that the addition of methanol to IMC loaded 
MCF silica hosts led to the formation of IMC form V through the intermediate phase of the IMC 
MeOH solvate.[88]. Through the application of different pulse programs and detection schemes it is 
possible to distinguish between mobile and rigid species. CLASSIC NMR (Combined Liquid- And 
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Solid-State In-situ Crystallization NMR) is a recent development in the field introduced by Harris et 
al..[329–331] This method enables in-situ monitoring of the evolution of the crystallisation process 
through by alternating between two pulse sequences (1H-13C CP/MAS and 13C MAS or 1H-31P 
CP/MAS), simultaneously probing both the solid component of the mixture and changes in the 
solution spectra during crystallisation.[329] Using CLASSIC NMR, the authors reported new transient 
polymorphs during crystallisation of the 1,10-dihydroxydecane-(urea)2 co-crystal and new phases 
of methyldiphenylphosphine oxide.[331] 
The difficulty of producing sufficiently large crystals for single crystal X-ray diffraction studies and 
the formation of disordered pharmaceutical polymorphs unsuitable for PXRD studies signifies the 
importance of NMR crystallography in the field of pharmaceuticals. We demonstrated an in depth 
understanding of order-disorder phenomena in orotic acid crystals formed upon solvent 
removal.[242] Through the application of multiple analytical techniques, together with CSP and 
chemical shift calculations, we proposed a mechanism for the structural reorganisation of orotic 
acid hydrate by the formation of a disordered anhydrous phase upon removal of water. Based on 
analysis of the changes in the 1H, 13C and 15N chemical shifts between the structures, we were able 
to identify the sites most affected by solvent removal, and use this information to gain molecular 
level understanding of the formation of stacking faults in the structure. Interestingly, it was possible 
to use line widths in 13C NMR spectra to distinguish between anhydrous orotic acid structures with 
different level of ordering, and aditionally we were able to identify the sites affected by solvent 
removal by identification of the presence of local disorder by peak broadening.[242] The importance 
of pharmaceutical hydrates from an industrial perspective makes structural analysis, understanding 
of hydration/dehydration mechanisms and the prediction of hydrate formation a vital topic in 
crystallography.[242,332,333] Due to the application of CSP alongside advanced solid-state NMR 
methods and chemical shift calculations, it is now possible to gain molecular level understanding of 
the role of water in crystal formation. 
In summary, we have shown that solid-state NMR can be successfully used to gain mechanistic 
insight into structural reorganisation during phase transitions or crystallisation, as it is possible to 
simultaneously monitor the changes in the liquid and solid phases. Additionally, the combined 
application of solid-state NMR together with CSP and robust DFT codes, enable identification the 
structures of low crystallinity materials, which are not suitable for X-ray diffraction studies.   
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8.5 Overall conclusions 
1. Mesoporous silica/pharmaceutical composites were successfully prepared using three model 
APIs (IMC, FFA and TB) with different structural and physicochemical properties and four 
model porous scaffolds with pores sizes between 3 and 55 nm at different host:guest ratios. It 
was possible to determine and correlate maximum loading capacity of the silica host with the 
structural parameters of the drug (molecular weight, molecular volume and three dimensional 
size). The combined application of complementary analytical techniques, including DSC, PXRD, 
nitrogen adsorption analysis and TGA, allowed successful investigation of the structure and 
mobility of confined molecules. The combined application of multiple analytical techniques 
was essential for full understanding of complex composite materials and to distinguish 
between the bulk and confined species. 
2. Based on the chosen model compounds and silica systems we developed a general strategy 
for knowledge based design of mesoporous silica based drug delivery systems. We have 
demonstrated the importance of several parameters in order to ensure either the stabilisation 
of the amorphous drug inside the silica pores or to obtain nanocrystalline composites. It was 
identified that small flexible molecules (e.g. TB) tend to crystallise inside 3 nm sized pores of 
the silica scaffolds, while more rigid (e.g. FFA) or larger compounds (e.g. IMC) require more 
space for the formation of sufficiently large critical nuclei for spontaneous growth. It was 
shown that at low drug loadings (15-20 wt. %), the formation of confined crystals is less likely 
as compared to high drug loadings (25-50 wt. %), due to preferential drug distribution at the 
surface of the pores of the silica scaffold, prior to filling of the pore void and formation of the 
nuclei in the pore centre. 
3. Through the application of 19F MAS NMR and 1H-13C CP/MAS NMR experiments at low 
temperatures, it was proven that confined molecules are present inside the silica pores in 
multiple local environments. It was demonstrated through the application of 19F T1, 1H T1 and 
1H T1ρ that highly mobile amorphous species, likely localised at the silica surface, are formed 
at low drug loading levels inside the pores, whilst at higher loadings, the molecules begin to 
form densely packed plugs in the centre of the pore, which eventually may achieve the size of 
critical nucleus and spontaneously grow as a nanocrystal. The highly mobile species are 
present alongside the densely packed amorphous or nanocrystalline phase likely forming an 
interface between the centre of the pore and the hydroxyl terminated silica walls.  
4. It was proven through the application of multiple NMR experiments sensitive to molecular 
dynamics, that water moisture may dissolve the confined species, which displayed liquid-like 
behaviour and increased mobility. The dissolved confined molecules may reside in more than 
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one conformation indicated through the application of multiple 13C experiments. The water 
moisture was shown to accelerate recrystallisation of the confined molecules loaded at high 
drug contents, however the penetration into the pores was restricted. The addition of organic 
solvents to the materials loaded with drug molecules in amorphous state enabled us to obtain 
and stabilise metastable IMC form V.    
5. The combined application of solid-state NMR together with computational conformational 
studies of known crystal structures of IMC enabled us to gain molecular insight into the 
structure of two low crystallinity Z’ = 2 polymorphs of IMC (IMC form IV and IMC form V). 
Through the application of conformational analogies and comparison between experimental 
and calculated 1H and 13C chemical shifts of IMC molecules isolated from different crystal 
structures, we were able to identify spectral features sensitive to the conformational changes. 
The structural information about two IMC polymorphs (form IV and form V) obtained in this 
investigation will be used in further computational studies using CSP methods to gain 
mechanistic insight and better understanding of desolvation processes, which may lead to 
discoveries of new polymorphs. 
6. A detailed understanding of crystallisation processes was achieved through the application of 
methods sensitive to the local environment of molecules. Advanced NMR methods helped us 
to explain the molecular processes in the early stages of crystal formation due to its sensitivity 
towards both solid and liquid species. Furthermore, the effect of water moisture on the 
physical state of confined TB enabled us to gain an insight into drug dissolution and 
identification of liquid-like and solid species inside the silica pores. These findings are of 
importance for further understanding of the APIs release mechanisms from mesoporous silica 
based drug delivery systems. 
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